Quarterlytics / Financial Services / Insurance - Diversified / Energy Save

Energy Save

esgr · NASDAQ Financial Services
Claim this profile
Ticker esgr
Exchange NASDAQ
Sector Financial Services
Industry Insurance - Diversified
Employees 1001-5000
← All annual reports
FY2019 Annual Report · Energy Save
Sign in to download
Loading PDF…
Enstar 
Annual 
Report  
2019

FINANCIAL RESULTS 

(Expressed in millions of U.S. Dollars, except share and per share data) 

Net Segment Contribution:

Non-life Run-off 
StarStone 
Atrium 

Other 

Net Earnings (Loss) Attributable to Enstar Ordinary Shareholders 

Non-GAAP Operating Income Attributable to Enstar Ordinary Shareholders 1 

Fully Diluted Earnings (Loss) Per Ordinary Share 2 

Weighted Average Fully Diluted Ordinary Shares Outstanding 

Ordinary Shareholders’ Equity Attributable to Enstar 3 

Return on Opening Ordinary Shareholders’ Equity Attributable to Enstar 

Fully Diluted Book Value Per Ordinary Share 3 

Fully Diluted Ordinary Shares Outstanding 3 

2019 

1,059.8 
(100.7) 
12.1 
(69.0) 

902.2 

553.4 

41.43 

 2018 

25.2 
(158.6) 
9.0 
(38.0) 

(162.4) 

61.6 

(7.84) 

2017

343.8
2.8
5.4
(40.6)

311.5

283.3

15.95

21,775,066 

20,904,176 

19,527,591

4,332 

26.6% 

197.93 

3,392 

(5.2)% 

155.94 

3,137

11.1%

159.19

21,989,971 

21,881,063 

19,830,767

$ 

$ 

$ 

$ 

$ 

$ 

Percent Change in Fully Diluted Book Value Per Ordinary Share 

26.9% 

(2.0)% 

10.8%

1  Non-GAAP Operating Income attributable to Enstar ordinary shareholders is a Non-GAAP financial measure that is calculated by the addition or subtraction of certain items from within our consolidated statements of earnings to or from net 
earnings (loss) attributable to Enstar ordinary shareholders, the most directly comparable GAAP financial measure. A complete reconciliation of our Non-GAAP operating income attributable to Enstar ordinary shareholders to net earnings (loss) 
attributable to Enstar ordinary shareholders is set forth on the financial calculations schedule on page vi. 
2 During a period of loss, the basic weighted average ordinary shares outstanding is used in the denominator of the diluted loss per ordinary share computation as the effect of including potentially dilutive securities would be anti-dilutive.
3 Calculations setting forth the breakdown of these items are set forth on the financial calculations schedule on page vi. 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dear Fellow Shareholders, 

Before I take you through our 2019 performance and outlook for 2020, let me express our 
deepest concern during this challenging time for the health and safety of people all over the 
world, including those in the Enstar community. I hope this report reaches you in good health. 

At Enstar, the impact of the pandemic has reminded us of the importance of strong risk and 
capital management, operational agility and our proven business model. These strengths will 
carry us through these challenging times.

$19.4bn
Assets 

2019 Financial Results

Enstar achieved exceptional financial results in 2019, delivering net earnings of $902.2 million, 
or $41.43 per fully diluted ordinary share. Our book value per share reached a new high of 
$197.93, up 26.9% from year-end 2018. 

Our business strategy has evolved over recent years with investment strategy playing a more 
prominent role than in our earlier years. Coupled with our continued success in acquiring and 
effectively managing our Non-life Run-off portfolios, we are confident in our strategy and our 
ability to deliver long-term value to our shareholders. 

The increase in the size and nature of our investment portfolios can lead to volatility in our 
reported financial results over the short term, as is very evident when we look at our results in 
2019 compared with 2018. Enstar’s investment results were the most significant contributor 
to earnings. Our net investment income of $321.3 million in 2019 was due to increased assets 
under management from our completed transactions and our asset allocation strategies. Net 
realised and unrealised gains were $1,031.4 million, which reversed and significantly exceeded 
losses in 2018 of $412.9 million.

In addition to investments, other key factors influencing our 2019 results were the performance 
of our core Non-life Run-off operations and the favourable results of our Atrium segment,  
along with the progression of our repositioning efforts at StarStone.

Investments

2019 was a favourable year for investments to say the least, fuelled by the fall in interest rates, 
narrowing credit spreads and a rally in equity markets, all of which resulted in significant 
unrealised gains across Enstar’s invested asset classes. 

$4.9bn

Total shareholders’ equity

$14.7bn

Total cash and  
investments

$31.9bn

Total assets acquired  
since inception

i

Annual CEO letterFrom Dominic Silvester,  Chief Executive OfficerEnstar is sufficiently 
capitalised to take 
advantage of pipeline 
opportunities in 2020

Annual CEO letter
From Dominic Silvester, Chief Executive Officer

Fixed Maturity Investments:

One of the main drivers was the $438.0 million impact of unrealised gains on fixed maturity 
investments, which comprise 72.8% of Enstar’s $13.2 billion investment portfolio. Our general 
practice is to hold these fixed income securities to maturity. Absent any losses from credit 
defaults, these investments will mature at full value. Unrealised gains or losses on these 
investments quarter-to-quarter are therefore not indicative of management’s view of our core 
performance and are adjusted for in our Non-GAAP Operating Income metric.  

The COVID-19 pandemic has caused interest rates to drop further to historically low levels, 
which creates additional unrealised gains in our fixed income portfolio. However, credit 
spreads in both the investment grade and high yield markets have widened. This will create 
unrealised losses that are greater than unrealised gains due to yields. Our fixed income 
portfolio was already well positioned with an A+ average credit rating, although we will 
continue to monitor credit risk during this time of volatility and take actions where necessary.  

Equities and Other Investments:

Our 2019 result was also positively impacted by $497.0 million of net realised and unrealised 
gains on the fair value of equities and other investments. We increased our allocation to these 
assets to 24.6% of our investment portfolio at 2019 year-end (2018: 20.6%). These assets 
provide diversification against fixed income investments and present the opportunity for 
improved risk-adjusted returns over the long term. We therefore accept that their returns may 
be more volatile in the short term.  

Historic volatility in equity markets has occurred during the pandemic, as ‘risk off’ sentiment 
has caused a sharp deterioration in equity prices. The first quarter of 2020 was the worst 
quarter for stocks since the global financial crisis and we expect that the volatility will 
continue this year. 

Capital Management

Enstar remains financially strong, with $19.4 billion in total assets and total shareholders’ 
equity of $4.9 billion as of December 31, 2019.

During 2019, we successfully executed a public offering of $500.0 million of ten-year senior notes. 
The proceeds were used to pay down debt on existing credit facilities and for general corporate 
purposes and the funding of acquisitions. In combination with capital raising efforts in 2018, 
Enstar is sufficiently capitalised to take advantage of pipeline opportunities in 2020 whilst 
ensuring we hold capital and liquidity at sufficient levels.

iiii

Transactions 

Enstar continued to grow acquisitions in 2019, with transactions announced during the year 
totalling $3.2 billion of liabilities assumed. In 2020, we have already announced three new 
deals totalling more than $1.4 billion of liabilities. 

TRANSACTION 

2020 TRANSACTIONS
Lyft  

Aspen ADC 

AXA XL 

TOTAL 

DATE CLOSED 
OR SIGNED 

ASSETS 
(IN USD) 

TOTAL 
LIABILITIES 
(IN USD) 

PRIMARY NATURE OF BUSINESS

March 31, 2020 

March 2, 2020* 

$465m 

$770m 

$465m 

$770m 

Novation of Lyft’s legacy U.S. automobile business

Adverse development cover of diversified property, liability and  
specialty lines across the U.S., U.K. and Europe

February 24, 2020* 

$211m 

$225m 

Loss portfolio transfer of U.S. construction general liability  
multi-year policies

$1,446m 

$1,460m 

2019 TRANSACTIONS
Morse TEC 

October 30, 2019 

$683m 

$683m 

Zurich 

Munich Re 

October 1, 2019 

$507m 

September 10, 2019* 

$160m 

$623m 

$160m 

Maiden Re 

August 5, 2019 

$445m 

$530m 

Amerisure 

April 11, 2019 

$45m 

$48m 

4 AmTrust RITCs 

February 14, 2019 

$1,144m 

$1,165m 

TOTAL 

$2,984m 

$3,209m 

 *Indicates transaction remains subject to closing conditions

U.S. liabilities associated with personal injury asbestos claims and  
environmental claims arising from legacy manufacturing operations

Reinsurance of U.S. asbestos and environmental insurance portfolios

Portfolio transfer of Australian public liability, professional liability  
and builders’ warranty liabilities 

Adverse development cover of Maiden Re’s quota share with AmTrust  
related to U.S. workers’ compensation and general casualty business

Partnership with Allianz Risk Transfer to provide loss portfolio  
transfer for U.S. construction defect business

Four separate RITCs involving Lloyd’s property, professional, marine,  
non-marine, affinity annual, extended warranty and political lines

With a recent industry study estimating global non-life run-off liabilities at nearly $800 billion, 
Enstar has an ever-increasing pipeline of future prospects.  

Our opportunities are typically generated by companies looking to dispose of non-core business, 
release capital, improve regulatory solvency capital ratios, achieve legal finality or manage claims 
volatility. Enstar stands ready to review new opportunities and find solutions for our partners, 
whether it be through acquisition, reinsurance, business transfer or consulting services. 

Efficient management of legacy business is becoming an increasingly important part of the 
mainstream industry and business within the legacy space is increasing every year. 
This, combined with the success of companies such as Enstar, is attracting new players –  
a sign of a healthy and expanding marketplace that brings more opportunities for companies 
who have proven they can be successful. Enstar’s track record, scale and operational strength, 
combined with our highly disciplined acquisition approach, positions us at the top of an 
expanding field. 

iii

Annual CEO letterFrom Dominic Silvester,  Chief Executive Officer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Annual CEO letter
From Dominic Silvester, Chief Executive Officer

The Morse TEC deal 
marked an important 
milestone in our 
history, as it was 
our 100th deal

Gross Non-life Run-off Reserves 
as of December 31, 2019

We have acquired and managed legacy business around the world for over two decades with 
a focus on major markets such as the U.S., the U.K., Lloyd’s, the EU, Bermuda and Australia. 
Highlights from 2019 include more than $1 billion of liabilities assumed from AmTrust related 
to reinsurance-to-close transactions (RITCs), which continue to provide attractive legacy 
opportunities for our Lloyd’s syndicate.

Building upon our prior deals, in 2019 we put in place an adverse development reinsurance 
agreement covering Maiden Re’s quota share reinsurance contracts with AmTrust, which 
closed in August. The ADC covers losses incurred before 2019 of up to $600 million in excess  
of Maiden Re’s $2.2 billion retention. 

Our October 2019 acquisition of Morse TEC was another highlight. We assumed $662.5 million 
of gross liabilities associated with its personal injury asbestos claims and environmental 
claims arising from legacy manufacturing operations. We continue to assist non-insurance 
corporate partners looking to de-leverage their balance sheets by taking on some of their 
asbestos and workers’ compensation liabilities. 

The Morse TEC deal marked an important milestone in our history, as it was our 100th deal. 
Since our founding in 1993, we have been a leader in our sector. We believe our success 
is derived from our consistent careful selection of acquisition targets and our efficient 
management of the underlying portfolios, as well as our commitment to maintaining strong 
relationships with regulators around the world.

Gross Reserves 
$8.4bn*

Non-life Run-off 

Asbestos and Environmental 

Workers’ Compensation 

General Casualty 

Professional Indemnity/D&O 

Construction Defect and Other 

Motor 

Marine, Aviation and Transit 

27%

27%

12%

11%

9%

9%

5%

*The percentages shown here do not reflect a fair 
value adjustment or unallocated loss adjustment 
expenses. “Other” includes Property and All Other. 
Gross Reserves does not include defendant asbestos 
and environment liabilities.

Our Non-life Run-off segment is our core business. This segment contributed $1.1 billion in net 
earnings to our consolidated results in 2019, including a reduction in estimates of net ultimate 
losses for prior periods of $220.0 million. Our expertise in claims management continues to 
be a cornerstone of our business, and our focus is ensuring that we meet our obligations to 
policyholders. We look to settle our liabilities efficiently, which allows us to achieve reserve 
savings and recycle capital that continuously feeds future business and investments.

In 2019, we paid $1.2 billion in claims to our policyholders, releasing and deploying the 
associated capital elsewhere in our businesses and facilitating our continued growth. Our 
claims teams manage our liabilities through verification of coverage, proper evaluation of 
exposures, and involvement of legal counsel to handle claims promptly.

Our mix of reserves as of December 31, 2019 remained diversified across property and 
casualty lines, with our asbestos and environmental and workers’ compensation reserves 
each comprising 27% of our gross reserves.

During 2019, significant progress was made in use of the legislative framework for insurance 
business transfers within the U.S. Similar to statutory provisions already in place in other 
countries, this regulatory framework provides legal finality for the transfer of insurance 
business. Enstar was honoured to have the first transaction approved by the Oklahoma 
Department of Insurance under new legislation in that state. As this type of legislation 
becomes more widely used across the U.S., we expect it will offer Enstar additional 
opportunities and flexibility in transaction structuring, allowing us to offer legal finality for 
transferred portfolios as we have successfully done in the U.K., Australia and Europe. 

iv

We have a strong 
company with a 
great team that 
continues to 
operate at the 
highest standard

Active Underwriting Business

Global insurance markets began a long-awaited upturn in 2019, with improved pricing and 
terms almost across the board. This has been driven in part by widespread withdrawals from 
various lines of property and casualty insurance by insurers around the world, especially at 
Lloyd’s, creating new opportunities for Enstar’s active underwriting segments. 

Atrium 

Atrium achieved another impressive result in 2019, yielding net earnings attributable to Enstar 
of $12.1 million, up 34.8% from 2018 with an improved combined ratio of 90.6%. Atrium 
remains one of the top performing managing agencies at Lloyd’s and has again outperformed 
the market. 

We were pleased that Atrium increased gross premiums written during 2019, especially in 
those lines of business that are displaying improving market conditions and where Atrium has 
a strong track record. 

StarStone 

StarStone made significant progress in repositioning its underwriting portfolio, which resulted 
in a reduction in premiums written to focus on core lines and improve profitability. While 
results improved from 2018, the StarStone segment contributed a loss of $100.7 million 
in 2019 due to unfavourable experience in exited lines and reserve strengthening in the 
U.S. casualty line, reflecting an increase in the frequency and severity of losses. Like other 
carriers, StarStone will feel the impact of the pandemic across a number of lines of business. 
Consequently, management has taken protective measures to reduce risk exposure where 
possible and will continually assess the market and the impact to the group’s business. 

Looking ahead 

I know we are all looking ahead to better times, when we can safely get back to life and 
business as usual. This will take time, but I am confident in Enstar’s ability to endure and 
prosper. We have a strong company with a great team that continues to operate at the highest 
standard through these tough times.

As ever, I am grateful for the commitment of our Enstar team, shareholders, business partners 
and clients. I thank you for your support and wish you well. 

Sincerely,

Dominic Silvester

April 28, 2020

v

Annual CEO letterFrom Dominic Silvester,  Chief Executive Officer 
FINANCIAL CALCULATIONS SCHEDULE
Non-GAAP operating income (loss) attributable to Enstar ordinary shareholders is calculated by the addition or subtraction of certain items  
from within our consolidated statements of earnings to or from net earnings (loss) attributable to Enstar ordinary shareholders, the most  
directly comparable GAAP financial measure, as illustrated in the table below, for the years ending December 31, 2019, 2018 and 2017 in 
thousands of U.S. Dollars.

Non-GAAP Operating Income 

Net earnings (loss) attributable to Enstar ordinary shareholders 

$ 

Adjustments: 

Net realized and unrealized (gains) losses on fixed maturity  
investments and funds held - directly managed 1 

Change in fair value of insurance contracts for which we  
have elected the fair value option  

Loss on sale of subsidiary 

Net (earnings) loss from discontinued operations 

Tax effects of adjustments 2 

Adjustments attributable to noncontrolling interest 3 

2019 

 902,175 

2018 

(162,354) 

(534,730) 

243,093 

117,181 

— 

— 

51,102 

17,689 

6,664 

— 

— 

(16,588) 

(9,166) 

61,649 

2017

311,458

(70,747)

30,256

16,349

(14,183)

5,364

4,840

283,337

Non-GAAP operating income attributable to Enstar ordinary shareholders 4 

$  

553,417 

1 Represents the net realized and unrealized gains and losses related to fixed maturity securities. Our fixed maturity securities are held directly on our balance sheet and also within the “Funds held - directly managed” balance. Refer to Note 6 - 
“Investments” in the notes to our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K for further details on our net realized and unrealized gains and losses.
2 Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated at the applicable jurisdictional tax rate.
3 Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interest associated with the specific subsidiaries to which the adjustments relate.
4 Non-GAAP financial measure.

The table below summarises the calculation of our fully diluted book value per ordinary share as of December 31, 2019, 2018 and 2017 in 
thousands of U.S. Dollars, including the calculation of ordinary shareholders’ equity and fully diluted ordinary shares outstanding. 

Numerator: 
Total Enstar Shareholder’s Equity 
Less: Series D and E Preferred Shares 
Total Enstar Ordinary Shareholders’ Equity 
Proceeds from assumed conversion of warrants 1 

Numerator for fully diluted book value per ordinary share calculations (A) 

2019 

2018 

2017

$ 

 4,842,183  
510,000 
4,332,183 
20,229 

4,352,412 

$ 3,901,933 
510,000 
3,391,933 
20,229 

3,412,162 

$ 3,136,684
—
3,136,684
20,229

3,156,913

Denominator: 

Ordinary shares outstanding 
Effect of dilutive securities: 

Share-based compensation plans 
Warrants 1 

Fully diluted ordinary shares outstanding (B) 

21,511,505 

21,459,997 

19,406,722

302,565 
175,901 

245,165 
175,901 

21,989,971 

21,881,063 

248,144
175,901

19,830,767

Fully diluted book value per ordinary share = (A) / (B) 

$  

197.93 

155.94 

159.19

1 There are warrants outstanding to acquire 175,901 Series C Non-Voting Ordinary Shares for an exercise price of $115.00 per share, subject to certain adjustments (the “Warrants”). The Warrants were issued in April 2011 and expire in April 
2021. The Warrant holder may, at its election, satisfy the exercise price of the Warrants on a cashless basis by surrender of shares otherwise issuable upon exercise of the Warrants in accordance with a formula set forth in the Warrants.

Cautionary Statement

This letter contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include 
statements regarding the intent, belief or current expectations of Enstar and its management team. Investors are cautioned that any such forward-looking 
statements speak only as of the date they are made, are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ 
materially from those projected in the forward-looking statements as a result of various factors. In particular, the evolving COVID-19 pandemic has caused significant 
economic and financial turmoil globally, as well as uncertainty in the financial markets, which has caused declines in the market value of our invested assets. Due 
to the global uncertainty, we are unable to predict the longer-term effects of the pandemic on our business at this time. Important risk factors regarding Enstar can 
be found under the heading “Risk Factors” in this Form 10-K for the year ended December 31, 2019 and are incorporated herein by reference. Furthermore, Enstar 
undertakes no obligation to update any written or oral forward-looking statements or publicly announce any updates or revisions to any of the forward-looking 
statements contained herein, to reflect any change in its expectations with regard thereto or any change in events, conditions, circumstances or assumptions 
underlying such statements, except as required by law.

vi

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019 
Commission File Number 001-33289 

ENSTAR GROUP LIMITED
(Exact name of Registrant as specified in its charter)

BERMUDA
(State or other jurisdiction of incorporation or organization)

N/A
(I.R.S. Employer Identification No.)

Windsor Place, 3rd Floor, 22 Queen Street, Hamilton HM JX, Bermuda 

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (441) 292-3645 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s) Name of Each Exchange on Which Registered

Ordinary shares, par value $1.00 per share

ESGR

The NASDAQ Stock Market LLC

Depositary Shares, Each Representing a 1/1,000th Interest in a 7.00%  ESGRP

The NASDAQ Stock Market LLC

Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Share,
Series D, Par Value $1.00 Per Share

Depositary Shares, Each Representing a 1/1,000th Interest in a 7.00% ESGRO

The NASDAQ Stock Market LLC

Perpetual Non-Cumulative Preferred Share, Series E, Par Value $1.00
Per Share

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☒    No  ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐    No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405  of  Regulation S-T  during  the  preceding  12 months  (or  for  such  shorter  period  that  the  registrant  was  required  to  submit  such
files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging
growth company" in Rule 12b-2 of the Exchange Act.

Large
accelerated filer

þ Accelerated filer ☐ Non-accelerated

filer

☐ Smaller reporting

☐ Emerging growth company ☐

 company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No  ☒

The  aggregate  market  value  of  the  registrant's  voting  and  non-voting  common  equity  held  by  non-affiliates  as  of  June 30,  2019  was
approximately $1.86 billion based on the closing price of $174.28 per ordinary share on the NASDAQ Stock Market on that date.  Shares held by
officers and directors of the registrant and their affiliated entities have been excluded from this computation. Such exclusion is not intended, nor
shall it be deemed, to be an admission that such persons are affiliates of the registrant. 

As of February 24, 2020, the registrant had outstanding 18,012,556 voting ordinary shares and 3,509,682 non-voting convertible ordinary

shares, each par value $1.00 per share.

DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A

relating to its 2020 annual general meeting of shareholders are incorporated by reference in Part III of this Form 10-K.

Enstar Group Limited

Annual Report on Form 10-K
For the Fiscal Year Ended December 31, 2019

Table of Contents

PART I

Item 1.

Business

Item 1A. Risk Factors

Item 1B. Unresolved Staff Comments

Item 2.

Item 3.

Item 4.

PART II

Item 5.

Item 6.

Item 7.

Properties

Legal Proceedings

Mine Safety Disclosures

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities

Selected Financial Data

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

Item 8.

Item 9.

Financial Statements and Supplementary Data

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9A. Controls and Procedures

Item 9B. Other Information

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Item 11.
Item 12.

Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related
Stockholder Matters

Item 13. Certain Relationships and Related Transactions, and Director Independence

Item 14.

Principal Accounting Fees and Services

PART IV

Item 15.

Exhibits, Financial Statement Schedules

Item 16.

Form 10-K Summary

Page

1

25

45

45

45

45

46

48

50

114

118

275

275

277

277

277

277

277

277

277

277

 
Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This  annual  report  and  the  documents  incorporated  by  reference  herein  contain  statements  that  constitute
"forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended,
or  the  Exchange Act,  with  respect  to  our  financial  condition,  results  of  operations,  business  strategies,  operating
efficiencies,  competitive  positions,  growth  opportunities,  plans  and  objectives  of  our  management,  as  well  as  the
markets for our securities and the insurance and reinsurance sectors in general. Statements that include words such
as "estimate," "project," "plan," "intend," "expect," "anticipate," "believe," "would," "should," "could," "seek," "may" and
similar statements of a future or forward-looking nature identify forward-looking statements for purposes of the federal
securities  laws  or  otherwise.  All  forward-looking  statements  are  necessarily  estimates  or  expectations,  and  not
statements  of  historical  fact,  reflecting  the  best  judgment  of  our  management  and  involve  a  number  of  risks  and
uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements.
These forward looking statements should, therefore, be considered in light of various important factors, including those
set forth in this annual report and the documents incorporated by reference herein, which could cause actual results
to differ materially from those suggested by the forward-looking statements. These factors include:

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

risks associated with implementing our business strategies and initiatives;

the adequacy of our loss reserves and the need to adjust such reserves as claims develop over time;

risks relating to our acquisitions, including our ability to evaluate opportunities, successfully price acquisitions,
address operational challenges, support our planned growth and assimilate acquired companies into our
internal control system in order to maintain effective internal controls, provide reliable financial reports and
prevent fraud;

risks relating to our active underwriting businesses, including unpredictability and severity of catastrophic
and other major loss events, failure of risk management and loss limitation methods, the risk of a ratings
downgrade or withdrawal, and cyclicality of demand and pricing in the insurance and reinsurance markets;

risks relating to the performance of our investment portfolio and our ability to structure our investments in a
manner that recognizes our liquidity needs;

changes and uncertainty in economic conditions, including interest rates, inflation, currency exchange rates,
equity markets and credit conditions, which could affect our investment portfolio, our ability to finance future
acquisitions and our profitability;

the risk that ongoing or future industry regulatory developments will disrupt our business, affect the ability
of our subsidiaries to operate in the ordinary course or to make distributions to us, or mandate changes in
industry practices in ways that increase our costs, decrease our revenues or require us to alter aspects of
the way we do business;

risks relating to the variability of statutory capital requirements and the risk that we may require additional
capital in the future, which may not be available or may be available only on unfavorable terms;

risks relating to the availability and collectability of our reinsurance;

losses due to foreign currency exchange rate fluctuations;

increased  competitive  pressures,  including  the  consolidation  and  increased  globalization  of  reinsurance
providers;

emerging claim and coverage issues;

lengthy and unpredictable litigation affecting the assessment of losses and/or coverage issues;

loss of key personnel;

the ability of our subsidiaries to distribute funds to us and the resulting impact on our liquidity;

our ability to comply with covenants in our debt agreements;

changes in our plans, strategies, objectives, expectations or intentions, which may happen at any time at
management’s discretion;

operational risks, including system, data security or human failures and external hazards;

Table of Contents

•

•

•

•

•

•

risks relating to our ability to obtain regulatory approvals, including the timing, terms and conditions of any
such approvals, and to satisfy other closing conditions in connection with our acquisition agreements, which
could affect our ability to complete acquisitions;

risks relating to our subsidiaries with liabilities arising from legacy manufacturing operations;

tax, regulatory or legal restrictions or limitations applicable to us or the insurance and reinsurance business
generally;

changes in tax laws or regulations applicable to us or our subsidiaries, or the risk that we or one of our non-
U.S. subsidiaries become subject to significant, or significantly increased, income taxes in the United States
or elsewhere;

changes in Bermuda law or regulation or the political stability of Bermuda; and

changes in accounting policies or practices.

The factors listed above should be not construed as exhaustive and should be read in conjunction with the Risk
Factors that are included in Item 1A below. We undertake no obligation to publicly update or review any forward-looking
statement, whether to reflect any change in our expectations with regard thereto, or as a result of new information,
future developments or otherwise, except as required by law.

Table of Contents

ITEM 1.   BUSINESS

Company Overview

PART I 

Enstar Group Limited ("Enstar") is a Bermuda-based holding company. We are a multi-faceted insurance group
that offers innovative capital release solutions and specialty underwriting capabilities through our network of group
companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and other international
locations. Enstar is listed on the NASDAQ Global Select Market under the ticker symbol "ESGR".  In this report, the
terms  "Enstar,"  "the  Company,"  "us,"  and  "we"  are  used  interchangeably  to  describe  Enstar  and  our  subsidiary
companies.

Our core focus is acquiring and managing insurance and reinsurance companies and portfolios of insurance
and reinsurance business in run-off. Since our formation, we have completed or announced the acquisition of over
100 insurance and reinsurance companies and portfolios of business.

Our fundamental corporate objective is growing our net book value per share.  We strive to achieve this primarily
through growth in net earnings from both organic and accretive sources, including the completion of new acquisitions,
the effective management of companies and portfolios of business acquired, and the execution of active underwriting
strategies.

Enstar also manages specialty active underwriting businesses:

•

•

Atrium Underwriting Group Limited and its subsidiaries ("Atrium"), which manage and underwrite specialist
insurance and reinsurance business for Lloyd’s Syndicate 609; and

StarStone Insurance Bermuda Limited and its subsidiaries ("StarStone"), which is an A.M. Best A- rated
global specialty insurance group with multiple underwriting platforms.

Business Strategy

Enstar aims to maximize growth in book value per share by employing the following strategies:

We Leverage Management’s Experience and Industry Relationships to Solidify Enstar’s Position in the Run-Off
Market.  Enstar leverages the extensive experience and relationships of our senior management team to solidify our
position as a leading run-off acquirer and generate future growth opportunities.

We Engage in Highly Disciplined Acquisition Practices. Enstar is highly selective and disciplined when assessing
potential acquisition targets, carefully analyzing risk exposures, claims practices and reserve requirements as part of
a detailed due diligence process. We believe this decreases risk and increases the probability that we can deliver
positive operating results from the companies and portfolios acquired.

We Prudently Manage Investments and Capital. In managing investments and deploying group capital, Enstar
strives  to  achieve  superior  risk-adjusted  returns,  while  growing  profitability  and  generating  long-term  growth  in
shareholder value.

We  Manage  Claims  Professionally,  Expeditiously,  and  Cost-Effectively. Enstar  aims  to  manage  claims  in  a
professional and disciplined manner, drawing on in-house expertise to dispose of claims efficiently. Enstar strives to
pay valid claims on a timely basis, while relying on well-documented policy terms and exclusions where applicable,
and litigation when necessary, to defend against paying invalid claims.

We Seek to Commute Assumed Liabilities and Insurance and Reinsurance Assets at a Discount to the Ultimate
Liability. Using detailed claims analysis and actuarial projections, Enstar seeks to negotiate with policyholders with a
goal of commuting existing insurance and reinsurance liabilities at a discount to the ultimate liability.

We Aim to Profitably Underwrite Selected Specialty Lines to Enhance Future Growth Opportunities.  Through
our Atrium and StarStone segments, we selectively underwrite in chosen specialty lines, with a focus on balancing
risk exposures.

1

Table of Contents

Strategic Growth

Enstar transactions typically take the form of either acquisitions or portfolio transfers. In an acquisition, we acquire
an insurance or reinsurance company and manage the run-off or continued underwriting of risk in its business lines.
In a portfolio transfer, a reinsurance contract transfers risk from the initial insurance or reinsurance company to a
company in the Enstar group. Enstar also enters into reinsurance to close ("RITC") transactions with Lloyd's of London
("Lloyd's") insurance and reinsurance syndicates in run-off, whereby a portfolio of run-off liabilities is transferred from
one Lloyd’s syndicate to another.

The substantial majority of Enstar’s acquisitions have been in the non-life run-off business, which generally
includes  property  and  casualty,  workers’  compensation,  asbestos  and  environmental,  construction  defect,  marine,
aviation and transit, professional indemnity and directors and officers, motor, and other closed business. Enstar evolved
from  a  stand-alone  run-off  consolidator  to  a  more  diversified  insurance  group  with  active  underwriting  capabilities
following our acquisitions of Atrium and StarStone, in 2013 and 2014, respectively. We partnered with the Trident funds
("Trident")  (managed  by  Stone  Point  Capital  LLC  ("Stone  Point"))  in  the  acquisitions  of  these  active  underwriting
businesses.  Stone  Point  Capital  is  a  financial  services-focused  private  equity  firm  that  has  significant  experience
investing in insurance and reinsurance companies and other insurance-related businesses, which Enstar believes is
valuable in our active underwriting joint ventures. In each of the Atrium and StarStone transactions, Enstar has a 59.0%
equity interest, Trident has a 39.3% equity interest, and Dowling Capital Partners L.P. ("Dowling") has a 1.7% equity
interest.

Recent Acquisitions and Significant New Business

AXA Group

On February 24, 2020, we entered into a loss portfolio transfer reinsurance agreement with AXA XL, a division
of AXA,  to  reinsure  specified  legacy  construction  general  liability  multi-year  policies.  We  will  assume  reinsurance
reserves of approximately $225.0 million in the transaction. Completion of the transaction is subject to, among other
things, regulatory approvals and satisfaction of various closing conditions. The transaction is expected to close in the
first half of 2020.

Munich Re

On  September 10,  2019,  we  signed  an  agreement  with  Great  Lakes  Insurance  SE  and  HSB  Engineering
Insurance Limited, both subsidiaries of Munich Reinsurance Company ("Munich Re"), pursuant to which we will acquire
certain portfolios from their Australian branches. In the transaction, which is subject to regulatory and Federal Court
of Australia approval, we will receive total assets of approximately AUD$228.2 million (approximately $160.3 million)
for assuming the associated net insurance reserves, which primarily relate to long tail insurance business. We are
pursuing a portfolio transfer of the insurance business under Division 3A of Part III of Australia’s Insurance Act 1973
(Cth), which would provide legal finality for Munich Re and its subsidiaries. This transaction is expected to close in
2020.

Morse TEC

On October 30, 2019, we completed the acquisition of Morse TEC LLC ("Morse TEC") through our subsidiary,
Enstar Holdings (US) LLC from BorgWarner Inc. Morse TEC holds $662.5 million in gross liabilities associated with
personal injury asbestos claims and environmental claims arising from BorgWarner's legacy manufacturing operations.

Zurich

On October 1, 2019, we completed a reinsurance transaction with Zurich Insurance Group ("Zurich"), pursuant
to  which  we  reinsured  certain  of  Zurich's  U.S.  asbestos  and  environmental  liability  insurance  portfolios.  In  the
transaction, we assumed $622.9 million of gross reserves, relating to 1986 and prior year business, for reinsurance
premium of $465.5 million and recorded a deferred charge of $115.8 million. We have ceded 10% of this transaction
to Enhanzed Reinsurance Ltd. ("Enhanzed Re"), in which we have an investment, on the same terms and conditions
as those received by Enstar. 

2

Table of Contents

Maiden ADC

On August 5, 2019, we and Maiden Reinsurance Ltd. (“Maiden Re Bermuda”) completed a transaction pursuant
to a Master Agreement with Maiden Holdings, Ltd. and Maiden Re Bermuda to provide adverse development cover
reinsurance to Maiden Re Bermuda, effective January 1, 2019. In the transaction, Maiden Re Bermuda ceded and we
assumed  as  retrocessionaire  Maiden  Re  Bermuda's  liability  under  its  quota  share  agreement  with  the  Bermuda
subsidiary ("AmTrust Bermuda") of AmTrust Financial Services, Inc. (“AmTrust”). The adverse development cover
reinsurance is for losses incurred on or prior to December 31, 2018 in excess of a $2.2 billion retention up to a $600.0
million limit, in exchange for a premium of $445.0 million. We assumed total gross reserves of $530.2 million and
recorded  a  deferred  charge  of  $85.2  million.  Enstar's  reinsurance  performance  obligations  in  the  transaction  are
collateralized in accordance with a Master Collateral Agreement among Enstar, Maiden Re Bermuda, AmTrust and
certain subsidiaries of AmTrust. 

Amerisure

On April 11, 2019, we completed a loss portfolio transfer reinsurance agreement with Amerisure Mutual Insurance
Company ("Amerisure") and Allianz Risk Transfer (Bermuda) Limited (“ART Bermuda”). In the transaction, Amerisure
ceded, and each of Enstar and ART Bermuda severally assumed, a 50% quota share of the construction defect losses
incurred by Amerisure and certain of its subsidiaries on or before December 31, 2012. Under the agreement, which
was effective as of January 1, 2019, we assumed $48.3 million of gross reserves in exchange for consideration of
$45.5 million and recorded a deferred charge asset of $2.9 million. 

AmTrust RITC Transactions

On  February 14,  2019,  we  completed  four  RITC  transactions  with  Syndicates  1206,  1861,  2526  and  5820,
managed by AmTrust Syndicates Limited, under which we reinsured to close the 2016 and prior underwriting years.
We assumed, among other items, gross loss reserves of £703.8 million ($897.1 million) and net loss reserves of £486.8
million ($620.4 million) relating to the portfolios in exchange for consideration of £539.9 million ($688.2 million) and
recorded a deferred charge asset of $20.6 million.

Acquisitions and Significant New Business since January 1, 2019

The  table  below  sets  forth  a  summary  of  acquisitions  and  significant  new  business  that  we  have  signed  or
completed since January 1, 2019, including those announced in 2020 prior to issuing this Annual Report on Form 10-
K. For a more detailed explanation of these transactions, as well as transactions completed in 2018 and 2017, refer
to Note 3 - "Acquisitions" and Note 4 - "Significant New Business" in the notes to our consolidated financial statements
included within Item 8 of this Annual Report on Form 10-K.

Acquisitions and Significant New Business (January 1, 2019 - Present)

Transaction
AXA XL

Munich Re

Purchase
Price
N/A

Assets
Acquired/
Assumed
$211 million

Total
Liabilities
Acquired/
Assumed
$225 million

N/A

$160 million

$160 million

Morse TEC

$— million

$683 million

$683 million

Zurich

Maiden Re Bermuda

Amerisure

AmTrust RITCs

N/A

N/A

N/A

N/A

$507 million

$623 million

$445 million

$530 million

$45 million

$48 million

$1,144 million

$1,165 million

Segment
Non-life
Run-off

Non-life
Run-off

Non-life
Run-off

Non-life
Run-off

Non-life
Run-off

Non-life
Run-off

Non-life
Run-off

Primary Nature of
Business
U.S. construction general liability

Australian public liability,
professional liability and builders'
warranty liabilities

U.S. liabilities associated with
personal injury asbestos claims
and environmental claims arising
from legacy manufacturing
operations

U.S. asbestos and environmental
liability

U.S. workers' compensation and
General Casualty

U.S. construction defect

Lloyd's property, professional,
marine, non-marine, affinity
annual, extended warranty and
political

3

Table of Contents

Sale of Life and Annuities

The following sections describe the sale of various life and annuities businesses and assets. Each of these was
an  opportunistic  sale,  allowing  us  to  release  capital  and  liquidity.  We  will  still  consider  life  and  annuities  business
opportunities, either for our own balance sheet, or via one of our affiliates, Enhanzed Re or Monument Insurance
Group ("Monument"). 

Alpha

On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-owned
subsidiary Alpha Insurance SA to a subsidiary of Monument. We have an investment in Monument. Our policy benefits
operations do not qualify for inclusion in our reportable segments and are therefore included within other activities.
The related assets, as well as the results from these operations, were not significant to our consolidated operations
and therefore they have not been classified as a discontinued operation. In addition, our transfer of these life assurance
polices to Monument was not classified as a held-for-sale business transaction since the underlying contracts did not
meet the definition of a business.

Pavonia

On December 29, 2017, we completed the sale of Pavonia Holdings (US), Inc. (“Pavonia”) to Southland National
Holdings, Inc. (“Southland”), a Delaware corporation and a subsidiary of Global Bankers Insurance Group, LLC. The
aggregate purchase price was $120.0 million. We used the proceeds to make repayments under our revolving credit
facility. A sale of one subsidiary, Pavonia Life Insurance Company of New York ("PLIC NY") has not yet been agreed
or completed. As of December 31, 2019 and 2018, included within other assets and other liabilities on our consolidated
balance sheet were amounts of $20.6 million and $11.7 million, and $24.0 million and $11.3 million, respectively, relating
to PLIC NY.

Other Transactions 

During 2019, we divested 16 dormant Lloyd’s corporate members for a de-minimis amount.

Operating Segments

We have three reportable segments of business that are each managed, operated and separately reported:
(i) Non-life Run-off; (ii) Atrium; and (iii) StarStone. Our other activities, which do not qualify as a reportable segment,
include our corporate expenses, debt servicing costs, holding company income and expenses, foreign exchange and
other  miscellaneous  items.  For  additional  information  and  financial  data  relating  to  our  segments,  see  "Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations - Results of Operations by
Segment,"  "Item 7.  Management’s  Discussion  and  Analysis  of  Financial  Condition  and  Results  of  Operations -
Investments" and Note 24 - "Segment Information" in the notes to our consolidated financial statements included within
Item 8 of this Annual Report on Form 10-K.

Non-life Run-off

Our Non-life Run-off segment comprises the operations of our subsidiaries that are running off their property

and casualty and other non-life lines of business.

In the primary (or direct) insurance business, the insurer assumes risk of loss from persons or organizations
that are directly subject to the given risks. In the reinsurance business, the reinsurer agrees to indemnify an insurance
or reinsurance company, referred to as the ceding company, against all or a portion of the insurance risks arising under
the policies the ceding company has written or reinsured. When an insurer or reinsurer stops writing new insurance
business, either entirely or with respect to a particular line of business, the insurer, reinsurer, or the line of discontinued
business is in run-off.

Participants in the industry often have portfolios of business that become inconsistent with their core competency
or provide excessive exposure to a particular risk or segment of the market. These non-core and/or discontinued
portfolios are often associated with potentially large exposures and lengthy time periods before resolution of the last
remaining insured claims, resulting in significant uncertainty to the insurer or reinsurer covering those risks. These
factors can distract management, drive up the cost of capital and surplus for the insurer or reinsurer and negatively
impact the insurer’s or reinsurer’s rating, which makes the disposal of the unwanted company or portfolio an attractive
option. The insurer or reinsurer may engage with a third party that specializes in run-off management, such as Enstar,
to purchase the company or assume the portfolio in run-off.

4

Table of Contents

In the sale of a company in run-off, a purchaser, such as Enstar, may pay a discount to the book value of the
company based on the risks assumed and the relative value to the seller of no longer having to manage the company
in run-off. Such a transaction can be beneficial to the seller because it receives an up-front payment for the company,
eliminates the need for its management to devote any attention to the disposed company and removes the risk that
the established reserves related to the run-off business may prove to be inadequate. The seller is also able to redeploy
its management and financial resources to its core businesses.

In some situations, an insurer or reinsurer may wish to divest itself of a portfolio of non-core legacy business
that may have been underwritten alongside other ongoing core business that the insurer or reinsurer does not want
to dispose of. In such instances, we are able to provide economic finality for the insurer or reinsurer by providing a
loss portfolio reinsurance contract to protect the insurer or reinsurer against deterioration of the non-core portfolio of
loss reserves.

Overall, the focus of our Non-life Run-off segment is to acquire companies or portfolios in run-off and to effectively
manage that business in ways that further our primary corporate objective of growing Enstar's net book value per
share.

Acquisition Process

We  evaluate  each  acquisition  and  loss  portfolio  transfer  opportunity  presented  by  carefully  reviewing  the
portfolio’s risk exposures, claim practices, reserve requirements and outstanding claims. Based on this initial analysis,
we can determine if a company or portfolio of business would add value to our current portfolio of run-off businesses.
If we decide to pursue the purchase of a company in run-off, we then proceed to price the acquisition in a manner we
believe will result in positive operating results based on certain assumptions including, without limitation, our ability to
favorably resolve claims, negotiate with direct insureds and reinsurers, manage our investment portfolio and otherwise
manage the nature of the risks posed by the business.

At the time we acquire a company in run-off, we estimate the fair value of assets and liabilities acquired based
on actuarial advice and our views of the exposures assumed. We primarily earn our total return on an acquisition from
disciplined  claims  management  and/or  commuting  the  liabilities  that  we  have  assumed,  maximizing  reinsurance
recoveries on the assumed portfolio of business and investment returns from the acquired investment portfolios.

Run-off Management

Following the acquisition of a company or portfolio of business in run-off, we strive to conduct the run-off in a
disciplined and professional manner to efficiently discharge the liabilities associated with the business while preserving
and maximizing its assets. Our approach to managing our companies and portfolios of business in run-off includes,
where  possible,  negotiating  with  third-party  insureds  and  reinsureds  to  commute  their  insurance  or  reinsurance
agreement (sometimes called policy buy-backs for direct insurance) for an agreed upon up-front payment by us and
to more efficiently manage payment of insurance and reinsurance claims. We attempt to commute policies with direct
insureds or reinsureds to eliminate uncertainty over the amount of future claims. Commutations and policy buy-backs
provide an opportunity for the company to exit exposures to certain policies and insureds generally at a discount to
the ultimate liability and provide the ability to eliminate exposure to further losses. Commutations can also reduce the
duration, administrative burden and ultimately the future cost of the run-off.

In certain lines of business, such as direct workers’ compensation insurance, commutations and policy buy-back
opportunities are not typically available, and our strategy with respect to these businesses is to derive value through
efficient and effective management of claims.

Integral to our success is our ability to analyze, administer, and settle claims while managing related expenses,
such  as  loss  adjustment  expenses  ("LAE").    We  have  implemented  claims  handling  guidelines  along  with  claims
reporting and control procedures in all of our claims units. All claims matters are reviewed regularly, with all material
claims  matters  being  circulated  to  and  authorized  by  management  prior  to  any  action  being  taken.  Our  claims
management processes also include leveraging our extensive relationships and developed protocols to more efficiently
manage outside counsel and other third parties to reduce expenses. With respect to certain lines of business, we have
agreements  with  third-party  administrators  to  manage  and  pay  claims  on  our  subsidiaries’  behalf  and  advise  with
respect to case reserves. These agreements generally set forth the duties of the third-party administrators, limits of
authority, indemnification language designed for our protection and various procedures relating to compliance with
laws and regulations. These arrangements are also subject to review by our relevant claims departments, and we
monitor these administrators on an ongoing basis.

5

Table of Contents

We provide consultancy services to third parties in the insurance and reinsurance industry primarily through our
subsidiaries, the Cranmore companies, Enstar Limited, Enstar (US), Inc., Enstar EU, Paladin Managed Care Services,
Inc. ("Paladin") and Kinsale Brokers Limited. In addition to third-party engagements, our consultancy companies also
perform these services in-house for our Enstar companies, using their expertise to assist in managing our run-off
portfolios and performing certain due diligence matters relating to acquired businesses. The services range from full-
service  incentive-based  or  fixed  fee  run-off  management  to  bespoke  solutions  such  as  claims  inspection,  claims
validation, reinsurance asset collection and IT consulting services. Paladin provides medical bill review, utilization
review, physician case management and related services in the workers’ compensation area. 

Following  the  acquisition  of  a  company  or  the  assumption  of  a  portfolio  of  business  through  a  reinsurance
transaction, we analyze the acquired exposures and reinsurance receivables on a policyholder-by-policyholder basis
to identify those we wish to approach to discuss commutation. In addition, policyholders and reinsurers often approach
us requesting commutation. We then carry out a full analysis of the underlying exposures in order to determine the
attractiveness of a proposed commutation. From the initial analysis of the underlying exposures, it may take several
months, or even years, before a commutation is completed. In certain cases, if we and the policyholder or reinsurer
are unable to reach a commercially acceptable settlement, the commutation may not be achievable, in which case we
will continue to settle valid claims from the policyholder, or collect reinsurance receivables from the reinsurer, as they
arise or become due.

Certain  insureds  and  reinsureds  are  often  willing  to  commute  with  us,  subject  to  receiving  an  acceptable
settlement, as this provides certainty of recovery of what otherwise may be claims that are disputed in the future, and
often provides a meaningful up-front cash receipt that, with the associated investment income, can provide funds to
meet future claim payments or even commutation of their underlying exposure. Therefore, subject to negotiating an
acceptable settlement, many of our insurance and reinsurance liabilities and reinsurance receivables can be either
commuted or settled by way of policy buy-back over time. Properly priced commutations may reduce the expense of
adjusting direct claims and pursuing collection of reinsurance, realize savings, remove the potential future volatility of
claims and reduce required regulatory capital.

We  manage  cash  flow  with  regard  to  reinsurance  recoverables  by  working  with  reinsurers,  brokers  and
professional advisors to achieve fair and prompt payment of reinsured claims, and we take appropriate legal action to
secure receivables when necessary. We also attempt where appropriate to negotiate favorable commutations with our
reinsurers by securing a lump sum settlement from reinsurers in complete satisfaction of the reinsurer’s past, present
and future liability in respect of such claims.

As a result of the number of transactions we have completed over the years, our organizational structure consists
of licensed entities across many jurisdictions. In managing our group, we continue to look for opportunities to simplify
our legal structure by way of company amalgamations and mergers, reinsurance, or other transactions to improve
capital efficiency and decrease ongoing compliance and operational costs over time. In addition, we seek to pool risk
in areas where we maintain the expertise to manage such risk to achieve operational efficiencies, which allows us to
most efficiently manage our assets to achieve capital diversification benefits.

Atrium

Our Atrium  segment  is  comprised  of  the  active  underwriting  operations  and  financial  results  of  Northshore
Holdings Ltd. ("Northshore"), a holding company that owns Atrium and its subsidiaries and Arden Reinsurance Company
Ltd. ("Arden"). Enstar acquired Atrium on November 25, 2013.

Atrium’s wholly-owned subsidiary, Atrium Underwriters Ltd, manages Syndicate 609, which underwrites specialist
insurance and reinsurance business at Lloyd’s. Atrium’s wholly-owned subsidiary, Atrium 5 Ltd., provides 25% of the
underwriting capacity and capital to Syndicate 609, with the balance provided by traditional Lloyd’s Names. Atrium
has offices in London and the United States. Generally, Atrium continues to operate in accordance with the underwriting
and  other  business  strategies  established  pre-acquisition,  although  we  and  Stone  Point  continually  review  these
strategies and business goals and continue to develop synergies with our existing business operations.

Arden is a Bermuda-based reinsurance company that provides reinsurance to Atrium (through a 65% quota
share  reinsurance  arrangement  with Atrium  5  Ltd.,  which  is  eliminated  upon  consolidation)  and  is  currently  in  the
process  of  running  off  certain  other  discontinued  business.  Results  related  to Arden’s  discontinued  business  are
included within our Non-life Run-off segment.

6

Table of Contents

Business Lines 

Syndicate 609 provides insurance and reinsurance on a worldwide basis including the United States, Europe,
the Far East and Australasia. Atrium specializes in a wide range of industry classes, including marine, aviation and
transit,  property  and  casualty  binding  authorities,  reinsurance,  accident  and  health  and  non-marine  direct  and
facultative. Lloyd’s business is often underwritten on a subscription basis across the insurance market. Atrium is the
lead underwriter in approximately 45% of the business it underwrites.

Lloyd’s is a surplus lines insurer and an accredited reinsurer in all U.S. states and territories, and a licensed (or

admitted) insurer in Illinois, Kentucky and the U.S. Virgin Islands.

A description of each of Atrium's lines of business follows:

Marine, Aviation and Transit.    The marine line of business is a worldwide portfolio writing marine hull, marine
war, cargo, fine art and specie, marine and energy liability and total loss only business. Atrium leads a number of the
major marine war contracts in London. Business is written on a direct, reinsurance, proportional and excess of loss
basis. The aviation portfolio includes all aspects of aviation insurance, with Atrium specializing in rotor wing and non-
major airlines. The majority of the account is sourced through London brokers as direct or facultative reinsurance of
a local reinsurer. Included within the marine, aviation and transit lines of business are the upstream energy and terrorism
portfolios. The upstream energy portfolio is split into two main categories of assureds: operators (private and publicly
quoted companies, national oil companies and Oil Insurance Limited members) and contractors (drilling, service and
construction  companies).  The  principal  coverage  is  physical  damage/business  interruption,  control  of  well  and
associated pollution, construction and Gulf of Mexico windstorm and other natural catastrophe perils. Nearly all of the
upstream energy line of business is sourced through Lloyd’s brokers, with the significant majority written on a facultative
basis and a smaller amount written on a treaty basis. The terrorism portfolio includes political violence, strikes, riots
and civil commotion, and war on land business. Most of the business is located in the U.K., the U.S. and the European
Economic Area.

Binding Authorities.    The property and casualty binding authority portfolio includes a broad range of small and
medium business entity insurance products offered across the United States and Canada. Typical property risks include
commercial,  vacant  and  hard-to-place  residential  dwellings.  Typical  casualty  risks  include  owners,  landlords  and
tenants,  business  owners,  artisan,  special  events  and  various  niche  products.  Business  is  written  through  both
traditional binding authorities as well as online binding authorities through AUGold, Atrium’s proprietary online system
that is used by brokers. The liability line of business includes a professional liability portfolio of products covering a
diverse range of classes including architects, consultants and lawyers and also a miscellaneous range encompassing
many different professions. Included within this line of business is international general liability, which is a book of
primary coverholder business covering the security, leisure and hotel industries. The majority of business is produced
through delegated binding authority contracts.

Reinsurance.        The  reinsurance  line  is  a  worldwide  portfolio  and  includes  aviation  reinsurance,  casualty
reinsurance,  property  reinsurance,  and  marine  reinsurance.  Business  is  mainly  written  on  a  risk  excess  of  loss,
catastrophe excess of loss or retrocessional basis. Aviation reinsurance is written through an underwriting consortium
managed by Atrium.

Accident and Health.    The accident and health line is a global account that encompasses a wide range of
classes,  including  group  and  individual  disability,  personal  accident,  travel  insurance,  medical  expenses,  aviation
personal accident, war risks, kidnap and ransom insurance, and sports accident insurance. The line includes both
insurance and reinsurance business, written as facultative placements and under delegated underwriting facilities and
both proportional and non-proportional treaties.

Non-Marine Direct and Facultative.    The non-marine direct and facultative portfolio includes a diverse mix of
property business offered in both the international and U.S. markets, comprised of physical loss or damage, business
interruption, extra expense, construction, contingency and pecuniary loss risks in respect of onshore property and
onshore engineered risks. The majority of this line of business is written through Lloyd’s brokers and under delegated
underwriting facilities.

7

Table of Contents

Distribution

All  of  the  business  in  the Atrium  segment  is  placed  through  insurance  and  reinsurance  brokers,  and  a  key
distribution channel for Syndicate 609 is the managing general agent binding authorities. Atrium seeks to develop
relationships with insurance and reinsurance brokers, insurance and reinsurance companies, large global corporations
and financial intermediaries to develop and underwrite business. Independent broker Marsh Inc. accounted for 13%
of Atrium’s gross premiums written in 2019. Other brokers (each individually less than 10%) accounted for the remaining
87% of gross premiums written.

Atrium’s proprietary online platform, AUGold, provides end-to-end processing, quote and policy production for
managing general agents across a range of classes of business.  The platform provides agents with efficient and cost
effective access to Lloyd’s binding authorities and is designed to enable Atrium to compete more effectively with North
American excess and surplus lines carriers.

Managing Agency Services

Atrium receives a managing agency fee of 0.7% of Syndicate 609 capacity and a 20% profit commission based
on the net earnings of Syndicate 609, pursuant to its management contract. Atrium also receives management fees
and  profit  commission  from  the  management  of  underwriting  consortiums.  These  fees  and  profit  commission  are
included within fees and commission income in our consolidated statement of earnings.

Claims Management

Claims in respect of business written by Syndicate 609 are primarily notified by various central market bureaus.
Where a syndicate is a "leading" syndicate on a Lloyd’s policy, its underwriters and claims adjusters work directly with
the broker or insured on behalf of itself and the following market for any particular claim. This may involve appointing
attorneys or loss adjusters. The claims bureaus and the leading syndicate advise movement in loss reserves to all
syndicates participating on the risk. If necessary, Atrium's claims department may adjust the case reserves it records
from those advised by the bureaus.

Reinsurance Ceded

On an annual basis Atrium purchases a tailored outwards reinsurance program designed to manage its risk
profile. The majority of Atrium’s third-party reinsurance cover is with Lloyd’s Syndicates or other highly rated reinsurers.

StarStone

Our StarStone segment is comprised of the active underwriting operations and financial results of StarStone
and  StarStone  Specialty  Holdings  Limited  ("StarStone  Group"),  a  holding  company  that  owns  StarStone  and  its
subsidiaries.  Our  StarStone  segment  also  includes  various  intra-group  cessions  and  the  results  of  KaylaRe's
reinsurance of StarStone Group from May 14, 2018, the date on which we completed the acquisition of KaylaRe. Refer
to Note 3 - "Acquisitions" in the notes to our consolidated financial statements included within Item 8 of this Annual
Report on Form 10-K for additional information. Effective September 30, 2019, KaylaRe and KaylaRe Ltd. merged
with Cavello Bay Reinsurance Limited, our wholly-owned subsidiary, with Cavello Bay Reinsurance Limited as the
surviving company.

We acquired StarStone (formerly known as Torus) on April 1, 2014 in partnership with Trident (managed by
Stone Point). Dowling also has a minority investment. StarStone’s strategy emphasizes underwriting discipline and
focuses on profitable lines and improvement of operational effectiveness and efficiency.  

StarStone is a global specialty insurer operating worldwide from key underwriting hubs in the Lloyd's and London
markets, Bermuda, Continental Europe, and the United States. StarStone has five wholly-owned insurance platforms
and licenses to serve a global client base. In December 2017, the London market and European business were merged
into a single European entity based in Liechtenstein. This was executed in order to improve operational efficiencies
and position the StarStone group post-Brexit. Through Syndicate 1301, StarStone offers a variety of specialty products
at Lloyd’s. Syndicate 1301 is managed by StarStone's wholly-owned Lloyd’s managing agency. 

In  2018,  we  appointed  new  executive  leadership  at  StarStone,  and  we  made  progress  in  repositioning  the
underwriting portfolio in 2019 to reflect market opportunities and to achieve a mix of business for improved underwriting
profitability. We will continue to focus on profitable lines, taking action to remediate certain lines that we wish to continue
writing and exiting lines of business that we no longer find attractive. As part of these remediation efforts we have
closed the StarStone offices in Australia, Hong Kong and Zurich and have disposed of our investment in Malakite
Underwriting Partners Ltd, a Dubai-based managing general agent.  

8

Table of Contents

Business Lines

StarStone offers a broad range of property, casualty and specialty insurance products to both large multi-national

and small and middle-market clients around the world. A description of StarStone's business lines is as follows:

Casualty.    Casualty is StarStone's largest product group, including StarStone’s U.S. excess casualty, global
management and professional liability, global healthcare, and accident and health products. The U.S. excess casualty
product includes umbrella, excess and retained limit products across a wide range of market segments focused on
small to mid-market businesses. The global management and professional liability product specializes in directors and
officers  and  professional  liability  protection  for  both  traditional  and  emerging  professions.  Our  healthcare  product
provides insurance for acute care centers, nursing homes, physician groups, senior living facilities, and others. The
accident and health product provides protection for a broad range of groups and individuals such as air crew personal
accident and loss of license, accidental death and permanent and temporary disability for individuals including athletes
and high net worth individuals.

Marine.    We provide a broad range of marine and specialty products including hull and machinery, marine and
energy liabilities, cargo, war, transport, specie and fine art, and terrorism. These products are written through Lloyd's
Syndicate 1301, our European branch network and by some of our U.S. based teams. We also provide high excess
casualty coverage placed in the London wholesale market which is focused on high excess layers for Fortune 500
companies.

Property.    This line includes all of our property insurance products. The run-off construction portfolio focuses
on large, complex, infrastructure and contractor cover across all risk areas.  Property also includes our onshore, power,
and upstream and offshore products written through our Lloyd's and London platforms.  Most lines are written on a
full value, primary, excess of loss or quota share basis.

Aerospace.    We serve a diverse client base within the aerospace sector including airlines, aircraft manufacturers
and airport service providers. Our products are split between short-tail and long-tail risks and by aircraft type into three
areas: airlines, aviation products and liability, and general aviation.

Workers' compensation.    This line provides workers' compensation solutions for a range of industries, including
energy and maritime businesses to high-hazard operations. We also cover cross-state, multi-jurisdictional exposures
in single policies. Business is written directly with clients and through partnerships with independent agents, managing
general underwriters, and select wholesale brokers throughout the United States.

Distribution 

StarStone's distribution strategy is to focus on proximity to clients and brokers, using its Lloyd’s platform, European
branch distribution network, its U.S. wholesale distribution strategy, as well as its relationships with insurance and
reinsurance brokers and risk carriers, corporations and financial intermediaries. 

Syndicate 1301 can conduct business in over 200 countries and territories worldwide. In addition to underwriting
business directly at Lloyd’s in London, it provides local access to Lloyd’s in Continental Europe and the United States.

In the United States, products are written locally through our admitted and excess and surplus lines carriers.
Our  U.S.  strategy  also  utilizes  our  online  e-commerce  broker  portal,  ESCAPE,  which  offers  immediate  wholesale
distribution to all 50 states. 

Business in the StarStone segment is generally placed through insurance and reinsurance brokers and managing
general agents. Independent broker Marsh Inc. accounted for 15% of StarStone’s gross premiums written for the year
ended December 31, 2019. Other brokers and managing general agents (each individually less than 6%) accounted
for the remaining 85% of gross premiums written.

Claims Management 

Claims in respect of business written by Syndicate 1301, as well as in respect of StarStone’s other London
market business, are primarily notified by various central market bureaus whereby the leading syndicate or company
advise all participants of movement in loss reserves. StarStone’s claims department adjusts bureau claims in respect
of coverages where StarStone is the lead underwriter and may choose to adjust the case reserves it records from
those advised by the bureaus.

9

Table of Contents

Claims  in  respect  of  non-bureau  business  are  handled  by  StarStone’s  experienced  claims  professionals.
StarStone  uses  claims  handling  guidelines  along  with  a  global  claims  management  system  to  review,  report  and
administer claims. With respect to certain lines of business, StarStone may use third-party administrators to manage
and pay claims on its behalf and advise with respect to case reserves. StarStone also utilizes Enstar’s experience in
claims management. 

Reinsurance Ceded 

StarStone purchases an annual tailored outwards reinsurance program designed to manage its risk profile. The
majority of StarStone’s third party reinsurance cover is with highly rated reinsurers or is collateralized by letters of
credit. Several of the StarStone affiliates previously had entered into a Quota Share Treaty with KaylaRe Ltd. pursuant
to  which  KaylaRe  Ltd.  reinsured  35%  of  all  business  written  by  these  StarStone  affiliates  for  risks  attaching  from
January 1, 2016, net of the StarStone affiliates' reinsurance programs. The portion of this quota share agreement
related to U.S. business was not renewed in 2018, and the remainder was not renewed in 2019. On May 14, 2018,
Enstar acquired all of the outstanding shares and warrants of KaylaRe, and the results of KaylaRe were included within
our consolidated financial statements from that date. Effective September 30, 2019, KaylaRe and KaylaRe Ltd. merged
with our wholly owned subsidiary, Cavello Bay Reinsurance Limited, with Cavello Bay Reinsurance Limited as the
surviving company.

In addition, effective October 1, 2018, April 1, 2019 and October 1, 2019 the StarStone Group transferred all
lines of business for 2018 and prior underwriting years and construction line of business for 2019 underwriting year
via  intra-group  reinsurance  agreements  with  other  Enstar  group  subsidiaries.  For  a  detailed  discussion  of  these
transactions refer to "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation
- Business Overview - Current Outlook."

Other activities

Our other activities, which do not qualify as a reportable segment, include our corporate expenses, debt servicing
costs, holding company income and expenses, foreign exchange and other miscellaneous items. Following the sale
of our life settlements investments during 2018 and the transfer of our remaining life assurance policies from Alpha to
Monument in 2019, we have de minimis residual life business in our consolidated operations.

10

Table of Contents

Liability for Losses and Loss Adjustment Expenses 

The  liability  for  losses  and  LAE,  also  referred  to  as  loss  reserves,  represents  our  gross  estimates  before
reinsurance for unpaid reported losses and losses that have been incurred but not reported ("IBNR") for our Non-life
Run-off, Atrium and StarStone segments. We recognize an asset for the portion of the liability that we expect to recover
from reinsurers. LAE reserves include allocated loss adjustment expenses ("ALAE"), and unallocated loss adjustment
expenses ("ULAE"). ALAE are linked to the settlement of an individual claim or loss, whereas ULAE are based on our
estimates of future costs to administer the claims. IBNR represents reserves for loss and LAE that have been incurred
but not yet reported to us.  This includes amounts for unreported claims, development on known claims and reopened
claims.

We establish reserves for individual claims incurred and reported, as well as IBNR claims.  We use considerable
judgment  in  estimating  losses  for  reported  claims  on  an  individual  claim  basis  based  upon  our  knowledge  of  the
circumstances  surrounding  the  claim,  the  severity  of  the  injury  or  damage,  the  jurisdiction  of  the  occurrence,  the
potential for ultimate exposure, the type of loss, and our experience with the line of business and policy provisions
relating to the particular type of claim.  We also use considerable judgment to establish reserves for IBNR claims using
a variety of generally accepted actuarial methodologies and procedures to estimate the ultimate cost of settling IBNR
claims.  See "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical
Accounting Policies - Losses and Loss Adjustment Expenses" for a description of our loss reserving process.

The estimation of unpaid claim liabilities at any given point in time is subject to a high degree of uncertainty for
a number of reasons. A significant amount of time can lapse between the assumption of risk, the occurrence of a loss
event, the reporting of the event to an insurance or reinsurance company and the ultimate payment of the claim on
the  loss  event.  Our  actuarial  methodologies  include  industry  benchmarking  which,  under  certain  methodologies,
compares the trend of our loss development to that of the industry. To the extent that the trend of our loss development
compared to the industry changes in any period, it is likely to have an impact on the estimate of ultimate liabilities.
Unpaid claim liabilities for property and casualty exposures in general are impacted by changes in the legal environment,
jury awards, medical cost trends and general inflation. Certain estimates for unpaid claim liabilities involve considerable
uncertainty  due  to  significant  coverage  litigation,  and  it  can  be  unclear  whether  past  claim  experience  will  be
representative  of  future  claim  experience.  Ultimate  values  for  such  claims  cannot  be  estimated  using  reserving
techniques  that  extrapolate  losses  to  an  ultimate  basis  using  loss  development  factors,  and  the  uncertainties
surrounding the estimation of unpaid claim liabilities are not likely to be resolved in the near future. In addition, reserves
are established to cover loss development related to both known and unasserted claims. Consequently, our subsequent
estimates of ultimate losses and LAE, and our liability for losses and LAE, may differ materially from our initial estimates.

In our Non-life Run-off segment, policy buy-backs and commutations provide an opportunity for us to exit and
settle exposures to policies with insureds and reinsureds, often at a discount to the previously estimated ultimate
liability. Commutations are beneficial to us as they extinguish liabilities, reduce the potential for future adverse loss
development,  and  reduce  future  claims  handling  costs.  Our  estimates  of  ultimate  claim  liabilities,  including  IBNR
reserves, are based upon actuarial methodologies applied to the remaining non-commuted aggregate exposures and
revised historical loss development information, after adjusting for the elimination of historical loss development relating
to commuted and bought-back exposures. In addition, the routine settlement of claims, at either below or above the
carried advised loss reserve, updates historical loss development information to which actuarial methodologies are
applied often, resulting in revised estimates of ultimate liabilities. A large portion of our loss reserves are related to
workers' compensation and casualty exposures, which include latent exposures primarily relating to asbestos and
environmental damage. In establishing reserves, we consider facts currently known and the current state of the law
and coverage litigation. Case reserves are recognized for known claims (including the cost of related litigation) when
sufficient information has been developed to indicate the involvement of a specific insurance policy.

Further  information  regarding  the  liability  for  net  losses  and  LAE,  including  loss  development  tables  and  a
reconciliation of activity, is included in the notes to our consolidated financial statements included within Item 8 of this
Annual Report on Form 10-K.

Further information regarding net incurred losses and LAE is included in "Item 7. Management’s Discussion and

Analysis of Financial Condition and Results of Operations - Results of Operations by Segment."

11

Table of Contents

Inception-to-Date Acquisition Loss Development for our Non-life Run-off segment 

The table below sets forth a summary of acquired and assumed net reserves and the resulting development for the 10 most recent acquisition years for our

Non-life Run-off segment:

Acquired
and
Assumed
Net
Reserves

Acquisition
Year

Net Paid
Losses

Net Loss
Development

Net Losses
recognized
on
Acquired
Unearned
Premium

Amortization
of Deferred
Charge
Assets

Change in
provisions
for bad
debt

Change in
provisions
for ULAE

Amortization
of Fair Value
Adjustments

Change
in Fair
Value -
FVO

Total Net
Incurred
losses and
LAE

Retro-
cession
of
reserves

Effect of
Exchange
Rate
Movement

Closing
Net
Reserves

Total Net Incurred Losses and LAE

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

1,245,093

(673,762)

712,867

422,476

657,982

465,395

(70,603)

(240,113)

(511,796)

(361,293)

(320,522)

(315,984)

(77,699)

—

—

—

(109,537)

110,285

(16,600)

1,491,256

(776,646)

(475,300)

1,350,463

(463,203)

1,504,561

(349,899)

2,873,675

(999,944)

1,586,993

(188,463)

6,762

(170,459)

(133,561)

(23,377)

62,404

53,481

—

—

68,518

54,601

(in thousands of U.S. dollars)

243

—

—

—

—

220,310

4,232

—

8,320

17,754

(29,003)

(31,096)

(242)

(127)

1,752

56

(542)

125

—

—

(50,008)

(53,369)

(9,004)

(6,417)

4,823

(76,486)

(8,158)

(32,974)

(46,376)

(7,759)

21,490

(22,001)

(9,132)

(29,909)

(44,964)

16,444

—

(1)

—

—

—

—

—

—

—

104,015

32,139

51,013

(377,800)

(8,274)

(28,647)

(422,450)

(90,104)

(2,373)

(96,077)

—

(25,605)

(35,705)

(28,391)

7,415

—

(4,553)

(3,269)

(261,495)

(50,466)

(13,117)

156,610

127,337

60,681

77,537

108,248

389,532

897,780

2,294

(99,294)

(19,947)

—

—

—

8,226

55,653

1,111,021

(49,971)

1,803,813

—

(927)

40,292

(47,018)

16,082

1,407,886

$12,310,761

$(4,635,722) $ (1,636,277) $

349,289

$

250,859

$

(59,077) $ (285,728) $

(35,934) $154,101

$(1,262,767) $(224,253) $ (47,574) $ 6,140,445

2009 and prior

Total Net Non-life Run-off Liability for Losses and LAE

338,840

$ 6,479,285

The above table presents the assumed and acquired net reserves in the year they were assumed or acquired in our Non-life Run-off segment, including the
impact of any fair value adjustments due to business combinations or electing the fair value option, deferred charge assets and unallocated LAE. The table also
presents the cumulative roll forward of those acquired and assumed net reserves from the year of acquisition to December 31, 2019. As such, each acquisition year
reflects a different time period and therefore impacts the comparability between acquisition years. We generally do not experience significant favorable or adverse
development on acquired or assumed net reserves in the year of acquisition. After the first year, and following detailed reviews of all open claims, we primarily earn
our total return from disciplined claims management and/or commuting the liabilities and maximizing reinsurance recoveries, in addition to maximizing investment
returns on the investment portfolio. 

12

Table of Contents

Investments

For  information  regarding  our  investment  strategy,  portfolio  and  results,  refer  to  "Item 7.  Management’s

Discussion and Analysis of Financial Condition and Results of Operations - Investments."

Ratings

In our active underwriting businesses, financial strength ratings are an important factor in establishing competitive
position and in product marketing. Financial strength ratings by third-party organizations provide an opinion of an
insurer’s or reinsurer’s financial strength and ability to meet ongoing obligations to its policyholders. These ratings
reflect  A.M.  Best’s,  Standard  and  Poor’s  ("S&P"),  and  Fitch  Ratings  Ltd.’s  ("Fitch")  opinions  of  capitalization,
performance and management, and are not a recommendation to buy, sell or hold securities. These ratings may be
changed, suspended or withdrawn at the discretion of the agencies. Rating agencies charge fees for their services.

Our Lloyd’s Syndicates 609 (Atrium) and 1301 (StarStone) are part of a group rating for the Lloyd's overall
market. Lloyd’s is rated "A" (Excellent) by A.M. Best, "A+" (Strong) by Standard and Poor’s (or S&P) and "AA-" (Very
Strong) by Fitch Ratings. 

StarStone’s operating insurance entities have been assigned a financial strength rating of "A-" (Excellent) by
A.M. Best. The A.M. Best rating for StarStone of "A-" (Excellent) by A.M. Best is the fourth highest of 16 rating levels.

Refer to "Item 1A. Risk Factors - Downgrades of financial strength ratings at StarStone or Lloyd’s could materially
and  negatively  impact  our  active  underwriting  business  and  our  company,"  for  more  information  regarding  the
importance of financial strength ratings.

Competition

Our Non-life Run-off segment competes in international markets with domestic and international reinsurance
companies to acquire and manage insurance and reinsurance companies in run-off and portfolios of insurance and
reinsurance  business  in  run-off. The  acquisition  and  management  of  companies  and  portfolios  in  run-off  is  highly
competitive, and driven by a number of factors, including proposed acquisition price, reputation, and financial resources.
Some of these competitors may have greater financial resources than we do, may have been operating for longer than
we have and may have established long-term and continuing business relationships throughout the insurance and
reinsurance industries, which can be a significant competitive advantage. As a result, we may not be able to compete
successfully in the future for suitable acquisition candidates or run-off portfolio management engagements.

Our  Atrium  and  StarStone  active  underwriting  segments  operate  in  the  highly  competitive  insurance  and
reinsurance markets, where companies compete on the basis of premium rates, reputation and perceived financial
strength, the terms and conditions of the products offered, ratings assigned by independent rating agencies, speed of
claims payments and quality of administrative services, relationships with insurance and reinsurance companies and
insurance  intermediaries,  capacity  and  coverage  offered,  experience  in  the  particular  risk  to  be  underwritten,  and
various other factors.

Atrium and StarStone compete in the international insurance and reinsurance markets directly with numerous
other parties, including established global insurance and reinsurance companies, start-up insurance and reinsurance
entities, other Lloyd’s syndicates, as well as capital markets and securitization structures aimed at managing risk.
Many of these competitors have significant operating histories, underwriting expertise and capacity, extensive capital
resources, and longstanding customer relationships. Any of these factors can be a significant competitive advantage
and may make it difficult for us to write business effectively and profitably. Because few barriers exist to prevent insurers
and reinsurers from entering the non-life active underwriting business, market conditions and capital capacity influence
the degree of competition at any given time. For a detailed discussion of competition and the cyclical pattern of the
insurance and reinsurance market, refer to "Item 1A. Risk Factors - Risks Relating to our Insurance Businesses." The
cyclical market pattern can be more pronounced in the specialty insurance and reinsurance markets in which Atrium
and StarStone compete.

Employees

As of December 31, 2019, we had 1,444 employees, as compared to 1,366 as of December 31, 2018. Although
our employee count was not significantly changed from last year, it may not be consistent from period to period due
to our business strategies, which include anticipated ongoing acquisition and integration activities. 

13

Table of Contents

Enterprise Risk Management 

Effective risk oversight is an important priority for our management and our Boards of Directors (both at the
Company level and at a subsidiary level), and we place strong emphasis on ensuring we have a robust risk management
framework to identify, measure, manage, monitor and report on risks that affect the achievement of our strategic,
operational and financial objectives.

An effective enterprise risk management ("ERM") framework contributes to the strength of our overall group (the
"Group"). The value of having effective risk management can positively impact many areas of the business such as
setting  and  achieving  business  strategy  and  objectives,  capital  management  decision  making,  efficiency  and
effectiveness  in  operations  and  processes,  financial  performance  and  reliable  financial  reporting,  regulatory
compliance, good reputation with key stakeholders and business continuity planning.

Risk Management Strategy

Our risk management strategy is to:

•

•

engage in highly disciplined acquisition, management and (re)insurance practices across a diverse portfolio
of loss reserves;

seek investment risk where it is adequately rewarded;

• maintain reserving risk at low to moderate levels;

•

via active underwriting segments, take on underwriting risks across a balanced range of select specialty
lines where the expected margins compensate for the risk and/or the costs of risk mitigation; and

• maintain capital, liquidity, credit, operational and regulatory risks at low levels. 

These strategies are pursued through the use of appropriate controls, governance structures and highly skilled

teams effectively working together.  

We embed our risk strategy in our organization by promoting a culture of high risk awareness.  This is achieved
in the demonstration of our day-to-day approach in how we manage our business and in how we manage and assess
challenges and opportunities. 

Risk Appetite

The primary objective of our risk appetite framework is to monitor and protect the Group from an unacceptable
level of loss, compliance failures and adverse reputational impact. It considers material risks in the business relating
to:  strategy,  capital  adequacy,  insurance,  investment/market,  reinsurance  counterparty/credit,  regulatory,  tax  and
operational risk. Risk appetite and tolerance is set by our Board and reviewed annually. It represents the amount of
risk  that  we  are  willing  to  accept  as  a  Group  compared  to  risk  metrics  based  on  our  shareholders'  equity,  capital
resources, potential financial loss, and other risk-specific measures.

Accountability for the implementation, monitoring and oversight of risk appetite is assigned to individual corporate
executives and monitored and maintained by the Risk Management function. Risk tolerance levels are monitored and
deviations from pre-established levels are reported in order to facilitate responsive action.

Our subsidiary companies’ risk appetite frameworks are aligned with the risk appetite framework of the Group,
while local company appetite and tolerances are set by the local boards. A review is undertaken annually to confirm
the subsidiary risk appetite does not in the aggregate exceed Group risk appetite.

Risk  metrics  levels  are  set  and  monitored  regularly  by  an  appointed  owner  and  reported  to  management
committees and to our Board and Risk Committee on at least a quarterly basis. Stress and scenario tests are key tools
within our risk appetite framework, used as risk indicators across risk categories and to support a forward looking
assessment of risk. As part of monitoring and aggregating risk exposures across the Group, capital impact assessments
are performed for risks that are deemed material. 

14

Table of Contents

Risk Governance and Risk Management Organization

Our ERM framework consists of numerous processes and controls that have been designed by management,
with oversight by the Board of Directors and its committees, and implemented by employees across the organization.
The purpose of our ERM framework is to appropriately assess and manage risk as we continue to take opportunities
to meet our business objectives. Senior executives are ultimately accountable for key defined risks and are responsible
for providing regular reporting to the Group Executive Team (our "executives"), Management Risk Committee ("MRC"),
Board Risk Committee and Board; and to facilitate the same to subsidiary committees and boards to support decision
making and strong risk governance. The collective boards, management and employees are responsible for the effective
implementation and/or operation of processes and controls.

Board of Directors

Our Board and its committees (and subsidiary boards of directors) receive management information from our
executives, Board committees and management committees relating to performance against strategy and regularly
review information regarding, among other things, acquisitions, active underwriting, loss reserves, credit, liquidity and
investments, operations and information security and the risks associated with each. 

Our Risk Committee has responsibility to assist the Board in overseeing the integrity and effectiveness of the
Company’s ERM framework, including by reviewing and evaluating the risks to which the Company is exposed, as
well  as  monitoring  and  overseeing  the  guidelines  and  policies  that  govern  the  processes  by  which  the  Company
identifies,  assesses  and  manages  its  exposure  to  risk.  Our  Audit  Committee,  comprised  entirely  of  independent
directors, oversees our accounting and financial reporting-related risks and internal control environment, receiving
regular  reports  via  the  annual  internal  and  external  audit  process.  Our  Investment  Committee  is  responsible  for
overseeing  the  Company’s  investment  portfolio  and  investment-related  risk,  determining  the  Group’s  investment
strategy and guidelines and approving investment transactions in accordance with these guidelines. Our Compensation
Committee oversees compensation-related risks. On an annual basis, the Compensation Committee undertakes a
risk assessment of our compensation programs to ensure they do not provide incentives for our employees to take
inappropriate or excessive risks. Our Nominating and Governance Committee considers risk relating to management
succession planning and other corporate governance matters.

Executive and Risk Management Organization

In addition to the director oversight provided by our Risk Committee, our ERM governance structure is supported
by our MRC comprising executives and members of senior management who are responsible for the management of
key risks and representatives from assurance functions.  At the operating subsidiary level, risks relating to our individual
insurance  and  reinsurance  subsidiaries  are  also  overseen  by  the  subsidiary  boards  of  directors,  subsidiary  risk
committees and other committees, and management teams, consistent with applicable regulatory requirements and
our ERM framework. 

The MRC is chaired by the Chief Operating Officer and meets regularly. The MRC discusses, challenges and
debates the risks in the business and those emerging and where required recommends changes to the course of
activity in reacting to these risks. The MRC also provides oversight and governance of ERM matters for the Group,
monitoring risk assumption and risk mitigation activities and their consistency with the Risk Appetite Framework while
promoting and sponsoring risk culture and awareness throughout the Group. 

Risk Ownership, Accountability and Assurance

We have adopted the "three lines of defense" model.  Our first line consists of our executives and members of
senior  management  and  their  function  as  leaders  and  risk  owners.  They  are  responsible  for  executing  the  risk
management strategy and appropriately managing the activities and conduct of the business functions, as well as
promoting staff understanding of strategy, risk mitigating policies and procedures. 

Our second line comprises our various risk, control and compliance oversight functions. Our Risk Management
function  reports  to  our  executives,  the  MRC  and  our  Risk  Committee  and  focuses  primarily  on  implementing  and
overseeing the administration of the MRC and Risk Committee directives and facilitating an efficient, effective and
consistent approach to risk management across the Group. Our management assurance is further complemented by
our compliance function which seeks to mitigate legal and regulatory compliance risks and ensures that appropriate,
effective and responsive compliance services are available to the business units across the Group. Other second line
functions include certain activities of our actuarial function and other Group functions contributing to our management
assurance. 

15

Table of Contents

Our third line of defense comprises our internal audit function which independently reviews the effectiveness of
our ERM framework. The results of audits are monitored by the Audit Committee.  Independent assurance from external
third parties (e.g., independent actuarial services, etc.) also sits within our third line of defense.

Entity Level Management

At the operating subsidiary level, risks relating to our individual insurance and reinsurance subsidiaries are also
overseen by the subsidiary boards of directors, subsidiary risk committees and other committees, and management
teams, consistent with applicable regulatory requirements and our ERM framework.

Certain risks relating to the Group’s underwriting segments (Atrium and StarStone) are distinct from the Non-
life  Run-off  segment.  These  businesses  include  external  stakeholders  that  also  differ  from  our  other  businesses,
including joint venture partners, rating agencies, and, with respect to Atrium, third party Lloyd’s names who provide
approximately  75%  of  the  underwriting  capacity  to Atrium’s  Syndicate  609. Atrium  and  StarStone  each  maintain
dedicated ERM frameworks to manage risk, return and capital in the individual businesses, which align with and form
part of Group ERM. These include oversight at the Atrium and StarStone boards of directors, as well as executive risk
committees and other committees that manage and monitor risks relevant to specified functional areas. Individualized
risk policies and risk appetites are established and tailored to the specific needs of Atrium and StarStone, respectively.
Enstar executives serve as members of the Atrium and StarStone boards of directors and certain committees.

The Group and each regulated insurance entity have a unique risk register documenting its risk landscape, with
risk, key risk metric, and control owners assigned, which is maintained through a risk management software system.
Specific functions, such as IT, maintain risk registers with more detailed and specific risks and controls. The risk and
control assessment process is carried out on a quarterly basis using a risk management software system. 

Risk Categories

We manage our ERM process based on the major categories of risk within our business discussed below. Our
ERM is a dynamic process, with updates continually being made as a result of changes in our business, industry and
the economic environment. This process and our controls cannot provide absolute assurance that our risk management
objectives will be met or that all risks will be appropriately identified and managed, and accordingly, the possibility of
material adverse effects on our company remains. See "Item 1A. Risk Factors" for important information on the risks
we face.

Strategic Risk.    Strategic risk is the risk of unintended adverse impact on the business plan objectives arising
from business decisions, improper implementation of those decisions, inability to adapt to changes in the external
environment, or circumstances that are beyond our control. We manage strategic risk by utilizing a strategic business
planning process involving our executives and Board. Our annual business plan is reviewed and overseen by our
executives and Board, and actual performance, trends, and uncertainties are monitored in comparison to the plan
throughout the year. We specifically evaluate acquisition opportunities pursuant to a detailed and proprietary process
that  takes  into  account,  among  other  things,  the  risk  of  the  transaction  and  potential  returns,  the  portfolio’s  risk
exposures, claims management practices, reserve requirements and outstanding claims, as well as risks specifically
related to our ability to integrate the acquired business and the impact it may have on our risk appetite framework and
related  tolerances.  Our  governance  process,  led  by  our  Board  of  Directors,  reviews  newly  proposed  transaction
opportunities, capital-raising matters, and other significant business initiatives. In order to effectively participate in
future  opportunities  and  manage  downside  risks  (due  to  external  events)  we  review  and  monitor  our  liquidity  and
available financing. We rely on our processes to help us to anticipate potential adverse changes and, where possible,
avoid or mitigate them.

Capital Adequacy Risk.    Capital adequacy risk is the risk that capital levels are or become insufficient to ensure
our insurance obligations will be met and policyholders are protected. We have a low appetite for capital adequacy
risk. As well as meeting our regulatory obligations, the ability to effectively participate in future opportunities is dependent
upon the Group and its subsidiaries continually meeting (and/or exceeding) solvency requirements. We endeavor to
manage our capital such that all of our regulated entities meet local regulatory capital requirements at all times and
maintain adequate capital to enable our insurance obligations to be met while taking into account the risks faced.  We
aim to deploy capital efficiently and to establish adequate loss reserves that we believe will protect against future
adverse developments. Capital adequacy and its ability on an ongoing basis to support the business under adverse
circumstances  is  assessed  via  stress  and  scenario  testing.  Specific  scenarios  are  mandated  under  the  various
regulatory regimes in which the Group and its subsidiaries operate. User-defined scenarios have also been developed
and are regularly tested and reported on.

16

Table of Contents

Insurance Risk.    Insurance risk spans many aspects of our insurance operations, including underwriting risk,

risk assumed upon acquisitions/portfolio transfers and risk associated with our reserving assumptions. 

Underwriting risk in our active underwriting businesses relates to the inherent uncertainty as to the occurrence,
amount and timing of insurance liabilities we assume through our underwriting process. We manage exposure levels
across risk categories to maintain them within the approved risk appetite. Underwriting risk management strategies
may differ depending on the line of business involved and the type of account being insured or reinsured. 

We  strive  to  mitigate  underwriting  risk  through  our  controls  and  strategies,  including  our  underwriting  risk
selection, diversification of our underwriting portfolios by class and geography, purchasing reinsurance, establishing
a business plan and associated parameters, underwriting peer review, authority limits, underwriting guidelines that
provide detailed underwriting criteria and a framework for pricing, along with the use of specialized underwriting teams
supported by actuarial, catastrophe modeling, claims, risk management, legal, finance, and other technical personnel.

We utilize internally developed pricing models to evaluate individual underwriting decisions within the context
of business plans and risk appetites. We also use internally developed capital models, which provide information on
key risks and facilitate an understanding of the interaction among the risks and related exposures, as a comprehensive
tool for business and capital planning. 

In some business lines we are exposed to multiple insured losses arising out of a single peril, such as a natural
catastrophe  event  (for  example,  a  hurricane,  windstorm,  tornado,  flood  or  earthquake)  or  a  man-made  event  (for
example, war, terrorism, airplane crashes and other transportation-related accidents, or building fires). We model and
manage our individual and aggregate exposures to these events and other material correlated exposures in accordance
with our risk appetite. Our modeling process utilizes major commercial vendor models to measure certain of these
exposures. The incidence, timing and severity of catastrophes and other event types are inherently unpredictable, and
it is difficult to estimate the amount of loss any given occurrence will generate. Accordingly, there is material uncertainty
around our ability to measure exposures, which can cause actual exposures and losses to deviate from our estimates.

To monitor catastrophe risk, we review exceedance probability curves aggregated across Atrium and StarStone
together with aggregated realistic disaster scenarios. We consider occurrence exceedance probability and aggregate
exceedance probability, which reflect losses resulting from single or multiple events, from individual perils and in the
aggregate. We manage our underwriting exposure through a combination of reporting zonal aggregations, realistic
disaster scenarios and stochastic modeling. StarStone also manages its underwriting exposure through monitoring
realistic disaster scenarios for man-made events and certain natural catastrophe risks, and applying absolute maximum
limits by line of business. 

Acquisition Risk.    We manage acquisition risks through our acquisition evaluation process and our reserving
practices discussed above in "Liability for Losses and Loss Adjustment Expenses." Acquisition pricing risk can arise
from a potential loss in value following an acquisition due to an underestimation of liabilities, a failure to generate
assumed future cash flows that supported the pricing analysis (due to an underperformance of investments and/or
underestimation of expenses) or an unexpected increase in capital requirements necessary to support the transaction
due to unanticipated regulatory changes. We rely on due diligence to strategically select risks, and assume only select
portfolios when our due diligence supports our negotiated pricing. In aggregate, we have a high risk appetite to continue
to execute transactions, with no express restrictions on the size, geography or lines of business that we will review
and consider. However, we have a low aggregate risk appetite for transactions that could ultimately have a negative
impact on book value per share. 

Reserving Risk.    Reserving risk is the risk that a Company's reserves are not sufficient to cover its unpaid loss
and loss adjustment expense costs. The estimation of reserves is subject to uncertainty because the ultimate cost of
settling claims is dependent upon future events and loss development trends that can vary with the impact of economic,
social, and legal and regulatory matters. We manage reserving risk through our reserving practices discussed above
in "Liability for Losses and Loss Adjustment Expenses - Loss Reserving," as well as through our commutation and
policy buy-back strategy and claims management practices. We also have a Reserving Committee that is responsible
for managing reserving risk and making recommendations to our Chief Financial Officer on the appropriate level of
reserves to include in our consolidated financial statements. For additional information relating to our loss reserves
by segment, "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Critical
Accounting Policies."

17

Table of Contents

Investment/Market Risk.    Investment / Market risk is the risk of loss resulting from under-performing investment
returns, dilution of investment capital, or adverse financial market movements (such as interest rates or exchange
rates). Investment / Market risk can be broken down into the following sub-risks which may threaten our ability to
effectively manage the investment portfolio: interest rate risk, credit spread risk, public equity risk, alternative investment
risk and concentration risk. We manage Investment / Market risk in a number of ways, including use of investment
guidelines; regular reviews of investment opportunities; market conditions; portfolio duration; oversight of the selection
and performance of external asset managers; regular stress testing of the portfolio against known and hypothetical
scenarios;  established  tolerance  levels;  and  we  manage  foreign  currency  by  asset/liability  matching  and  use  of
derivatives.  Investments  are  primarily  managed  by  our  Investment  function,  which  is  overseen  by  our  Investment
Committee. 

Liquidity Risk.    Liquidity risk is the risk that we are unable to realize investments and other assets in order to
settle financial obligations when they fall due or that we would have to incur excessive cost to do so. We manage this
risk generally by following an investment strategy designed to emphasize the preservation of our invested assets and
provide  sufficient  liquidity  for  the  prompt  payment  of  claims  and  contract  liabilities,  as  well  as  for  settlement  of
commutation  payments.  Liquidity  risk  also  includes  the  risk  of  our  dependence  of  our  future  cash  flows  upon  the
availability of dividends or other statutorily permissible payments from our subsidiaries, which is limited by applicable
laws and regulations. Due to our acquisitive strategy, liquidity risk at the Group level also includes immediate cash
needs as a result of the purchase of (re)insurance portfolios and/or capital injections into a new or existing subsidiary
to support associated solvency requirements as a direct result of merger and acquisition activity or other significant
changes. We manage this risk through our capital management and planning processes, which include reviews of
minimum  capital  resources  requirements  at  our  regulated  subsidiaries  and  anticipated  distributions,  as  well  as
anticipated capital needs. 

Credit / Counterparty Risk.     Credit risk relates to the uncertainty of a counterparty’s ability to make timely
payments in accordance with contractual terms of the instrument or contract. We are exposed to direct credit risk
primarily  within  our  portfolios  of  fixed  maturity  and  short-term  investments,  and  through  customers,  brokers  and
reinsurers in the form of premiums receivable and reinsurance recoverables.  In addition, we are exposed to credit
risk through our funds withheld arrangements if the reinsured company is unable to honor the value of the funds held
balances, such as in the event of insolvency. In our run-off businesses, we manage credit risk with respect to our
reinsurance recoverables by ongoing monitoring of counterparty ratings and working to achieve prompt payment of
reinsured claims, as well as through our commutation strategy. For funds withheld arrangements, we generally have
the contractual ability to offset any shortfall in the payment of the funds held balances with amounts owed by us to the
reinsured for losses payable and other amounts contractually due. In our active underwriting businesses, we firstly
mitigate credit risk through our reinsurance purchasing process, where reinsurers are subject to financial security and
rating requirements prior to approval and by limiting exposure to individual reinsurers. Thereafter we manage credit
risk  by  the  regular  monitoring  of  reinsurance  recoveries  and  premium  due  directly  or  via  brokers  and  other
intermediaries. In our fixed maturity and short-term investment portfolios, we attempt to mitigate credit risk through
diversification and issuer exposure limitation. 

Operational Risk.    Operational risk is the risk of a loss arising from inadequate or failed internal processes, or
from external events, personnel, systems or third parties. Due to our acquisitive strategy, operational risk also includes
risks and challenges associated with integrating new companies into the Group. We seek to mitigate operational risks
through the application of our policies and procedures and internal control and compliance processes throughout the
Group and a focus on acquisition integration and assimilation of new companies into our internal control systems,
including  but  not  limited  to  operational  incident  management,  business  continuity  planning,  information  security
procedures, financial reporting controls and a review process for material third-party vendor usage. 

Regulatory Risk.   Regulatory risk is the risk of legal or regulatory sanctions resulting in a financial loss, or loss
of reputation as a result of an insurer’s failure to comply with laws, regulations, rules, related self-regulatory organization
standards, and codes of conduct. We manage regulatory risk through a focus on compliance with laws and regulations,
adherence to our policies and procedures (including our Code of Conduct) and our internal controls, an established
corporate governance framework and practices, and communication and engagement with external stakeholders.

Tax Risk.   Tax risk is the risk that tax requirements are not adhered to accurately or in a timely manner resulting
in a financial loss. We proactively seek to identify, evaluate, manage, monitor and mitigate tax risks. We are committed
to complying with all tax laws, rules and regulations applicable to the Group. In evaluating potential transactions we
consider the overall commercial, financial and tax aspects. Where there is uncertainty or complexity in relation to a
tax  risk,  we  may  seek  external  advice  and,  where  appropriate,  we  may  obtain  tax  clearances  from  relevant  tax
authorities. 

18

Table of Contents

Emerging Risks

As part of our ERM Framework, we maintain a Framework for the Management of Emerging Risk, which sets
out the minimum standards by which emerging risks are identified, analyzed, evaluated, treated and reported on.
Pursuant to this framework, the MRC and our Board Risk Committee continually monitor emerging risks and oversee
changes to our ERM Framework to react to these risks, where appropriate. Emerging risks are defined as risks which
may develop or which already exist but are difficult to quantify. They are marked by a high degree of uncertainty, and
may or may not fall within the categories outlined above under "Risk Categories." While emerging risks are not fully
understood or explicitly considered within the day-to-day operation of our business due to the lack of quantifiable data,
we expect that the potential impacts of these risks may crystallize over time and therefore merit additional analysis,
monitoring, evaluation and when appropriate treatment. Recent examples of emerging risks that we review and consider
include:

•

•

•

•

•

•

•

Risks relating to the increased use of letters of credit by our subsidiaries to satisfy collateral obligations in our
reinsurance and run-off transactions;

Risks relating to changes in Bermuda solvency capital eligibility requirements;

Risks relating to cybersecurity and data privacy;

Risks relating to the transition from LIBOR;

Risks relating to our claims management activities, including social inflation, increased litigation funding, and
laws that impose absolute liability for certain types of claims; 

Risks relating to climate change, including as a result of our investments in companies that may be exposed
to "transition risk;" and 

Risks arising from global pandemics, such as coronavirus.

Regulation 

General 

The business of insurance and reinsurance is regulated in most countries, although the degree and type of
regulation varies significantly from one jurisdiction to another. Our material operations are in Bermuda, the United
Kingdom,  the  United  States, Australia  and  several  Continental  European  countries.  We  are  subject  to  extensive
regulation under the applicable statutes in these countries and any others in which we operate.  In addition, the Bermuda
Monetary Authority ("BMA") acts as group supervisor of our insurance and reinsurance companies (our "Group").  A
summary of the material regulations governing us in these countries is set forth below.  

We  may  become  subject  in  the  future  to  regulation  in  new  jurisdictions  or  additional  regulations  in  existing
jurisdictions depending on the location and nature of any companies acquired and the volume and location of business
being transacted by our existing companies. 

Bermuda 

Group Supervision

The BMA’s group supervision objective is to provide a coordinated approach to the regulation of an insurance
group and its supervisory and capital requirements. Bermuda has been recognized by the U.S. National Association
of Insurance Commissioners ("NAIC") as a qualified jurisdiction, and the E.U. recognizes Bermuda's full equivalence
under Solvency II.

We  are  group  supervised  by  the  BMA. As  our  Group  supervisor,  the  BMA  performs  a  number  of  functions
including: (i) coordinating the gathering and dissemination of information for other regulatory authorities; (ii) carrying
out a supervisory review and assessment of our Group; (iii) carrying out an assessment of our Group's compliance
with the rules on solvency, risk concentration, intra-group transactions and good governance procedures; (iv) planning
and coordinating, through regular meetings with other authorities, supervisory activities in respect of our Group; (v)
coordinating any enforcement action that may need to be taken against our Group or any Group members; and (vi)
coordinating meetings of colleges of supervisors in order to facilitate the carrying out of these functions. Cavello Bay
Reinsurance Limited ("Cavello") has been named as our Group’s Designated Insurer, effective December 11, 2019.
As Designated Insurer, Cavello is required to facilitate compliance by our Group with the insurance solvency and
supervision rules.  

19

Table of Contents

On an annual basis, the Group is required to file Group statutory financial statements, a Group statutory financial
return, a Group capital and solvency return, audited Group financial statements, a Group Solvency Self-Assessment
("GSSA"), and a financial condition report with the BMA. The GSSA is designed to document our perspective on the
capital  resources  necessary  to  achieve  our  business  strategies  and  remain  solvent,  and  to  provide  the  BMA  with
insights on our risk management, governance procedures and documentation related to this process.  In addition, the
Group is required to file a quarterly financial return with the BMA. 

We are required to maintain available Group statutory capital and surplus in an amount that is at least equal to
the group enhanced capital requirement ("Group ECR"). The BMA has also established a group target capital level
equal to 120% of the Group ECR.

The BMA also maintains supervision over the controllers of all Bermuda registered insurers, and accordingly,
any person who, directly or indirectly, becomes a holder of at least 10%, 20%, 33% or 50% of our ordinary shares
must notify the BMA in writing within 45 days of becoming such a holder (or ceasing to be such a holder). The BMA
may object to such a person and require the holder to reduce its holding of ordinary shares and direct, among other
things, that voting rights attaching to the ordinary shares shall not be exercisable. 

Operating Subsidiaries

The Insurance Act 1978 of Bermuda and related regulations, as amended (together, the "Insurance Act"), regulate
the insurance and reinsurance business of our operating subsidiaries in Bermuda. The Insurance Act imposes certain
solvency and liquidity standards and auditing and reporting requirements and grants the BMA powers to supervise,
investigate, require information and the production of documents and intervene in the affairs of insurance companies.

Significant requirements pertaining to our regulated Bermuda subsidiaries vary depending on the class in which
our  company  is  registered,  but  generally  include  the  appointment  of  a  principal  representative  in  Bermuda,  the
appointment of an independent auditor, the appointment of an approved loss reserve specialist, the filing of annual
statutory and GAAP financial statements, the filing of statutory financial returns, compliance with group solvency and
supervision  rules,  and  compliance  with  the  Insurance  Code  of  Conduct  (relating  to  corporate  governance,  risk
management and internal controls). 

Our regulated Bermuda subsidiaries must also comply with a minimum liquidity ratio and minimum solvency
margin. The minimum liquidity ratio requires that the value of relevant assets must not be less than 75% of the amount
of relevant liabilities. The minimum solvency margin, which varies depending on the class of the insurer, is determined
as a percentage of either net reserves for losses and LAE or premiums or pursuant to a risk-based capital measure.
StarStone Insurance Bermuda Limited, a Class 4 insurer, Cavello Bay Reinsurance Limited, a Class 3B insurer and
Fitzwilliam  Insurance  Limited,  a  Class  3A  insurer,  all  domiciled  in  Bermuda,  are  subject  to  an  enhanced  capital
requirement  ("ECR")  determined  pursuant  to  a  risk-based  capital  measure  and  are  required  to  file  a  Commercial
Insurer’s Solvency Self-Assessment (“CISSA”), and a financial condition report with the BMA.

Each of our regulated Bermuda subsidiaries would be prohibited from declaring or paying any dividends if it
were in breach of its minimum solvency margin or liquidity ratio or if the declaration or payment of such dividends
would cause it to fail to meet such margin or ratio. In addition, each of our regulated Bermuda subsidiaries is prohibited,
without the prior approval of the BMA, from reducing by 15% or more its total statutory capital, or from reducing by
25% of more its total statutory capital and surplus, as set out in its previous year’s statutory financial statements. Our
Bermuda insurance companies that are in run-off are required to seek BMA approval for any dividends or distributions.

Economic Substance Act

The Economic Substance Act 2018 (the “ESA”) was passed in Bermuda in December 2018 in response to the
decision of the European Union Code of Conduct Group (Business taxation) (the "EU Code Group") to place Bermuda,
as  well  as  other  offshore  jurisdictions,  on  notice  of  being  included  in  a  list  of  non-cooperative  jurisdictions  for  tax
purposes. Under the provisions of the ESA, any Bermuda-registered entity engaged in a “relevant activity” (which
includes insurance business and holding entity activities) must maintain a substantial economic presence in Bermuda.
To the extent that the ESA applies to our entities registered in Bermuda, we will be required to demonstrate compliance
with  economic  substance  requirements  by  filing  an  annual  economic  substance  declaration  with  the  Registrar  of
Companies in Bermuda.

20

Table of Contents

United Kingdom and Lloyd’s 

United Kingdom 

Our  U.K.-based  insurance  subsidiaries  consist  of  wholly-owned  run-off  companies.  These  subsidiaries  are
authorized by the U.K. Prudential Regulation Authority (the "PRA"), and are also regulated by the Financial Conduct
Authority (the "FCA", together with the PRA, the "U.K. Regulator"). Our U.K. run-off subsidiaries may not underwrite
new  business  without  the  approval  of  the  U.K.  Regulator.  E.U.  directives  also  allow  certain  of  our  regulated  U.K.
subsidiaries to conduct business in E.U. states other than the U.K. within the scope of permission granted by the U.K.
Regulator without the necessity of additional licensing or authorization in E.U. countries. 

The United Kingdom left the European Union on January 31, 2020 (commonly referred to as “Brexit”).  There is
an 11-month transition period that ends on December 31, 2020 during which existing European Union rules remain in
force. For a discussion of the potential impact of Brexit on our operations, refer to "Item 1A. Risk Factors - Risks
Relating to Laws and Regulation."  Pending the end of the transition period (and then subject to the outcome of the
negotiations between the United Kingdom and the European Union. as to the terms of their future trading relationship),
E.U. directives allow certain of our regulated U.K. subsidiaries to conduct business in E.U. states other than the United
Kingdom within the scope of permission granted by the U.K. Regulator without the necessity of additional licensing or
authorization in E.U. countries.

Our U.K.-based insurance subsidiaries are required to maintain adequate financial resources in accordance
with the requirements of the U.K. Regulator. The calculation of the minimum capital resources requirements in any
particular case depends on, among other things, the type and amount of insurance business written and claims paid
by the insurance company.

The Solvency II framework directive, which took effect on January 1, 2016, sets out E.U.-wide requirements on
capital adequacy and risk management for insurers with the aim of further increasing policyholder protection, instilling
greater risk awareness and improving the international competitiveness of E.U. insurers. Insurers must comply with
a Solvency Capital Requirement ("SCR"), which is calculated using either the Solvency II standard formula or a bespoke
internal model. Our non-Lloyd's U.K. companies use the standard formula.

The U.K. Regulator’s rules require our U.K. insurance subsidiaries to obtain regulatory approval for any proposed
or actual payment of a dividend. The U.K. Regulator uses the SCR, among other tests, when assessing requests to
make distributions. 

Under the Financial Services and Markets Act of 2000 ("FSMA"), any company or individual (together with its
or his concert parties) proposing to directly or indirectly acquire "control" over a U.K. authorized insurance company
(which is generally defined as acquiring 10% or more of the shares or voting power in a U.K. authorized insurance
company or its parent company) must seek prior approval of the U.K. Regulator of his intention to do so. A person who
is already deemed to have "control" will require prior regulatory approval if the person increases the level of "control"
beyond 20%, 30% and 50%. 

Lloyd’s

We participate in the Lloyd’s market through our interests in: (i) Atrium’s Syndicate 609, which is managed by
Atrium Underwriters Limited, a Lloyd's managing agent; (ii) StarStone’s Syndicate 1301, which is managed by StarStone
Underwriting Limited ("SUL"), a Lloyd’s managing agent; and (iii) Syndicate 2008, a wholly aligned syndicate that has
permission to underwrite RITC business and other run-off or discontinued business type transactions with other Lloyd’s
syndicates. SUL serves as managing agent for Syndicate 2008. All of the Group’s underwriting by these syndicates
is supported by one or more internal corporate members.

Our Lloyd’s operations are subject to authorization and regulation by the U.K. Regulator and compliance with
the Lloyd’s Act(s) and Byelaws and regulations, as well as the applicable provisions of the FSMA. The Council of
Lloyd’s has wide discretionary powers to regulate members’ underwriting, and its exercise of these powers might affect
the return on an investment of the corporate member in a given underwriting year. This discretion includes the ability
to assess up to 3% of a member’s underwriting capacity in any one year as a Central Fund contribution. 

The underwriting capacity of a corporate member of Lloyd’s must be supported by providing a deposit (referred
to as "Funds at Lloyd’s") in the form of cash, securities or letters of credit in satisfaction of its capital requirement. The
amount of the Funds at Lloyd’s is assessed annually and is determined by Lloyd’s in accordance with applicable capital
adequacy rules. 

21

Table of Contents

Business plans, including maximum underwriting capacity, for Lloyd’s syndicates requires annual approval by
the  Lloyd’s  Franchise  Board,  which  may  require  changes  to  any  business  plan  or  additional  capital  to  support
underwriting plans. 

In order to achieve finality and to release their capital, Lloyd’s members are usually required to have transferred
their liabilities through an approved RITC, such as offered by Syndicate 2008. RITC is generally put in place after the
third year of a syndicate year of account. On successful conclusion of RITC, any profit from the syndicate for that year
of account can be fully remitted by the managing agent to the syndicate’s members. 

The  Lloyd’s  market  has  applied  the  Solvency  II  internal  model  under  Lloyd’s  supervision,  and  our  Lloyd’s
operations are required to meet Solvency II standards. The Society of Lloyd's has received approval from the PRA to
use its internal model under the Solvency II regime.

Lloyd’s  approval  is  required  before  any  person  can  acquire  control  of  a  Lloyd’s  managing  agent  or  Lloyd’s

corporate member. 

United States 

Our  insurance  and  reinsurance  companies  domiciled  in  the  United  States  consist  of  property  and  casualty
companies in run-off, as well as StarStone Specialty Insurance Company (a U.S. excess and surplus lines insurer)
and StarStone National Insurance Company (a U.S. admitted insurer that is licensed in all 50 states and the District
of Columbia). Our U.S. insurers are subject to extensive governmental regulation and supervision by the states in
which they are domiciled, licensed and/or eligible to conduct business. The insurance laws and regulations of the state
of domicile have the most significant impact on operations. We currently have U.S. insurers and reinsurers domiciled
in Texas, New York, Delaware, Missouri, Oklahoma and Rhode Island, with one of these insurers also commercially
domiciled in California.

Generally,  regulatory  authorities  have  broad  regulatory  powers  over  such  matters  as  licenses,  standards  of
solvency, premium rates and policy forms (except for excess and surplus lines insurers), marketing practices, claims
practices, investments, security deposits, restrictions on size of risks that may be insured under a single policy, methods
of accounting, form and content of financial statements, corporate governance, enterprise risk management, reserves
and  provisions  for  unearned  premiums,  unpaid  losses  and  LAE,  reinsurance,  minimum  capital  and  surplus
requirements, dividends and other distributions to shareholders, periodic examinations, annual and other report filings,
and transactions among affiliates. 

As to periodic examinations, regulators have begun to look well beyond financial solvency and market conduct.
In 2017, for example, the New York Department of Financial Services (“NYDFS”) increased its focus on cybersecurity,
requiring financial institutions regulated by the NYDFS to establish a cybersecurity program. The NYDFS now also
requires  the  completion  of  an  extensive  questionnaire  regarding  each  New  York  domestic  insurer’s  cybersecurity
program  in  connection  with  such  examinations.  Additionally,  most  states  require  the  completion  of  an  extensive
questionnaire, similar to that required by New York, in connection with such examinations. Other states have since
enacted similar laws based on the NAIC’s Insurance Data Security Model Law, adopted in 2017.

U.S. insurers are also required to maintain minimum levels of solvency and liquidity as determined by law, and
to comply with risk-based capital requirements and licensing rules. Insurers having less statutory surplus than required
by the risk-based capital calculation will be subject to varying degrees of regulatory action. If any of our U.S. insurers
were to have risk-based capital levels that are below required levels, they would be subject to increased regulatory
scrutiny and control by their domestic and possibly other insurance regulators. As of December 31, 2019, all of our
U.S. insurers exceeded their required levels of risk-based capital. 

Applicable insurance laws also limit the amount of dividends or other distributions our U.S. insurers can pay to
us. The insurance regulatory limitations are generally based on statutory net income and/or certain levels of statutory
surplus as determined by the insurer’s state or states of domicile. Generally, prior regulatory approval must be obtained
before an insurer may pay a dividend or make a distribution above a specified level. 

22

Table of Contents

All states have enacted legislation regulating insurance holding company systems that requires each insurance
company  in  the  system  to  register  with  the  insurance  department  of  its  state  of  domicile  and  furnish  information
concerning the operations of companies within the holding company system that may materially affect the operations,
management  or  financial  condition  of  the  insurers  within  the  system. The  NAIC  has  adopted  amendments  to  the
Insurance Holding Company System Regulatory Act and associated regulations, which all states in which our U.S.
insurers are domiciled or commercially domiciled have adopted. The amendments provide the regulators with additional
tools to evaluate risks to an insurance company within the insurance holding company system. They impose more
extensive informational requirements on parents and other affiliates of licensed insurers with the purpose of protecting
them from enterprise risk, including requiring an annual enterprise risk report by the ultimate controlling person of the
insurers identifying the material risks within the insurance holding company system that could pose enterprise risk to
the insurers and requiring a person divesting its controlling interest to make a confidential advance notice filing. 

The NAIC has also adopted the Risk Management and Own Risk and Solvency Assessment Model Act, which
requires insurers to maintain a risk management framework and establishes a legal requirement for insurers or their
insurance group to conduct an Own Risk and Solvency Assessment ("ORSA") in accordance with the NAIC’s ORSA
Guidance Manual. The ORSA Model Act has been adopted in all of the states in which our U.S. insurers are domiciled,
and our insurers in these states may be subject to ORSA requirements if certain premium thresholds are exceeded.
Where applicable, we must regularly conduct an ORSA consistent with the ORSA Model Act, including undertaking
an internal risk management review no less often than annually and preparing a summary report assessing the adequacy
of risk management and capital in light of our insurers’ current and future business plans.

In addition, the NAIC’s Corporate Governance Annual Disclosure (“CGAD”) Model Act and Regulation requires
the annual filing of a disclosure describing the insurance group’s corporate governance structure, policies, and practices.
The Model Act and Regulation have been adopted in some, though not all, of the states in which we have insurers
domiciled. There are no premium thresholds for CGAD.

The Dodd Frank Wall Street Reform and Consumer Protection Act of 2010 (the "Dodd-Frank Act"), represented
a  comprehensive  overhaul  of  the  financial  services  industry  within  the  United  States  and,  among  other  things,
established the Financial Services Oversight Council and created within the United States Department of the Treasury
a Federal Insurance Office ("FIO"). The FIO is authorized to study, monitor and report to Congress on the U.S. insurance
industry and the significance of global reinsurance to the U.S. insurance market. The Dodd-Frank Act also authorizes
the federal preemption of certain state insurance laws and streamlines the regulation of reinsurance and surplus lines/
non-admitted insurance. 

Before a person can acquire control of a domestic insurer (including a reinsurer) or any person controlling such
insurer (including acquiring control of Enstar Group Limited), prior written approval must be obtained from the insurance
commissioner of the state in which the domestic insurer is domiciled and, under certain circumstances, from insurance
commissioners in other jurisdictions. Generally, state statutes and regulations provide that "control" over a domestic
insurer or person controlling a domestic insurer is presumed to exist if any person, directly or indirectly, owns, controls,
holds with the power to vote, or holds proxies representing, 10% or more of the voting securities or securities convertible
into voting securities of the domestic insurer or of a person who controls the domestic insurer. 

Australia 

Our Australian regulated insurance entities (which include our insurance subsidiary and our non-operating holding
company) are subject to prudential supervision by the Australian Prudential Regulation Authority ("APRA"). APRA is
the primary regulatory body responsible for regulating compliance with the Insurance Act 1973. APRA has issued
prudential standards that apply to general insurers in relation to capital adequacy, the holding of assets in Australia,
risk  management,  business  continuity  management,  reinsurance  management,  outsourcing,  audit  and  actuarial
reporting and valuation, the transfer and amalgamation of insurance businesses, governance, and the fit and proper
assessment of the insurer’s responsible persons. 

APRA’s  prudential  standards  require  that  all  insurers  maintain  and  meet  prescribed  capital  adequacy

requirements to enable their insurance obligations to be met under a wide range of circumstances. 

23

Table of Contents

APRA also prescribes prudential standards on risk management and governance. These requirements include
the need for regulated insurance entities to have a risk management framework that is consistent and integrated with
its risk profile and capital strength, supported by a risk management function and subject to comprehensive review.
APRA’s risk management requirements also include the need for regulated insurance entities to have a board risk
committee that provides the Board with objective non-executive oversight of the implementation and on-going operation
of its risk management framework, and the requirement that regulated insurance entities designate a chief risk officer
who is involved in, and provides effective challenge to, activities and decisions that may materially affect the regulated
insurance entities’ risk profile. Our Australian regulated insurance entities are compliant with these requirements. 

An insurer must obtain APRA’s written consent prior to making any capital releases, including any payment of
dividends in excess of current year earnings. Our insurance subsidiary must provide APRA a valuation prepared by
an appointed actuary that demonstrates that the tangible assets of the insurer, after the proposed capital reduction,
are sufficient to cover its insurance liabilities to a 99.5% level of sufficiency of capital before APRA will consent to a
capital release or dividend. 

Under the Financial Sector (Shareholdings) Act 1998, the interest of an individual shareholder or a group of
associated  shareholders  in  an  insurer  is  generally  limited  to  a  15%  "stake"  of  the  insurer. A  person’s  stake  is  the
aggregate of the person’s voting power and the voting power of the person’s associates. A higher percentage limit
may be approved by the Treasurer of the Commonwealth of Australia on national interest grounds. Any shareholder
of Enstar Group Limited with a "stake" greater than 15% has received approval to hold that stake from the Treasurer
of the Commonwealth of Australia. 

Europe

In addition to Bermuda, the United Kingdom, Australia and the United States, we have subsidiaries in Belgium,
as well as StarStone Insurance SE, a Liechtenstein-based company that continues to underwrite new business through
branches across Europe and is regulated by the Financial Markets Authority. StarStone Insurance Europe AG was
merged  into  StarStone  Insurance  SE  in  Liechtenstein  effective  from  October  1,  2017,  following  the  relocation  of
StarStone Insurance SE’s principal office from the U.K. to Liechtenstein on May 8, 2017. With effect from January 1,
2019, our Swiss insurance subsidiary redomesticated to Bermuda and is now regulated by the BMA. It continues to
have a UK branch.

Our subsidiaries and branches in European jurisdictions such as Belgium and Liechtenstein are regulated in
their respective home countries. Typically, such regulation is for the protection of policyholders and ceding insurance
companies  rather  than  shareholders.  Regulatory  authorities  generally  have  broad  supervisory  and  administrative
powers over such matters as licenses, standards of solvency, investments, reporting requirements relating to capital
structure,  ownership,  financial  condition  and  general  business  operations,  special  reporting  and  prior  approval
requirements with respect to certain transactions among affiliates, reserves for unpaid losses and LAE, reinsurance,
minimum capital and surplus requirements, dividends and other distributions to shareholders, periodic examinations
and annual and other report filings. The application of the Solvency II framework across such European jurisdictions
from January 1, 2016 generally results in a more uniform approach to regulation.  

Available Information

We maintain a website with the address http://www.enstargroup.com. The information contained on our website
is not included as a part of, or incorporated by reference into, this filing. We make available free of charge through our
website  our  annual  report  on  Form  10-K,  quarterly  reports  on  Form  10-Q,  current  reports  on  Form  8-K,  and  all
amendments to these reports, as soon as reasonably practicable after the material is electronically filed with or otherwise
furnished to the U.S. Securities and Exchange Commission, (the "SEC"). Our annual reports on Form 10-K, quarterly
reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports are also available on the SEC’s
website at http://www.sec.gov. In addition, copies of our Code of Conduct and the governing charters for the Audit,
Compensation, Nominating and Governance, Investment, and Risk Committees of our Board of Directors are available
free of charge on our website.

24

Table of Contents

ITEM 1A.   RISK FACTORS 

Any of the following risk factors could cause our actual results to differ materially from historical or anticipated
results. These risks and uncertainties are not the only ones we face. There may be additional risks that we currently
consider not to be material or of which we are not currently aware, and any of these risks could cause our actual results
to differ materially from historical or anticipated results.  

You should carefully consider these risks along with the other information included in this document, including
the matters addressed above under "Cautionary Note Regarding Forward-Looking Statements" before investing in
any of our securities. We may amend, supplement or add to the risk factors described below from time to time in future
reports filed with the SEC.  

We have categorized our risk factors into the following areas:

•

•

•

•

•

•

•

•

Risks Relating to our Insurance Businesses

Risks Relating to our Acquisitions

Risks Relating to Liquidity and Capital Resources

Risks Relating to our Investments

Risks Relating to Laws and Regulations

Risks Relating to our Operations

Risks Relating to Taxation

Risks Relating to Ownership of our Shares

Risks Relating to Our Insurance Businesses

If we are unable to implement our business strategies successfully, our business, results of operations

and financial condition may be materially and adversely affected. 

Our future results of operations will depend in significant part on the extent to which we can implement our
business strategies successfully, including with respect to our active underwriting segments and investments. Our
business strategies are described in "Item 1. Business - Business Strategy." We may not be able to implement these
strategies or any future strategies fully or realize the anticipated results of our strategies as a result of significant
business, economic, regulatory and competitive uncertainties, many of which are beyond our control. If we are unable
to successfully implement our business strategies, we may not be able to achieve future growth in our earnings and
our financial condition and ability to access capital may suffer and, as a result, holders of our securities may receive
lower returns.

Inadequate  loss  reserves  could  reduce  our  net  earnings  and  capital  surplus,  which  could  have  a

materially adverse impact on our results of operations and financial condition.

Our success is dependent upon our ability to assess accurately the risks associated with the business we have
insured and reinsured. We are required to maintain reserves to cover the estimated ultimate liability for losses and
LAE for both reported and unreported incurred claims. As of December 31, 2019, gross reserves for losses and LAE
reported on our balance sheet were $10.4 billion. The process of establishing these reserves includes a significant
level of judgment. As a result, these reserves are only estimates of what we expect the settlement and administration
of claims will cost based on facts and circumstances known to us, as well as actuarial methodologies, historical industry
loss ratio experience, loss development patterns, estimates of future trends and developments and other variable
factors such as inflation. We cannot be certain that ultimate losses will not exceed our estimates of losses and LAE
because of the uncertainties that surround the estimation process (which are discussed above in "Item 1. Business -
Liability for Losses and Loss Adjustment Expense"). As a result, actual losses and LAE paid will deviate, perhaps
substantially, from the reserve estimates reflected in our financial statements due to legal, judicial, social, technological
or other factors, including changes in loss inflation. If our reserves are insufficient to cover our actual losses and LAE,
we would have to augment our reserves and incur a charge to our earnings. These charges could be material and
would reduce our net earnings and capital and surplus.

25

Table of Contents

In  our  non-life  run-off  businesses,  loss  reserves  include  asbestos  and  environmental  ("A&E")  liabilities  and
liabilities associated with personal injury A&E claims from acquired companies with legacy manufacturing businesses.
Ultimate values for A&E claims cannot be estimated using traditional reserving techniques, and there are significant
uncertainties in estimating losses for these claims. Factors contributing to the uncertainty include long waiting periods,
reporting delays and difficulties identifying contamination sources and allocating damage liability. Developed case law
and adequate claim history do not always exist for A&E claims, and changes in the legal and tort environment affect
the development of such claims. To further understand this risk, see "Item 7. Management’s Discussion and Analysis
of Financial Condition and Results of Operations - Critical Accounting Policies - Losses and Loss Adjustment Expenses
- Non-Life Run-off - Latent Claims". 

In  our  active  underwriting  businesses,  U.S.  GAAP  does  not  permit  insurers  and  reinsurers  to  reserve  for
catastrophes until they occur, which means that claims from these events could cause substantial volatility in our
financial results for any fiscal quarter or year and could have a material adverse effect on our financial condition and
results of operations, as well as our financial strength ratings. 

Our active underwriting businesses present inherent risks and uncertainties which could have a material

adverse effect on our business, financial condition and results of operations. 

Underwriting is inherently a matter of judgment, involving assumptions about matters that are unpredictable and
beyond our control, and for which historical experience and probability analysis may not provide sufficient guidance.
Our StarStone and Atrium active underwriting businesses expose us to significant risks that could result in under-
performance of the active underwriting businesses compared to our expectations, which could have a material adverse
effect on our business, financial condition and results of operations. Those risks include, but are not limited to:

•

•

•

•

•

•

exposure  to  claims  arising  out  of  unpredictable  natural  and  man-made  catastrophic  events  (including
hurricanes,  windstorms,  tsunamis,  severe  weather,  earthquakes,  floods,  fires,  droughts,  explosions,
environmental contamination, acts of terrorism, cyber events and war or political unrest); 

changing climate patterns and ocean temperature conditions that could increase the frequency and severity
of catastrophe events and natural disasters to which we have loss exposure; 

failure of our risk management and loss limitation methods (described in "Item 1. Business - Enterprise Risk
Management") to adequately manage our loss exposure or provide sufficient protection against losses; 

the intense competition for business in the insurance and reinsurance industries, including competition from
major  global  insurance  and  reinsurance  companies  and  underwriting  syndicates  that  may  have  greater
experience and resources than our companies or that may be more highly rated than our companies, or
competition resulting from industry consolidation; 

dependence on a limited number of brokers, managing general agents and other third parties to support our
business, both in terms of the volume of business we rely on them to place and the credit risk we assume
from them; and 

susceptibility to the effects of inflation due to premiums being established before the ultimate amounts of
losses and LAE are known. 

The cyclical nature of the insurance and reinsurance industries may make it more difficult for StarStone
and Atrium to execute their underwriting strategies successfully, which could negatively impact our earnings
and our financial condition. 

The  insurance  and  reinsurance  industry  has  historically  been  characterized  by  periods  of  intense  price
competition due to excess underwriting capacity, as well as periods of more favorable pricing due to limited underwriting
capacity.  Periods  of  favorable  pricing  tend  to  attract  additional  underwriting  capacity  (by  new  entrants,  market
instruments and structures, and additional commitments by existing insurers) that ultimately cause prices to decrease.
Changes in the frequency and severity of losses suffered by insureds and insurers also impact industry cycles, and
we may not be able to accurately predict whether market conditions will improve, remain constant or deteriorate. Any
of these factors could lead to a significant reduction in premium rates, impair our ability to underwrite at appropriate
rates, result in less favorable policy terms and drive fewer submissions for our active underwriting services, which
could decrease our earnings or adversely affect our financial condition. 

26

Table of Contents

Cyclical  market  conditions  also  impact  the  availability  and  cost  of  reinsurance  purchased  by  StarStone  and
Atrium  as  part  of  our  risk  management  strategy.  Market  conditions  may  limit  or  prevent  our  active  underwriting
companies from obtaining adequate reinsurance protection for our business needs. If our active underwriting companies
are unable to purchase reinsurance, or if reinsurance is available only on unfavorable terms or with less creditworthy
reinsurers, we may retain a higher proportion of risks than we would otherwise prefer, incur additional expense, or
purchase reinsurance from companies with higher credit risk, or we may underwrite fewer or smaller contracts. Any
of these factors could negatively impact our financial performance. 

Downgrades of financial strength ratings at StarStone or Lloyd’s could materially and negatively impact

our ability to write new business or renew our existing business in our active underwriting segments. 

Financial  strength  ratings  are  an  important  factor  in  establishing  the  competitive  position  of  insurance  and
reinsurance companies. The StarStone operating insurance entities are currently assigned a financial strength rating
of "A-" (Excellent) by A.M. Best with a stable outlook. The stability of StarStone's credit rating depends on the continued
financial, strategic and operational support provided by its shareholders, including Enstar. A ratings downgrade, outlook
change or withdrawal could negatively impact StarStone’s competitive position in the industry, and severely limit or
prevent StarStone from writing new insurance and reinsurance contracts if policyholders move their business to other
more  highly-rated  companies.  Such  a  change  could  also  inhibit  our  ability  to  implement  our  business  and  growth
strategies successfully. Additionally, many of StarStone's reinsurance contracts permit the ceding companies to cancel
the  contract  if  StarStone's  financial  strength  rating  is  downgraded.  Whether  a  ceding  company  would  cancel  a
reinsurance contract after a ratings downgrade would depend on a number of factors (including the reason for and
extent of the downgrade, and the pricing and availability of replacement reinsurance) and, accordingly, we cannot
predict the extent to which these cancellation rights would be exercised or what effect any such cancellations would
have on our financial condition or results of operations. 

Lloyd’s ratings apply to business written through Syndicate 609 (Atrium) and Syndicate 1301 (StarStone). Lloyd’s
is rated "A" (Excellent) by A.M. Best, "A+" (Strong) by S&P and "AA-" (Very Strong) by Fitch Ratings. Financial strength
ratings downgrades at Lloyd’s could adversely affect our Lloyd’s syndicates’ ability to trade in certain classes of business
at current levels. 

Emerging claim and coverage issues could adversely affect our business. 

As industry practices and legal, judicial, social and other environmental conditions change, unexpected and
unintended issues related to claims and coverage may emerge. These issues may adversely affect the adequacy of
our provision for losses and LAE by either extending coverage beyond the envisioned scope of insurance policies and
reinsurance contracts, or by increasing the number or size of claims. Our exposure to these uncertainties could be
exacerbated by an increase in insurance and reinsurance contract disputes, arbitration and litigation, as well as social
inflation trends, including expanded theories of liability and higher jury awards. Increasingly, the handling of insurance
claims can also lead to bad faith or other forms of extra-contractual damages. The full effects of these and other
unforeseen emerging claim and coverage issues are extremely hard to predict. In some instances, these changes
may not become apparent until long after we have acquired or issued the affected contracts. As a result, the full extent
of liability under these insurance or reinsurance contracts may not be known for many years after a contract has been
issued. 

Our  investments  in  life  insurance  businesses,  including  through  certain  of  our  equity  method
investments, are subject to the risk that actual mortality, morbidity, policy persistency, and investment yield
may  be  different  than  our  assumptions  and  could  render  the  reserves  established  by  these  businesses
inadequate, causing a decline in our financial returns from these investments.

The performance of our investments in life businesses depends on the ability of these businesses to operate
effectively  and  efficiently.  Reserves  for  life  policy  benefits  are  based  on  certain  assumptions,  including  mortality,
morbidity, lapse rates, expenses, and discount rates based on expected yields at acquisition. The adequacy of the
reserves established by the businesses in which we invest is contingent on actual experience related to these key
assumptions. If actual experience differs from these assumptions, or the assumptions are changed based on new
information or experience, it could materially and adversely impact our financial returns on these investments.

The life insurance businesses in which we have invested have exposure to the risk of catastrophic mortality,
such as a pandemic or other event that causes a large number of deaths. In an economic downturn, these businesses
may also experience an elevated incidence of lapses of life insurance policies due to increased risk that policyholders
may choose to cease paying insurance premiums (resulting in a non-diversified pool of policyholders). Any of these
events could adversely affect our financial returns on these investments.

27

Table of Contents

Risks Relating to Our Acquisitions 

We may not be able to continue to grow our business through acquisitions. 

We have pursued and, as part of our strategy, will continue to pursue growth through acquisitions of reinsurance
companies  and  portfolios  of  insurance  and  reinsurance  business,  primarily  in  our  run-off  segment.  However,  the
acquisition and management of companies and portfolios in run-off is highly competitive, and driven by a number of
factors, including proposed acquisition price, reputation, and financial resources. Some of our competitors have greater
financial resources than we do, have been operating for longer than we have and have established long-term and
continuing business relationships throughout the insurance and reinsurance industries, which can be a significant
competitive advantage. In recent years, new competitors have entered the insurance run-off space, including through
the formation of reinsurance companies or the use of other financial products intended to acquire insurance liabilities
in run-off. We expect competition from these sources and others to continue to increase over time. As a result, we
may not be able to compete successfully in the future for suitable acquisition candidates, and if we do not continue to
acquire companies or portfolios, we may not be able to achieve our strategic goals. 

There can be no assurance that our acquisitions will be financially beneficial to us or our shareholders.

The evaluation and negotiation of potential acquisitions, as well as the integration of acquired businesses or
portfolios, can be complex and costly and may require substantial management resources. Our acquisitions could
involve numerous additional risks that we may not be able to identify during the due diligence process, such as potential
losses from unanticipated litigation, levels of claims or other liabilities and exposures, an inability to generate sufficient
revenue to offset acquisition costs and financial exposures in the event that sellers are unable or unwilling to meet
their indemnification, reinsurance and other obligations to us.

Our  run-off  business  entails  acquiring  and  managing  insurance  and  reinsurance  companies,  portfolios  of
insurance and reinsurance, and companies with liabilities related to legacy manufacturing operations. Unlike traditional
insurers and reinsurers, our companies and portfolios in run-off no longer underwrite new policies and their stated
provisions for losses and LAE may not be sufficient to cover future losses and the cost of run-off. Because our non-
life companies and portfolios in run-off generally no longer collect underwriting premiums, our sources of capital to
cover losses are limited to our stated reserves, reinsurance coverage and equity.

To achieve positive operating results from an acquisition, we must first price transactions on favorable terms
relative to the risks posed by the acquired businesses and then successfully manage the acquired businesses by
efficiently  managing  claims,  collecting  from  insurers  or  reinsurers,  generating  investment  returns  on  the  assets
supporting the acquired businesses and controlling expenses. Failure to do these things successfully could result in
us having to cover losses sustained with retained earnings, which would materially and adversely impact our ability
to grow our business and may result in material losses. 

We  may  not  be  able  to  realize  the  anticipated  benefits  of  acquisitions,  which  may  result  in
underperformance  relative  to  our  expectations  and  a  material  adverse  effect  on  our  business,  financial
condition or results of operations. 

The acquisitions we have made and expect to make in the future may pose operational challenges that divert

management’s time and energy and expose us to risks relating to:  

•

•

•

•

•

•

•

the value of liabilities assumed being greater than expected;

the value of assets or our anticipated return on assets being lower than expected or diminishing because
of credit defaults, changes in interest rates, or delays in implementation of our intended investment strategies;

funding cash flow shortages that may occur if anticipated revenues are not realized or are delayed, or if
expenses are greater than anticipated; 

integrating  financial  and  operational  reporting  systems  and  internal  controls,  including  assurance  of
compliance with Section 404 of the Sarbanes-Oxley Act of 2002 and our reporting requirements under the
Exchange Act; 

leveraging  our  existing  capabilities  and  expertise  into  the  business  acquired  and  establishing  synergies
within our organization; 

funding increased capital needs and overhead expenses; 

integrating technology platforms and managing any increased cybersecurity risk; 

28

Table of Contents

•

•

•

•

obtaining and retaining management personnel required for expanded operations; 

fluctuating foreign currency exchange rates relating to the assets and liabilities we may acquire; 

goodwill and intangible asset impairment charges; and 

complying with applicable laws and regulations. 

If we are unable to address some or all of these challenges, our acquisitions may underperform relative to our

expectations and our business may be materially and adversely affected. 

We may not complete future acquisitions within the time frame we anticipate or at all, which could have

a negative effect on our business, financial condition or results of operations. 

Once we have signed a definitive agreement to acquire a business or portfolio, conditions to closing, such as
obtaining regulatory approvals or shareholder approvals, must be met before the acquisition can be consummated.
These and other closing conditions may not be satisfied at all, or may cause a material delay in the anticipated timing
of closing. In addition, our ability to complete the acquisition on the originally anticipated terms, or at all, could be
jeopardized if a seller receives competing proposals, if litigation is brought challenging the transaction or certain of its
terms, or if regulators impose unexpected terms and conditions on the transaction. Failure to consummate an acquisition
on the originally anticipated terms, or a significant delay in the closing, could result in significant expense, diversion
of time and resources, reputational damage, litigation and a failure to realize the anticipated benefits of the acquisition,
all of which could materially adversely impact our business, financial condition and results of operations. 

Risks Relating to Liquidity and Capital Resources 

The amount of statutory capital that we must hold to maintain our financial strength and credit ratings
and meet certain regulatory requirements can vary significantly from time to time and is sensitive to several
factors.

Statutory  capital  and  reserve  requirements  for  our  insurance  subsidiaries  are  prescribed  by  the  applicable
insurance regulators in the jurisdictions in which we operate, including Bermuda, the United States, the United Kingdom,
the European Union and Australia. Insurance regulators have established risk-based capital adequacy measures, such
as the BSCR in Bermuda and the Solvency II regime in the European Union and United Kingdom, which provide
minimum  solvency  and  liquidity  requirements  for  insurance  companies. The  amount  of  capital  that  we  and/or  our
insurance subsidiaries are required to hold may increase or decrease depending on a variety of factors including the
amount of statutory income or losses generated by our insurance subsidiaries (which itself is sensitive to equity market
and credit market conditions), the amount of additional capital our non-life run-off and live underwriting insurance
subsidiaries must hold to support future growth, changes in the value of investments, changes in interest rates and
foreign currency exchange rates, as well as changes to the relevant regulatory capital adequacy measures. Many of
these factors are outside of our control, and our overall liquidity and credit ratings are significantly influenced by our
insurance  subsidiaries’  statutory  capital  amounts.  If  statutory  capital  requirements  increase  or  if  our  insurance
subsidiaries' solvency decreases, our subsidiaries would be required to hold more capital, and our ability to obtain
distributions from these subsidiaries could be limited. If we fail to maintain adequate statutory capital, the regulators
may restrict our activities and prohibit us and our subsidiaries from completing acquisitions without raising additional
capital.

We  may  require  additional  capital  and  credit  in  the  future  that  may  not  be  available  or  may  only  be

available on unfavorable terms. 

Our future capital requirements depend on many factors, including acquisition and investment activity, our ability
to manage the run-off of our assumed policies, our ability to establish reserves at levels sufficient to cover losses, our
underwriting plans, and our obligations to satisfy statutory capital requirements. We may need to raise additional funds
through equity or debt financings in the future. Our ability to secure this financing may be affected by a number of
factors, including volatility in the worldwide financial markets, the strength of our capital position and operating results.
In addition, an unfavorable change or downgrade of our issuer credit ratings could increase the interest rate charged
under our revolving credit facility and may make it more expensive for us to access capital markets. Any equity or debt
financing, if available at all, may be on terms that are not favorable to us, and could limit our strategic, financial and
operational flexibility, including as a result of the need to dedicate a greater portion of our cash flows from operations
to preferred share dividends and interest and principal payments on our debt financing. In the case of equity financings,
dilution to our existing shareholders could result, and any securities that are part of an equity financing may have
rights, preferences and privileges that are senior to those of our already outstanding securities.

29

Table of Contents

In addition, we may not achieve the desired regulatory capital treatment for any potential issuance of debt or
equity  securities  due  to  changing  solvency  capital  eligibility  requirements  under  the  Bermuda  Insurance  (Group
Supervision)  Rules  2011  (the  "Group  Supervision  Rules")  to  which  we  are  subject.  For  example,  our  outstanding
preferred shares and senior notes qualify as Tier 2 and Tier 3 capital, respectively, in accordance with the Group
Supervision Rules. In order for these instruments to continue to receive the intended regulatory capital treatment, their
terms must reflect the criteria contained in the Group Supervision Rules and any amendments thereto. Although our
expectation is that any changes to the Group Supervision Rules governing eligible capital would not apply retroactively,
no assurance can be made that the BMA will in the future deem that our preferred shares and senior notes constitute
Tier 2 and Tier 3 capital, respectively, under the Group Supervision Rules. If we cannot obtain adequate capital or
credit, our business, results of operations and financial condition could be adversely affected by, among other things,
our inability to finance future acquisitions. 

Our reinsurance subsidiaries may be required to provide collateral to ceding companies pursuant to
their reinsurance contracts. Their ability to conduct business could be significantly and negatively affected
if they are unable to do so or if any letters of credit posted as collateral are drawn upon by a ceding company.

Our reinsurance subsidiaries are often required to post collateral in the form of letters of credit, trust funds or
other assets in order to provide security for their reinsurance obligations and to provide ceding companies with statutory
credit for such reinsurance. If our reinsurance subsidiaries are unable to post the required collateral or the cost of
providing such collateral materially increases, their operations could be significantly and negatively affected, which in
turn could limit our ability to complete certain run-off acquisitions on favorable terms, which could negatively impact
our business, financial condition and results of operations. In addition, if the beneficiary of any letter of credit draws
funds against the letter of credit, we would be obligated to immediately repay the bank that issued the letter of credit
the amount of such drawn funds, which could increase our indebtedness and significantly and negatively affect our
liquidity and financial condition.

Uncertain  conditions  in  the  global  economy  generally  may  materially  adversely  affect  our  business,

results of operations and financial condition. 

In the event of financial turmoil affecting the global banking system and global financial markets (which may
result from a variety of events such as natural or man-made disasters including global pandemic such as coronavirus,
war, or terrorism) or significant financial service institution failures, there could be a new or incremental tightening in
the credit markets, low liquidity, and extreme volatility in fixed maturity, credit, currency, and equity markets. This could
have  a  number  of  effects  on  our  business,  including  our  ability  to  obtain  financing  for  future  acquisitions.  Even  if
financing  is  available,  it  may  only  be  available  on  terms  that  are  not  favorable  to  us,  which  would  decrease  our
profitability. 

Global and local economic conditions could also affect demand for and claims made under our policies, our
counter-party  credit  risk,  and  the  ability  of  our  customers  and  other  counterparties  to  establish  or  maintain  their
relationships with us. 

Net  investment  income  and  net  realized  and  unrealized  gains  or  losses  also  could  vary  materially  from
expectations  depending  on  gains  or  losses  realized  on  the  sale  or  exchange  of  financial  instruments;  impairment
charges resulting from revaluations of debt and equity securities and other investments; interest rates; cash balances;
and changes in the fair value of financial and derivative instruments. Increased volatility in the financial markets and
overall economic uncertainty would increase the risk that the actual amounts realized in the future on our financial
instruments could differ significantly from the fair values currently assigned to them. 

Reinsurers may not satisfy their obligations to our insurance and reinsurance subsidiaries, which could

result in significant losses or liquidity issues for us. 

Our insurance and reinsurance subsidiaries are subject to credit risk with respect to their reinsurers because
the transfer of risk to a reinsurer does not relieve our subsidiaries of their liability to the insured. Reinsurance companies
may be negatively impacted or downgraded during difficult financial and economic conditions in the worldwide capital
markets and economies. In addition, reinsurers may be unwilling to pay our subsidiaries even though they are able to
do so, or disputes may arise regarding payment obligations. The failure of one or more of our subsidiaries’ reinsurers
to honor their obligations in a timely fashion may affect our cash flows, reduce our net earnings or cause us to incur
a significant loss. Disputes with our reinsurers may also result in unforeseen expenses relating to litigation or arbitration
proceedings. A reinsurer’s inability or unwillingness to honor its obligations to StarStone and Atrium may negate the
intended risk-reducing impact of our reinsurance purchasing programs. 

30

Table of Contents

Exposure to reinsurers who from time to time represent meaningful percentages of our total reinsurance balances
recoverable  on  paid  and  unpaid  losses  may  increase  the  risks  described  above.  For  information  on  reinsurance
balances recoverable on paid and unpaid losses, see "Item 7. Management’s Discussion and Analysis of Financial
Condition and Results of Operations - Liquidity and Capital Resources - reinsurance balances recoverable on paid
and unpaid losses." 

We are a holding company, and we are dependent on the ability of our subsidiaries to distribute funds

to us. 

We  are  a  holding  company  and  therefore  we  are  dependent  on  distributions  of  funds  from  our  operating
subsidiaries to fund acquisitions, fulfill financial obligations in the normal course of our business, including payments
on our outstanding Senior Notes, and pay dividends to our shareholders, including holders of our preferred shares
and, in turn, the related depositary shares. The ability of our insurance and reinsurance subsidiaries to make distributions
to us may be limited by various business considerations and applicable insurance laws and regulations in jurisdictions
in which we operate (which are described in "Item 1. Business - Regulation"). The ability of our subsidiaries to make
distributions to us may also be restricted by, among other things, other applicable laws and regulations and the terms
of our debt obligations and our subsidiaries’ debt obligations. If our subsidiaries are restricted from making distributions
to us, we may be unable to maintain adequate liquidity to fund acquisitions or fulfill our financial obligations. 

Fluctuations in currency exchange rates may cause us to experience losses. 

We maintain a portion of our investments, insurance liabilities and insurance assets denominated in currencies
other than U.S. dollars. Consequently, we and our subsidiaries may experience foreign exchange losses, which could
adversely affect our results of operations. We publish our consolidated financial statements in U.S. dollars. Therefore,
fluctuations in exchange rates used to convert other currencies, particularly Australian dollars, Canadian dollars, British
pounds and Euros, into U.S. dollars will impact our reported financial condition, results of operations and cash flows
from year to year. 

Our failure to comply with covenants contained in our credit facilities or in the indenture governing our
4.5% Senior Notes due 2022 ("2022 Senior Notes") and our 4.95% Senior Notes due 2029 (the "2029 Senior
Notes" and, together with the 2022 Senior Notes, the "Senior Notes") could trigger prepayment obligations,
which could adversely affect our results of operations and financial condition. 

We and our subsidiaries currently have several outstanding credit facilities and outstanding Senior Notes. We
depend on access to these funds in operating our business. The credit facilities and the indentures governing our
Senior  Notes  contain  various  business  and  financial  covenants  that  impose  restrictions  on  us  and  certain  of  our
subsidiaries  with  respect  to,  among  other  things,  limitations  on  mergers  and  consolidations,  acquisitions,
amalgamations and sales of substantially all assets, indebtedness and guarantees, restrictions as to certain dispositions
of stock and dividends and stock repurchases, investment constraints and limitations on liens on the capital stock of
certain  subsidiaries.  We  may  also  enter  into  future  debt  arrangements  containing  similar  or  different  restrictive
covenants. Our failure to comply with these covenants could result in an event of default under the credit facilities or
the indentures governing our Senior Notes, which could result in us being required to repay the amounts outstanding
under these facilities or the Senior Notes prior to maturity. These prepayment obligations could have an adverse effect
on our results of operations and financial condition. 

In addition, complying with these covenants could limit our financial and operational flexibility. Our credit facilities
and Senior Notes are described in more detail in "Item 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations - Liquidity and Capital Resources - Debt Obligations."

31

Table of Contents

Risks Relating to Our Investments 

The  value  of  our  insurance  and  reinsurance  subsidiaries’  investment  portfolios  and  the  investment
income that our insurance and reinsurance subsidiaries receive from these portfolios may decline materially
as a result of market fluctuations and economic conditions, including those related to interest rates and
credit spreads.

We derive a significant portion of our income from our invested assets, which consist primarily of investments
in fixed maturity securities. The value and net investment income that our subsidiaries obtain from investments in fixed
maturity securities will generally increase or decrease with changes in interest rates. Interest rates are highly sensitive
to many factors, including governmental monetary policies, domestic and international economic and political conditions
and other factors beyond our control. A rise in interest rates would increase net unrealized losses, which would decline
over time as the security approaches maturity. Conversely, a decline in interest rates would increase net unrealized
gains, which would decline over time as the security approaches maturity. The fair market value can also decrease as
a result of a deterioration of the credit quality of those securities. Any perceived decrease in credit quality may cause
credit spreads to widen and this would result in an increase in net unrealized losses. A deterioration of credit ratings
on  our  fixed  maturity  security  investments  may  result  in  a  preference  to  liquidate  these  securities  in  the  financial
markets. If we liquidate these securities during a period of tightening credit, we may realize a significant loss.

The Financial Conduct Authority of the United Kingdom plans to phase out the London Interbank Offered Rate
("LIBOR") by the end of 2021. A significant portion of our investments in fixed maturities is in LIBOR-based instruments.
There is currently no definitive replacement rate for LIBOR, and we therefore are unable to determine the potential
impact of the LIBOR change on our investment results.

Some  of  our  fixed  maturity  securities,  such  as  mortgage-backed  and  other  asset-backed  securities,  carry
prepayment risk, or the risk that principal will be returned more rapidly or slowly than expected, as a result of interest
rate fluctuations. When interest rates decline, consumers will generally make prepayments on their mortgages, causing
us to be repaid more quickly than we might have originally anticipated, meaning that our opportunities to reinvest these
proceeds back into the investment markets may be at reduced interest rates (with the converse being true in a rising
interest rate environment). Mortgage-backed and other asset-backed securities are also subject to default risk on the
underlying securitized mortgages, which would decrease the value of our investments.

The changes in the market value of our securities that are classified as trading or available-for-sale are reflected
in our financial statements. Other-than-temporary impairment losses in the value of our fixed maturity securities are
also reflected in our financial statements. As a result, a decline in the value of the securities in our investment portfolios
may materially reduce our net income and shareholders’ equity, and may cause us to incur a significant loss. For more
information on our investment portfolios, see "Item 7. Management’s Discussion and Analysis of Financial Condition
and Results of Operations - Investable Assets."

Our  investments  in  alternative  investments  and  our  investments  in  joint  ventures  and/or  entities
accounted for using the equity method may be illiquid and volatile in terms of value and returns, which could
negatively affect our investment income and liquidity.

In  addition  to  fixed  maturity  securities,  we  have  invested,  and  may  from  time  to  time  continue  to  invest,  in
alternative investments such as hedge funds, fixed income funds, equity funds, private equity funds and co-investments,
collateralized loan obligation ("CLO") equities, CLO equity funds, real estate funds and other alternative investments.
These and other similar investments may be illiquid due to restrictions on sales, transfers and redemption terms, may
have different, more significant risk characteristics than our investments in fixed maturity securities and may also have
more volatile values and returns, all of which could negatively affect our investment income and overall portfolio liquidity.

We have also invested, and from time to time may continue to make investments in joint ventures and in other
entities that we do not control. In these investments, many of which are accounted for using the equity method, we
may lack management and operational control over the entities in which we are invested, which may limit our ability
to take actions that could protect or increase the value of our investment. In addition, these investments may be illiquid
due  to  contractual  provisions,  and  our  lack  of  operational  control  may  prevent  us  from  obtaining  liquidity  through
distributions from these investments in a timely manner or on favorable terms.

Alternative or "other" investments may not meet regulatory admissibility requirements or may result in increased
regulatory capital charges to our insurance subsidiaries that hold these investments, which could limit those subsidiaries’
ability to make capital distributions to us and, consequently, negatively impact our liquidity. For more information on
our alternative investments, see "Item 7. Management’s Discussion and Analysis of Financial Condition and Results
of Operations - Investable Assets."

32

Table of Contents

The valuation of our investments may include methodologies, estimations and assumptions that are
subject to differing interpretations and could result in changes to investment valuations that may materially
adversely affect our financial condition or results of operations.

Fixed maturity and alternative investments, such as hedge funds, fixed income funds, equity funds, private equity
funds and co-investments, CLO equities, CLO equity funds and real estate funds represent the majority of our total
cash and invested assets. These investments are reported at fair value on our consolidated balance sheet. Fair value
prices for all trading and available-for-sale securities in the fixed maturities portfolio are independently provided by our
investment  accounting  service  providers,  investment  managers  and  investment  custodians,  each  of  which  utilize
internationally recognized independent pricing services. We record the unadjusted price provided by our accounting
service providers, managers or custodians, after we perform an internal validation process. Fair value for our alternative
investments is estimated based primarily on the most recently reported net asset values reported by the fund manager,
which we may adjust following our internal review.

These valuation procedures involve estimates and judgments, and during periods of market disruptions (such
as periods of significantly rising or high interest rates, rapidly widening credit spreads or illiquidity), it may be difficult
to value certain of our securities if trading becomes less frequent or market data becomes less observable. In addition,
there may be certain asset classes that are now in active markets with significant observable data that become illiquid
due to changes in the financial environment. In these cases, the valuation of a greater number of securities in our
investment portfolio may require more subjectivity and management judgment. As a result, valuations may include
inputs and assumptions that are less observable or require greater estimation as well as valuation methods that are
more sophisticated or require greater estimation, which may result in valuations greater than the value at which the
investments could ultimately be sold. Further, rapidly changing and unpredictable credit and equity market conditions
could materially affect the valuation of securities carried at fair value as reported within our consolidated financial
statements and the period-to-period changes in value could vary significantly. Decreases in value could have a material
adverse effect on our financial condition and results of operations.

The nature of our business liquidity demands and the structure of our entities’ investment portfolios
may adversely affect the performance of our investment portfolio and financial results and our investing
flexibility.

We strive to structure our investments in a manner that recognizes our liquidity needs for future liabilities. Because
of the unpredictable nature of losses that may arise under the insurance and reinsurance policies issued by certain of
our subsidiaries and as a result of our opportunistic commutation strategy, our liquidity needs can be substantial and
may arise at any time. In that regard, we attempt to correlate the maturity and duration of our investment portfolio to
our general liability profile. If we are unsuccessful in managing our investment portfolio within the context of this strategy,
we may be forced to liquidate our investments at times and at prices that are not optimal, and we may have difficulty
liquidating some of our alternative investments due to restrictions on sales, transfers and redemption terms. This could
have a material adverse effect on the performance of our investment portfolio.

We have many individual portfolios of cash and investments from our acquired companies and portfolios. Each
investment portfolio has its own regulatory admissibility requirements, and each run-off entity is likely to have negative
operating and financing cash flows due to commutation activity, claims settlements and capital distributions. These
factors reduce our overall investing flexibility. 

33

Table of Contents

Risks Relating to Laws and Regulations 

Insurance laws and regulations restrict our ability to operate, and any failure to comply with these laws
and regulations, or any investigations, inquiries or demands by government authorities, may have a material
adverse effect on our business. 

We are subject to the insurance laws and regulations of a number of jurisdictions worldwide. Existing laws and
regulations, among other things, limit the amount of dividends that can be paid to us by our insurance and reinsurance
subsidiaries,  prescribe  solvency  and  capital  adequacy  standards,  impose  restrictions  on  the  amount  and  type  of
investments that can be held to meet solvency and capital adequacy requirements, require the maintenance of reserve
liabilities, and require pre-approval of acquisitions and certain affiliate transactions. Failure to comply with these laws
and  regulations  or  to  maintain  appropriate  authorizations,  licenses,  and/or  exemptions  under  applicable  laws  and
regulations may cause governmental authorities to preclude or suspend our insurance or reinsurance subsidiaries
from carrying on some or all of their activities, place one or more of them into rehabilitation or liquidation proceedings,
impose monetary penalties or other sanctions on them or our affiliates, or commence insurance company delinquency
proceedings against our insurance or reinsurance subsidiaries. The application of these laws and regulations by various
governmental authorities may affect our liquidity and restrict our ability to expand our business operations through
acquisitions or to pay dividends on our ordinary or preferred shares. Furthermore, compliance with legal and regulatory
requirements may result in significant expenses, which could have a negative impact on our profitability. To further
understand these regulatory requirements, see "Item 1. Business - Regulation." 

In addition, the insurance and reinsurance industry has experienced volatility as a result of investigations, litigation
and regulatory activity by various insurance, governmental and enforcement authorities concerning certain practices
within the insurance and reinsurance industry. Insurance and reinsurance companies that we have acquired, or may
acquire in the future, may have been or may become involved in these or other investigations, litigation or regulatory
activity and may have lawsuits filed or other regulatory actions taken against them. Our involvement in any such activity
would cause us to incur legal costs and, if we or any of our insurance or reinsurance subsidiaries were found to have
violated any laws or regulations, we could be required to pay fines and damages and incur other sanctions, perhaps
in material amounts, which could have a material negative impact on our profitability. 

Political, regulatory and industry initiatives could materially adversely affect our business by increasing
the amount of regulation we face or changing the nature of the regulations that apply to us in operating our
insurance businesses or acquiring new insurance businesses. 

Increasingly, governmental authorities have taken interest in the potential systemic risks posed by the insurance
and reinsurance industry as a whole. The insurance regulatory environment has become subject to increased scrutiny
across a number of jurisdictions, and authorities regularly consider enhanced or new regulatory requirements and
seek to exercise their supervisory authority in new and more extensive ways. Regulators are generally concerned with
the protection of policyholders above other constituencies, including our shareholders. Additional laws and regulations
have been and may continue to be enacted that may have adverse effects on our operations, financial condition,
statutory  capital  adequacy,  and  liquidity.  We  cannot  predict  the  exact  nature,  timing  or  scope  of  these  initiatives;
however, we believe it is likely there will continue to be increased regulatory intervention in our industry in the future,
and these initiatives could adversely affect our business.

In many of the jurisdictions in which we operate, including Bermuda, there are increased regulations relating to
group  supervision  though  cooperation  and  coordination  among  insurance  regulators  regardless  of  an  individual
company’s  domiciliary  jurisdiction.  The  BMA  acts  as  our  Group  supervisor,  as  described  in  "Item  1.  Business  -
Regulation" which has led to increased regulatory reporting and oversight.

The implementation of Solvency II, an E.U.-wide directive covering the capital adequacy, risk management and
regulatory  reporting  for  insurers,  requires  significant  resources  to  ensure  compliance  by  our  E.U.  companies.
Additionally,  if  our  non-E.U.  subsidiaries  engage  in  E.U.  insurance  or  reinsurance  business,  additional  capital
requirements may be imposed for such companies to continue to insure or reinsure E.U.-domiciled risk or cedants if
their regulatory regime is not deemed to have Solvency II equivalence. Bermuda has gained Solvency II equivalence,
and our Bermuda reinsurers are subject to requirements in line with a Solvency II framework.

In the United States, the Dodd-Frank Act addresses the entire financial services industry and includes initiatives
such  as  the  creation  of  a  Federal  Insurance  Office  and  other  federal  oversight  agencies,  the  requiring  of  more
transparency, accountability and focus in protecting investors and businesses, the input of shareholders regarding
executive  compensation,  and  the  enhanced  empowerment  of  regulators  to  punish  fraud  and  unethical  business
practices. Continued compliance with these laws and regulations is likely to result in additional regulation and additional

34

Table of Contents

costs for us. 

In addition, increased scrutiny by insurance regulators of investments in or acquisitions of insurers or insurance
holding companies by private equity firms or hedge funds may result in imposition of additional regulatory requirements
and restrictions. We have in the past partnered with private equity firms in making acquisitions and may do so in the
future. This increased scrutiny may make it difficult to complete U.S. acquisitions with private equity or hedge funds
should we seek to do so. In addition, private equity firms and hedge funds have invested in Enstar and may seek to
do  so  in  the  future.  This  increased  scrutiny  may  materially  adversely  impact  our  ability  to  raise  capital  through
transactions with these types of investors. 

Our business is subject to laws and regulations relating to sanctions and foreign corrupt practices, the

violation of which could adversely affect our financial condition and results of operations. 

We are legally required to comply with all applicable economic sanctions and anti-bribery laws and regulations
of the jurisdictions in which we operate. U.S. laws and regulations applicable to our U.S. subsidiaries include the
economic trade sanctions laws and regulations administered by the Treasury’s Office of Foreign Assets Control, as
well as certain laws administered by the U.S. Department of State. New sanction regimes may be initiated, or existing
sanctions expanded, at any time, which can impact our business activities. In addition, our companies are subject to
the U.S. Foreign Corrupt Practices Act and other anti-bribery laws such as the Bermuda Bribery Act and the U.K.
Bribery Act that generally bar corrupt payments or unreasonable gifts to foreign governments or officials. Although we
have policies and controls in place that are designed to ensure compliance with these laws and regulations, it is possible
that an employee or intermediary could fail to comply with applicable laws and regulations. In such event, we could
be exposed to civil penalties, criminal penalties and other sanctions, including fines or other punitive actions. Such
civil or criminal penalties, sanctions, fines or other punitive actions, and the possibility of resulting damage to our
business and/or reputation, could have a material adverse effect on our financial condition and results of operations.

The United Kingdom’s referendum vote to leave the European Union ("Brexit") could adversely affect

our business.

There has been volatility in the financial and foreign exchange markets following the advisory referendum held
on June 23, 2016, in which the United Kingdom voted to leave the European Union (commonly referred to as “Brexit”),
and this is expected to continue. On March 29, 2017, Article 50 of the Lisbon Treaty was triggered, and following the
successful passing of the Withdrawal Agreement Bill by the U.K. Parliament, the United Kingdom left the European
Union on January 31, 2020 pursuant to the terms of a withdrawal agreement concluded between the U.K. government
and the E.U. Council (the “Withdrawal Agreement”). The Withdrawal Agreement allows for a transition period during
which the United Kingdom’s trading relationship with the European Union will remain largely unchanged. This transition
period is due to end on December 31, 2020. During the transition period, the United Kingdom and the European Union
will  continue  to  negotiate  the  terms  of  their  ongoing  relationship.  However,  uncertainty  remains  over  the  United
Kingdom's future relationship with the European Union after 2020. As a result, we face risks associated with the potential
uncertainty  and  consequences  that  may  follow  Brexit,  including  with  respect  to  volatility  in  the  financial  markets,
exchange rates and interest rates. We also have significant operations and employees in the United Kingdom, including
in our Lloyd’s and StarStone businesses. Brexit’s impact on our U.K. businesses will depend on the United Kingdom
and Lloyd’s abilities to retain access to the E.U. markets, and our U.K. businesses could be adversely affected if
adequate access to these markets is not obtained. Brexit may also lead to legal uncertainty and differences in national
laws and regulations as the United Kingdom determines which E.U. laws to replace or replicate, and these issues
could  impact  our  structure  and  operations. Any  of  these  effects  of  Brexit,  and  others  we  cannot  anticipate,  could
adversely affect our business, results of operations, and financial condition.

Changes  in  accounting  principles  and  financial  reporting  requirements  could  impact  our  reported

financial results and our reported financial condition. 

Our financial statements are prepared in accordance with U.S. GAAP, which is periodically revised by the Financial
Accounting Standards Board ("FASB"), and they are subject to the accounting-related rules and interpretations of the
SEC. We are required to adopt new and revised accounting standards implemented by the FASB. 

35

Table of Contents

Unanticipated developments in accounting practices may require us to incur considerable additional expenses
to comply with such developments, particularly if we are required to prepare information relating to prior periods for
comparative purposes or to apply the new requirements retroactively. The impact of changes in accounting standards,
particularly those that apply to insurance companies, cannot be predicted but may affect the calculation of net earnings,
shareholders’ equity and other relevant financial statement line items. In addition, such changes may cause additional
volatility in reported earnings, decrease the understandability of our financial results and affect the comparability of
our reported results with the results of others. 

Risks Relating to our Operations 

We are dependent on our executive officers, directors and other key personnel and the loss of any of

these individuals could adversely affect our business. 

Our success depends on our ability to attract and retain qualified employees and upon the ability of our senior
management and other key employees to implement our business strategy. We believe that there are only a limited
number of available qualified personnel in the businesses in which we compete, and the pool of highly skilled employees
available to fill key positions at our companies may fluctuate based on market conditions. We rely substantially upon
the  services  of  our  executive  officers  and  our  subsidiaries’  executive  officers  and  directors,  as  well  as  our  local
management teams, to implement our business strategies. The loss of the services of any of our management or other
key personnel, or the loss of the services of or our relationships with any of our directors, could have a material adverse
effect on our business. Higher demand for employees with appropriate skills could lead to increased compensation
expectations  for  existing  and  prospective  personnel  across  our  organization,  which  could  also  make  it  difficult  to
maintain labor expenses at desired levels. 

Some of our directors, large shareholders and their affiliates have interests and/or other involvement

with entities that can create conflicts of interest, through related party transactions or competition. 

We have participated in transactions, investments and investment management arrangements in which one or
more of our directors, large shareholders or their affiliates has an interest, and we may continue to do so in the future.
These matters, called related party transactions, are described in Note 21 - "Related Party Transactions" in the notes
to our consolidated financial statements included in Item 8 of this Annual Report. In addition, some of our directors,
large shareholders or their affiliates from time to time have ownership interests or other involvement with entities that
compete against us or otherwise have interests that could, at times, be considered potentially adverse to us, either in
the  pursuit  of  acquisition  targets,  investments  or  in  our  business  operations.  The  interests  of  our  directors,  large
shareholders or their affiliates in related party transactions or competitive businesses may create the potential for, or
result in, conflicts of interests. 

Cybersecurity events or other difficulties with our information technology systems could disrupt our
business, result in the loss of critical and confidential information, increased costs, and adversely impact
our reputation and results of operations. 

We rely heavily on the successful, uninterrupted functioning of our information technology systems, as well as
those of any third-party service providers we use. We rely on these systems to securely and accurately process, store,
and transmit confidential and other data in connection with our critical operational functions such as paying claims,
performing actuarial and other modeling, pricing, quoting and processing policies, cash and investment management,
acquisition analysis, financial reporting and other necessary support functions. Our active underwriting companies rely
on broker portals to bind certain business, and, therefore, a service interruption would negatively impact our ability to
write business. Where we rely on third parties for outsourced functions and other services, our information may be
exposed  to  the  risk  of  a  data  breach  or  cyber-security  incident  through  their  systems. A  failure  of  our  information
technology systems or those of our third-party service providers could materially impact our ability to perform the critical
functions described above, affect the confidentiality, availability or integrity of our proprietary information and expose
us to litigation and increase our administrative expenses.

Computer  viruses,  cyber-attacks,  and  other  external  hazards,  as  well  as  any  internal  process  or  employee
failures, could expose our information technology systems to security breaches that may cause critical data to be
corrupted  or  confidential  or  proprietary  information  to  be  exposed,  or  cause  system  disruptions  or  shut-downs.  In
addition to our own information, we receive and may be responsible for protecting confidential or personal information
of ceding companies, policyholders, employees, and other third parties, which could also be compromised in the event
of a security breach. 

36

Table of Contents

Although we utilize numerous controls, protections and risk management strategies to attempt to mitigate these
risks, and management is not aware of a material cyber-security incident to date, the sophistication and volume of
these security threats continues to increase. We may not have the technical expertise or resources to successfully
prevent every data breach or cyber-security incident. The potential consequences of a data breach or cyber-security
incident could include claims against us, significant reputational damage to our company, damage to our business as
a result of disclosure of proprietary information, and regulatory action against us, which may include fines and penalties.
Such an incident could cause us to lose business and commit resources, management time and money to remediate
these breaches and notify aggrieved parties, any of which in turn could have an adverse impact on our business. We
may also experience increasing costs associated with implementing and maintaining adequate safeguards against
these types of incidents and attacks. 

In addition, the information security and data privacy regulatory environment is increasingly demanding. We are
subject  to  numerous  laws  and  regulations  in  multiple  jurisdictions  governing  the  protection  of  the  personal  and
confidential  information  of  our  clients  and/or  employees,  including  in  relation  to  medical  records  and  financial
information.  These  laws  and  regulations  are  rapidly  expanding,  increasing  in  complexity  and  sometimes  conflict
between jurisdictions. For example, the E.U. General Data Protection Regulation ("GDPR") creates rights for individuals
to control their personal data and sets forth the requirements with which companies handling the personal data of
E.U.-based data subjects have to comply (regardless of whether such data handling involves E.U.-based operations).
We are also subject to the GDPR through our handling of the personal data of E.U.-based subjects in connection with
our ordinary course operations. If any person, including any of our employees or those with whom we share such
information, negligently disregards or intentionally breaches our established controls with respect to our client data,
or otherwise mismanages or misappropriates that data, we could be subject to significant monetary damages, regulatory
enforcement actions, fines and/or criminal prosecution in one or more jurisdictions, including as a result of a violation
of the GDPR. 

If  outsourced  providers  such  as  third-party  administrators,  managing  general  agents,  investment
managers or other service providers were to breach obligations owed to us, our business and results of
operations could be adversely affected. 

We  outsource  certain  business  functions  to  third-party  providers,  and  these  providers  may  not  perform  as
anticipated or may fail to adhere to their obligations to us. For example, certain of our subsidiaries rely on relationships
with a number of third-party administrators under contracts pursuant to which these third-party administrators manage
and pay claims on our subsidiaries’ behalf and advise with respect to case reserves. In these relationships, we rely
on controls incorporated in the provisions of the administration agreement, as well as on the administrator’s internal
controls, to manage the claims process within our prescribed parameters. Our StarStone and Atrium subsidiaries use
managing general agents, general agents and other producers to write and administer business on their behalf within
prescribed underwriting authorities. We also rely on external investment managers to provide services pursuant to the
terms of our investment management agreements, including following established investment guidelines. Although
we monitor these administrators, agents and producers, and investment managers on an ongoing basis, our monitoring
efforts may not be adequate or our service providers could exceed their authorities or otherwise breach obligations
owed to us, which, if material, could adversely affect our business and results of operations.

Risks Relating to Taxation 

Recently  enacted  U.S.  tax  reform  legislation,  various  international  tax  transparency  and  economic
substance initiatives, and possible future tax reform legislation and regulations could materially affect us
and our shareholders.

On December 22, 2017, the US government enacted comprehensive tax legislation commonly referred to as
the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act is broad and contains many provisions that have significant
implications on us, and potentially on our shareholders, including re-measurement of deferred taxes and surplus due
to the reduction in corporation income tax rate, and imposition of a new base-erosion anti-abuse tax (“BEAT”) on
affiliate transactions (including reinsurance arrangements between affiliated companies). In response to the introduction
of BEAT, we non-renewed (as of January 1, 2018) certain of our active underwriting affiliate reinsurance transactions
between our operating entities that are subject to U.S. taxation and our non-U.S. affiliates that are not. We continue
to assess the future impact of BEAT on our transaction structuring. 

37

Table of Contents

The Tax Act also includes modifications of the taxation of non-U.S. companies owned by U.S. shareholders.
Certain aspects of the Tax Act require clarification through future regulatory action and accordingly, we are unable to
definitively determine the impact to our shareholders. The Tax Act may increase the likelihood that we or our non-U.S.
subsidiaries or joint ventures managed by us will be deemed a “controlled foreign corporation” (CFC) within the meaning
of the Internal Revenue Code of 1986, as amended (the “Code”) for U.S. federal tax purposes. Specifically, the Tax
Act expands the definition of “United States shareholder” for CFC purposes to include U.S. persons who own, directly
or constructively, 10% or more of the value of a non-U.S. corporation’s shares, rather than looking only to voting power
held. The Tax Act  also  expands  certain  attribution  rules  for  share  ownership  in  a  way  that  would  cause  non-U.S.
subsidiaries to now be treated as CFCs if owned in a group, such as Enstar, that has a non-U.S. parent company and
also includes at least one U.S. subsidiary. In the event a corporation is characterized as a CFC, any “United States
shareholder” of the CFC is required to include in taxable income each year the shareholder’s proportionate share of
certain insurance and related investment income for the taxable year, even if such income is not distributed.

The Tax Act also contains modifications to certain provisions relating to passive foreign investment company
(“PFIC”) status that if applicable to us could result in adverse tax consequences to U.S. persons who own our ordinary
shares. On July 10, 2019, the U.S. Internal Revenue Service and Department of the Treasury released proposed
regulations relating to PFICs that may have an impact on foreign insurance companies and their investors, and other
participants  in  transactions  involving  foreign  insurers.  The  new  proposed  regulations  withdraw  a  set  of  proposed
regulations that were issued in April 2015.  The proposed regulations provide guidance relating to changes in the PFIC
regime made by the Tax Act, address the application and interaction of certain “look-through” rules contained in the
Code and introduce new rules relating to the determination of the “active conduct” test. While the proposed regulations
make it more difficult to qualify for certain exceptions to PFIC status, we believe that we will not be a PFIC for U.S.
federal income purposes for the foreseeable future under the proposed regulations. In particular, we believe that the
income of our non-U.S. subsidiaries that are insurance companies is derived in the "active conduct of an insurance
business" by corporations that are predominately engaged in such business under the provision of the Tax Act, and
that this is also the case for us when the operations of our subsidiaries are considered as a whole, under the look-
through rules applicable to foreign holding companies. There are currently no final regulations regarding the application
of  the  PFIC  provisions  of  the  Code  to  an  insurance  company,  so  the  application  of  those  provisions  to  insurance
companies remains unclear in certain respects. The proposed regulations are expected to become final, possibly as
early as the first half of 2020.

The United States and other countries and governing bodies have also enacted reform legislation aimed at
increasing transparency on companies’ global tax footprint and profile. The Organization for Economic Co-operation
and  Development  (the  "OECD")  is  an  intergovernmental  economic  organization  founded  to  stimulate  economic
progress and trade. It develops economic policy recommendations to encourage policy reform in member countries.
Created by the OECD under the initiative known as the “Base Erosion and Profit Shifting Project (“BEPS”), “Country-
by-Country Reporting” (Action 13) aims to ensure that multi-national businesses provide appropriate and accurate
information to each respective member and non-member region based on various metrics. These metrics are directed
at counteracting the effects of global preferential tax regimes and increasing tax transparency. Bermuda has adopted
OECD compliant Country-by-Country Reporting regulations for Bermuda headquartered companies which requires
the Company to file a report containing results of our global operations. It is uncertain how cooperating jurisdictions,
including those in which we operate, will utilize the data collected in our Bermuda filing. These initiatives could increase
the burden and costs of compliance.

In December 2017, the European Union's Code Group included Bermuda on a list of jurisdictions that it considered
to be non-cooperative for tax purposes. In order to be removed from such list, Bermuda passed the Economic Substance
Act 2018 (the “ESA”) in December 2018, which came into effect on January 1, 2019 and required compliance by pre-
existing entities by July 1, 2019. The legislation requires Bermuda companies engaging in a “relevant activity” (which
includes insurance business and holding entity activities) to be locally managed and directed, to carry on core income
generating activities in Bermuda, to maintain adequate physical presence in Bermuda, and to have an adequate level
of local full time qualified employees and incur adequate operating expenditure in Bermuda. The guidance as to how
Bermuda authorities will interpret and enforce the ESA is pending, and we therefore cannot predict their potential
impact on our results of operations and financial condition. In the event that we are required to maintain additional
staff or operations in Bermuda, we may incur increased operating expenditures that could negatively impact our results
of operations. 

38

Table of Contents

U.S. persons who own our ordinary shares might become subject to adverse U.S. tax consequences as

a result of "related person insurance income," if any, of our non-U.S. insurance company subsidiaries.

For any of our wholly-owned non-U.S. insurance company subsidiaries, if (1) U.S. persons are treated as owning
25% or more of our shares, (2) the related person insurance income ("RPII") of that subsidiary were to equal or exceed
20% of its gross insurance income in any taxable year, and (3) direct or indirect insureds of that subsidiary (and persons
related to such insureds) own (or are treated as owning) 20% or more of the voting power or value of our shares, then
a U.S. person who owns our shares directly, or indirectly through non-U.S. entities, on the last day of the taxable year
would be required to include in income for U.S. federal income tax purposes that person's pro rata share of the RPII
of such a non-U.S. insurance company for the entire taxable year, whether or not any such amounts are actually
distributed. In the case of any of our partially-owned non-U.S. insurance company subsidiaries, the RPII provisions
apply  similarly,  except  that  the  percentage  share  ownership  thresholds  described  in  the  preceding  sentence  are
measured in terms of indirect ownership of the subsidiary’s shares rather than in terms of ownership of our shares.

Moreover, if the RPII rules of the Code were to apply to any of our non-U.S. insurance company subsidiaries,
any RPII that is includible in the income of a U.S. tax-exempt organization would generally be treated as unrelated
business taxable income. Although we and our subsidiaries intend to operate generally in a manner so as to avoid
exceeding the foregoing thresholds for application of the RPII rules, there can be no assurance that this will always
be the case. Accordingly, there can be no assurance that U.S. persons who own our ordinary shares will not be required
to recognize gross income inclusions attributable to RPII.

In addition, the RPII rules provide that if a shareholder who is a U.S. person disposes of shares in a foreign
insurance company that has RPII and in which U.S. persons collectively own 25% or more of the total combined voting
power of all classes of stock entitled to vote, or the total value of the stock, any gain from the disposition will generally
be treated as dividend income to the extent of the shareholder’s share of the corporation’s undistributed earnings and
profits that were accumulated during the period that the shareholder owned the shares (whether or not those earnings
and  profits  are  attributable  to  RPII).  Such  a  shareholder  would  also  be  required  to  comply  with  certain  reporting
requirements, regardless of the amount of shares owned by the shareholder. These rules should not apply to dispositions
of our ordinary shares because we will not be directly engaged in the insurance business. The RPII rules have not
been  interpreted  by  the  courts  or  the  IRS  and  regulations  interpreting  the  RPII  rules  exist  only  in  proposed  form.
Accordingly, there is no assurance that our views as to the inapplicability of these rules to a disposition of our ordinary
shares will be accepted by the IRS or a court.

We might incur unexpected U.S., U.K., Australia, or other tax liabilities if companies in our group that
are incorporated outside those jurisdictions are determined to be carrying on a trade or business in such
jurisdictions. 

We and a number of our subsidiaries are companies formed under the laws of Bermuda or other jurisdictions
that do not impose income taxes, and it is our contemplation that these companies will not incur substantial income
tax liabilities from their operations. Because the operations of these companies generally involve, or relate to, the
insurance or reinsurance of risks that arise in higher tax jurisdictions, such as the United States, the United Kingdom
and Australia, it is possible that the taxing authorities in those jurisdictions may assert that the activities of one or more
of these companies creates a sufficient nexus in that jurisdiction to subject the company to income tax there. There
are uncertainties in how the relevant rules apply to insurance businesses, and in our eligibility for favorable treatment
under applicable tax treaties. Accordingly, it is possible that we could incur substantial unexpected tax liabilities. 

Risks Relating to Ownership of our Shares 

The market price for our ordinary shares and the depositary shares representing our preferred shares

may experience volatility, thereby causing a potential loss of value to our investors.

The market price for our ordinary shares may fluctuate substantially and could cause investment losses due to,

among other things, the following factors:

•

•

•

•

•

announcements with respect to an acquisition or investment; 

changes in the value of our assets; 

our financial condition, performance and prospects, including our quarterly and annual operating results; 

sales, or the possibility or perception of future sales, by our existing shareholders; 

changes in general conditions in the economy and the insurance industry; 

39

Table of Contents

•

•

economic, financial, geopolitical, regulatory or judicial events that affect us or the financial markets generally;
and 

adverse press or news announcements. 

The market price for our depositary shares representing our preferred shares may fluctuate substantially and
could cause investments losses due to, among other things and in addition to the factors listed above, the following:

•

•

•

•

•

•

whether dividends have been declared and are likely to be declared on the preferred shares from time to
time;

whether the ratings on the depositary shares representing our preferred shares provided by any ratings
agency have changed;

changes in our credit ratings or the ratings of our insurance subsidiaries’ financial strength and claims paying
ability published by major credit ratings agencies;

the amount of total indebtedness we have outstanding;

the level, direction and volatility of market interest rates generally; and

the market for similar securities.

A few significant shareholders may influence or control the direction of our business. If the ownership
of our ordinary shares continues to be highly concentrated, it may limit the ability of other shareholders to
influence significant corporate decisions. 

We have a number of shareholders with large interests, including several that may be affiliated with members
of our Board of Directors. The interests of certain significant shareholders, including those affiliated with members of
our Board of Directors, may not be fully aligned with those of other shareholders, and this may lead to a strategy that
is not in such other shareholders’ best interests. As of December 31, 2019, CPPIB, funds managed by Hillhouse Capital
Advisors Ltd. and its affiliates, funds managed by Stone Point and its affiliates, Beck Mack & Oliver, and two of Enstar's
executive  officer  co-founders  (collectively)  beneficially  owned  approximately12.5%,  9.7%,9.1%,  3.9%  and  4.1%,
respectively, of our outstanding voting ordinary shares. CPPIB owns additional non-voting ordinary shares that, together
with its voting shares, represented an economic interest of approximately 17.8% as of December 31, 2019. Hillhouse
owns additional non-voting shares and warrants that, together with its voting shares, represented an economic interest
of approximately 17.0% as of December 31, 2019. 

Although they do not act as a group, the shareholders identified above may exercise significant influence over
matters requiring shareholder approval, and their concentrated holdings may delay or deter possible changes in control
of Enstar, which may reduce the market price of our ordinary shares. 

Some aspects of our corporate structure may discourage third-party takeovers and other transactions

or prevent the removal of our board of directors and management. 

Some provisions of our bye-laws have the effect of making more difficult or discouraging unsolicited takeover
bids from third parties or preventing the removal of our current board of directors and management. In particular, our
bye-laws provide for a classified board, whose members may be removed by our shareholders only for cause by a
majority vote, and contain restrictions on the ability of shareholders to nominate persons to serve as directors, submit
resolutions to a shareholder vote and request special general meetings. In addition, our board of directors may limit
a shareholder’s exercise of voting rights where it deems it necessary to do so to avoid adverse tax, legal or regulatory
consequences. We also have the authority under our bye-laws to reasonably request information from any shareholder
for the purpose of determining whether a shareholder’s voting rights are to be limited pursuant to the bye-laws. If a
shareholder fails to respond to our request for information or submits incomplete or inaccurate information in response
to a request by us, we may, in our reasonable discretion, eliminate the shareholder’s voting rights. These provisions
may  encourage  persons  seeking  to  acquire  control  of  us  to  negotiate  with  our  directors,  which  we  believe  would
generally best serve the interests of our shareholders. In addition, these bye-law provisions may prevent the removal
of our current board of directors and management. To the extent these provisions discourage takeover attempts, they
may deprive shareholders of opportunities to realize takeover premiums for their shares or may depress the market
price of the shares. 

40

Table of Contents

There are regulatory limitations on the ownership and transfer of our ordinary shares. 

Insurance laws and regulations in the jurisdictions in which our insurance and reinsurance subsidiaries operate
require  prior  notices  or  regulatory  approval  of  changes  in  control  of  an  insurer  or  its  holding  company.  Different
jurisdictions define changes in control differently, and generally any purchaser of 10% or more of the vote or value of
our ordinary shares could become subject to regulation and be required to file certain notices and reports with the
applicable insurance authorities. These laws may discourage potential acquisition proposals and may delay, deter or
prevent a change in control of us, including transactions that some shareholders might consider to be desirable. 

Our  board  of  directors  may  decline  to  register  a  transfer  of  our  ordinary  shares  under  certain

circumstances.

Our board of directors may decline to register a transfer of ordinary shares under certain circumstances, including
if it has reason to believe that any non-de minimis adverse tax, regulatory or legal consequences to us, any of our
subsidiaries or any of our shareholders may occur as a result of such transfer. Further, our bye-laws provide us with
the option to repurchase, or to assign to a third party the right to purchase, the minimum number of shares necessary
to eliminate any such non-de minimis adverse tax, regulatory or legal consequence. In addition, our board of directors
may decline to approve or register a transfer of shares unless all applicable consents, authorizations, permissions or
approvals of any governmental body or agency in Bermuda, the United States, the United Kingdom and other applicable
jurisdictions required to be obtained prior to such transfer shall have been obtained. The proposed transferor of any
shares will be deemed to own those shares for dividend, voting and reporting purposes until a transfer of such shares
has been registered on our shareholder register. It is our understanding that while the precise form of the restrictions
on  transfer  contained  in  our  bye-laws  is  untested,  as  a  matter  of  general  principle,  restrictions  on  transfers  are
enforceable under Bermuda law and are not uncommon. These restrictions on transfer may also have the effect of
delaying, deferring or preventing a change in control.

The market value of our ordinary shares may decline if large numbers of shares are sold.

Pursuant to our contractual obligations, on October 10, 2017, we filed a resale registration statement covering
approximately 9.8 million ordinary shares (including voting ordinary shares issuable upon conversion of outstanding
non-voting ordinary shares) primarily held by CPPIB, Hillhouse and Trident. Upon effectiveness of the resale registration
statement on December 13, 2018, a large number of ordinary shares became freely tradable without restrictions under
the Securities Act. Our ordinary shares have in the past been, and may from time to time continue to be, thinly traded,
and significant sales could adversely affect the market price for our ordinary shares and impair our ability to raise
capital through offerings of our equity securities.

Because we are incorporated in Bermuda, it may be difficult for shareholders to serve process or enforce

judgments against us or our directors and officers. 

We are a Bermuda company. In addition, certain of our officers and directors reside in countries outside the
United States. All or a substantial portion of our assets and the assets of these officers and directors are or may be
located outside the United States. Investors may have difficulty effecting service of process within the United States
on our directors and officers who reside outside the United States or recovering against us or these directors and
officers on judgments of U.S. courts based on civil liabilities provisions of the U.S. federal securities laws even though
we have appointed an agent in the United States to receive service of process. Further, no claim may be brought in
Bermuda against us or our directors and officers for violation of U.S. federal securities laws, as such laws do not have
force of law in Bermuda. A Bermuda court may, however, impose civil liability, including the possibility of monetary
damages, on us or our directors and officers if the facts alleged in a complaint constitute or give rise to a cause of
action under Bermuda law.

We believe that there is doubt as to whether the courts of Bermuda would enforce judgments of U.S. courts
obtained in actions against us or our directors and officers, as well as our independent auditors, predicated upon the
civil liability provisions of the U.S. federal securities laws or original actions brought in Bermuda against us or these
persons predicated solely upon U.S. federal securities laws. Further, there is no treaty in effect between the United
States and Bermuda providing for the enforcement of judgments of U.S. courts, and there are grounds upon which
Bermuda courts may not enforce judgments of U.S. courts. Some remedies available under the laws of U.S. jurisdictions,
including some remedies available under the U.S. federal securities laws, may not be allowed in Bermuda courts as
contrary to that jurisdiction’s public policy. Because judgments of U.S. courts are not automatically enforceable in
Bermuda, it may be difficult for you to recover against us based upon such judgments.

41

Table of Contents

Shareholders  who  own  our  shares  may  have  more  difficulty  in  protecting  their  interests  than

shareholders of a U.S. corporation.

The Bermuda Companies Act (the "Companies Act"), which applies to us, differs in certain material respects
from laws generally applicable to U.S. corporations and their shareholders. As a result of these differences, shareholders
who own our shares may have more difficulty protecting their interests than shareholders who own shares of a U.S.
corporation.  For  example,  class  actions  and  derivative  actions  are  generally  not  available  to  shareholders  under
Bermuda law. Under Bermuda law, only shareholders holding collectively 5% or more of our outstanding ordinary
shares or groups of shareholders numbering 100 or more are entitled to propose a resolution at our general meeting.

We do not intend to pay cash dividends on our ordinary shares.

We do not intend to pay a cash dividend on our ordinary shares. Rather, we intend to use any retained earnings
to fund the development and growth of our business. From time to time, our board of directors will review our alternatives
with respect to our earnings and seek to maximize value for our ordinary shareholders. In the future, we may decide
to commence a dividend program for the benefit of our ordinary shareholders. Any future determination to pay dividends
on our ordinary shares will be at the discretion of our board of directors and will be limited by our position as a holding
company  that  lacks  direct  operations,  the  results  of  operations  of  our  subsidiaries,  our  financial  condition,  cash
requirements and prospects and other factors that our board of directors deems relevant. In addition, there are significant
regulatory  and  other  constraints  that  could  prevent  us  from  paying  dividends  in  any  event.  As  a  result,  capital
appreciation, if any, on our ordinary shares may be your sole source of gain for the foreseeable future.

Dividends on our preferred shares are non-cumulative.

Dividends on our preferred shares are non-cumulative and payable only out of available funds under Bermuda
law. If our board of directors (or a duly authorized committee of the board) does not authorize and declare a dividend
for any dividend period, holders of our preferred shares and, in turn, the depositary shares representing preferred
shares, would not be entitled to receive any such dividend, and such unpaid dividend will not accrue and will not be
payable. We will have no obligation to pay dividends for a dividend period on or after the dividend payment date for
such period if our board of directors (or a duly authorized committee of the board) has not declared such dividend
before the related dividend payment date, whether or not dividends are declared for any subsequent dividend period
with respect to any outstanding preferred shares and/or our ordinary shares.

Certain regulatory and other constraints may limit our ability to pay dividends on our securities.

We  are  subject  to  Bermuda  regulatory  constraints  that  affect  our  ability  to  pay  dividends  and  make  other
distributions on our ordinary and preferred shares. Under the Companies Act, we may declare or pay a dividend or
distribution out of contributed surplus only if we have reasonable grounds to believe that we are, and would after the
payment be, able to meet our liabilities as they become due or is the realizable value of our assets would thereby not
be less than our liabilities.

Our ordinary and preferred shares are subordinate to our existing and future indebtedness.

Our preferred shares are equity interests and do not constitute indebtedness. As such, the preferred shares, in
addition to our ordinary shares, will rank junior to all of our indebtedness and other non-equity claims with respect to
assets  available  to  satisfy  our  claims,  including  in  our  liquidation.  The  preferred  shares  are  also  contractually
subordinated in right of payment to all obligations of our subsidiaries including all existing and future policyholder
obligations of our subsidiaries. Additionally, neither our ordinary shares nor our preferred shares represent an interest
in any of our subsidiaries, and accordingly, are structurally subordinated to all obligations of our subsidiaries. 

There is no limitation on our issuance of securities that rank equally with or senior to the preferred

shares.

We may issue, without limitation, (1) additional depositary shares representing additional preferred shares that
would  form  part  of  one  of  the  series  of  depositary  shares  representing  our  outstanding  preferred  shares,  and
(2) additional series of securities that rank equally with or senior to the outstanding preferred shares. The issuance of
additional preferred shares on par with or senior to the outstanding preferred shares would dilute the interests of the
holders of our preferred shares, and any issuance of preferred shares senior to our outstanding preferred shares or
of additional indebtedness could affect our ability to pay dividends on, redeem or pay the liquidation preference on our
preferred shares, or to make payments to holders of our ordinary shares from remaining assets of the Company, in
the event of a liquidation, dissolution or winding-up of Enstar. 

42

Table of Contents

Our ordinary shares rank junior to our outstanding preferred shares in the event of a liquidation, winding

up or dissolution of the Company.

In the event of a liquidation, winding up or dissolution of the Company, our ordinary shares rank junior to our
outstanding preferred shares. In such an event, there may not be sufficient assets remaining after payments to holders
of our outstanding preferred shares to ensure payments to holders of ordinary shares.

Under certain limited circumstances, the terms of the preferred shares may change without the holders’

consent or approval.

Under the terms of our outstanding preferred shares, at any time following specified tax or capital disqualification
events, we may, without the consent of any holders of the preferred shares, vary the terms of the preferred shares
such that they remain securities, or exchange the preferred shares for new securities, which (i) in the case of a tax
event, would eliminate the substantial probability that we or any successor company would be required to pay any
additional amounts with respect to such preferred shares as a result of a change in tax law or (ii) in the case of a capital
disqualification event, for purposes of determining the solvency margin, capital adequacy ratios or any other comparable
ratios, regulatory capital resource or level of Enstar Group or any member thereof, where subdivided into tiers, qualify
as Tier 2 capital securities under then-applicable capital adequacy regulations imposed upon us by the BMA (or any
successor agency or then-applicable regulatory authority) which would include, without limitation, the ECR. However,
our exercise of this right is subject to certain conditions, including that the terms considered in the aggregate cannot
be less favorable to the holders of the applicable preferred shares than the terms of such securities prior to being
varied or exchanged. 

The voting rights of holders of our preferred shares and, in turn, the depositary shares representing the

preferred shares are limited.

Holders of our outstanding preferred shares and, in turn, the depositary shares representing the preferred shares
have no voting rights with respect to matters that generally require the approval of voting shareholders. In addition, if
dividends on any of our outstanding preferred shares have not been declared or paid for the equivalent of six dividend
payments, whether or not for consecutive dividend periods, holders of the outstanding preferred shares and, in turn,
the depositary shares, will, subject to the terms and conditions contained in the certificates of designation governing
the preferred shares, be entitled to vote for the election of two additional directors to our board of directors. The holders
shall be divested of the foregoing voting rights if and when dividends for at least four dividend periods, whether or not
consecutive, following a nonpayment event have been paid in full (or declared and a sum sufficient for such payment
shall have been set aside). In addition, holders of the depositary shares must act through the depositary to exercise
any voting rights in respect of the preferred shares. Although each depositary share is entitled to 1/1,000th of a vote,
the depositary can vote only whole preferred shares. While the depositary will vote the maximum number of whole
preferred shares in accordance with the instructions it receives, any remaining votes of holders of the depositary shares
will not be voted. 

Our preferred shares ratings may be downgraded.

Our  preferred  shares  are  rated.  However,  if  any  ratings  assigned  to  our  preferred  shares  are  subsequently
lowered or withdrawn, or if it we issue other rated securities and they are rated lower than market expectations, it could
adversely affect the market for or the market value of the outstanding depositary shares representing our preferred
shares. A rating is not a recommendation to purchase, sell or hold any particular security, including our preferred shares
and, in turn, the depositary shares. Ratings do not reflect market prices or suitability of a security for a particular investor
and any rating of our preferred shares may not reflect all risks related to us and our business, or the structure or market
value of the preferred shares or the depositary shares. Ratings only reflect the views of the rating agency or agencies
issuing the ratings and such ratings could be revised downward or withdrawn entirely at the discretion of the issuing
rating agency if in its judgment circumstances so warrant. Any such downward revision or withdrawal of a rating could
have an adverse effect on the market price of the depositary shares.

43

Table of Contents

Market interest rates may adversely affect the value of the depositary shares representing our preferred

shares.

One of the factors that will influence the price of the depositary shares representing our preferred shares will be
the current dividend yield on the relevant series of preferred shares (as a percentage of the price of the depositary
shares representing such preferred shares, as applicable) relative to market interest rates. An increase in market
interest rates, which are currently at low levels relative to historical rates, may lead prospective purchasers of our
depositary shares representing the preferred shares to seek a higher dividend yield, which could cause the market
price of our depositary shares representing the preferred shares to decrease. Higher interest rates would also likely
increase our borrowing costs and potentially decrease funds available to pay dividends on the preferred shares, which
may also cause the market price of our depositary shares representing the preferred shares to decrease.

In addition, during the floating rate period of our outstanding series D preferred shares, the interest rate on such
preferred shares is determined with reference to three-month LIBOR.  To the extent that the three-month LIBOR rate
is discontinued or is no longer quoted, the applicable base rate used to calculate the dividend rate on such preferred
shares beginning on September 1, 2028 (when the floating rate period begins) will be determined using the alternative
methods described in the certificate of designations relating to such preferred shares.  Any of these alternative methods
may result in dividend rates that are lower than or that do not otherwise correlate over time with the dividend rates that
would have been applicable if the three-month LIBOR rate was available in its current form. Such alternative methods
may include determinations and adjustments made by the calculation agent in consultation with us. Our interests and
the interests of any calculation agent appointed by us and making the foregoing determinations or adjustments may
be adverse to your interests as a holder of depositary shares representing preferred shares, and any of the foregoing
determinations, adjustments or actions by such calculation agent could result in adverse consequences to the applicable
dividend rate on such preferred shares, which could have adverse effects on the returns on, value of and market for
such preferred shares and the depositary shares representing such preferred shares. If the calculation agent determines
that LIBOR has been discontinued, in certain circumstances, such preferred shares would bear a fixed dividend rate
and could decline in value because the premium, if any, over market dividend rates will decline. 

We have no obligation to maintain any listing of the depositary shares representing our outstanding

preferred shares.

Although the depositary shares representing our outstanding preferred shares are listed on NASDAQ, such
listings may not provide significant liquidity, and transaction costs in any secondary market could be high. The difference
between bid and ask prices in any secondary market could be substantial. As a result, holders of depositary shares
representing our preferred shares (which do not have a maturity date) may be required to bear the financial risks of
an investment in the depositary shares representing preferred shares for an indefinite period of time. We do not expect
that there will be any separate public trading market for the preferred shares except as represented by the depositary
shares. In addition, we undertake no obligation, and expressly disclaim any obligation, to maintain the listing of the
depositary shares representing our preferred shares on NASDAQ or any other stock exchange. If we elect to discontinue
the listing at any time or the depositary shares representing the preferred shares otherwise are not listed on an applicable
stock exchange, the dividends paid after the delisting would not constitute qualified dividend income for U.S. federal
income tax purposes. This is because dividends paid by a Bermuda corporation are qualified dividend income only if
the stock with respect to which the dividends are paid is readily tradeable on an established securities market in the
United States.

A classification of the depositary shares representing our preferred shares by the National Association

of Insurance Commissioners may impact U.S. insurance companies that purchase our preferred shares.

The  National Association  of  Insurance  Commissioners  (the  “NAIC”)  may  from  time  to  time,  in  its  discretion,
classify securities in U.S. insurers’ portfolios as debt, preferred equity or common equity instruments. The NAIC’s
written guidelines for classifying securities as debt, preferred equity or common equity include subjective factors that
require the relevant NAIC examiner to exercise substantial judgment in making a classification. There is therefore a
risk that the depositary shares representing our preferred shares may be classified by the NAIC as common equity
instead  of  preferred  equity. The  NAIC  classification  determines  the  amount  of  risk-based  capital  (“RBC”)  charges
incurred by insurance companies in connection with an investment in a security. Securities classified as common equity
by the NAIC carry RBC charges that can be significantly higher than the RBC requirement for debt or preferred equity.
Therefore,  any  classification  of  the  depositary  shares  representing  our  preferred  shares  as  common  equity  may
adversely affect U.S. insurance companies that hold depositary shares representing our preferred shares. In addition,
a determination by the NAIC to classify the depositary shares representing our preferred shares as common equity
may adversely impact the trading of the depositary shares representing our preferred shares in the secondary market.

44

Table of Contents

Our preferred shares are subject to our rights of redemption.

Our preferred shares are redeemable pursuant to the terms set forth in the certificate of designations governing
such  series.  Whenever  we  redeem  preferred  shares  held  by  the  depositary,  the  depositary  will,  as  of  the  same
redemption date, redeem the number of depositary shares representing preferred shares so redeemed. We have no
obligation to redeem or repurchase the preferred shares under any circumstances. If the preferred shares are redeemed
by us, you may not be able to reinvest the redemption proceeds in a comparable security at a similar return on your
investment.

ITEM 1B.   UNRESOLVED STAFF COMMENTS

Not applicable.

ITEM 2.   PROPERTIES

We renew and enter into new leases in the ordinary course of our business. We lease office space in Hamilton,
Bermuda, where our principal executive office is located. We also lease office space in a number of U.S. states, the
United Kingdom, Australia, Ireland, Switzerland, Canada and several Continental European countries. We believe that
this office space is sufficient for us to conduct our current operations for the foreseeable future, although in connection
with future acquisitions from time to time, we may expand to different locations or increase space to support any such
growth.

In connection with the acquisition of DCo, LLC ("DCo") in December 2016, we acquired properties in the United

States. The acquired properties have no present value and are not used to run our operations. 

ITEM 3.   LEGAL PROCEEDINGS

For a discussion of legal proceedings, see Note 23 - "Commitments and Contingencies" in the notes to our
consolidated financial statements included in Item 8 of this Annual Report on Form 10-K, which is incorporated herein
by reference.

ITEM 4.   MINE SAFETY DISCLOSURES

Not applicable.

45

Table of Contents

PART II

ITEM 5.   MARKET FOR THE REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES

Market Information and Number of Holders

Our ordinary voting shares are listed on the NASDAQ Global Select Market under the symbol "ESGR." There
is  no  established  trading  market  for  our  non-voting  ordinary  shares.  On  February 24,  2020,  there  were  1,492
shareholders of record of our voting ordinary shares and four shareholders of record of our non-voting ordinary shares.
This is not the number of beneficial owners of our voting ordinary shares as some shares are held in “street name” by
brokers and others on behalf of individual owners.

Dividend Information

We have not historically declared a dividend on our ordinary shares. Our strategy is to retain earnings and invest
distributions from our subsidiaries back into the company. We do not currently expect to pay any dividends on our
ordinary shares. Any payment of dividends must be approved by our Board of Directors. Our ability to pay dividends
is subject to certain restrictions, as described in Note 22 - "Dividend Restrictions and Statutory Financial Information"
in the notes to our consolidated financial statements included in Item 8 of this Annual Report on Form 10-K, which is
incorporated herein by reference.

Issuer Purchases of Equity Securities

The following table provides information about ordinary shares acquired by the Company during the three months
ended December 31, 2019, which are related to shares withheld from employees in order to facilitate the payment of
withholding taxes on restricted shares. The Company does not have a share repurchase program.

Period

October 1, 2019 - October 31, 2019

November 1, 2019 - November 30, 2019

December 1, 2019 - December 31, 2019

Total Number of
Shares
Purchased(1)

Average Price
Paid per Share

— $

635 $

— $

635

—

202.55

—

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans or
Programs

Maximum Number
(or Approximate
Dollar Value) of
Shares that May Yet
be Purchased Under
the Program

— $

— $

— $

— $

—

—

—

—

(1)

Includes shares withheld from employees in order to facilitate the payment of withholding taxes on restricted shares granted pursuant to our
equity incentive plan. The shares are calculated at their fair market value, as determined by reference to the closing price of our ordinary shares
on the vesting date. 

46

Table of Contents

Performance Graph

The following performance graph compares the cumulative total return on our ordinary shares with the cumulative
total  return  on  the  NASDAQ  Composite  Index  and  the  NASDAQ  Insurance  Index  for  the  period  that  commenced
December 31, 2014 and ended on December 31, 2019. The performance graph shows the value as of December 31
of each calendar year of $100 invested on December 31, 2014 in our ordinary shares, the NASDAQ Composite Index,
and the NASDAQ Insurance Index assuming the reinvestment of dividends. Returns have been weighted to reflect
relative market capitalization. This information is not necessarily indicative of future returns.

Comparison of 5 Year Cumulative Total Return

$200

$150

$100

$50

$0

2014

2015

2016

2017

2018

2019

Enstar Group Limited

NASDAQ Composite Index

NASDAQ Insurance Index

Indexed Returns* for Years Ended December 31,

2014

2015

2016

2017

2018

2019

Enstar Group Limited
NASDAQ Composite Index
NASDAQ Insurance Index

100.00
100.00
100.00

98.14
106.96
103.70

129.31
116.45
131.49

131.30
150.96
142.17

109.60
146.67
124.49

135.30
200.49
159.49

*$100 invested on December 31, 2014 in stock or index, including reinvestment of dividends.

47

Table of Contents

ITEM 6.   SELECTED FINANCIAL DATA

The following selected historical financial information for each of the past five fiscal years has been derived from
our audited historical financial statements. This information is only a summary and should be read in conjunction with
"Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations" and our consolidated
financial statements and notes thereto included in Item 8 of this Annual Report on Form 10-K. The results of operations
for historical accounting periods are not necessarily indicative of results to be expected for future accounting periods.

Since  our  inception,  we  have  made  numerous  acquisitions  of  companies  and  portfolios  of  business,  and
discontinued and sold certain life and annuities business, that significantly impacts the comparability between periods
of the information reflected below. Our recent acquisitions, significant new business and discontinued operations are
described in Note 3 - "Acquisitions", Note 4 - "Significant New Business", and Note 5 - "Divestitures, Held-for-Sale
Businesses and Discontinued Operations" of our consolidated financial statements included in Item 8 of this Annual
Report on Form 10-K.

Statements of Earnings Data:

Net premiums earned

Fees and commission income

Net investment income

Net realized and unrealized gains (losses)

Net incurred losses and LAE

Acquisition costs

Total other expenses, net

Earnings (loss) before income taxes

Income tax (expense) benefit

Earnings (losses) from equity method investments

Net earnings (loss) from discontinuing operations

Net earnings (loss)

Net earnings (loss) attributable to noncontrolling interest

Net earnings (loss) attributable to Enstar Group Limited

Dividends on preferred shares

Net earnings (loss) attributable to Enstar Group Limited

Ordinary Shareholders

Years Ended December 31,

2019

2018

2017

2016

2015

(in thousands of U.S. dollars, except share and per share data)

$

1,154,861

$

895,575

$

613,121

$

823,514

$

753,744

28,453

321,276

1,031,351

(872,575)

(305,951)

(480,669)

876,746

(4,437)

55,910

35,088

270,671

(412,884)

(454,025)

(192,790)

(402,178)

(260,543)

6,124

42,147

—

928,219

9,870

938,089

(35,914)

—

(212,272)

62,051

(150,221)

(12,133)

66,103

208,789

190,334

(193,551)

(96,906)

(479,383)

308,507

6,395

5,904

320,806

10,993

331,799

(20,341)

311,458

—

39,364

185,463

77,818

(174,099)

(186,569)

(432,767)

332,724

(34,874)

(5,400)

292,450

11,963

304,413

(39,606)

264,807

—

39,347

122,564

(41,523)

(104,333)

(163,716)

(381,061)

225,022

(12,650)

—

212,372

(2,031)

210,341

9,950

220,291

—

$

902,175

$

(162,354) $

311,458

$

264,807

$

220,291

Net earnings (loss) from continuing operations

928,219

(212,272)

Per Ordinary Share Data:(1)
Earnings per ordinary share attributable to Enstar Group
Limited:

Basic:

Net earnings (loss) from continuing operations

Net earnings (loss) from discontinuing operations

Net earnings (loss) per ordinary share

Diluted:

Net earnings (loss) from continuing operations

Net earnings (loss) from discontinuing operations

Net earnings (loss) per ordinary share

Weighted average ordinary shares outstanding:

$

$

$

$

42.00

$

(7.84) $

15.50

$

13.10

$

—

—

0.56

0.62

42.00

$

(7.84) $

16.06

$

13.72

$

41.43

$

(7.84) $

15.39

$

13.00

$

—

—

0.56

0.62

41.43

$

(7.84) $

15.95

$

13.62

$

11.55

(0.11)

11.44

11.46

(0.11)

11.35

Basic

Diluted

21,482,617

20,698,310

19,388,621

19,299,426

19,252,072

21,775,066

20,904,176

19,527,591

19,447,241

19,407,756

(1) Earnings per share is a measure based on net earnings divided by weighted average ordinary shares outstanding. Basic earnings per share is
defined as net earnings available to ordinary shareholders divided by the weighted average number of ordinary shares outstanding for the period,
giving no effect to dilutive securities. Diluted earnings per share is defined as net earnings available to ordinary shareholders divided by the weighted
average number of shares and share equivalents outstanding calculated using the treasury stock method for all potentially dilutive securities. When
the effect of dilutive securities would be anti-dilutive, these securities are excluded from the calculation of diluted earnings per share.

48

Table of Contents

Balance Sheet Data:

Total investments

Total cash and cash equivalents (inclusive of
restricted)

Reinsurance balances recoverable on paid
and unpaid losses

Total assets

Losses and loss adjustment expense liabilities

Defendant asbestos and environmental
liabilities

Debt obligations

Total Liabilities

Total Enstar Group Limited shareholders’
equity

Book Value per Share:(1)

Basic

Diluted

Shares Outstanding:

Basic

Diluted

2,379,890

19,363,315

10,429,238

847,685

1,191,207

2019

2018

2017

2016

2015

(in thousands of U.S. dollars, except share and per share data)

December 31,

$

13,207,513

$

11,242,061

$

8,755,130

$

7,332,425

$

6,340,781

1,055,777

982,584

1,212,836

1,318,645

1,295,169

2,029,663

2,021,030

1,460,743

1,451,921

16,556,270

13,606,422

12,865,744

11,772,534

9,409,504

7,398,088

5,987,867

5,720,149

203,320

861,539

219,164

646,689

234,020

673,603

14,068,173

12,183,738

9,980,868

9,600,390

—

599,750

8,834,088

4,842,183

3,901,933

3,136,684

2,802,312

2,516,872

$

$

201.39

197.93

$

$

158.06

155.94

$

$

161.63

159.19

$

$

144.66

143.68

$

$

130.65

129.65

21,511,505

21,989,971

21,459,997

21,881,063

19,406,722

19,830,767

19,372,178

19,645,309

19,263,742

19,714,810

(1) Basic book value per share is calculated as total Enstar Group Limited shareholders’ equity available to ordinary shareholders divided by the
number of ordinary shares outstanding as of the end of the period, giving no effect to dilutive securities. Diluted book value per share is calculated
as total Enstar Group Limited shareholders’ equity available to ordinary shareholders plus the assumed proceeds from the exercise of outstanding
warrants divided by the sum of the number of ordinary shares and ordinary share equivalents and warrants outstanding at the end of the period.

49

Table of Contents

ITEM 7.      MANAGEMENT’S  DISCUSSION  AND  ANALYSIS  OF  FINANCIAL  CONDITION  AND  RESULTS  OF
OPERATIONS 

The following discussion and analysis of our financial condition and results of operations should be read in
conjunction with our consolidated financial statements and the related notes included elsewhere in this annual report.
Some of the information contained in this discussion and analysis or included elsewhere in this annual report, including
information with respect to our plans and strategy for our business, includes forward-looking statements that involve
risks, uncertainties and assumptions. Our actual results and the timing of events could differ materially from those
anticipated  by  these  forward-looking  statements  as  a  result  of  many  factors,  including  those  discussed  under
"Cautionary Statement Regarding Forward-Looking Statements", "Item 1A. Risk Factors" and elsewhere in this annual
report.

For a comparison of our results of operations for the fiscal years ended December 31, 2018 and 2017, see Part
II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations of our annual
report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 1, 2019. 

Table of Contents

Section
Business Overview

Key Performance Indicator

Non-GAAP Financial Measures

Underwriting Ratios

Current Outlook

Consolidated Results of Operations — for the Years Ended December 31, 2019 and 2018

Results of Operations by Segment — for the Years Ended December 31, 2019 and 2018

Non-life Run-off Segment

Atrium Segment

StarStone Segment

Other Activities

Investable Assets

Liquidity and Capital Resources

Critical Accounting Policies

Business Overview 

Page

50

51

52

53

54

55

57

58

64

68

74

75

82

91

We are a multi-faceted insurance group that offers innovative capital release solutions and specialty underwriting
capabilities through our network of group companies in Bermuda, the United States, the United Kingdom, Continental
Europe,  Australia,  and  other  international  locations.  Our  core  focus  is  acquiring  and  managing  insurance  and
reinsurance companies and portfolios of insurance and reinsurance business in run-off. Since the formation of our
Bermuda-based holding company in 2001, we have completed or announced over 100 acquisitions or portfolio transfers.
The substantial majority of our acquisitions have been in the non-life run-off business, which generally includes property
and casualty, workers’ compensation, asbestos and environmental, construction defect, marine, aviation and transit,
and other closed business. 

While our core focus remains acquiring and managing non-life run-off business, we expanded our business to
include  active  underwriting  through  our  acquisitions  of Atrium  and  StarStone  in  2013  and  2014,  respectively.  We
partnered with Trident in the Atrium and StarStone acquisitions, with Enstar owning a 59.0% interest, Trident owning
a 39.3% interest, and Dowling owning a 1.7% interest. We also expanded our portfolio of run-off businesses in 2013
to include closed life and annuities, primarily through our acquisition of Pavonia, which we sold in 2017 and which had
made up the majority of our life and annuities business. 

We also manage our investment portfolio with the goal of achieving superior risk-adjusted returns, while growing

profitability and generating long-term growth in shareholder value.

Our businesses strategies are discussed in "Item 1. Business - Company Overview", "- Business Strategy", "-

Strategic Growth" and "- Recent Acquisitions and Significant New Business."

50

Table of Contents

Key Performance Indicator

Our primary corporate objective is growing our book value per share, and we believe that long-term growth in
fully diluted book value per share is the most appropriate measure of our financial performance. We create growth in
our book value through the execution of the strategies discussed in "Item 1. Business - Business Strategy." 

During 2019, our book value per share on a fully diluted basis increased by 26.9% to $197.93 per share. The

growth of our fully diluted book value per share since becoming a public company is shown in the table below.

Growth in Fully Diluted Book Value Per Share

$197.93

$159.19 $155.94

$143.68

$129.65

$119.22

E
R
A
H
S
R
E
P
E
U
L
A
V
K
O
O
B
D
E
T
U
L
D
Y
L
L
U
F

I

$200

$180

$160

$140

$120

$100

$80

$60

$40

$20

$0

$105.20

$93.30

$82.97

$71.68

$58.06

$45.18

$36.92

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

YEAR

The table below summarizes the calculation of our fully diluted book value per ordinary share as of December 31,

2019 and 2018:

2019

2018

Change

(in thousands of U.S. Dollars)

Numerator:
Total Enstar Group Limited Shareholder's Equity

Less: Series D and E Preferred Shares

Total Enstar Group Limited Ordinary Shareholders' Equity (A)
Proceeds from assumed conversion of warrants (1)
Numerator for fully diluted book value per ordinary share
calculations (B)

$

4,842,183 $
510,000

3,901,933 $
510,000

940,250

—

4,332,183

3,391,933

940,250

20,229

20,229

—

$

4,352,412 $

3,412,162 $

940,250

Denominator:
Ordinary shares outstanding (C)

Effect of dilutive securities:

Share-based compensation plans
Warrants(1)
Fully diluted ordinary shares outstanding (D)

21,511,505

21,459,997

51,508

302,565

175,901

245,165

175,901

21,989,971

21,881,063

57,400

—

108,908

Book value per ordinary share
Basic book value per ordinary share = (A) / (C)

Fully diluted book value per ordinary share = (B) / (D)

$
$

201.39 $
197.93 $

158.06 $
155.94 $

43.33

41.99

(1) There are warrants outstanding to acquire 175,901 Series C Non-Voting Ordinary Shares for an exercise price of $115.00 per share, subject to
certain adjustments (the "Warrants"). The Warrants were issued in April 2011 and expire in April 2021. The Warrant holder may, at its election,
satisfy  the  exercise  price  of  the  Warrants  on  a  cashless  basis  by  surrender  of  shares  otherwise  issuable  upon  exercise  of  the  Warrants  in
accordance with a formula set forth in the Warrants.

51

 
Table of Contents

Non-GAAP Financial Measure

In addition to presenting net earnings (losses) attributable to Enstar Group Limited ordinary shareholders and
diluted earnings (losses) per ordinary share determined in accordance with U.S. GAAP, we believe that presenting
non-GAAP operating income (loss) attributable to Enstar Group Limited ordinary shareholders and non-GAAP diluted
operating income (loss) per ordinary share provides investors with valuable measures of our performance. 

Non-GAAP operating income (loss) attributable to Enstar Group Limited ordinary shareholders is calculated by
the addition or subtraction of certain items from within our consolidated statements of earnings to or from net earnings
(loss)  attributable  to  Enstar  Group  Limited  ordinary  shareholders,  the  most  directly  comparable  GAAP  financial
measure, as illustrated in the table below, for the years ending December 31, 2019 and 2018:

2019

2018

(in thousands of U.S.
dollars, except per share
data)

Net earnings (loss) attributable to Enstar Group Limited ordinary shareholders

$

902,175 $ (162,354)

Adjustments:

Net realized and unrealized (gains) losses on fixed maturity investments and funds
held - directly managed (1)
Change in fair value of insurance contracts for which we have elected the fair value
option
Tax effects of adjustments (2)
Adjustments attributable to noncontrolling interest (3)

Non-GAAP operating income attributable to Enstar Group Limited ordinary
shareholders (4)

Diluted net earnings (loss) per ordinary share (5)
Adjustments:

(534,730)

243,093

117,181

51,102

17,689

6,664
(16,588)
(9,166)

$

$

553,417 $

61,649

41.43 $

(7.84)

Net realized and unrealized (gains) losses on fixed maturity investments and funds
held - directly managed (1)
Change in fair value of insurance contracts for which we have elected the fair value
option
Tax effects of adjustments (2)
Adjustments attributable to noncontrolling interest (3)
Diluted non-GAAP operating income per ordinary share (4)

(24.55)

11.70

5.38

2.35

0.81

$

25.42 $

0.32
(0.79)
(0.44)
2.95

Weighted average ordinary shares outstanding - diluted

21,775,066

20,904,176

(1) Represents the net realized and unrealized gains and losses related to fixed maturity securities. Our fixed maturity securities are held directly on
our balance sheet and also within the "Funds held - directly managed" balance. Refer to Note 6 - "Investments" in the notes to our consolidated
financial statements included within Item 8 of this Annual Report on Form 10-K for further details on our net realized and unrealized gains and
losses.

(2) Represents an aggregation of the tax expense or benefit associated with the specific country to which the pre-tax adjustment relates, calculated

at the applicable jurisdictional tax rate.

(3)  Represents the impact of the adjustments on the net earnings (loss) attributable to noncontrolling interest associated with the specific subsidiaries

to which the adjustments relate.

(4) Non-GAAP financial measure.

(5) During a period of loss, the basic weighted average ordinary shares outstanding is used in the denominator of the diluted loss per ordinary share

computation as the effect of including potentially dilutive securities would be anti-dilutive.

52

Table of Contents

Basis of Non-GAAP Operating Income (Loss) financial measure

Our  non-GAAP  measure  shown  above,  as  defined  in  Item  10(e)  of  Regulation  S-K,  enables  readers  of  the
consolidated financial statements to more easily analyze our results in a manner more aligned with the manner in
which our management analyzes our underlying performance. We believe that presenting this non-GAAP financial
measure, which may be defined and calculated differently by other companies, improves the understanding of our
consolidated results of operations. This measure should not be viewed as a substitute for those calculated in accordance
with U.S. GAAP.

Non-GAAP operating income (loss) excludes: (i) net realized and unrealized (gains) losses on fixed maturity
investments and funds held - directly managed, (ii) change in fair value of insurance contracts for which we have
elected the fair value option, (iii) gain (loss) on sale of subsidiaries, if any, (vi) net earnings (loss) from discontinued
operations, if any, (v) tax effect of these adjustments where applicable, and (vi) attribution of share of adjustments to
noncontrolling interest where applicable. We eliminate the impact of net realized and unrealized (gains) losses on fixed
maturity investments and funds held - directly managed and change in fair value of insurance contracts for which we
have elected the fair value option because these items are subject to significant fluctuations in fair value from period
to period, driven primarily by market conditions and general economic conditions, and therefore their impact on our
earnings is not reflective of the performance of our core operations. When applicable, we eliminate the impact of gain
(loss) on sale of subsidiaries and net earnings (loss) on discontinued operations because these are not reflective of
the performance of our core operations.

Underwriting Ratios

In presenting our results for the Atrium and StarStone segments, we discuss the loss ratio, acquisition cost ratio,
operating  expense  ratio,  and  the  combined  ratio  of  our  active  underwriting  operations  within  these  segments.
Management  believes  that  these  ratios  provide  the  most  meaningful  measure  for  understanding  our  underwriting
profitability. These measures are not defined in GAAP, but are calculated using GAAP amounts presented on the
statements of earnings for both Atrium and StarStone. 

The loss ratio is calculated by dividing net incurred losses and LAE by net premiums earned. The acquisition
cost ratio is calculated by dividing acquisition costs by net premiums earned. The operating expense ratio is calculated
by dividing operating expenses by net premiums earned. The combined ratio is the sum of the loss ratio, the acquisition
cost ratio and the operating expense ratio. 

The Atrium segment also includes corporate expenses that are not directly attributable to the underwriting results
in the segment. The corporate expenses include general and administrative expenses related to amortization of the
definite-lived intangible assets in the holding company, and expenses relating to Atrium Underwriters Limited ("AUL")
employee salaries, benefits, bonuses and current year share grant costs. The AUL general and administrative expenses
are  incurred  in  managing  the  syndicate.  These  are  principally  funded  by  the  profit  commission  fees  earned  from
Syndicate 609, which is a revenue item not included in the insurance ratios. 

The StarStone segment also includes corporate expenses that are not directly attributable to the underwriting
results  in  the  segment  and  are  not  included  in  the  insurance  ratios.  The  corporate  expenses  include  non-
recurring expenses, reorganization expenses and holding company expenses.

53

Table of Contents

Current Outlook

Our business strategy includes generating growth through acquisitions and reinsurance transactions, particularly
in our Non-life Run-off segment. During 2019, we completed seven significant reinsurance transactions with Zurich
Insurance  Group,  Maiden  Reinsurance  Ltd.,  Amerisure  Mutual  Insurance  Company,  and  four  AmTrust's  Lloyd's
Syndicates. We also completed the acquisition of Morse TEC, a company that holds personal injury asbestos and
environmental liabilities. During 2019, we acquired $2.8 billion of assets and liabilities in aggregate in these transactions.
In 2019, we also completed a Part VII transfer in the U.K., delivering legal finality to RSA for its employers' liability
portfolio, and in Oklahoma, we are pursuing an insurance business transfer under the newly enacted Insurance Business
Transfer Act with respect to an intra-group transaction. As this legislation becomes more widely used in the U.S., we
expect it will offer us additional opportunities and flexibility in how we structure U.S. transactions.  We have signed
two transactions with AXA XL and Munich Re, representing approximately $0.4 billion of assets and liabilities, that are
expected to close in the first half of 2020. Our strong operating platforms in all of the major insurance markets are well
positioned to take on additional business opportunities. We recently completed our 100th acquisition, demonstrating
our ability to successfully execute upon transactions. We are market-leading in acquiring companies in run-off, entering
into reinsurance transactions through loss portfolio transfers, adverse development covers, reinsurance-to-close, or
insurance business transfers. 

Our business operates in the insurance, reinsurance and investments markets. As with others in our industry,
we are subject to economic factors such as interest rates, foreign exchange rates, underwriting events, regulation, tax
policy changes, political risks and other market risks that can impact our strategy and operations. Economic conditions
have recently been characterized by historically low interest rates, international trade tensions, signs of slowing global
growth,  significant  catastrophe  events,  coronavirus,  and  other  political  and  economic  uncertainties.  However,  our
business continued to perform well in 2019. 

We experienced favorable investment conditions during 2019, and we expect that investment results will continue
to be a key driver of our consolidated results going forward. However, we cannot be assured that the recent positive
market conditions will continue into the future. We also anticipate that our consolidated earnings will be impacted by
volatility in the investment markets. Our fixed income portfolio is prudently invested to earn us a reasonable return,
whilst ensuring that funds will be available to pay our obligations when they become due. While it is possible that fixed
income yields will improve over time, we anticipate that interest rates will remain low in the near-term which may
adversely impact reinvestment yields.  Our other investments, including equities, hedge funds and other non-fixed
income investments carry higher expected returns, have a longer investment time horizon, and diversify against our
fixed income portfolio. Our enterprise risk management framework enables us to hold sufficient capital for possible
risk events and ensures our business strategies can be deployed through market cycles to deliver attractive returns
for our capital providers. 

While Non-life Run-off is our predominant business activity, we also allocate our capital to our active underwriting

businesses and to strategic investments as described below.

•

•

Atrium  has  been  a  consistent  top-quartile  performing  Lloyd's  business  and  is  currently  seeing  market
opportunities that are resulting in an increase to premiums written. 

StarStone, with the strong support from its shareholders, has undertaken a significant re-positioning of its
underwriting portfolio, resulting in lower premiums written in 2019. StarStone's focus is to achieve consistent
underwriting profitability from its core lines of business. We believe StarStone is better positioned for the future
and we expect that StarStone will seek to write more premiums through selective growth opportunities. 

• Our significant strategic investments include Enhanzed Re, Monument Re, AmTrust, amongst others, more
fully described in Note 21 - "Related Party Transactions" in the notes to our consolidated financial statements
included within Item 8 of this Annual Report on Form 10-K. 

54

Table of Contents

Consolidated Results of Operations - For the Years Ended December 31, 2019 and 2018

The following table sets forth our consolidated statements of earnings for the years ended December 31, 2019
and 2018. For a discussion of the critical accounting policies that affect the results of operations, see "Critical Accounting
Policies" below.  

INCOME

Net premiums earned

Fees and commission income

Net investment income

Net realized and unrealized gains (losses)

Other income

EXPENSES

Net incurred losses and LAE
Life and annuity policy benefits

Acquisition costs

General and administrative expenses

Interest expense

Net foreign exchange (gains) losses

EARNINGS (LOSS) BEFORE INCOME TAXES

Income tax benefit (expense)

Earnings from equity method investments

NET EARNINGS (LOSS)

Net loss (earnings) attributable to noncontrolling interest

NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR GROUP
LIMITED

Dividends on preferred shares

2019

2018

Change

(in thousands of U.S. dollars)

$ 1,154,861 $
28,453

321,276

1,031,351

37,170

895,575 $

35,088

270,671
(412,884)
35,085

259,286
(6,635)
50,605

1,444,235

2,085

2,573,111

823,535

1,749,576

872,575

454,025

91

305,951

473,086

52,541
(7,879)
1,696,365

876,746
(4,437)
55,910

928,219

9,870

1,003

192,790

407,375

26,217

2,668

1,084,078
(260,543)
6,124

42,147
(212,272)
62,051

418,550
(912)
113,161

65,711

26,324
(10,547)
612,287

1,137,289
(10,561)
13,763

1,140,491
(52,181)

938,089
(35,914)

(150,221)
(12,133)

1,088,310
(23,781)

NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR GROUP
LIMITED ORDINARY SHAREHOLDERS

$

902,175 $ (162,354) $ 1,064,529

Highlights

Consolidated Results of Operations for 2019:

•

•

•

•

•

•

Consolidated net earnings of $902.2 million and basic and diluted earnings per share of $42.00 and $41.43,
respectively;

Non-GAAP operating income of $553.4 million and diluted non-GAAP operating income per ordinary share
of $25.42. For a reconciliation of non-GAAP operating income to net earnings (loss) calculated in accordance
with GAAP and diluted non-GAAP operating income per ordinary share to diluted net earnings (loss) per
ordinary share calculated in accordance with GAAP, see "Non-GAAP Financial Measure" above;

Net earnings from Non-life Run-off segment of $1,059.8 million;

Combined ratio of 90.6% for our Atrium segment, with net premiums earned of $164.1 million. 

Combined  ratio  of  103.4%  for  StarStone's  core  business  lines,  and  111.9%  for  StarStone  Group  after
intragroup reinsurance cessions.                                     

Net investment income of $321.3 million and net realized and unrealized gains of $1,031.4 million.

55

Table of Contents

Consolidated Financial Condition as of December 31, 2019: 

•

•

•

•

•

•

Total cash and investments of $14,263.0 million;

Total reinsurance balances recoverable on paid and unpaid losses of $2,379.9 million;

Total assets of $19,363.3 million;

Total gross and net reserves for losses and LAE of $10,429.2 million and $8,047.1 million, respectively. In
our Non-life Run-off operations during 2019, gross and net reserves acquired and assumed were $2,109.1
million and $1,587.0 million, respectively;

Total capital under management of $6,486.3 million, including common equity of $4,332.2 million, preferred
equity of $510.0 million, noncontrolling interests of $453.0 million, and debt of $1,191.2 million; and

Diluted book value per ordinary share of $197.93, an annual increase of 26.9%.

Consolidated Overview

2019  versus  2018:  We  reported  consolidated  net  earnings  attributable  to  Enstar  Group  Limited  ordinary
shareholders of $902.2 million in 2019, a change of $1,064.5 million from net losses of $162.4 million in 2018. The
comparability  of  our  results  across  different  periods  was  impacted  by  the  acquisitions  and  loss  portfolio  transfer
reinsurance transactions we completed during 2019 with Morse TEC, Zurich, Maiden Re, Amerisure and AmTrust and
in 2018 with Maiden Re, Maiden Re North America, KaylaRe, Neon, Novae, Zurich, Coca-Cola and Allianz. The most
significant drivers of the change in our financial performance during 2019 as compared to 2018 included:

•

•

•

•

Non-life Run-off Segment - Our Non-life Run-off segment is the predominant driver of our results, contributing
$1,059.8 million of net income to our consolidated results in 2019, an increase of  $1,034.6 million compared
to 2018, primarily due to net realized and unrealized gains on both our fixed income portfolio and our other
investments;

Higher Net Investment Income - Total net investment income increased by $50.6 million in 2019, compared
to 2018. The increase was primarily attributable to an increase in average invested assets and an increase
in the book yield we obtained on our assets. The increase in average invested assets was primarily due to
the new business we acquired by completing the Morse TEC, Zurich, Maiden Re Bermuda, Amerisure and
AmTrust RITC transactions in 2019. The increase in the book yield was primarily due to the contractual yield
received on the 2019 transactions and our asset allocation strategies;

Atrium - Net earnings attributable to the Atrium segment were $12.1 million in 2019, compared to $9.0 million
in 2018. The combined ratio in 2019 was 90.6%, compared to 94.5% in 2018, and the improvement was
primarily driven by a lower operating expense ratio;

StarStone - The StarStone segment results improved by $57.8 million, with net losses of $100.7 million in
2019, compared to net losses of $158.6 million in 2018. The decrease in net losses was primarily due to
net realized and unrealized gains on investments in 2019, compared to net realized and unrealized losses
on investments in 2018. Included in the segment results, the combined ratio for the StarStone Group was
111.9% in 2019 compared to 125.3% in 2018. StarStone has been repositioning the underwriting portfolio,
resulting in significant improvement in the profitability of the core lines to achieve a combined ratio of 103.4%.
The segment's underwriting result was impacted by large current year loss activity predominantly related to
exited lines, and prior year adverse loss development; 

• Other Activities - Net losses attributable to our other activities were $69.0 million in 2019, compared to $38.0
million in 2018. The increase in net losses was primarily driven by the dividends on our preferred shares
and largely related to increased performance-based compensation due to higher net earnings.

•

Net Realized and Unrealized Gains (Losses) - In 2019, net realized and unrealized gains were $1,031.4
million, compared to net losses of $412.9 million in 2018. The net realized and unrealized gains in 2019
were primarily attributable to an increase in the valuation of our fixed maturity investments due to declining
interest  rates  and  tighter  credit  spreads  and  gains  on  our  other  investments  primarily  due  to  strong
performance in the global equity markets. Many insurance companies predominantly use available-for-sale
accounting where unrealized amounts are recorded directly to shareholders’ equity and therefore do not
impact earnings. Unrealized amounts would only become realizable in the event of a sale of the specific
securities prior to maturity or a credit default. We have historically utilized trading accounting which is reflected

56

Table of Contents

in earnings, however from October 1, 2019 we have been electing to use available-for-sale accounting for
all new acquisitions and, where permissible, as trading fixed maturity securities mature, we are reinvesting
the proceeds into available-for-sale securities for the Non-Life Run-off and StarStone segments;

•

•

Noncontrolling Interest - Net (earnings) losses attributable to noncontrolling interest is the share of results
from  those  subsidiary  companies  in  which  there  are  either  noncontrolling  interests  or  redeemable
noncontrolling interests. In 2019, the net loss attributable to noncontrolling interest was $9.9 million, compared
to net loss attributable to noncontrolling interest of $62.1 million in 2018. The reduction in losses attributable
to noncontrolling interest was primarily due to an improvement in StarStone, as discussed above;

Income Taxes - We recorded an income tax expense of $4.4 million in 2019, compared to an income tax
benefit of $6.1 million in 2018, a change of $10.6 million. Our effective tax rate was 0.5% in 2019 compared
with 2.8% in 2018, primarily relating to the geographic distribution of our pre-tax net earnings (losses) between
our taxable and non-taxable jurisdictions in 2018; and

• Our non-GAAP operating income, which excludes the impact of unrealized losses on fixed maturity securities
and other items, was $553.4 million for the year ended December 31, 2019, an increase of $491.8 million
from non-GAAP operating income of $61.6 million for the year ended December 31, 2018.  The increase
was primarily attributable to our other investments results. For a reconciliation of non-GAAP operating income
to net earnings (loss) calculated in accordance with GAAP, see "Non-GAAP Financial Measures" above.

Results of Operations by Segment - For the Years Ended December 31, 2019 and 2018

We have three reportable segments of business that are each managed, operated and reported on separately:
(i) Non-life Run-off; (ii) Atrium; and (iii) StarStone. In addition, our other activities include our corporate expenses, debt
servicing  costs,  holding  company  income  and  expenses,  foreign  exchange  and  other  miscellaneous  items.  For  a
description of our segments, see "Item 1. Business - Operating Segments." The following is a discussion of our results
of operations by segment. 

The below table provides a split by operating segment of the net earnings attributable to Enstar Group Limited

ordinary shareholders for the years ended December 31, 2019 and 2018:

2019

2018
(in thousands of U.S. dollars)

Change

Segment split of net earnings (loss) attributable to Enstar Group
Limited:

Non-life Run-off

Atrium

StarStone

Other

$ 1,059,804 $
12,125
(100,733)
(69,021)

25,222 $ 1,034,582
3,128

8,997
(158,580)
(37,993)

57,847
(31,028)

Net earnings (loss) attributable to Enstar Group Limited ordinary
shareholders

$

902,175 $ (162,354) $ 1,064,529

The following is a discussion of our results of operations by segment. 

57

Table of Contents

Non-life Run-off Segment

The following is a discussion and analysis of the results of operations for our Non-life Run-off segment for the

years ended December 31, 2019 and 2018, which are summarized below:

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Acquisition costs

Operating expenses

Underwriting income (loss)

Net investment income

Net realized and unrealized gains (losses)

Fees and commission income

Other income

Corporate expenses

Interest expense

Net foreign exchange gains

2019

2018

Change

(in thousands of U.S. dollars)

(25,069) $

(8,910) $

(16,159)

(25,338) $

(9,217) $

(16,121)

168,496 $

9,427 $

159,069

$

$

$

(51,625)

(73,642)

(199,756)

(156,527)

275,236

968,350

18,293

34,809

(70,689)

(62,055)

9,918

306,067

(4,006)

(158,731)

152,757

226,287

(357,692)

(69,636)

(41,025)

(309,284)

48,949

(381,712)

1,350,062

16,466

35,978

(39,093)

(30,616)

2,534

1,827

(1,169)

(31,596)

(31,439)

7,384

EARNINGS (LOSS) BEFORE INCOME TAXES

1,017,335

(17,399)

1,034,734

Income tax benefit (expense)

Earnings from equity method investments

NET EARNINGS

Net earnings attributable to noncontrolling interest

NET EARNINGS ATTRIBUTABLE TO ENSTAR GROUP LIMITED
ORDINARY SHAREHOLDERS

(7,250)

56,128

1,066,213

(6,409)

3,581

42,147

28,329

(3,107)

(10,831)

13,981

1,037,884

(3,302)

$ 1,059,804 $

25,222 $ 1,034,582

Overall Results 

Net earnings were $1,059.8 million in 2019, compared to $25.2 million in 2018, an increase of $1,034.6 million.
This increase was primarily attributable to net realized and unrealized gains on both our fixed income portfolio and our
other investments during 2019, compared to net unrealized losses during 2018. Net investment income increased due
to higher assets under management from our completed transactions in 2019, as well as our asset allocation strategies.
Our underwriting result included a favorable reduction in estimates of prior period net ultimate losses of $220.0 million
in 2019, compared to $286.4 million in 2018. Our underwriting result also includes the amortization of deferred charge
assets, amortization of fair value adjustments and the change in fair value for those liabilities where we elected the
fair value option, representing an aggregate expense of $205.9 million in 2019 compared to an aggregate expense of
$33.3 million in 2018. These amortization and fair value amounts relating to our underwriting were generally offset by
our investment results.    

Investment results are separately discussed in the "Investments Results - Consolidated" section. 

58

Table of Contents

Net Premiums Earned:

The following table shows the gross and net premiums written and earned for the Non-life Run-off segment for

the years ended December 31, 2019 and 2018:

2019

2018

Change

Gross premiums written

Ceded reinsurance premiums written

Net premiums written

Gross premiums earned

Ceded reinsurance premiums earned

Net premiums earned

$

$

(in thousands of U.S. dollars)
(25,069) $
(269)
(25,338)
197,009
(28,513)
168,496 $

(8,910) $
(307)
(9,217)
25,230
(15,803)

(16,159)
38
(16,121)
171,779
(12,710)
159,069

9,427 $

As business in this segment is in run-off, our general expectation is for premiums associated with legacy business
to decline in future periods. However, the actual amount in any particular year will be impacted by new transactions
during the year and the run-off of premiums from transactions completed in recent years. Premiums earned in this
segment are generally offset by net incurred losses and LAE related to the premiums. Premiums earned may be higher
than premiums written as we may assume unearned premium without writing the premium ourselves. 

Net premiums written in 2019 of $(25.3) million were primarily related to reductions in net written premium on
legacy business for which corresponding unearned premium was also released. Net premiums earned in 2019 of
$168.5 million were primarily related to the run-off business assumed as a result of the AmTrust RITC transactions
and the acquisition of Maiden Reinsurance North America, Inc. ("Maiden Re North America"). Premiums written and
earned in 2018 were primarily related to the run-off business assumed as a result of the RITC transaction with Novae.

Net Incurred Losses and LAE:

The following table shows the components of net incurred losses and LAE for the Non-life Run-off segment for

the years ended December 31, 2019 and 2018:

Prior
Periods

2019

Current
Period

Total

Prior
Periods

(in thousands of U.S. dollars)

2018

Current
Period

Total

Net losses paid
Net change in case and LAE reserves (1)
Net change in IBNR reserves (2)

$ 1,182,804

$

64,820

$ 1,247,624

$ 838,812

$

5

$ 838,817

(553,996)

(848,776)

23,105

35,194

(530,891)

(552,124)

(813,582)

(573,127)

4,704

7,742

(547,420)

(565,385)

Increase (reduction) in estimates of net ultimate losses

(219,968)

123,119

(96,849)

(286,439)

12,451

(273,988)

Increase (reduction) in provisions for unallocated LAE

Amortization of deferred charge assets

Amortization of fair value adjustments

Changes in fair value - fair value option

Net incurred losses and LAE

(57,844)

38,627

50,070

117,181

440

(57,404)

(65,401)

—

—

—

38,627

50,070

117,181

13,781

12,877

6,664

—

—

—

—

(65,401)

13,781

12,877

6,664

$

(71,934) $ 123,559

$

51,625

$ (318,518) $

12,451

$ (306,067)

(1) Net change in case and LAE reserves comprises the movement during the year in specific case reserve liabilities as a result of claims settlements
or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a
result of the settlement or movement of assumed claims. 

(2) Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable. 

59

Table of Contents

2019: Net incurred losses and LAE for the year ended December 31, 2019 of $51.6 million included net incurred
losses and LAE of $123.6 million related to current period net earned premium. Excluding current period net incurred
losses and LAE of $123.6 million, the reduction in net incurred losses and LAE liabilities relating to prior periods was
$71.9 million, which was attributable to a reduction in estimates of net ultimate losses of $220.0 million and a reduction
in provisions for unallocated LAE of $57.8 million relating to 2019 run-off activity, partially offset by an increase in the
fair value of liabilities of $117.2 million related to our assumed retroactive reinsurance agreements for which we have
elected the fair value option, amortization of fair value adjustments of $50.1 million and the amortization of deferred
charge assets of $38.6 million. The reduction in estimates of prior period net ultimate losses of $220.0 million for the
year ended December 31, 2019 included a net reduction in case and IBNR reserves of $1,402.8 million, partially offset
by net losses paid of $1,182.8 million. 

Drivers of the change in estimates of net ultimate losses:

The significant drivers of the 2019 results are explained below.

Workers' Compensation

A $136.4 million reduction in estimates of net ultimate losses in our workers' compensation line of business
arose  across  multiple  portfolios,  where  reported  loss  development  was  generally  significantly  less  than  expected
development. The lower than expected actual development was driven by significant proactive settlement activity on
individual claimants where we were able to settle claims lower than the case reserve estimates.  For example, in two
of our portfolios we observed favorable reported loss development, where we paid $39.3 million in loss payments to
release  a  corresponding  $53.6  million  of  associated  case  reserves  for  $14.3  million  in  favorable  reported  loss
development. These settlement activities and the favorable actual loss development versus expected loss development,
led to a change in the actuarial assumptions in the annual reserve study that reflect this favorable loss development.
For workers' compensation, we paid $209.0 million, offset by a reduction in case reserves of $156.4 million and a
reduction in IBNR reserves of $188.9 million.

We also continue to actively seek to commute policies in our workers' compensation line of business when
possible, and where the commutation of the policy is settled at a level below the carried value of the loss reserves,
we record a reduction in our estimates of net ultimate losses. During the year ended December 31, 2019, we completed
6 commutations across several workers' compensation portfolios that contributed to a $6.1 million reduction in estimates
of net ultimate losses.

Professional Indemnity/Directors & Officers

A $38.6 million reduction in estimates of net ultimate losses in our professional indemnity/directors’ & officers’
line of business arose based on the annual actuarial analysis which reflected the better than expected loss development
during 2019.  As part of the reserve analysis, an in-depth review of recently acquired portfolios’ ceded reinsurance
programs led to an increase in the ceded reinsurance asset of $13.5 million, which is a reduction in net ultimate losses.

Asbestos

A $6.8 million increase in estimates of net ultimate losses in our asbestos line of business arose primarily due
to changes in our actuarial assumptions related to dismissal rates.  During 2019, the number of new defendants and
filed claims was less than expected, but this was offset by a lowering of the dismissal rate.  In asbestos, the dismissal
rates are extremely high as many of the claims do not have merit against the insured.  However, we have seen a trend
in both US and UK exposure of the dismissal rate decreasing in the range of 2 to 3 percentage points.  

Similar  to  workers’  compensation  business,  during  the  year  ended  December  31,  2019,  we  completed  6
commutations across several portfolios that contributed to a $9.8 million reduction in estimates of net ultimate losses.

Other

All other line of business changes in estimates of net ultimate losses were primarily due to the application of our

reserving methodologies, favorable actual versus expected loss development and proactive claim management.

Other Components of Net incurred Losses and LAE

The reduction of $57.8 million in provisions for unallocated LAE was due to a reduction in our estimate of the

total future costs to administer the claims.

60

Table of Contents

The increase in the fair value of liabilities for which we have elected the fair value option of $117.2 million was
primarily due to changes in the discount rate and the application of the discount rate to the updated expected cash
flow patterns.

The amortization of fair value adjustments of $50.1 million was related to the fair value adjustments associated
with the acquisition of companies. On acquisition, we are required to fair value the net assets acquired, including the
reinsurance balances recoverable and the liability for losses and LAE. The resulting fair value adjustments are then
amortized over the expected life of the reinsurance balances recoverable and the liability for losses and LAE.

The amortization of deferred charge assets of $38.6 million was associated with retroactive reinsurance contracts
where, at the inception of the contract, the estimated ultimate losses payable was in excess of premium received.
Deferred charge assets are amortized over the estimated claim payment period of the related contract and are adjusted
periodically to reflect new estimates of the amount and timing of the remaining loss payments.

2018: The reduction in net incurred losses and LAE for the year ended December 31, 2018 of $306.1 million
included net incurred losses and LAE of $12.5 million related to current period net earned premium from previously
acquired businesses that renewed certain policies while being run-off. Excluding current period net incurred losses
and LAE of $12.5 million, the reduction in net incurred losses and LAE liabilities relating to prior periods was $318.5
million, which was attributable to a reduction in estimates of net ultimate losses of $286.4 million, and a reduction in
provisions for unallocated LAE of $65.4 million, relating to 2018 run-off activity, partially offset by an increase in the
fair value of liabilities of $6.7 million related to our assumed retroactive reinsurance agreements for which we have
elected the fair value option, the amortization of the deferred charge assets of $13.8 million and the amortization of
fair value adjustments relating to companies acquired amounting to $12.9 million.

The reduction in estimates of prior period net ultimate losses of $286.4 million for the year ended December 31,
2018 included a net reduction in case and IBNR reserves of $1,125.3 million, partially offset by net losses paid of
$838.8 million.

Drivers of the change in estimates of net ultimate losses:

The significant drivers of the 2018 results are explained below.

Workers' Compensation

The $154.6 million reduction in estimates of net ultimate losses in our workers' compensation line of business
in 2018 arose across multiple portfolios, where reported incurred loss development was generally significantly less
than expected. When actual development is less than expected for a sustained period of time across a significant
volume of exposures, an updated actuarial analysis tends to indicate reductions in IBNR reserves. Updates to actuarial
analysis, factoring in the less-than-expected reported incurred loss development for the year, is the primary driver of
the $154.6 million reduction to Workers' Compensation net ultimate loss estimates.

For certain of our portfolios, the lower than expected actual development was driven by significant proactive
settlement activity on individual claimants where we were able to close open claims earlier than was indicated by the
original payout pattern, and in other portfolios, based on the review of recent loss development activity we revised our
actuarial development "tail factor" assumption, which led to a reduction in net ultimate losses. For example, in one
portfolio we observed favorable incurred loss development, primarily relating to accident years 1995 through 2005
where we paid $22.7 million in loss payments to release a corresponding $37.0 million of associated case reserves
for $14.3 million in favorable incurred loss development. 

For recently acquired portfolios of workers' compensation business, we have utilized our subsidiary, Services
Paladin, to assist us in reviewing claims. Paladin generally produces savings related to medical expense liabilities
over and above savings achieved by prior vendors of such services, and the savings lead to actual development that
is less than expected, thereby driving reductions to the estimates of net ultimate losses. In one particular program, our
claims  personnel  pursued  a  proactive  strategy  of  settling  with  numerous  workers'  compensation  claimants  whose
injuries arose in recent accident years. For this portfolio, the claims team reduced the open inventory of claims by 78%
during 2018. This reduction in exposure, when incorporated into an updated actuarial analysis, led to a reduction in
our estimate of ultimate net losses of $30.2 million, primarily relating to accident years 2010 through 2014.

We also continue to actively seek to commute policies when possible, and where the commutation of the policy
is settled at a level below the carried value of the loss reserves, we record a reduction in our estimates of net ultimate
losses.  During  the  year  ended  December 31,  2018,  we  completed  7  commutations  across  several  portfolios  that
contributed to an $11.2 million reduction in estimates of net ultimate losses. 

61

Table of Contents

Asbestos

The $64.9 million reduction in estimates of net ultimate losses in our asbestos line of business arose primarily
due to one asbestos portfolio where lower than expected volume of claims reported and a lower than expected severity
on claims settled in the period, when projected to net ultimate losses through actuarial methodologies, resulted in a
significant reduction in estimates of net ultimate losses. The volume of claims reported was 3% less than expected
and the average cost per claim was 5% less than expected. Across our other asbestos portfolios, we completed 8
commutations  and  2  policy  buy-backs  contributing  to  a  $9.5  million  reduction  in  estimates  of  net  ultimate  losses.
Furthermore, detailed actuarial studies and lower than expected incurred loss development also resulted in reductions
to estimates of net ultimate losses.

All Other

All other line of business changes in estimates of net ultimate losses were primarily due to the application of our

reserving methodologies, favorable actual versus expected loss development and proactive claim management.

Other Components of Net incurred Losses and LAE

The reduction of $65.4 million in provisions for unallocated LAE was due to a reduction in our estimate of the

total future costs to administer the claims.

The amortization of deferred charge assets of $13.8 million was associated with retroactive reinsurance contracts

where, at the inception of the contract, the estimated ultimate losses payable was in excess of premium received. 

The amortization of fair value adjustments of $12.9 million was related to the fair value adjustments associated

with the acquisition of companies.

The increase in the fair value of liabilities for which we have elected the fair value option of $6.7 million was
primarily due to decreases in the estimated duration of the net liabilities, partially offset by changes in the corporate
bond yield.

Acquisition Costs:

Acquisition costs for the Non-life Run-off segment were $73.6 million in 2019, compared to $4.0 million in 2018,
an increase of $69.6 million. The increase in acquisition costs for 2019 primarily related to the run-off business assumed
through the AmTrust RITC Transactions and the acquisition of Maiden Re North America.

Fees and Commission Income:

Our management companies in the Non-life Run-off segment earned fees and commission income of $18.3
million in 2019, broadly consistent with income of $16.5 million in 2018. While our consulting subsidiaries continue to
provide management and consultancy services, claims inspection services and reinsurance collection services to third-
party clients in limited circumstances, the core focus of these subsidiaries is providing in-house services to companies
within the Enstar group. These internal fees are eliminated upon consolidation of our results of operations.

Other Income:

Other income was $34.8 million in 2019, broadly consistent with other income of $36.0 million in 2018. 

General and Administrative Expenses:

General and administrative expenses consist of operating expenses and corporate expenses.

Operating expenses
Corporate expenses
General and administrative expenses

$

$

2019

2018
(in thousands of U.S. dollars)
199,756 $

158,731 $

Change

70,689

39,093

270,445 $

197,824 $

41,025
31,596
72,621

General and administrative expenses for the Non-life Run-off segment increased by $72.6 million, from $197.8
million in 2018 to $270.4 million in 2019. The increase in expenses in 2019 was primarily attributable to an increase

62

Table of Contents

in performance-based salary and benefit expenses due to significantly higher net earnings of the Non-life Run-off
segment in 2019 compared to lower earnings in 2018.

Interest Expense:

Interest expense was $62.1 million in 2019, compared to interest expense of $30.6 million in 2018, an increase
of $31.4 million. The increase of $31.4 million was primarily driven by interest on the 2018 EGL Term Loan Facility
which was entered into on December 27, 2018 and partially used to fund the acquisition of Maiden Re North America,
and interest on the 2029 Senior Notes. 

Net Foreign Exchange Gains (Losses):

Net foreign exchange gains for the Non-life Run-off segment were $9.9 million in 2019 compared to $2.5 million
in 2018. The increase of $7.4 million in net foreign exchange gains arose primarily as a result of increased volatility in
exchange rates in 2019 and the resulting impact on our foreign currency denominated investments and subsidiaries,
which  was  partially  offset  by  the  change  in  currency  translation  adjustment  in  the  consolidated  statement  of
comprehensive income.

Income Tax Benefit (Expense):

We recorded an income tax expense of $7.3 million for our Non-life Run-off segment in 2019, compared to an
income tax benefit of $3.6 million in 2018, a change of $10.8 million. The effective tax rate was 0.7% in 2019 compared
with  (14.5)%  in  2018.  Our  tax  rate  was  impacted  by  having  proportionately  higher  net  income  in  our  tax  paying
subsidiaries in 2019 than in 2018. Income tax expense is primarily generated through our foreign operations outside
of Bermuda, principally in the United States, the United Kingdom, Continental Europe and Australia. The effective tax
rate, which is calculated as income tax expense or benefit divided by income before tax, is driven primarily by the
geographic distribution of pre-tax net income between jurisdictions with comparatively higher tax rates and those with
comparatively lower income tax rates and as a result may fluctuate significantly from period to period.

Earnings from Equity Method Investments:

We recorded earnings from equity method investments of $56.1 million for our Non-life Run-off segment in 2019,
compared to earnings of $42.1 million in 2018, an increase of $14.0 million. The increase in 2019 was primarily due
to increased earnings from our investments in Monument and Enhanzed Re.

Noncontrolling Interest:

Net earnings attributable to noncontrolling interest in our Non-life Run-off segment were $6.4 million in 2019,
compared to $3.1 million in 2018, a change of $3.3 million. The change of $3.3 million in 2019 was due primarily to
the increase in earnings for those companies where there is a noncontrolling interest. The number of subsidiaries in
this segment with a noncontrolling interest remained unchanged at two as of December 31, 2019 and December 31,
2018.

63

Table of Contents

Atrium Segment

The Atrium segment includes Atrium 5 Ltd. ("Atrium 5"), Atrium Underwriters Limited ("AUL") and Northshore
Holdings Limited. Atrium 5 results represent its proportionate share of the results of Syndicate 609 for which it provides
25% of the underwriting capacity and capital. AUL results largely represent fees charged to Syndicate 609 and a 20%
profit commission on the results of the syndicate less salaries and general and administrative expenses incurred in
managing the syndicate. AUL also includes other Atrium Group non-syndicate fee income and associated expenses.
Northshore Holdings Limited results include the amortization of intangible assets that were fair valued upon acquisition.

The following is a discussion and analysis of the results of operations for our Atrium segment for the years ended

December 31, 2019 and 2018, which are summarized below. 

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Acquisition costs

Operating expenses

Underwriting income

Net investment income

Net realized and unrealized gains (losses)

Fees and commission income

Other income

Corporate expenses

Net foreign exchange losses

EARNINGS BEFORE INCOME TAXES

Income tax expense

NET EARNINGS

Net earnings attributable to noncontrolling interest

$

$

$

2019

2018

Change

(in thousands of U.S. dollars)

$

$

$

$

$

$

192,373

172,356

164,059

(77,276)

(56,956)

(14,452)

15,375

7,049

6,195

10,160

140

(13,825)

(504)

24,590

(4,033)

20,557

(8,432)

171,494

153,488

146,315

(69,810)

(50,646)

(17,777)

8,082

5,686

(3,251)

18,622

162

(6,921)

(3,394)

18,986

(3,732)

15,254

(6,257)

20,879

18,868

17,744

(7,466)

(6,310)

3,325

7,293

1,363

9,446

(8,462)

(22)

(6,904)

2,890

5,604

(301)

5,303

(2,175)

NET EARNINGS ATTRIBUTABLE TO ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

$

12,125

$

8,997

$

3,128

Underwriting ratios:
Loss ratio (1)
Acquisition cost ratio (1)
Operating expense ratio (1)
Combined ratio (1)

47.1%

34.7%

8.8%

90.6%

47.7%

34.6%

12.2%

94.5%

(0.6)%

0.1 %

(3.4)%

(3.9)%

(1)Refer to "Underwriting Ratios" for a description of how these ratios are calculated. 

Overall Results

An analysis of the components of the segment's net earnings is shown below, after the attribution of net earnings

to noncontrolling interest.

The combined ratio in 2019 was 90.6%, compared to 94.5% in 2018, and the decrease was primarily driven by

a lower operating expense ratio.

Investment results are separately discussed in the "Investments Results - Consolidated" section. 

64

Table of Contents

Gross Premiums Written:

The following table provides gross premiums written by line of business for the Atrium segment for the years

ended December 31, 2019 and 2018:

2019

2018

Change

Marine, Aviation and Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and Facultative

Total

$

(in thousands of U.S. dollars)
49,275 $
78,825

40,227 $
76,389

9,048

2,436

17,778

21,585

24,910

17,763

18,836

18,279

15

2,749

6,631

$

192,373 $

171,494 $

20,879

Gross premiums written for the Atrium segment were $192.4 million in 2019, compared to $171.5 million in 2018,
an increase of $20.9 million. The increase was seen predominantly across the Marine, Aviation and Transit and Non-
Marine Direct and Facultative lines of business. Both lines of business have benefited from an increase in rates. The
Non-Marine Direct and Facultative class are continuing to see new opportunities to write new business.

Net Premiums Earned:

The following table provides net premiums earned by line of business for the Atrium segment for the years ended

December 31, 2019 and 2018:

2019

2018

Change

Marine, Aviation and Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and Facultative

Total

$

(in thousands of U.S. dollars)
36,312 $
75,142

31,738 $
67,423

4,574

7,719

14,433

18,922

19,250

14,029

17,689

15,436

404

1,233

3,814

$

164,059 $

146,315 $

17,744

Net premiums earned for the Atrium segment were $164.1 million in 2019, compared to $146.3 million in 2018,
an increase of $17.7 million. The increase was seen across all lines of business in 2019 and was primarily due to an
increase in the Binding Authorities line of business following continued growth of products placed on AU Gold, Atrium’s
proprietary online underwriting platform, and increases in the Marine, Aviation and Transit line of business. 

65

Table of Contents

Net Incurred Losses and LAE: 

The following table shows the components of net incurred losses and LAE for the Atrium segment for the years

ended December 31, 2019 and 2018:

Net losses paid
Net change in case and LAE reserves (1)
Net change in IBNR reserves (2)

Increase (reduction) in estimates of net ultimate losses

Amortization of fair value adjustments

Net incurred losses and LAE

Prior
Periods

2019

Current
Period

Total

Prior
Periods

(in thousands of U.S. dollars)

2018

Current
Period

Total

$

43,572

$

34,617

$

78,189

$

28,969

$

35,537

$

64,506

(13,278)

(38,380)

(8,086)

335

16,812

33,598

85,027

—

3,534

(4,782)

76,941

335

(10,161)

(27,507)

(8,699)

(5,118)

16,492

31,598

83,627

—

6,331

4,091

74,928

(5,118)

$

(7,751) $

85,027

$

77,276

$ (13,817) $

83,627

$

69,810

(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements
or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a
result of the settlement or movement of assumed claims.

(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable.

Net incurred losses and LAE were $77.3 million in 2019, compared to $69.8 million in 2018, an increase of $7.5
million. Net favorable prior period loss development in 2019 and 2018 was $7.8 million and $13.8 million, respectively,
and was experienced across most lines of business. Excluding prior year loss development, net incurred losses and
LAE in 2019 and 2018 were $85.0 million and $83.6 million, respectively. The net earned premium increased in 2019
and claims performance was better than 2018 due to lower levels of catastrophe losses. The losses in 2019 include
$2.8 million in respect of Hurricane Dorian. 2018 catastrophe losses amounted to $6.7 million and were related to
California Wildfires and Hurricane Matthew.

Acquisition Costs:

Acquisition costs were $57.0 million in 2019, compared to $50.6 million in 2018, an increase of $6.3 million. The

Atrium acquisition cost ratio for 2019 was 34.7%, relatively consistent with 34.6% in 2018.

Operating Expenses:

Operating expenses for the Atrium segment were $14.5 million in 2019, compared to $17.8 million in 2018. The
operating expense ratio was 8.8% in 2019 compared to 12.2% in 2018, a decrease of 3.4%, primarily due to increased
net premiums earned and a reduction in operating expense due to lower performance-based compensation and bonus
expense within Atrium 5. The large catastrophe losses, primarily hurricanes Harvey, Irma and Maria, in the third quarter
of 2017 continued to impact the earning of performance-based compensation expenses and agency profit commission
in Atrium 5.

Fees and Commission Income:

Fees and commission income was $10.2 million in 2019, compared to $18.6 million in 2018, a decrease of $8.5
million. The fees represent management and profit commission fees earned by us in relation to AUL’s management
of Syndicate 609 and other underwriting consortiums. The decrease of $8.5 million in 2019 was primarily due to profit
commission on lower syndicate profits arising on the prior year underwriting profits in 2019 as compared with 2018,
principally due to the large catastrophe losses, primarily hurricanes Harvey, Irma and Maria, in the third quarter of
2017, which continued to impact the profit commission in 2019.

Corporate Expenses:

Corporate expenses for the Atrium segment were $13.8 million in 2019, compared to $6.9 million in 2018, an
increase of $6.9 million. This increase in corporate expenses was due to higher variable compensation costs in 2019
due to improved performance in the Atrium segment in 2019.

66

Table of Contents

Income Tax Expense:

We recorded income tax expense of $4.0 million in 2019, compared to $3.7 million in 2018, an increase of $0.3
million, primarily due to higher earnings in the Atrium segment. Income tax expense is associated with the operations
of Atrium 5 and AUL in the United Kingdom. The effective tax rates for the Atrium segment in 2019 and 2018 were
16.4% and 19.7%, respectively. 

Noncontrolling Interest:

Net earnings attributable to noncontrolling interest in our Atrium segment were $8.4 million in 2019, compared
to $6.3 million in 2018, a change of $2.2 million, which was primarily due to higher earnings in the Atrium segment.
As of December 31, 2019, Trident and Dowling had a combined 41.0% noncontrolling interest in the Atrium segment.

67

Table of Contents

StarStone Segment 

The results of our StarStone segment include the results of StarStone and StarStone Specialty Holdings Limited

("StarStone Group") and intragroup reinsurance cessions.  

StarStone made significant progress in repositioning the underwriting portfolio during 2019 to focus on core lines
of business, which have a track record of performing, and exiting under-performing lines of business in order to achieve
improved underwriting profitability for StarStone Group. As part of the new strategy for the StarStone segment, we
have exited or disposed of various operations and investments that are no longer considered to be key to the new
strategy.  The  StarStone  leadership  has  separated  the  book  into  "core  lines"  and  "exited  lines"  to  manage  the
performance during the repositioning phase. The exited lines represent segments or lines of business where new
business has ceased and includes some aerospace, casualty and property lines.

Our  StarStone  segment  also  includes  the  results  of  intragroup  reinsurance  cessions.  In  partnership  with
StarStone's other shareholders, we completed the following transactions to provide strategic and capital support to
StarStone in the form of: 

(i) a contribution to its contributed surplus account and a loss portfolio transfer and adverse development cover,
effective October 1, 2018. To fund the transaction, the shareholders of StarStone contributed an aggregate amount
of $135.0 million to StarStone in December 2018 in proportion to their ownership interests;  

(ii) a loss portfolio transfer, effective April 1, 2019, for which the StarStone shareholders agreed to contribute an

aggregate amount of $48.0 million;

(iii) a loss portfolio transfer and adverse development cover with StarStone effective October 1, 2019, whereby
StarStone transferred $189.4 million in loss reserves and unearned premium to a wholly-owned Enstar subsidiary in
exchange for premium of $189.4 million. Enstar also provided an additional $59.0 million adverse development cover
in excess of the $189.4 million. 

(iii) our wholly-owned subsidiary, KaylaRe, provided quota share reinsurance to StarStone's U.S., E.U. and U.K.
affiliates. These were non-renewed as of January 1, 2018 for U.S. business, and January 1, 2019, for E.U. and U.K.
business.  However,  losses  in  the  earlier  calendar  years  will  continue  to  fall  due  under  the  previous  quota  share
agreements. Effective May 14, 2018, Enstar completed the acquisition of the portion of KaylaRe it did not already own.

These  reinsurance  transactions  between  StarStone  Group  and  other  group  entities,  including  KaylaRe,  are
reflected within StarStone Intra-Group Cessions below (the "StarStone Intra-Group Cessions") and are eliminated
upon consolidation. 

68

Table of Contents

The following is a discussion and analysis of the results of operations for the StarStone segment for the years

ended December 31, 2019 and 2018, which are summarized below: 

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Acquisition costs

Operating expenses

Underwriting loss

Net investment income

Net realized and unrealized gains (losses)

Other income (losses)

Corporate expenses

Interest expense

Net foreign exchange losses

LOSS BEFORE INCOME TAXES

Income tax benefit

Losses from equity method investments

NET LOSS

Net loss attributable to noncontrolling interest

$

$

$

2019

2018

Change

(in thousands of U.S. dollars)

917,555

$ 1,121,135

$ (203,580)

735,429

801,926

(727,636)

(174,711)

(120,629)

(221,050)

47,401

50,957

338

(7,790)

(475)

(1,538)

$

$

805,562

714,959

(673,383)

(135,452)

(156,726)

(250,602)

35,973

(17,672)

(541)

—

(624)

(2,856)

$

$

(70,133)

86,967

(54,253)

(39,259)

36,097

29,552

11,428

68,629

879

(7,790)

149

1,318

(132,157)

(236,322)

104,165

6,931

(218)

6,327

—

(125,444)

(229,995)

24,711

71,415

604

(218)

104,551

(46,704)

NET LOSS ATTRIBUTABLE TO ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

$ (100,733)

$ (158,580)

$

57,847

Underwriting ratios:

Loss ratio (1)
Acquisition cost ratio (1)
Operating expense ratio (1)
Combined ratio (1)

(1) Refer to "Underwriting Ratios" for a description of how these ratios are calculated.

90.7%

21.8%

15.1%

94.2%

18.9%

22.0%

127.6%

135.1%

(3.5)%

2.9 %

(6.9)%

(7.5)%

69

Table of Contents

The following table summarizes the impact of the StarStone Intra-Group Cessions, which are included in our
StarStone segment for the years ended December 31, 2019 and 2018. The discussion below also describes the results
of  the  StarStone  Group,  which  does  not  reflect  the  impact  of  the  StarStone  Intra-Group  Cessions,  as  well  as  the
StarStone segment which does include the impact of the StarStone Intra-Group Cessions.

Net premiums earned

Net incurred losses and LAE

Acquisition costs

Operating expenses

Underwriting loss

Net investment income

Net realized and unrealized gains (losses)

Other income (losses)

Corporate expenses

Interest income (expenses)

Net foreign exchange gain

2019

StarStone
Intra-Group
Cessions

StarStone
Group

StarStone
Segment

StarStone
Group

(in thousands of U.S. dollars)

2018

StarStone
Intra-Group
Cessions

StarStone
Segment

$ 708,188

$

93,738

$ 801,926

$ 560,670

$ 154,289

$ 714,959

(533,671)

(193,965)

(727,636)

(472,564)

(200,819)

(673,383)

(138,970)

(120,044)

(35,741)

(174,711)

(75,952)

(59,500)

(135,452)

(585)

(120,629)

(153,733)

(2,993)

(156,726)

(84,497)

(136,553)

(221,050)

(141,579)

(109,023)

(250,602)

47,307

43,834

338

(7,790)

(16,612)

(677)

94

7,123

—

—

16,137

(861)

47,401

50,957

338

(7,790)

(475)

(1,538)

35,973

(17,672)

(541)

—

(2,500)

(1,208)

—

—

—

—

1,876

(1,648)

35,973

(17,672)

(541)

—

(624)

(2,856)

LOSS BEFORE INCOME TAXES

(18,097)

(114,060)

(132,157)

(127,527)

(108,795)

(236,322)

Income tax benefit

Losses from equity method investments

6,931

(218)

—

—

6,931

(218)

6,327

—

—

—

6,327

—

NET LOSS

(11,384)

(114,060)

(125,444)

(121,200)

(108,795)

(229,995)

Net loss attributable to noncontrolling interest

4,663

20,048

24,711

49,877

21,538

71,415

NET LOSS ATTRIBUTABLE TO ENSTAR
GROUP LIMITED ORDINARY SHAREHOLDERS

$

(6,721)

$

(94,012)

$ (100,733)

$ (71,323)

$

(87,257)

$ (158,580)

Underwriting ratios:

Loss ratio (1)
Acquisition cost ratio (1)
Operating expense ratio (1)
Combined ratio (1)

75.4%

19.6%

16.9%

206.9%

38.1%

0.7%

90.7%

21.8%

15.1%

84.3%

13.5%

27.5%

130.2%

38.6%

1.9%

94.2%

18.9%

22.0%

111.9 %

245.7%

127.6%

125.3%

170.7%

135.1%

(1) Refer to "Underwriting Ratios" for a description of how these ratios are calculated.

In addition, the below table presents StarStone Group's underwriting income split by the lines of business that

we consider core and exited:

2019

2018

Core Lines

Exited Lines

StarStone
Group

Core Lines

Exited Lines

StarStone
Group

(in thousands of U.S. dollars)

Net premiums earned

$

616,176

$

92,012

$

708,188

$

409,725

$

150,945

$

560,670

Net incurred losses and LAE

Acquisition costs

Operating expenses

(416,981)

(121,366)

(98,983)

(116,690)

(17,604)

(21,061)

(533,671)

(138,970)

(120,044)

(309,750)

(68,608)

(108,405)

(162,814)

(7,344)

(45,328)

(472,564)

(75,952)

(153,733)

Underwriting income (loss)

$

(21,154)

$

(63,343)

$

(84,497)

$

(77,038)

$

(64,541)

$

(141,579)

Underwriting ratios(1):

Loss ratio 

Acquisition cost ratio

Operating expense ratio

Combined ratio

67.7%

19.7%

16.0%

103.4%

126.8%

19.1%

22.9%

168.8%

75.4%

19.6%

16.9%

111.9 %

75.6%

16.7%

26.5%

118.8%

107.9%

4.9%

30.0%

142.8%

84.3%

13.5%

27.5%

125.3%

70

Table of Contents

Overall Results

Net losses for the StarStone segment decreased to $100.7 million in 2019, compared to net losses of $158.6
million in 2018. The combined ratio decreased to 127.6% in 2019, compared to 135.1% in 2018. Whilst this was an
improvement from 2018, the unfavorable results in 2019 were attributable to losses from exited lines of business as
well as reserve strengthening in the U.S. casualty line of business, and prior year adverse development on our U.S.
healthcare, excess casualty, marine, aviation and construction lines of business in 2019. The decrease in net premiums
written was due to our strategy to exit certain lines of business and to focus on core lines. The improvement in the
underwriting performance was primarily due to the repositioning actions to improve underwriting profitability in core
lines and reduced exposure in exited lines of business. The increase of 2.9 percentage points in the acquisition cost
ratio was partially driven by the elimination of the ceding commission earned on the cession to KaylaRe, following our
acquisition of KaylaRe in May 2018. The decrease of 6.9 percentage points in the operating expense ratio was a result
of net premiums earned increasing and operating expenses decreasing.

Net losses for the StarStone Group reduced to $6.7 million in 2019, compared to net losses of $71.3 million in
2018, a change of $64.6 million. The 2019 result was primarily driven by an underwriting loss of $84.5 million that was
primarily due to losses from exited lines of business as well as reserve strengthening in U.S. casualty line of business,
offset by $47.3 million of net investment income and $43.8 million of net realized and unrealized gains. The loss ratio
for the StarStone Group decreased by 8.9 percentage points, reflecting repositioning actions focused on underwriting
profitability. The acquisition cost ratio increased by 6.1 percentage points and the operating expense ratio decreased
by 10.6 percentage points due to reduction on expenses and higher net premiums earned from the non-renewal of
KaylaRe.

Investment results are separately discussed in the "Investments Results - Consolidated" section. 

Gross Premiums Written:

The following table provides gross premiums written by line of business for the StarStone segment for the years

ended December 31, 2019 and 2018:

2019

2018

Change

Casualty

Marine

Property

Aerospace

Workers' Compensation

Total

$

$

118,574

332,042 $
272,714

(in thousands of U.S. dollars)
364,413 $
245,046

32,371
(27,668)
(186,365)
(1,203)
117,191
(20,715)
137,906
917,555 $ 1,121,135 $ (203,580)

304,939

72,331

73,534

Gross premiums written were $917.6 million and $1,121.1 million for the years ended December 31, 2019 and
2018, respectively, a decrease of $203.6 million. Lower premiums in 2019 compared to 2018 were largely a result of
our strategy to exit certain lines of business and to focus on core lines. The property and marine lines of business
decreased by $186.4 million and $27.7 million, respectively. The $32.4 million increase in the casualty line of business
was due to improving rates in the U.S. and new business opportunities underwritten through our European platform.
The $20.7 million decrease in Workers' Compensation was due to the non-renewal of two programs.

71

Table of Contents

Net Premiums Earned:

The following table provides net premiums earned by line of business for the StarStone segment for the years

ended December 31, 2019 and 2018: 

2019

2018

Change

Casualty

Marine

Property

Aerospace

Workers' Compensation

Total

$

(in thousands of U.S. dollars)
321,088 $
221,740

253,065 $
188,556

138,090

156,695

44,755

76,253

57,776

58,867

68,023

33,184
(18,605)
(13,021)
17,386

$

801,926 $

714,959 $

86,967

Net premiums earned for the StarStone segment were $801.9 million and $715.0 million for the years ended
December 31, 2019 and 2018, respectively, an increase of $87.0 million. The increase in net premiums earned in the
StarStone Group was due to the impact of lower ceded premium earned related to KaylaRe after its acquisition. 

Net  premiums  earned  for  the  StarStone  Group  for  2019  were  $708.2  million,  an  increase  of  $147.5  million
compared to 2018. The increase was primarily driven by lower ceded premiums due to the non-renewal of the quota
share arrangement with KaylaRe.

Net Incurred Losses and LAE:

The following table shows the components of net incurred losses and LAE for the StarStone segment for the

years ended December 31, 2019 and 2018:

Net losses paid
Net change in case and LAE reserves (1)
Net change in IBNR reserves (2)

Prior
Periods

2019

Current
Period

Total

Prior
Periods

(in thousands of U.S. dollars)

2018

Current
Period

Total

$ 435,372

$

96,261

$ 531,633

$ 326,352

$ 150,778

$ 477,130

(85,983)

111,950

25,967

(81,491)

157,378

(214,787)

381,214

166,427

(144,212)

258,091

75,887

113,879

666,896

6,753

(266)

Increase in estimates of net ultimate losses

134,602

589,425

724,027

100,649

566,247

Increase (reduction) in provisions for unallocated LAE

Amortization of fair value adjustments

Net incurred losses and LAE

(5,602)

168

9,043

—

3,441

168

(5,892)

12,645

(266)

—

$ 129,168

$ 598,468

$ 727,636

$

94,491

$ 578,892

$ 673,383

(1) Net change in case and LAE reserves comprises the movement during the period in specific case reserve liabilities as a result of claims settlements
or changes advised to us by our policyholders and attorneys, less changes in case reserves recoverable advised by us to our reinsurers as a
result of the settlement or movement of assumed claims. 

(2) Net change in IBNR reserves represents the gross change in our actuarial estimates of IBNR reserves, less amounts recoverable. 

Net incurred losses and LAE for 2019 and 2018 were $727.6 million and $673.4 million, respectively. The increase
in net incurred losses was due to lower reinsurance recoveries due to the non-renewal of the KaylaRe quota share
arrangement and net unfavorable prior year loss development. Net unfavorable prior year loss development for 2019
was $129.2 million, compared to $94.5 million for 2018, primarily related to reserve strengthening for the U.S. casualty
line of business, reflecting an increase in the frequency and severity of losses and social inflation, and lines of business
which we have exited. Excluding prior year loss development, net incurred losses and LAE for 2019 and 2018 were
$598.5 million and $578.9 million, respectively. 

72

Table of Contents

Acquisition Costs: 

Acquisition  costs  for  the  StarStone  segment  were  $174.7  million  and  $135.5  million  for  2019  and  2018,
respectively,  an  increase  of  $39.3  million. The  acquisition  cost  ratios  for  2019  and  2018  were  21.8%  and  18.9%,
respectively, an increase of 2.9 percentage points. The increase in the acquisition cost ratio was primarily attributable
to the non-renewal of the quota share arrangement with KaylaRe, and as a result, the StarStone Group benefited less
from the quota share ceding commission for 2019 than it did in 2018.

Acquisition costs for the StarStone Group were $139.0 million and $76.0 million for 2019 and 2018, respectively,
an increase of $63.0 million. The acquisition cost ratios for December 31, 2019 and 2018 were 19.6% and 13.5%,
respectively, an increase of 6.1 percentage points.

Operating Expenses: 

Operating expenses for the StarStone segment were $120.6 million in 2019, compared to $156.7 million in 2018,
a decrease of $36.1 million. The operating expense ratios for 2019 and 2018 were 15.1% and 22.0%, respectively, a
decrease of 6.9 percentage points. The decrease was due to lower staff compensation, costs of exiting lines of business
and a decrease in IT costs of $5.0 million. 

Operating expense ratios for the StarStone Group for 2019 and 2018 were 16.9% and 27.5%, respectively, a
decrease of 10.6 percentage points. The decrease in the operating expense ratio is attributable to the withdrawal from
certain lines of business and higher net premiums earned due to the non-renewal of KaylaRe.

Corporate expenses:

Corporate expenses for StarStone segment were $7.8 million in 2019. These expenses primarily related to non-
recurring expenses related to reorganization and remediation initiatives, which were not a cost of underwriting, as well
as certain holding company expenses. 

Noncontrolling Interest:

Net losses attributable to noncontrolling interest were $24.7 million in 2019, compared to $71.4 million in 2018,
a change of $46.7 million, primarily due to the net losses in both the StarStone Group and the StarStone Intra-Group
Cessions, as discussed above. 

As of December 31, 2019 and 2018, Trident and Dowling had a combined 41.0% noncontrolling interest in the

StarStone Group.

73

Table of Contents

Other

Our other activities, which do not qualify as a reportable segment, include our corporate expenses, debt servicing
costs, preferred share dividends, holding company income and expenses, foreign exchange and other miscellaneous
items. On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-
owned subsidiary Alpha Insurance SA to a subsidiary of Monument. 

The following is a discussion and analysis of our results of operations for our other activities for the years ended

December 31, 2019 and 2018, which are summarized below:

Net premiums earned

Net incurred losses and LAE

Life and annuity policy benefits

Acquisition costs

Underwriting income

Net investment (losses) income

Net realized and unrealized gains (losses)

Other income (losses)

Corporate expenses

Interest income

Net foreign exchange gains

LOSS BEFORE INCOME TAXES

Income tax expense

NET LOSS ATTRIBUTABLE TO ENSTAR GROUP LIMITED

Dividends on preferred shares

2019

2018

Change

(in thousands of U.S. dollars)

$

20,380 $

24,874 $

(4,494)

(16,038)

(16,899)

(91)

(642)

3,609

(8,410)

5,849

1,883

(45,945)

9,989

3

(1,003)

(2,686)

4,286

2,725

(10,249)

(514)

(28,127)

5,023

1,048

(33,022)

(25,808)

(85)

(33,107)

(35,914)

(52)

(25,860)

(12,133)

861

912

2,044

(677)

(11,135)

16,098

2,397

(17,818)

4,966

(1,045)

(7,214)

(33)

(7,247)

(23,781)

NET LOSS ATTRIBUTABLE TO ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

$

(69,021) $

(37,993) $

(31,028)

Overall Results:

Net losses were $69.0 million for 2019 and $38.0 million for 2018, an increase in net losses of $31.0 million,
which primarily resulted from a $23.8 million increase in dividends on preferred shares, a $17.8 million increase in
corporate  expenses,  an  $11.1  million  decrease  in  net  investment  income,  and  a  $1.0  million  decrease  in  foreign
exchange gains, partially offset by a $16.1 million increase in net realized and unrealized gains (losses) and a $5.0
million increase in interest income. The primary changes are discussed below. 

•

•

•

•

•

Underwriting income was $3.6 million in 2019, compared to $4.3 million in 2018, a decrease of $0.7 million.

Investment results are separately discussed in the "Investments Results - Consolidated" section. 

Corporate expenses were $45.9 million in 2019, compared to $28.1 million in 2018, an increase of $17.8
million, primarily due to an increase in performance-related compensation as a result of higher consolidated
net earnings in 2019 compared to 2018.

Interest income was $10.0 million in 2019, compared to $5.0 million in 2018, an increase of $5.0 million. This
represents the elimination of interest expense between our reportable segments.

In 2019, we paid $35.9 million of dividends on our Series D and Series E Preferred Shares compared to $12.1
million in 2018. On June 28, 2018, we issued 16,000 Series D Preferred Shares with an aggregate liquidation
value of $400.0 million. On November 21, 2018, we issued 4,400 Series E Preferred Shares with an aggregate
liquidation value of $110.0 million. 

74

 
Table of Contents

Investable Assets

We define investable assets as the sum of total investments, cash and cash equivalents, restricted cash and
cash equivalents and funds held. Investments consist primarily of investment grade, liquid, fixed maturity securities of
short-to-medium duration, equities and other investments. Cash and cash equivalents and restricted cash and cash
equivalents  is  comprised  mainly  of  cash,  high-grade  fixed  deposits,  and  other  highly  liquid  instruments  such  as
commercial paper with maturities of less than three months at the time of acquisition and money market funds. Funds
held primarily consists of investment grade, liquid, fixed maturity securities of short-to-medium duration.

Investable assets were $14.7 billion as of December 31, 2019 as compared to $12.5 billion as of December 31,
2018, an increase of 16.9%. The increase was primarily due to the investments and funds held balance acquired in
relation to the Morse TEC, Zurich, Maiden Re Bermuda, Amerisure and the AmTrust RITC transactions.

Schedules of maturities for our fixed maturity securities are included in Note 6 - "Investments" of our consolidated

financial statements included within Item 8 of this Annual Report on Form 10-K.

Investment Strategies

Our key investment objectives are as follows:

•

•

•

•

To follow an investment strategy designed to emphasize the security and growth of our invested assets that
also meet our credit quality and diversification objectives. 

To provide sufficient liquidity for the prompt payment of claims and contract liabilities.

To  seek  superior  risk-adjusted  returns,  by  allocating  a  portion  of  our  portfolio  to  non-investment  grade
securities in accordance with our investment guidelines. 

To consider the duration characteristics of our liabilities in determining the extent to which we correlate with
assets of comparable duration depending on our other investment strategies and to the extent practicable.

In the Non-life Run-off, Atrium and StarStone segments, we generally seek to maintain investment portfolios
that are shorter or of equivalent duration to the liabilities in order to provide liquidity for the settlement of losses and,
where  possible,  to  avoid  having  to  liquidate  longer-dated  investments.  In  the  Non-life  Run-off  segment,  the
commutations of liabilities also have the potential to accelerate the natural payout of losses, which requires liquidity. 

Our  fixed  maturity  securities  include  U.S.  government  and  agency  investments,  highly  rated  sovereign  and
supranational investments, high-grade corporate investments, and mortgage-backed and asset-backed investments.
We allocate a portion of our investment portfolio to other investments, including private equity funds, fixed income
funds, hedge funds, equity funds, CLO equities, CLO equity funds, real estate debt fund and private credit funds. 

We utilize and pay fees to various companies to provide investment advisory and/or management services.
These  fees,  which  are  predominantly  based  upon  the  amount  of  assets  under  management,  are  included  in  net
investment income. 

Our investment performance is subject to a variety of risks, including risks related to general economic conditions,
market volatility, interest rate fluctuations, foreign exchange risk, liquidity risk and credit and default risk. Interest rates
are highly sensitive to many factors, including governmental monetary policies, domestic and international economic
and political conditions and other factors beyond our control. An increase in interest rates could result in significant
losses, realized or unrealized, in the value of our investment portfolio. A portion of our non-investment grade securities
consists of alternative investments that subject us to restrictions on redemption, which may limit our ability to withdraw
funds for some period of time after the initial investment. The values of, and returns on, such investments may also
be  more  volatile.  For  more  information  on  these  risks,  refer  to  "Item 1A.  Risk  Factors - Risks  Relating  to  Our
Investments" and "Item 7A. Quantitative and Qualitative Disclosures About Market Risk."

In  2018  and  2019,  we  increased  our  allocation  to  other  investments  and  equity  method  investments,  which
collectively constituted 19.4% of our investable assets as of December 31, 2019 (2018: 17.2%), and 58.7% of our total
shareholders' equity as of December 31, 2019 (2018: 55.2%). We believe our other investments and equity method
investments portfolio provides diversification against our fixed income investments and an opportunity for improved
risk-adjusted return, however, the returns of these investments may be more volatile and we may experience significant
unrealized gains or losses in a particular quarter or year.

75

Table of Contents

Composition of Investable Assets By Segment

Across all of our segments, we strive to structure our investments in a manner that recognizes our liquidity needs
and in order to meet our obligation to pay losses. Our remaining life business did not qualify as a reportable segment
and is reflected as Other below. We consider the duration characteristics of our liabilities in determining the extent to
which we correlate with assets of comparable duration depending on our other investment strategies and to the extent
practicable. If our liquidity needs or general liability profile change unexpectedly, we may adjust the structure of our
investment  portfolio  to  meet  our  revised  expectations.  The  following  tables  summarize  the  composition  of  total
investable assets by segment as of December 31, 2019 and 2018: 

2019

Non-life 
Run-off

Atrium

StarStone

Other

Total

(in thousands of U.S. dollars)

Short-term investments, trading, at fair value

$

50,268

$

1,222

$

— $

— $

51,490

Short-term investments, available-for-sale, at fair
value

Fixed maturities, trading, at fair value

Fixed maturities, available-for-sale, at fair value

Funds held - directly managed

Equities, at fair value

Other investments, at fair value

Other investments, at cost

Equity method investments

Total investments

121,780

5,378,533

1,446,912

1,187,552

576,893

2,386,776

—

326,277

—

155,510

15,310

—

22,079

7,417

—

—

6,555

812,286

451,167

—

130,749

130,227

—

—

11,474,991

201,538

1,530,984

—

—

—

—

—

—

—

—

—

Cash and cash equivalents (including restricted cash)

Funds held by reinsured companies

666,705

336,470

58,369

27,451

326,136

36,194

4,567

8,620

128,335

6,346,329

1,913,389

1,187,552

729,721

2,524,420

—

326,277

13,207,513

1,055,777

408,735

Total investable assets
Duration (in years) (1)
Average credit rating (2)

$ 12,478,166

$

287,358

$

1,893,314

$

13,187

$

14,672,025

5.24

A+

1.86

AA-

2.53

A+

0.00

AAA

4.76

A+

2018

Non-life 
Run-off

Atrium

StarStone

Other

Total

(in thousands of U.S. dollars)

Short-term investments, trading, at fair value

$

106,375

$

541

$

7,200

$

— $

114,116

Fixed maturities, trading, at fair value

Fixed maturities, available-for-sale, at fair value

Funds held - directly managed

Equities, at fair value

Other investments, at fair value

Equity method investments

Total investments

Cash and cash equivalents (including restricted cash)

Funds held by reinsured companies

Total investable assets
Duration (in years) (1)
Average credit rating (2)

5,790,219

—

1,198,154

335,632

1,825,307

204,507

9,460,194

585,956

263,713

139,121

29,975

—

3,193

7,166

—

1,319,453

—

7,248,793

—

—

28,300

113,024

—

121,634

—

—

151,609

1,198,154

367,125

12,260

1,957,757

—

204,507

179,996

1,467,977

133,894

11,242,061

54,679

26,489

318,811

20,823

23,138

10,242

982,584

321,267

$ 10,309,863

$

261,164

$

1,807,611

$

167,274

$

12,545,912

5.41

A+

1.70

AA-

2.66

A+

5.70

AA-

4.86

A+

(1) The duration calculation includes cash and cash equivalents, short-term investments, fixed maturities and the fixed maturities within our funds

held - directly managed portfolios at December 31, 2019 and 2018.

(2) The average credit ratings calculation includes cash and cash equivalents, short-term investments, fixed maturities and the fixed maturities within

our funds held - directly managed portfolios at December 31, 2019 and 2018.

76

U.K. government

Other government

Corporate

Municipal

Residential mortgage-
backed

Commercial mortgage-
backed

Asset-backed

Total

Table of Contents

As of both December 31, 2019 and 2018, our investment portfolio, including funds held - directly managed had
an average credit quality rating of A+. As of December 31, 2019 and 2018, our fixed maturity investments (classified
as trading and available-for-sale and our fixed maturity investments included within funds held - directly managed)
that were non-investment grade (i.e. rated lower than BBB- and non-rated securities) comprised 4.3% and 3.8% of
our total fixed maturity investment portfolio, respectively. A detailed schedule of average credit ratings by asset class
as of December 31, 2019 is included in Note 6 - "Investments" of our consolidated financial statements included within
Item 8 of this Annual Report on Form 10-K.

Composition of Investment Portfolio by Asset Class

The following table summarizes the composition of our investment portfolio by asset class as of December 31,

2019 and 2018: 

AAA
Rated

AA Rated

A Rated

2019

BBB
Rated

Non-
investment
Grade

Not Rated

Total

%

Fixed maturity and short-term investments, trading and available-for-sale and funds held - directly managed

(in thousands of U.S. dollars, except percentages)

U.S. government & agency

$ 736,043

$

— $

— $

— $

736,043

—

316,151

149,108

16,381

161,772

154,072

— $

—

— $

—

63,270

144,557

619,707

2,911,867

1,703,328

77,291

50,938

23,272

—

24,807

311,167

—

—

—

161,772

702,857

5.6%

1.2%

5.3%

1,890

5,697,067

43.1%

—

167,882

1.3%

381,502

47,489

2,295

1,882

34,055

4,613

471,836

3.6%

632,461

378,116

89,347

89,418

95,508

66,573

174,118

117,275

6,224

15,694

9,916

781

900,029

775,402

6.8%

5.9%

2,609,762

1,239,096

3,297,996

2,056,887

391,947

17,200

9,612,888

72.8%

Other assets included within funds held - directly managed

14,207

0.1%

Equities

Publicly traded equities

Exchange-traded funds

Privately held equities

Total

Other investments

Hedge funds

Equity funds

Fixed income funds

Private equity funds

CLO equities

CLO equity funds

Private credit funds

Other

Total

Equity method investments

327,875

133,047

268,799

729,721

1,121,904

410,149

481,039

329,885

87,555

87,509

—

6,379

2.5%

1.0%

2.0%

5.5%

8.5%

3.1%

3.6%

2.5%

0.7%

0.7%

—%

—%

2,524,420

19.1%

326,277

2.5%

Total investments

$2,609,762

$ 1,239,096

$ 3,297,996

$ 2,056,887

$

391,947

$

17,200

$ 13,207,513

100.0%

77

Table of Contents

AAA
Rated

AA Rated

A Rated

2018

BBB
Rated

Non-
investment
Grade

Not
Rated

Total

%

(in thousands of U.S. dollars, except percentages)

Fixed maturity and short-term investments, trading and available-for-sale and funds held - directly managed

U.S. government & agency

$ 502,819

$

7,426

$

— $

— $

510,245

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-
backed

Asset-backed

Total

2,144

322,606

129,059

7,934

644,418

487,054

358,574

298,487

213,639

— $

—

— $

—

69,601

154,800

470,571

2,306,532

1,731,398

69,270

51,729

70,620

68,174

41,666

8,658

77,538

125,644

11,395

10,495

60,879

66,136

—

32,592

197,822

—

54,727

7,297

17,573

4.5%

2.7%

7.1%

—

572

300,631

793,810

4,458

4,839,840

43.1%

—

3,530

9,675

380

130,265

773,557

713,063

636,481

1.2%

6.9%

6.3%

5.7%

2,454,608

1,249,916

2,629,639

2,035,103

310,011

18,615

8,697,892

77.5%

Other assets included within funds held - directly managed

14,780

0.1%

Equities

Publicly traded equities

Privately held equities

Total

Other investments

Hedge funds

Equity funds

Fixed income funds

Private equity funds

CLO equities

CLO equity funds

Private credit funds

Other

Total

Equity method investments

138,415

228,710

367,125

852,584

333,681

403,858

248,628

39,052

37,260

33,381

9,313

1.2%

2.0%

3.2%

7.6%

3.0%

3.6%

2.2%

0.3%

0.3%

0.3%

0.1%

1,957,757

17.4%

204,507

1.8%

Total investments

$2,454,608

$1,249,916

$ 2,629,639

$ 2,035,103

$

310,011

$ 18,615

$ 11,242,061

100.0%

A description of our investment valuation processes is included in "Item 7. Management's Discussion and Analysis
of Financial Condition and Results of Operations - Critical Accounting Policies - Investments" and Note 12 - "Fair Value
Measurements" of our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K.

78

Fair
Value

736,043

161,772

702,857

(117)

(6,254)

(19,293)

5,697,067

(147)

(1,538)

(3,892)

(5,912)

167,882

471,836

900,029

775,402

Fair
Value

510,245

300,631

793,810

(7,644)

(26,065)

(191,373)

4,839,840

(3,157)

(4,746)

(18,782)

(7,169)

130,265

773,557

713,063

636,481

Table of Contents

The following tables summarize the amortized cost, gross unrealized gains and losses and the fair value of our
short-term  investments  and  fixed  maturity  investments,  classified  as  trading  and  available-for-sale,  and  the  fixed
maturity investments included within our funds held - directly managed as of December 31, 2019 and 2018:

U.S. government and agency

$

730,396 $

6,869 $

(1,222) $

Amortized
Cost

Gross
Unrealized
Gains

2019

Gross
Unrealized
Losses
Non-OTTI

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

155,261

684,117

5,479,839

157,868

466,932

882,603

779,279

6,628

24,994

236,521

10,161

6,442

21,318

2,035

$

9,336,295 $

314,968 $

(38,375) $

9,612,888

U.S. government and agency

$

512,360 $

1,904 $

(4,019) $

Amortized
Cost

Gross
Unrealized
Gains

2018

Gross
Unrealized
Losses
Non-OTTI

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

301,749

814,614

5,019,018

132,928

772,457

729,232

642,618

6,526

5,261

12,195

494

5,846

2,613

1,032

$

8,924,976 $

35,871 $

(262,955) $

8,697,892

We have generally accounted for our fixed maturity securities as "trading." However, from October 1, 2019, we
elected to use available-for-sale accounting for all new acquisitions and, where permissible, as trading fixed maturity
securities mature, we are reinvesting the proceeds into available-for-sale securities for our Non-Life and StarStone
segments. The difference is that unrealized changes on investments classified as trading are recorded through earnings,
whereas unrealized changes on investments classified as available-for-sale are recorded directly to shareholders'
equity. We may experience unrealized losses on our fixed maturity investments, depending on investment conditions
and general economic conditions. Unrealized amounts would only become realized in the event of a sale of the specific
securities prior to maturity or a credit default. For further information on the sensitivity of our portfolio to changes in
interest rates, refer to the Interest Rate Risk section within "Item 7A. Quantitative and Qualitative Disclosures About
Market  Risk",  included  within  this  Annual  Report  on  Form  10-K.  For  further  discussion  of  our  investments,  see
"Investable Assets" below. 

79

Table of Contents

The following table summarizes the composition of our top ten corporate issuers included within our short-term
investments  and  fixed  maturity  investments,  classified  as  trading  and  available-for-sale  and  the  fixed  maturity
investments included within our funds held - directly managed balance as of December 31, 2019:

Citigroup Inc

Bank of America Corp

JPMorgan Chase & Co

Morgan Stanley

Apple Inc

Wells Fargo & Co

Comcast Corp

HSBC Holdings PLC

Walmart Inc
Goldman Sachs Group Inc

Fair Value

(in thousands of U.S.
dollars)

Average Credit
Rating

$

115,392

111,165

109,528

106,453

101,538

86,221

80,342

68,469

59,773

56,038

BBB+

A

A

A-

AA+

A

A-

A

AA

A-

$

894,919

Investment Results - Consolidated

Comparability between periods is impacted by our acquisitions and significant new business as described in
"Item 1.  Business  -  Recent Acquisitions  and  Significant  New  Business"  and  Note  3  -  "Acquisitions"  and  Note  4  -
"Significant New Business" of our consolidated financial statements included in Item 8 of this Annual Report on Form
10-K.

The following table summarizes our consolidated investment results for the years ended December 31, 2019

and 2018:

2019

Non-life 
Run-off

Atrium

StarStone

Other

Total

(in thousands of U.S. dollars)

Net investment income:

Fixed maturities and cash and cash equivalents

$

258,277

$

6,292

$

42,518

$

Equity securities

Other

Gross investment income

Investment expenses

14,660

14,916

287,853

(12,617)

72

975

7,339

(290)

1,939

5,425

49,882

(2,481)

984

—

(9,524)

(8,540)

130

$

308,071

16,671

11,792

336,534

(15,258)

Net investment income (expense)

$

275,236

$

7,049

$

47,401

$

(8,410)

$

321,276

Net realized and unrealized gains and losses:

Fixed maturity securities

Equity securities

Other investments

Net realized and unrealized gains and losses

Annualized income from cash and fixed maturities

Average aggregate fixed maturities and cash and
cash equivalents, at cost (1)

480,579

55,336

432,435

968,350

258,277

$

$

$

$

4,396

817

982

6,195

6,292

$

$

45,604

(1,168)

6,521

50,957

42,518

$

$

4,151

—

1,698

5,849

984

534,730

54,985

441,636

$

$

1,031,351

308,071

9,031,708

256,109

1,638,695

72,045

10,998,557

Annualized Investment Book Yield

2.86%

2.46%

2.59%

1.37 %

2.80%

Total financial statement return (2)
Average aggregate invested assets, at fair value (1)

$

1,243,586

$

13,244

$

98,358

$

(2,561)

$

1,352,627

11,799,264

270,590

1,837,229

79,478

13,986,561

Financial Statement Portfolio Return

10.54%

4.89%

5.35%

(3.22)%

9.67%

80

Table of Contents

2018

Non-life 
Run-off

Atrium

StarStone

Other

Total

(in thousands of U.S. dollars)

Net investment income:

Fixed maturities and cash and cash equivalents

$

207,390

$

5,221

$

34,619

$

1,551

$

248,781

Equity securities

Other investments and other

Gross investment income

Investment expenses

Net investment income

Net realized and unrealized gains and losses:

Fixed maturity securities

Equity securities

Other investments

Net realized and unrealized losses

Annualized income from cash and fixed maturities

Average aggregate fixed maturities and cash and
cash equivalents, at cost (1)

3,831

21,638

232,859

(6,572)

$

226,287

$

(222,442)

(8,383)

(150,887)

(381,712)

207,390

$

$

$

$

$

$

55

684

5,960

(274)

1,511

2,522

38,652

(2,679)

—

1,370

2,921

(196)

5,397

26,214

280,392

(9,721)

5,686

$

35,973

$

2,725

$

270,671

(2,514)

$

(18,143)

$

$

(243,093)

(154)

(583)

(3,251)

5,221

$

$

2,722

(2,251)

(17,672)

34,619

(10,255)

(10,249)

1,551

$

$

$

$

(5,815)

(163,976)

(412,884)

248,781

6

—

7,537,621

265,238

1,535,360

160,359

9,498,578

Annualized Investment Book Yield

2.75 %

1.97%

2.25%

0.97 %

2.62 %

Total financial statement return (2)
Average aggregate invested assets, at fair value (1)

$

(155,425)

$

2,435

$

18,301

$

(7,524)

$

(142,213)

9,041,377

272,386

1,670,240

222,822

11,206,825

Financial Statement Portfolio Return

(1.72)%

0.89%

1.10%

(3.38)%

(1.27)%

(1) These amounts are an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.

(2) This is the sum of net investment income and net realized and unrealized gains (losses) from our U.S. GAAP consolidated financial statements.

2019 versus 2018: Net investment income increased by $50.6 million during 2019, primarily due to a $59.3
million increase in net investment income from fixed maturities and cash and cash equivalents, principally driven by
an increase of $1.5 billion in our average balance of fixed maturities and cash and cash equivalents. The increase in
average balance of fixed maturities and cash and cash equivalents was primarily due to the Morse TEC, Zurich, Maiden
Re Bermuda, Amerisure and the AmTrust RITC transactions in 2019. The book yield increased by 18 basis points
primarily due to the contractual yield received on the 2019 transactions.

Net realized and unrealized gains were $1,031.4 million in 2019, compared to net realized and unrealized losses
of $412.9 million in 2018, a change of $1,444.2 million. Included in net realized and unrealized gains (losses) are the
following items:

•

•

•

net realized and unrealized gains on fixed income securities, including fixed income securities within our funds
held portfolios, of $534.7 million in 2019, compared to net realized and unrealized losses of $243.1 million in
2018, an increase of $777.8 million, primarily driven by higher valuations due to declining interest rates and
tighter credit spreads in the current period, compared to lower valuations in the comparative period due to
higher interest rates and wider credit spreads;

net realized and unrealized gains on equity securities of $55.0 million in 2019, compared to net unrealized
losses of $5.8 million in 2018, an increase of $60.8 million, primarily driven by a more favorable movement in
global equity markets in 2019 compared to the comparative period; and

net realized and unrealized gains on other investments of $441.6 million in 2019, compared to net realized
and unrealized losses of $164.0 million in 2018, representing a change of $605.6 million. The unrealized gains
in 2019 primarily comprised unrealized gains in our hedge funds, equity funds, fixed income funds and private
equity  funds,  principally  driven  by  declining  interest  rates,  tighter  credit  spreads,  and  a  more  favorable
movement in global equity markets in 2019. The unrealized losses in 2018 primarily comprised unrealized
losses in our equity funds, call options on equity, hedge funds, fixed income funds and CLO equities, partially
offset by unrealized gains on our private debt and private equities.

81

Table of Contents

Liquidity and Capital Resources

Overview

We aim to generate cash flows from our insurance operations and investments, preserve sufficient capital for

future acquisitions, and develop relationships with lenders who provide borrowing capacity at competitive rates.  

Our capital resources as at December 31, 2019 included ordinary shareholders' equity of $4.3 billion, preferred
equity of $510.0 million, redeemable noncontrolling interest of $438.8 million classified as temporary equity, and debt
obligations of $1,191.2 million. The redeemable noncontrolling interest may be settled in the future in cash or our
ordinary shares, at our option. Based on our current loss reserves position, our portfolios of in-force insurance and
reinsurance business, and our investment positions, we believe we are well capitalized. 

The following table details our capital position as of December 31, 2019 and 2018:

Ordinary shareholders' equity

Series D and E Preferred Shares

Total Enstar Group Limited Shareholders' Equity (A)

Noncontrolling interest

Total Shareholders' Equity (B)

Senior Notes

Revolving credit facility

Term loan facility

Total debt (C)

2019

2018

Change

(in thousands of U.S. dollars)

$

4,332,183

$

3,391,933

$

940,250

510,000

4,842,183

14,168

4,856,351

842,216

—

348,991

1,191,207

510,000

3,901,933

12,056

3,913,989

348,054

15,000

498,485

861,539

—

940,250

2,112

942,362

494,162
(15,000)
(149,494)
329,668

Redeemable noncontrolling interest (D)

438,791

458,543

(19,752)

Total capitalization = (B) + (C) + (D)

Total capitalization attributable to Enstar = (A) + (C)

$

$

6,486,349

6,033,390

$

$

5,234,071

4,763,472

$

$

1,252,278

1,269,918

Debt to total capitalization

Debt and Series D and E Preferred Shares to total
capitalization

Debt to total capitalization attributable to Enstar

Debt and Series D and E Preferred Shares to total
capitalization attributable to Enstar

18.4%

26.2%

19.7%

28.2%

16.5%

26.2%

18.1%

28.8%

1.9 %

— %

1.6 %

(0.6)%

As of December 31, 2019, we had $703.1 million of cash and cash equivalents, excluding restricted cash that
supports insurance operations, and included in this amount was $485.1 million held by our foreign subsidiaries outside
of Bermuda. Based on our group's current corporate structure with a Bermuda domiciled parent company and the
jurisdictions in which we operate, if the cash and cash equivalents held by our foreign subsidiaries were to be distributed
to us, as dividends or otherwise, such amount would not be subject to incremental income taxes, however in certain
circumstances withholding taxes may be imposed by some jurisdictions, including by the United States. Based on
existing tax laws, regulations and our current intentions, there were no accruals as of December 31, 2019 for any
material withholding taxes on dividends or other distributions, as described in Note 20 - "Income Taxation" in the notes
to our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K. 

82

Table of Contents

Dividends

Enstar has not historically declared a dividend on our ordinary shares. Our strategy is to retain earnings and
invest distributions from our subsidiaries back into the company. We do not currently expect to pay any dividends on
our ordinary shares.

On June 28, 2018, we issued 16,000 Series D Preferred Shares with an aggregate liquidation value of $400.0
million. On November 21, 2018, we issued 4,400 Series E Preferred Shares with an aggregate liquidation value of
$110.0 million. The dividends on the Series D and E Preferred Shares are non-cumulative and may be paid quarterly
in arrears on the first day of March, June, September and December of each year, only when, as and if declared.

The following table details the dividends that have been declared and paid on our Series D and E Preferred

Shares from January 1, 2019 to February 27, 2020:

Preferred
Share
Series

Series D

Series E

Series D

Series E

Series D

Series E

Series D

Series E

Series D

Series E

Dividend per:

Date
Declared

Record Date

Date Paid or
Payable

Preferred
Share

Depositary
Share

(in U.S. dollars)

Total dividends paid
and declared in the
year ended
December 31, 2019
(in thousands of U.S.
dollars)

February 21, 
2019

February 15, 
2019

February 21, 
2019

February 15, 
2019

May 3, 
2019

May 3, 
2019

August 5, 
2019

August 5, 
2019

May 15, 
2019

May 15, 
2019

August 15, 
2019

August 15, 
2019

March 1, 
2019

March 1, 
2019

June 1, 
2019

June 1, 
2019

September 3, 
2019

September 3, 
2019

November 5, 
2019

November 15, 
2019

December 2, 
2019

November 5, 
2019

November 15, 
2019

December 2, 
2019

February 4, 
2020

February 4, 
2020

February 15, 
2020

February 15, 
2020

March 2, 
2020

March 2, 
2020

$

$

$

$

$

$

$

$

$

$

437.50 $

0.43750 $

486.11 $

0.48611

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

437.50 $

0.43750

7,000

2,139

7,000

1,925

7,000

1,925

7,000

1,925

—

—

Any payment of common or preferred dividends must be approved by our Board of Directors. Our ability to pay
common and preferred dividends is subject to certain restrictions, as described in Note 22 - "Dividend Restrictions
and Statutory Financial Information" in the notes to our consolidated financial statements included within Item 8 of this
Annual Report on Form 10-K.

$

35,914

83

Table of Contents

Sources and Uses of Cash

Holding Company Liquidity

The potential sources of cash flows to Enstar as a holding company consist of cash flows from our subsidiaries
including dividends, advances and loans, and interest income on loans to our subsidiaries. We also borrow from our
credit and loan facilities, and we have also issued senior notes and preferred shares.

We use cash to fund new acquisitions of companies and significant new business. We also utilize cash for our
operating expenses associated with being a public company and to pay interest and principal on loans from subsidiaries
and debt obligations, including loans under our credit facilities, our 4.50% senior notes due 2022 (the “2022 Senior
Notes”) and our 4.95% senior notes due 2029 (the "2029 Senior Notes” and, together with the 2022 Senior Notes, the
"Senior Notes").

Our holding company cash flows are summarized in "Item 8. Financial Statements and Supplementary Data -
Schedule II - Condensed Financial Information of Registrant - Statements of Cash Flows - Parent Company Only for
the years ended December 31, 2019, 2018 and 2017" and the notes thereto.

We may, from time to time, raise capital from the issuance of equity, debt or other securities as we continuously
evaluate our strategic opportunities. We filed an automatic shelf registration statement on October 10, 2017 with the
U.S.  Securities  and  Exchange  Commission  ("SEC")  to  allow  us  to  conduct  future  offerings  of  certain  securities,  if
desired, including debt, equity and other securities. 

On March 26, 2019, we entered into a second supplemental indenture relating to our 2022 Senior Notes, which
limits our right to redeem the 2022 Senior Notes at our option, except in the circumstances set forth in the second
supplemental indenture. This change enabled the 2022 Senior Notes to qualify as Tier 3 capital under the eligible
capital rules of the Bermuda Monetary Authority. Because this amendment did not materially and adversely affect the
holders of or the coupons on the 2022 Senior Notes, entry into the second supplemental indenture did not require the
consent of the holders of the 2022 Senior Notes. The 2029 Senior Notes qualify as Tier 3 capital under the eligible
capital rules of the Bermuda Monetary Authority.

As we are a holding company and have no substantial operations of our own, our assets consist primarily of
investments in subsidiaries and our loans and advances to subsidiaries. Dividends from our insurance subsidiaries
are restricted by insurance regulation, as described below.

Operating Company Liquidity

The ability of our insurance and reinsurance subsidiaries to pay dividends and make other distributions is limited
by the applicable laws and regulations of the jurisdictions in which our insurance and reinsurance subsidiaries operate,
including Bermuda, the United Kingdom, the United States, Australia and Continental Europe, which subject these
subsidiaries to significant regulatory restrictions. These laws and regulations require, among other things, certain of
our insurance and reinsurance subsidiaries to maintain minimum capital resources requirements and limit the amount
of dividends and other payments that these subsidiaries can pay to us, which in turn may limit our ability to pay dividends
and make other payments. For more information on these laws and regulations, see "Item 1. Business - Regulation."
As of December 31, 2019, all of our insurance and reinsurance subsidiaries’ capital resources levels were in excess
of the minimum levels required. The ability of our subsidiaries to pay dividends is subject to certain restrictions, as
described in Note 22 - "Dividend Restrictions and Statutory Financial Information" in the notes to our consolidated
financial statements included within Item 8 of this Annual Report on Form 10-K. Our subsidiaries’ ability to pay dividends
and make other forms of distributions may also be limited by our repayment obligations under certain of our outstanding
loan facility agreements. Variability in ultimate loss payments may also result in increased liquidity requirements for
our subsidiaries. During 2019 and 2018, our regulated subsidiaries paid aggregate capital distributions and dividends
of $530.6 million and $243.0 million, respectively. 

In the Non-life Run-off segment, sources of funds primarily consist of cash and investment portfolios acquired
on the completion of acquisitions and loss portfolio transfer reinsurance agreements. Cash balances acquired upon
our purchase of insurance or reinsurance companies are classified as cash provided by investing activities. Cash
acquired from loss portfolio transfer reinsurance agreements is classified as cash provided by operating activities. We
expect to use funds acquired from cash and investment portfolios, collected premiums, collections from reinsurance
debtors, fees and commission income, investment income and proceeds from sales and redemptions of investments
to meet expected claims payments and operational expenses with the remainder used for acquisitions and additional
investments. In the Non-life Run-off segment, we generally expect negative operating cash flows to be met by positive
investing  cash  flows.  In  2019,  cash  provided  by  operating  activities  was  positive  as  the  proceeds  from  sales  and

84

Table of Contents

maturities of trading securities exceeded cash used in the purchase of trading securities, with the net proceeds being
used in the purchase of available-for-sale securities included within investing cash flows.

In the Atrium and StarStone segments we expect a net provision of cash from operations as investment income
earned and collected premiums should generally be in excess of total net claim payments, losses incurred on earned
premiums and operating expenses. 

Overall, we expect our cash flows, together with our existing capital base and cash and investments acquired
on the acquisition of insurance and reinsurance subsidiaries, to be sufficient to meet cash requirements and to operate
our business. 

Cash Flows

The following table summarizes our consolidated cash flows, including those related to restricted cash, from

operating, investing and financing activities for the years ended December 31, 2019 and 2018:

Cash provided by (used in):

Operating activities

Investing activities

Financing activities

Effect of exchange rate changes on cash

Net increase (decrease) in cash and cash equivalents

Cash and cash equivalents, beginning of year

Cash and cash equivalents, end of year

2019

2018

Change

(in thousands of U.S. dollars)

$

1,763,516 $

(160,072) $

1,923,588

(1,983,537)

(825,754)

(1,157,783)

293,538

(324)

73,193

982,584

752,986

2,588

(230,252)

1,212,836

(459,448)

(2,912)

303,445

(230,252)

$

1,055,777 $

982,584 $

73,193

Details of our consolidated cash flows are included in "Item 8. Financial Statements and Supplementary Data -

Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018 and 2017."  

2019 versus 2018: Cash and cash equivalents increased by $73.2 million in 2019 compared with a decrease

of $230.3 million during 2018.

Cash provided by operating activities was $1,763.5 million in 2019 compared cash used of $160.1 million in
2018. The positive operating cash flow in 2019 was predominantly driven by: (i) net proceeds from sales and maturities
of trading securities of $1,237.8 million in 2019 as we used the proceeds from maturing trading securities to purchase
available-for-sale securities compared to net cash used in the purchase of trading securities of $790.1 million in 2018;
and (ii) cash and restricted cash acquired in Non-life Run-off reinsurance transactions for the years ended December 31,
2019 and 2018 of $1,201.3 million and $652.0 million, respectively; partially offset by net paid losses in our Non-Life
Run-off segment for the years ended December 31, 2019 and 2018 of $1,247.6 million and $838.8 million, respectively.

Cash used in investing activities for 2019 primarily related to: (i) net purchases of available-for-sale securities
of $1,867.9 million; and (ii) net purchases of other investments of $214.3 million; partially offset by net cash acquired
as a result of acquisitions of $172.5 million. In 2018, cash used in investing activities of $825.8 million was primarily
due to net purchases of other investments of $464.7 million and cash used in acquisitions of $245.2 million.

Cash provided by financing activities for 2019 of $293.5 million primarily related to the net inflows of $327.9
million from loan obligations, notably the $500.0 million of Senior Notes issued, which were principally used to fund
new business and acquisitions, partially offset by dividends paid on preferred shares of $35.9 million. Cash provided
by financing activities for 2018 of $753.0 million primarily related to net proceeds of $495.4 million from the issuance
of the Series D and E Preferred Shares,  net inflows of $218.2 million from our credit facilities, which were principally
used to fund new business and acquisitions,  $55.4 million of inflows in respect of contributions by noncontrolling
interests, partially offset by dividends paid on preferred shares of $12.1 million and $3.9 million in dividends paid to
noncontrolling interests.

85

Table of Contents

Investable Assets

We define investable assets as the sum of total investments, cash and cash equivalents, restricted cash and
cash equivalents and funds held. Investable assets were $14.7 billion as of December 31, 2019 as compared to $12.5
billion as of December 31, 2018, an increase of 16.9%. The increase was primarily due to the investments and funds
held balance acquired in relation to the Morse TEC, Zurich, Maiden Re Bermuda, Amerisure and the AmTrust RITC
transactions.

For  information  regarding  our  investment  strategy,  portfolio  and  results,  refer  to  "Item 7.  Management’s

Discussion and Analysis of Financial Condition and Results of Operations - Investments".

Included within our investable assets we had funds held - directly managed as of December 31, 2019 and 2018,
of $1,187.6 million and $1,198.2 million, respectively. Our funds held - directly managed is carried on our consolidated
balance sheets at fair value. For further information regarding our funds held - directly managed, refer to Note 6 -
"Investments" in the notes to our consolidated financial statements included within Item 8 of this Annual Report on
Form 10-K.

In addition, as of December 31, 2019 and 2018, we had funds held by ceding companies of $408.7 million and

$321.3 million, respectively, which are carried at cost with a fixed crediting rate.

For information regarding credit risk, refer to "Item 7A. Quantitative and Qualitative Disclosures About Market

Risk - Credit Risk - Funds Held" of this Annual Report on Form 10-K. 

Reinsurance Balances Recoverable on Paid and Unpaid Losses

As of December 31, 2019 and 2018, we had reinsurance balances recoverable on paid and unpaid losses of
$2,379.9 million and $2,029.7 million, respectively. The increase is primarily related to the AmTrust RITC transactions.

Our  insurance  and  reinsurance  run-off  subsidiaries  and  portfolios,  prior  to  acquisition,  used  retrocessional
agreements to reduce their exposure to the risk of insurance and reinsurance assumed. On an annual basis, both
Atrium and StarStone purchase a tailored outwards reinsurance program designed to manage their risk profiles. The
majority of Atrium’s and StarStone's third-party reinsurance cover is with highly rated reinsurers or is collateralized by
letters of credit.

We remain liable to the extent that retrocessionaires do not meet their obligations under these agreements, and
therefore, we evaluate and monitor concentration of credit risk among our reinsurers. Provisions are made for amounts
considered potentially uncollectible. 

For further information regarding our reinsurance balances recoverable on paid and unpaid losses, refer to Note
8  -  "Reinsurance  Balances  Recoverable  on  Paid  and  Unpaid  Losses"  in  the  notes  to  our  consolidated  financial
statements included within Item 8 of this Annual Report on Form 10-K. 

Debt Obligations

We utilize debt financing and loan facilities primarily for acquisitions and significant new business, and, from
time to time, for general corporate purposes. For information regarding our debt arrangements, including our loan
covenants, refer to Note 15 - "Debt Obligations and Credit Facilities" in the notes to our consolidated financial statements
included within Item 8 of this Annual Report on Form 10-K. Our debt obligations as of December 31, 2019 and 2018
were $1,191.2 million and $861.5 million, respectively, as detailed in the below table: 

Facility

4.50% Senior Notes due 2022

4.95% Senior Notes due 2029

Total Senior Notes

EGL Revolving Credit Facility

2018 EGL Term Loan Facility

Total debt obligations

Origination Date

Term

2019

2018

March 10, 2017

5 years

$

348,616 $

348,054

May 28, 2019

10 years

August 16, 2018

December 27, 2018

5 years

3 years

493,600

842,216

—

348,991

$

1,191,207 $

—

348,054

15,000

498,485

861,539

86

Table of Contents

On March 10, 2017, we issued the 2022 Senior Notes for an aggregate principal amount of $350.0 million. The
2022  Senior  Notes  pay  4.5%  interest  semi-annually  and  mature  on  March  10,  2022. The  2022  Senior  Notes  are
unsecured  and  unsubordinated  obligations  that  rank  equal  to  any  of  our  other  unsecured  and  unsubordinated
obligations,  senior  to  any  future  obligations  that  are  expressly  subordinated  to  the  2022  Senior  Notes,  effectively
subordinated to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness,
and structurally subordinated to all liabilities of our subsidiaries.

On May 28, 2019, we issued the 2029 Senior Notes for an aggregate principal amount of $500.0 million. The
2029 Senior Notes pay 4.95% interest semi-annually and mature on June 1, 2029. The 2029 Senior Notes are unsecured
and unsubordinated obligations that rank equal to any of our other unsecured and unsubordinated obligations, senior
to any future obligations that are expressly subordinated to the 2029 Senior Notes, effectively subordinate to any of
our  secured  indebtedness  to  the  extent  of  the  value  of  the  assets  securing  such  indebtedness,  and  contractually
subordinate to all liabilities of our subsidiaries.

On August 16, 2018, we and certain of our subsidiaries, as borrowers and guarantors, entered into a new five-
year unsecured $600.0 million revolving credit agreement. The credit agreement expires in August 2023 and we have
the option to increase the commitments under the facility by up to an aggregate of $400.0 million, subject to the terms
of the agreement. Borrowings under the facility will bear interest at a rate based on the Company's long term senior
unsecured debt ratings. In connection with our entry into the credit agreement described above, we terminated and
fully repaid our previous revolving credit agreement. As of December 31, 2019, we were permitted to borrow up to an
aggregate of $600.0 million under the facility. As of December 31, 2019, there was $600.0 million of available unutilized
capacity under this facility. We are in compliance with the covenants of the facility. Subsequent to December 31, 2019,
we utilized $5.0 million and repaid $nil, bringing the unutilized capacity under this facility to $595.0 million. 

On December 27, 2018, we entered into and fully utilized a three-year $500.0 million unsecured term loan (the
"2018 EGL Term Loan Facility"). Interest is payable at least every three months at the London Interbank Offered Rate
("LIBOR") or the alternate base rate ("ABR") plus a margin set forth in the agreement. In the event of default, the
interest  rate  may  increase  and  the  agent  may,  and  at  the  request  of  the  required  lenders  shall,  cancel  lender
commitments  and  demand  early  repayment.  The  proceeds  were  partially  used  to  fund  the  acquisition  of  Maiden
Reinsurance North America, Inc. We repaid $50.0 million outstanding under the 2018 EGL Term Loan Facility using
some of the proceeds from the issuance of our 2029 Senior Notes in May 2019 and repaid an additional $100.0 million
in September 2019 using available funds on hand. There is $349.0 million outstanding on this loan, which includes
unamortized issuance costs of $1.0 million as of December 31, 2019. 

Financial and business covenants imposed on us, in relation to our revolving credit facility and our term loan
credit facility include certain limitations on mergers and consolidations, acquisitions, indebtedness and guarantees,
restrictions as to dispositions of stock and assets, and limitations on liens. Generally, the financial covenants require
us to maintain a gearing ratio of consolidated indebtedness to total capitalization of not greater than 0.35 to 1.0 and
to maintain a consolidated net worth of not less than the aggregate of (i) $2.3 billion, (ii) 50% of net income available
for distribution to the Company's ordinary shareholders at any time after August 16, 2018, and (iii) 50% of the proceeds
of any common stock issuance made after August 16, 2018. In addition, we must maintain eligible capital in excess
of the enhanced capital requirement imposed on us by the Bermuda Monetary Authority pursuant to the Insurance
(Group Supervision) Rules 2011 of Bermuda. We are in compliance with these covenants.

Unsecured Letters of Credit

We utilize unsecured letters of credit to support our insurance and reinsurance performance obligations. 

Funds at Lloyd's

We have an unsecured letter of credit agreement for Funds at Lloyd's ("FAL Facility") to issue up to $375.0 million
of letters of credit, with provision to increase the facility by an additional $25.0 million up to an aggregate amount of
$400.0 million, subject to lenders approval. On November 6, 2019, we amended and restated the FAL Facility to extend
its term by one year. The FAL Facility is available to satisfy our Funds at Lloyd's requirements and expires in 2022. As
of December 31, 2019, our combined Funds at Lloyd's were comprised of cash and investments of $639.3 million and
unsecured letters of credit of $252.0 million.

87

Table of Contents

$120.0 million Letter of Credit Facility

We use this facility to support certain reinsurance collateral obligations of our subsidiaries. On December 6,
2019, we reduced the facility size from $170.0 million to $120.0 million. Pursuant to the facility agreement, we have
the option to increase commitments under the facility by an additional $60.0 million. As of December 31, 2019 and
December 31, 2018, we had issued an aggregate amount of letters of credit under this facility of $115.3 million and
$78.4 million, respectively. 

$760.0 million Letter of Credit Facility 

During  2019,  we  entered  into  an  unsecured  $760.0  million  letter  of  credit  facility  agreement,  most  recently
amended on December 9, 2019. We may increase the commitments by an aggregate amount of $40.0 million. The
facility is used to post letters of credit to collateralize reinsurance performance obligations to various parties, including
$445.0 million relating to the reinsurance transaction with Maiden Re Bermuda, as described in Note 4 - "Significant
New Business". As of December 31, 2019, we had issued an aggregate amount of letters of credit under this facility
of $608.0 million.  

88

Table of Contents

Contractual Obligations

The following table summarizes, as of December 31, 2019, our future payments under contractual obligations
and estimated payments for losses and LAE and policy benefits by expected payment date. The table excludes short-
term liabilities and includes only obligations that are expected to be settled in cash.  

Total

Less than
1 Year

1 - 3
years

3 - 5
years

6 - 10
years

More than
10 Years

(in millions of U.S. dollars)

Operating Activities

Estimated gross reserves for losses and
LAE (1)

Asbestos

Environmental

General Casualty

Workers' compensation/personal
accident

Marine, aviation and transit
Construction defect

Professional indemnity/ Directors &
Officers

Motor

Property

Other

$ 1,916.4 $
343.3

991.0

2,248.3

411.6

128.1

959.3

714.5

204.2

435.8

166.5 $

287.4 $

237.0 $

377.6 $

38.5

215.7

189.7

125.7

35.3

236.2

197.5

83.9

114.1

66.2

263.1

305.5

130.0

46.5

300.5

190.8

68.7

93.1

53.0

199.6

356.6

60.1

22.8

75.5

195.3

502.7

51.6

13.9

156.2

145.0

88.3

25.3

57.4

88.5

16.0

71.0

847.9

110.1

117.3

893.8

44.2

9.6

121.4

149.4

10.3

100.2

Total Non-Life Run-off

8,352.5

1,403.1

1,751.8

1,256.3

1,537.1

2,404.2

Atrium

StarStone

Other

ULAE

225.7

1,851.1

23.1

362.3

88.7

644.4

3.4

64.1

82.0

664.2

9.3

81.3

33.1

273.9

4.2

51.9

18.3

191.7

4.2

62.4

3.6

76.9

2.0

102.6

Estimated gross reserves for losses and
LAE (1)

10,814.7

2,203.7

2,588.6

1,619.4

1,813.7

2,589.3

Operating lease obligations

105.6

29.3

47.9

13.6

12.7

2.1

Investing Activities

Investment commitments to private
equity funds, CLO equity funds and real
estate debt fund

Investment commitments to equity
method investments

Financing Activities

Loan repayments (including estimated
interest payments)

Total

482.3

185.8

155.0

141.5

93.1

93.1

—

—

—

—

—

—

1,505.8

—
$13,001.5 $ 2,566.7 $ 3,580.7 $ 1,825.0 $ 2,437.7 $ 2,591.4

789.2

611.3

54.8

50.5

(1) The reserves for losses and LAE represent management’s estimate of the ultimate cost of settling losses. The estimation of losses is based on
various complex and subjective judgments. Actual losses paid may differ, perhaps significantly, from the reserve estimates reflected in our financial
statements. Similarly, the timing of payment of our estimated losses is not fixed and there may be significant changes in actual payment activity.
The assumptions used in estimating the likely payments due by period are based on our historical claims payment experience and industry
payment patterns, but due to the inherent uncertainty in the process of estimating the timing of such payments, there is a risk that the amounts
paid in any such period can be significantly different from the amounts disclosed above. The amounts in the above table represent our estimates
of known liabilities as of December 31, 2019 and do not take into account corresponding reinsurance recoverable amounts that would be due to
us. Furthermore, certain of the reserves included in the audited consolidated financial statements as of December 31, 2019 were acquired by
us and initially recorded at fair value with subsequent amortization, whereas the expected payments by period in the table above are the estimated
payments at a future time and do not reflect the fair value adjustment in the amount payable.

89

  
Table of Contents

In addition to the contractual obligations in the table above, we also have the right to purchase the redeemable
noncontrolling interests ("RNCI") from the RNCI holders at certain times in the future (each such right, a "call right")
and the RNCI holders have the right to sell their RNCI interests to us at certain times in the future (each such right, a
"put right"). The RNCI rights are described in Note 21 - "Related Party Transactions" in the notes to our consolidated
financial statements included within Item 8 of this Annual Report on Form 10-K.

For information relating to our commitments and contingencies, see Note 23 - "Commitments and Contingencies"
in the notes to our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K. For
information relating to our defendant asbestos and environmental liabilities, see Note 11 - "Defendant Asbestos and
Environmental Liabilities" in the notes to our consolidated financial statements included within Item 8 of this Annual
Report on Form 10-K. 

Off-Balance Sheet Arrangements

At December 31, 2019, we did not have any off-balance sheet arrangements, as defined by Item 303(a) (4) of

Regulation S-K.

90

Table of Contents

Critical Accounting Policies

We believe the following accounting policies impact the most significant judgments and estimates used in the

preparation of our financial statements.

Losses and Loss Adjustment Expenses

Non-Life Run-off

The following tables provide a breakdown of gross and net losses and LAE reserves, consisting of Outstanding
Loss Reserve ("OLR") and IBNR by line of business and adjustments for fair value resulting from business combinations,
adjustments for where we elected the fair value option, deferred charge assets and ULAE, as of December 31, 2019
and 2018:

Workers' compensation/personal accident

1,270,530

977,808

2,248,338

Asbestos

Environmental

General casualty

Marine, aviation and transit

Construction defect

Professional indemnity/Directors & Officers

Motor

Property

Other

Fair value adjustments

Fair value adjustments - fair value option

Deferred charge assets on retroactive
reinsurance

ULAE

Total

Asbestos

Environmental

General casualty

Workers' compensation/personal accident

Marine, aviation and transit

Construction defect

Professional indemnity/Directors & Officers

Motor

Property

Other

Fair value adjustments

Fair value adjustments - fair value option
Deferred charge assets on retroactive
reinsurance

ULAE

Total

OLR

Gross

IBNR

2019

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

542,681

$ 1,373,678

$ 1,916,359

$

490,117

$ 1,271,982

$ 1,762,099

187,165

501,863

156,121

489,129

343,286

990,992

290,067

29,772

693,760

480,668

140,620

269,956

121,577

98,312

265,490

233,806

63,604

165,882

411,644

128,084

959,250

714,474

204,224

435,838

173,878

399,396

963,578

244,611

29,245

485,478

317,829

122,010

208,647

142,351

421,426

751,074

100,135

94,888

170,926

165,543

56,450

97,573

316,229

820,822

1,714,652

344,746

124,133

656,404

483,372

178,460

306,220

$

4,407,082

$ 3,945,407

$ 8,352,489

$ 3,434,789

$ 3,272,348

$ 6,707,137

(170,689)

(217,933)

—

331,494

$ 8,295,361

2018

(157,036)

(129,848)

(272,462)

331,494

$ 6,479,285

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

341,544

$ 1,275,476

$ 1,617,020

$

321,356

$ 1,171,754

$ 1,493,110

96,665

500,033

1,454,178

301,783

20,712

603,665

564,307

168,267

220,615

126,035

379,484

832,615

72,888

99,288

216,839

321,992

37,631

165,519

222,700

879,517

93,095

416,097

2,286,793

1,115,116

374,671

120,000

820,504

886,299

205,898

386,134

227,994

19,310

426,020

414,847

160,873

175,289

117,384

298,612

537,782

78,023

94,736

166,898

304,874

36,817

111,453

210,479

714,709

1,652,898

306,017

114,046

592,918

719,721

197,690

286,742

$

4,271,769

$ 3,527,767

$ 7,799,536

$ 3,369,997

$ 2,918,333

$ 6,288,330

(217,527)

(374,752)

—

333,405

$ 7,540,662

91

(203,183)

(244,013)

(86,585)

333,405

$ 6,087,954

Table of Contents

As of December 31, 2019 and 2018, the IBNR reserves (net of reinsurance balances receivable) accounted for
$3,272.3 million, or 48.8%, and $2,918.3 million, or 46.4%, respectively, of our total Non-life Run-off net losses and
LAE, excluding the fair value adjustments, deferred charge assets and ULAE.

Our  primary  objective  in  running  off  the  operations  of  acquired  companies  and  portfolios  of  insurance  and
reinsurance business in run-off is to increase book value by settling loss reserves below their acquired fair value. The
earnings created in each acquired company or portfolio of insurance and reinsurance business, together with the
related decrease in loss reserves, lead to a reduction in the capital required for each company, thereby providing the
ability to distribute both earnings and excess capital to the parent company.

•

•

To the extent that the nature of the acquired loss reserves are conducive to commutation, our aim is to settle
the majority of the acquired loss reserves within a time frame of approximately five to seven years from the
date of acquisition.

To the extent that acquired reserves are not conducive to commutation, we will instead adopt a disciplined
claims management approach to pay only valid claims on a timely basis and endeavor to reduce the level of
acquired LAE provisions by streamlining claims handling procedures.

By adopting either of the above run-off strategies, we would expect that over the targeted life of the run-off,
acquired ultimate loss reserves would settle below their acquired value, resulting in reductions in ultimate losses and
LAE liabilities. There can be no assurance, however, that we will successfully implement our strategy.

Commutations of blocks of policies, along with disciplined claims management, have the potential to produce
favorable claims development compared to established reserves. For each newly-acquired company, we determine
a commutation strategy that broadly identifies commutation targets using the following criteria:

•

•

•

•

•

previous commutations completed by existing portfolio companies with policyholders of the newly-acquired
company;

nature of liabilities;

size of incurred loss reserves;

recent loss development history; and

targets for claims audits.

Once commutation targets are identified, they are prioritized into target years of completion. At the beginning of
each year, the approach to commutation negotiations is determined by the commutation team, including claims and
exposure analysis and broker account reconciliations. On completion of this analysis, settlement parameters are set
around  incurred  liabilities.  Commutation  discussions  can  take  many  months  or  even  years  to  come  to  fruition.
Commutation targets not completed in a particular year are re-prioritized for the following year.

Every commutation, irrespective of value, requires the approval of our senior management. The impact of the
commutation activity on the IBNR reserve is reflected as part of our annual actuarial reviews of reserves. However, if
a significant commutation is completed during the year, loss reserves will be adjusted in the corresponding quarter to
reflect management’s then best estimate of the impact on remaining IBNR reserves.

Commutations provide an opportunity for us to exit exposures to entire policies with insureds and reinsureds for
an agreed upon payment, or payments, often at a discount to the previously estimated ultimate liability. As a result of
exiting all exposures to such policies, all advised case reserves and IBNR reserves relating to the insured or reinsured
are  eliminated. A  commutation  is  recognized  upon  the  execution  of  a  commutation  release  agreement.  Following
completion of a commutation, all the related balances, including insurance and reinsurance balances payable and/or
receivable, funds held by ceding companies, and losses and LAE (including fair value adjustments and estimated
IBNR), are written off with corresponding gain or loss recorded in the net reduction of ultimate losses. A commutation
may result in a net gain irrespective of whether the settlement exceeds the advised case reserves. Advised case
reserves are those reserve estimates for a specific loss or losses reported by either the broker or insured or reinsured.

IBNR reserves are established at a class of business level. A commutation settlement is a negotiated settlement
of both the advised case reserves and an estimate of the IBNR reserves that relate to the policies being commuted.

92

Table of Contents

For latent exposures with a long reporting tail, the estimated level of IBNR reserves may be significantly higher
than the advised case reserves. In such an instance, the commutation settlement of a block of such policies may be
greater than the advised case reserves but less than the aggregate of the advised case reserves plus the estimated
related IBNR reserves, resulting in a total saving on the remaining liability.

On a quarterly basis, we adjust our estimates of ultimate loss and LAE liabilities in the quarter that any significant

commutation is concluded. The agreed commutation settlement is recorded in net losses paid.

To the extent that commuted policies are protected by reinsurance, then we will, on completion of a commutation
with an insured or reinsured, negotiate with the reinsurers to contribute their share of the commutation settlement. Any
amounts received from such reinsurers will be recorded in net losses paid and the impact of any savings or loss on
reinsurance recoverable on unpaid losses will be included in the actuarial reassessment of net ultimate liabilities.

Annual Losses and Loss Adjustment Reviews

Because a significant amount of time can lapse between the assumption of risk, the occurrence of a loss event,
the reporting of the event to an insurance or reinsurance company and the ultimate payment of the claim on the loss
event, the liability for unpaid losses and LAE is based largely upon estimates. On a quarterly basis, our management
must use considerable judgment in the process of developing these estimates. Management reviews the actual loss
development in the quarter and receives input from the actuarial, claims and legal staff on the drivers of any favorable
or unfavorable loss emergence. The liability for unpaid losses and LAE for property and casualty business includes
amounts determined from loss reports on individual cases and amounts for IBNR reserves.

Loss advices or reports from ceding companies are generally provided via the placing broker and comprise

treaty statements, individual claims files, electronic messages and large loss advices or cash calls.

•

•

•

Large loss advices and cash calls are provided to us as soon as practicable after an individual loss or claim
is made or settled by the insured. 

The remaining broker advices are issued monthly, quarterly or annually depending on the provisions of the
individual policies or the ceding company’s practice. 

For certain direct insurance policies where the claims are managed by Third Party Administrators (TPAs) and
Managing General Agents (MGAs), loss bordereaux are received either monthly or quarterly depending on
the arrangement with the TPA and MGA. Loss advices for direct insurance policies may be received from the
broker, agent or directly from the insured. 

Where we provide reinsurance or retrocession reinsurance protection, the process of claims advice from the
direct  insurer  to  the  reinsurers  and/or  retrocessionaires  naturally  involves  more  levels  of  communication,  which
inevitably creates delays or lags in the receipt of loss advice by the reinsurers/retrocessionaires relative to the date of
first advice to the direct insurer. Certain types of exposure, typically latent health exposures such as asbestos-related
claims,  have  inherently  long  reporting  delays,  in  some  cases  many  years,  from  the  date  a  loss  occurred  to  the
manifestation and reporting of a claim and ultimately until the final settlement of the claim. 

An  industry-wide  weakness  in  cedant  reporting  affects  the  adequacy  and  accuracy  of  reserving  for  advised

claims. We attempt to mitigate this inherent weakness as follows:

• We closely monitor cedant loss reporting and, for those cedants identified as providing inadequate, untimely
or unusual reporting of losses, we conduct, in accordance with the provisions of the insurance and reinsurance
contracts, detailed claims audits at the insured’s or reinsured’s premises. Such claims audits have the benefit
of validating advised claims, determining whether the cedant’s loss reserving practices and reporting are
adequate and identifying potential loss reserving issues of which our actuaries need to be made aware. Any
required adjustments to advised claims reserves reported by cedants identified during the claims audits will
be recorded as an adjustment to the advised case reserve.

• Onsite claims audits are often supplemented by further reviews by our internal and external legal advisors
to determine the reasonableness of advised case reserves and, if considered necessary, an adjustment to
the reported case reserve will be recorded.

• Our actuaries project expected paid and incurred loss development for each class of business, which is
monitored on a quarterly basis. Should actual paid and incurred development differ significantly from the
expected paid and incurred development, we will investigate the cause and, in conjunction with our actuaries,
consider whether any adjustment to total loss reserves is required.

93

Table of Contents

• Our actuaries consider the quality of ceding company data as part of their ongoing evaluation of the liability
for ultimate losses and LAE, and the methodologies they select for estimating ultimate losses inherently
compensate for potential weaknesses in this data, including weaknesses in loss reports provided by cedants.

We strive to apply the highest standards of discipline and professionalism to our claims adjusting, processing
and settlement, and disputes with cedants are rare. However, we are from time to time involved in various disputes
and  legal  proceedings  in  the  ordinary  course  of  our  claims  adjusting  process.  We  are  often  involved  in  disputes
commenced by other co-insurers who act in unison with any litigation or dispute resolution controlled by the lead
underwriter. Coverage disputes arise when the insured/reinsured and insurer/reinsurer cannot reach agreement as to
the interpretation of the policy and/or application of the policy to a claim. Most insurance and reinsurance policies
contain dispute resolution clauses requiring arbitration or mediation. In the absence of a contractual dispute resolution
process, civil litigation would be commenced. We aim to reach a commercially acceptable resolution to any dispute,
using arbitration or litigation as a last resort. We regularly monitor and provide internal reports on disputes involving
arbitration  and  litigation  and  engage  external  legal  counsel  to  provide  professional  advice  and  assist  with  case
management.

In establishing reserves, management includes amounts for IBNR reserves using information from the actuarial
estimates of ultimate losses. We use generally accepted actuarial methodologies to estimate ultimate losses and LAE
and those estimates are reviewed by our management. On an annual basis, independent actuarial firms are retained
by management to provide their estimates of ultimate losses and to review the estimates developed by our actuaries.

Nearly all of our unpaid claims liabilities are considered to have a long claims payout tail. Net loss reserves,
excluding the fair value adjustments, deferred charge assets and ULAE, for our non-life run-off subsidiaries relate
primarily to casualty exposures, including latent claims, of which 31.0% in 2019 (2018: 27.1%) relate to asbestos and
environmental ("A&E") exposures.

Within the annual loss reserve studies produced by either our actuaries or independent actuaries, exposures
for each subsidiary are separated into homogeneous reserving categories for the purpose of estimating IBNR. Each
reserving category contains either direct insurance or assumed reinsurance reserves and groups relatively similar
types of risks and exposures (for example, asbestos, environmental, casualty, property) and lines of business written
(for example, marine, aviation, non-marine). Based on the exposure characteristics and the nature of available data
for each individual reserving category, a number of methodologies are applied. Recorded reserves for each category
are selected from the actuarial indications produced by the various methodologies after consideration of exposure
characteristics, data limitations and strengths and weaknesses of each method applied. This approach to estimating
IBNR has been consistently adopted in the annual loss reserve studies for each period presented.

Our  management,  through  the  loss  reserving  committees,  considers  the  reasonableness  of  loss  reserves
recommended by our actuaries, including actual loss development during the year, using the following reports produced
internally on a quarterly basis for each of our insurance and reinsurance subsidiaries:

• Gross, ceded and net incurred loss report - This report provides, for each reporting period, the total (including
commuted policies) gross, ceded and net incurred loss development for each company and a commentary
on each company’s loss development. The report highlights the causes of any unusual or significant loss
development activity (including commutations).

•

•

•

Actual versus expected gross incurred loss development schedule - This schedule provides a summary,
and commentary thereon, of each company’s (excluding companies or portfolios of business acquired in
the current year) non-commuted incurred gross losses compared to the estimate of the development of non-
commuted incurred gross losses provided by our actuaries at the beginning of the year as part of the prior
year’s reserving process.

Commutations summary schedule - This schedule summarizes all commutations completed during the year
for all companies, and identifies the policyholder with which we commuted, the incurred losses settled by
the  commutation  (comprising  outstanding  unpaid  losses  and  case  reserves)  and  the  amount  of  the
commutation settlement.

Analysis  of  paid,  incurred  and  ultimate  losses  - This  analysis  for  each  company,  and  in  the  aggregate,
provides a summary of the gross, ceded and net paid and incurred losses and the impact of applying our
actuaries’  recommended  loss  reserves.  This  report,  reviewed  in  conjunction  with  the  previous  reports,
provides an analytical tool to review each company’s incurred loss or gain and reduction in IBNR reserves
to assess whether the ultimate reduction in loss reserves appears reasonable in light of known developments
within each company.

94

Table of Contents

The above reports provide management with the relevant information to determine whether loss development
(including commutations) during the year has, for each company, been sufficiently meaningful so as to warrant an
adjustment to the reserves recommended by our actuaries in the most recent actuarial study.

When establishing loss reserves we have an expectation that, in the absence of commutations and significant
favorable or unfavorable non-commuted loss development compared to expectations, loss reserves will not exceed
the high, or be less than the low, end of the following ranges of gross losses and LAE reserves implied by the various
methodologies used by each of our insurance subsidiaries as of December 31, 2019.

The range of gross loss and LAE reserves implied by the various methodologies used by each of our insurance
and reinsurance subsidiaries as of December 31, 2019 and December 31, 2018 is presented in the following table
("Range of Outcomes"):

Asbestos

Environmental

General casualty

2019

2018

Low

Selected

High

Low

Selected

High

(in thousands of U.S. dollars)

$ 1,639,077 $ 1,916,359 $ 2,447,051 $ 1,384,890 $ 1,617,020 $ 1,931,409

296,253

875,288

343,286

413,991

990,992

1,116,946

184,749

803,851

222,700

879,517

267,159

976,457

Workers' compensation/personal accident

1,983,940

2,248,338

2,555,782

2,063,005

2,286,793

2,577,116

Marine, aviation and transit

Construction defect

Professional indemnity/Directors &
Officers

Motor

Property

Other

368,090

112,549

876,445

633,338

184,028

380,793

411,644

128,084

480,875

145,253

959,250

1,062,111

714,474

204,224

435,838

800,217

226,688

520,909

338,318

107,126

758,021

806,731

192,869

346,674

374,671

120,000

820,504

886,299

205,898

386,134

419,911

139,129

910,718

951,734

225,013

428,904

7,349,801

8,352,489

9,769,823

6,986,234

7,799,536

8,827,550

Fair value adjustments

(147,158)

(170,689)

(194,310)

(198,969)

(217,527)

(239,227)

Fair value adjustments - fair value option

(190,549)

(217,933)

(265,609)

(329,874)

(374,752)

(420,609)

ULAE

Total

291,696

331,494

385,762

296,704

333,405

373,360

$ 7,303,790 $ 8,295,361 $ 9,695,666 $ 6,754,095 $ 7,540,662 $ 8,541,074

Quarterly Reserve Reviews

In addition to an in-depth annual review, we also perform quarterly reserve reviews. This is done by examining
quarterly paid and incurred loss development to determine whether it is consistent with reserves established during
the preceding annual reserve review and with expected development. Loss development is reviewed separately for
each major exposure type (e.g., asbestos, environmental, etc.), for each of our relevant subsidiaries, and for large
"wholesale" commutation settlements versus "routine" paid and advised losses. This process is undertaken to determine
whether loss development experience during a quarter warrants any change to held reserves.

Loss development is examined separately by exposure type because different exposures develop differently
over time. For example, the expected reporting and payout of losses for a given amount of asbestos reserves can be
expected  to  take  place  over  a  different  time  frame  and  in  a  different  quarterly  pattern  from  the  same  amount  of
environmental reserves.

In addition, loss development is examined separately for each of our relevant subsidiaries. Companies can differ
in their exposure profile due to the mix of insurance versus reinsurance, the mix of primary versus excess insurance,
the  underwriting  years  of  participation  and  other  criteria. These  differing  profiles  lead  to  different  expectations  for
quarterly and annual loss development by company.

Our  quarterly  paid  and  incurred  loss  development  is  often  driven  by  large,  wholesale  settlements -  such  as
commutations  and  policy  buy-backs -  which  settle  many  individual  claims  in  a  single  transaction.  This  allows  for
monitoring of the potential profitability of large settlements, which, in turn, can provide information about the adequacy
of reserves on remaining exposures that have not yet been settled. 

95

Table of Contents

•

•

For example, if it were found that large settlements were consistently leading to large negative, or favorable,
incurred losses upon settlement, it might be an indication that reserves on remaining exposures are redundant.

Conversely, if it were found that large settlements were consistently leading to large positive, or adverse,
incurred losses upon settlement, it might be an indication—particularly if the size of the losses were increasing
—that certain loss reserves on remaining exposures are deficient.

Moreover, removing the loss development resulting from large settlements allows for a review of loss development
related only to those contracts that remain exposed to losses. Were this not done, it is possible that savings on large
wholesale settlements could mask significant underlying development on remaining exposures.

Once the data has been analyzed as described above, an in-depth review is performed on classes of exposure
with  significant  loss  development.  Discussions  are  held  with  appropriate  personnel,  including  individual  company
managers, claims handlers and attorneys, to better understand the causes. If it were determined that development
differs significantly from expectations, reserves would be adjusted.

As described above, our management regularly reviews and updates reserve estimates using the most current
information available and employing various actuarial methods. Adjustments resulting from changes in our estimates
are recorded in the period when such adjustments are determined. The ultimate liability for losses and LAE is likely
to differ from the original estimate due to a number of factors, primarily consisting of the overall claims activity occurring
during any period, including the completion of commutations of assumed liabilities and ceded reinsurance receivables,
policy buy-backs and general incurred claims activity.

Loss Reserving (All Classes, except Latent Claims)

For our "All Other" (non-latent) loss exposure, including workers' compensation, our actuaries apply a range of
traditional loss development extrapolation techniques. These methods assume that cohorts, or groups, of losses from
similar  exposures  will  increase  over  time  in  a  predictable  manner.  Historical  paid,  incurred,  and  outstanding  loss
development experience is examined for earlier years to make inferences about how later years’ losses will develop.
The application and consideration of multiple methods is consistent with the Actuarial Standards of Practice.

When determining which loss development extrapolation methods to apply to each company and each class of
exposure within each company, we consider the nature of the exposure for each specific subsidiary and reserving
segment and the available loss development data, as well as the limitations of that data. In cases where company-
specific loss development information is not available or reliable, we select methods that do not rely on historical data
(such as incremental or run-off methods) and consider industry loss development information published by industry
sources such as the Reinsurance Association of America. In determining which methods to apply, we also consider
cause of loss coding information when available.

A brief summary of the methods that are considered most frequently in analyzing non-latent exposures is provided
below. This summary discusses the strengths and weaknesses of each method, as well as the data requirements for
each method, all of which are considered when selecting which methods to apply for each reserve segment.

1. Cumulative Reported and Paid Loss Development Methods.    The Cumulative Reported (Case Incurred)
Loss Development method relies on the assumption that, at any given state of maturity, ultimate losses can be predicted
by multiplying cumulative reported losses (paid losses plus case reserves) by a cumulative development factor. The
validity of the results of this method depends on the stability of claim reporting and settlement rates, as well as the
consistency of case reserve levels. Case reserves do not have to be adequately stated for this method to be effective;
they  only  need  to  have  a  fairly  consistent  level  of  adequacy  at  all  stages  of  maturity.  Historical  "age-to-age"  loss
development factors ('LDFs') are calculated to measure the relative development of an accident year from one maturity
point to the next. Age-to-age LDFs are then selected based on these historical factors. The selected age-to-age LDFs
are used to project the ultimate losses. The Cumulative Paid Loss Development Method is mechanically identical to
the Cumulative Reported Loss Development Method described above, but the paid method does not rely on case
reserves or claim reporting patterns in making projections. The validity of the results from using a cumulative loss
development approach can be affected by many conditions, such as internal claim department processing changes,
a shift between single and multiple payments per claim, legal changes, or variations in a company’s mix of business
from year to year. Typically, the most appropriate circumstances in which to apply a cumulative loss development
method are those in which the exposure is mature, full loss development data is available, and the historical observed
loss development is relatively stable.

96

Table of Contents

2. Incremental Reported and Paid Loss Development Methods.    Incremental incurred and paid analyses are
performed in cases where cumulative data is not available. The concept of the incremental loss development methods
is similar to the cumulative loss development methods described above, in that the pattern of historical paid or incurred
losses is used to project the remaining future development. The difference between the cumulative and incremental
methods is that the incremental methods rely on only incremental incurred or paid loss data from a given point in time
forward, and do not require full loss history. These incremental loss development methods are therefore helpful when
data limitations apply. While this versatility in the incremental methods is a strength, the methods are sensitive to
fluctuations in loss development, so care must be taken in applying them.

3. IBNR-to-Case Outstanding Method.    This method requires the estimation of consistent cumulative paid and
reported (case) incurred loss development patterns and age-to-ultimate LDFs, either from data that is specific to the
segment being analyzed or from applicable benchmark or industry data. These patterns imply a specific expected
relationship between IBNR, including both development on known claims (bulk reserve) and losses on true late reported
claims, and reported case incurred losses. The IBNR-to-Case Outstanding method can be used in a variety of situations.
It is appropriate for loss development experience that is mature and possesses a very high ratio of paid losses to
reported case incurred losses. The method also permits an evaluation of the difference in maturity between the business
being reviewed and benchmark development patterns. Depending on the relationship of paid to incurred losses, an
estimate of the relative maturity of the business being reviewed can be made and a subsequent estimate of ultimate
losses driven by the implied IBNR to case outstanding ratio at the appropriate maturity can be made. This method is
also useful where loss development data is incomplete and only the case outstanding amounts are determined to be
reliable. This method is less reliable in situations where relative case reserve adequacy has been changing over time.

4. Bornhuetter-Ferguson Expected Loss Projection Reported and Paid Methods.    The Bornhuetter-Ferguson
Expected Loss Projection Method based on reported loss data relies on the assumption that remaining unreported
losses are a function of the total expected losses rather than a function of currently reported losses. The expected
losses used in this analysis are based on initial selected ultimate loss ratios by year. The expected losses are multiplied
by the unreported percentage to produce expected unreported losses. The unreported percentage is calculated as
one minus the reciprocal of the selected cumulative incurred LDFs. Finally, the expected unreported losses are added
to  the  current  reported  losses  to  produce  ultimate  losses.  The  calculations  underlying  the  Bornhuetter-Ferguson
Expected Loss Projection Method based on paid loss data are similar to the Bornhuetter-Ferguson calculations based
on reported losses, with the exception that paid losses and unpaid percentages replace reported losses and unreported
percentages. The Bornhuetter-Ferguson method is most useful as an alternative to other models for immature years.
For these immature years, the amounts reported or paid may be small and unstable and therefore not predictive of
future development. Therefore, future development is assumed to follow an expected pattern that is supported by more
stable historical data or by emerging trends. This method is also useful when changing reporting patterns or payment
patterns distort historical development of losses. Similar to the loss development methods, the Bornhuetter-Ferguson
method may be applied to loss and ALAE on a combined or separate basis. The Bornhuetter-Ferguson method may
not be appropriate in circumstances where the liabilities being analyzed are very mature, as it is not sensitive to the
remaining amount of case reserves outstanding, or the actual development to date.

5. Reserve Run-off Method.    This method first projects the future values of case reserves for all underwriting
years to future ages of development. This is done by selecting a run-off pattern of case reserves. The selected case
run-off ratios are chosen based on the observed run-off ratios at each age of development. Once the ratios have been
selected, they are used to project the future values of case reserves. A paid on reserve factor is selected in a similar
way. The ratios of the observed amounts paid during each development period to the respective case reserves at the
beginning of the periods are used to estimate how much will be paid on the case reserves during each development
period. These paid on reserve factors are then applied to the case reserve amounts that were projected during the
first phase of this method. A summation of the resulting paid amounts yields an estimate of the liability. The Reserve
Run-off Method works well when the historical run-off patterns are reasonably stable and when case reserves ultimately
show a decreasing trend. Another strength of this method is that it only requires case reserves at a given point in time
and incremental paid and incurred losses after that point, meaning that it can be applied in cases where full loss history
is not available. In cases of volatile data where there is a persistent increasing trend in case reserves, this method will
fail to produce a reasonable estimate. In several cases, reliance upon this method was limited due to this weakness.

97

Table of Contents

Our actuaries select the appropriate loss development extrapolation methods to apply to each company and
each class of exposure, and then apply these methods to calculate an estimate of ultimate losses. Our management,
which  is  responsible  for  the  final  estimate  of  ultimate  losses,  reviews  the  calculations  of  our  actuaries,  considers
whether  the  appropriate  method  was  applied,  and  adjusts  the  estimate  of  ultimate  losses  as  it  deems  necessary.
Historically, we have not deviated from the recommendations of our actuaries. Paid-to-date losses are then deducted
from the estimate of ultimate losses to arrive at an estimated total loss reserve, and reported outstanding case reserves
are then deducted from estimated total loss reserves to calculate the estimated IBNR reserve.

Loss Reserving (Latent Claims)

Asbestos Claims

Asbestos continues to be the most significant and difficult mass tort for the insurance industry in terms of claims
volume, legal expense and indemnity payments. In the United States, asbestos-related lawsuits emerged in the early
1970s, accelerated through the 1980s and continue today, nearly fifty years after the first significant lawsuit against
an asbestos manufacturer. A unique feature of U.S. asbestos litigation is that a plaintiff will identify numerous defendants,
often over 50, in a lawsuit, creating additional expense to defend the suit. Asbestos lawsuits have led to many of the
traditional defendants filing for bankruptcy. We believe the insurance industry has been adversely affected by judicial
interpretations  that  have  had  the  effect  of  maximizing  insurance  recoveries  from  both  a  coverage  and  liability
perspective.

A number of our subsidiaries, and counterparties who wrote portfolios we assumed, have exposure to bodily
injury claims from alleged exposure to asbestos. The United States asbestos exposure arises mainly from general
liability insurance policies underwritten prior to 1986, which our subsidiaries or counterparties either wrote directly, on
a primary or excess basis, or as reinsurance. Our United Kingdom asbestos exposures emanates from Employers
Liability insurance policies. Asbestos bodily injury claims differ from other bodily injury claims due to the long latency
period for asbestos, which often triggers a policyholder’s coverage over multiple policy periods. The long latency period,
combined with the lack of clear judicial precedent with respect to coverage interpretations and expanded theories of
liability, increase the uncertainty of the asbestos claim reserve estimates.

The  following  table  provides  a  reconciliation  of  our  gross  and  net  loss  and  ALAE  reserves  from  asbestos

exposures and the movement in gross and net reserves for the years ended December 31, 2019 and 2018:

Balance as at January 1

Less: reinsurance reserves recoverable

Net balance as at January 1

Total net incurred losses and LAE

Total net paid losses

Effect of exchange rate movement

Acquired on purchase of subsidiaries

Assumed business

Ceded business

Net balance as at December 31

Plus: reinsurance reserves recoverable

Balance as at December 31

2019

2018

(in thousands of U.S. dollars)

$

$

1,617,020 $
123,910

1,493,110

6,811
(118,557)
37,249

—

382,474
(38,988)
1,762,099

154,260
1,916,359 $

1,801,044

122,222

1,678,822
(64,949)
(108,248)
(70,084)
7,569

50,000

—

1,493,110

123,910

1,617,020

The liability for unpaid losses and ALAE for asbestos reserves reflects our best estimate for future amounts
needed to pay losses and related ALAE as of each of the balance sheet dates reflected in the financial statements
herein in accordance with U.S. GAAP. As of December 31, 2019 and 2018, the net loss reserves for asbestos-related
claims comprised 26.3% and 23.7%, respectively, of total non-life run-off net reserves for losses and LAE liabilities
excluding the fair value adjustments, deferred charge assets and ULAE. In addition, we also have defendant asbestos
liabilities, as described in Note 11 - "Defendant Asbestos and Environmental Liabilities" in the notes to our consolidated
financial statements included within Item 8 of this Annual Report on Form 10-K.

98

Table of Contents

Environmental Claims

Environmental pollution claims represent another exposure where we believe the insurance industry has been
adversely  affected  by  various  legislative  changes  and  judicial  interpretations.  Unlike  asbestos  claims  which  are
generated primarily from injured individuals, environmental claims generally result from state or federal government
activities  initiated  against  a  commercial  enterprise.  The  most  well-known  legislation,  passed  in  1980,  is  the
Comprehensive Environmental Restoration, Compensation and Liability Act (“CERCLA”, also known as Superfund).
CERCLA imposed strict and retroactive liability on potentially responsible parties (“PRP”), which expanded in the court
system to be interpreted as joint and several liability. 

Our subsidiaries and counterparties who wrote portfolios we assumed have exposure to environmental claims
from general liability insurance policies written prior to the mid-1980s, that were not specifically written to cover damage
to the environment from gradual releases of pollutants. Similar to asbestos, there is additional uncertainty with respect
to  environmental  reserves  as  compared  to  other  general  liability  exposures. This  added  uncertainty  is  due  to  the
multiple policy periods and allocation of claims to policy years, number of solvent PRPs at any site, ultimate cost of
the remediation, the number of ultimate sites and changes to judicial precedence.

The following table provides a reconciliation of our gross and net loss and ALAE reserves from environmental

exposures and the movement in gross and net reserves for the years ended December 31, 2019 and 2018:

Balance as at January 1

Less: reinsurance reserves recoverable

Net balance as at January 1

Total net incurred losses and LAE

Total net paid losses

Effect of exchange rate movement

Acquired on purchase of subsidiaries

Assumed business

Ceded business

Net balance as at December 31

Plus: reinsurance reserves recoverable

Balance as at December 31

2019

2018

(in thousands of U.S. dollars)

$

222,700 $

12,221

210,479

14,988
(16,899)
(3,615)
—

124,009
(12,733)
316,229

27,057

$

343,286 $

191,060

6,666

184,394

14,153
(21,273)
(320)
13,525

20,000

—

210,479

12,221

222,700

The liability for unpaid losses and ALAE, for environmental reserves, reflects our best estimate for future amounts
needed to pay losses and related ALAE as of each of the balance sheet dates reflected in the financial statements
herein in accordance with U.S. GAAP. As of December 31, 2019 and 2018, the net loss reserves for environmental
pollution-related claims comprised 4.7% and 3.3%, respectively, of total non-life run-off net reserves for losses and
LAE  excluding  the  fair  value  adjustments,  deferred  charge  assets  and  ULAE.    In  addition,  we  also  have  direct
environmental liabilities, as described in Note 11 - "Defendant Asbestos and Environmental Liabilities" in the notes to
our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K.

Asbestos and Environmental Reserving

The ultimate losses from asbestos and environmental claims cannot be estimated using traditional actuarial
reserving techniques that extrapolate losses to an ultimate basis using loss development. Claims are spread across
multiple policy years based on the still evolving case law in each jurisdiction, making historical development patterns
unreliable to forecast the future claim payments. There can be no assurance that the reserves we establish will be
adequate or not be adversely affected by the development of other latent exposures.

99

Table of Contents

We use a variety of methodologies to estimate the appropriate IBNR reserves required for our asbestos and
environmental exposures. We estimate the IBNR reserves separately for each of our subsidiaries in order to apply the
appropriate methodologies and assumptions to match the distinct portfolios of exposure. For example, where we have
policy and claim data at the defendant or claimant level, we will use a ground-up frequency/severity method (described
later  in  this  section).  For  our  subsidiaries  that  primarily  have  reinsurance  portfolios,  we  generally  use  industry
benchmarking methodologies to estimate appropriate IBNR reserves. These methods are based on comparisons of
our loss experience on A&E exposures relative to industry loss experience on similar exposures. The discussion that
follows describes, in greater detail, the primary actuarial methodologies used by us to estimate IBNR for A&E exposures.

In addition to the specific considerations for each method described below, many general factors are considered
in the application of the methods and the interpretation of results for each portfolio of exposures. These factors include:

•

•

•

•

•

the mix of product types (e.g., primary insurance, excess insurance, reinsurance of primary, excess of loss
reinsurance, retrocession)

the average attachment point and limit of coverages (e.g., first-dollar primary versus umbrella over primary
versus high-excess)

payment and reporting lags related to the international domicile of our subsidiaries as well as the difference
in lags between primary, excess and reinsurance policies 

payment and reporting pattern acceleration due to large "wholesale" settlements (e.g., policy buy-backs and
commutations) pursued by us, and

lists of individual risks remaining and general trends within the legal and tort environments.

1. Paid Survival Ratio Method.    In this method, our expected annual average payment amount is multiplied by
an expected future number of payment years to develop an indicated reserve. Our historical calendar year payments
are examined to determine an expected future annual average payment amount. This amount is multiplied by an
expected number of future payment years to estimate a reserve. Trends in calendar year payment activity are considered
when  selecting  an  expected  future  annual  average  payment  amount. Accepted  industry  benchmarks  are  used  in
determining an expected number of future payment years. Each year, annual payments data is updated, trends in
payments are re-evaluated and changes to benchmark future payment years are reviewed. Advantages of this method
are ease of application and simplicity of assumptions. A potential disadvantage of the method is that results could be
misleading for portfolios of high excess exposures where significant payment activity has not yet begun.

2. Paid Market Share Method.    In this method, our estimated market share is applied to the industry estimated
unpaid losses or estimate of industry ultimate losses. The ratio of our historical calendar year payments to industry
historical calendar year payments is examined to estimate our market share. This ratio is then applied to the estimate
of industry unpaid losses or estimate of industry ultimate losses. Each year, calendar year payment data is updated
(for both us and industry), estimates of industry unpaid losses are reviewed and the selection of our estimated market
share is revisited. This method has the advantage that trends in calendar year market share can be incorporated into
the selection of company share of remaining market payments. A potential disadvantage of this method is that it is
particularly sensitive to assumptions regarding the time-lag between industry payments and our payments.

3. Reserve-to-Paid Method.    In this method, the ratio of estimated industry reserves to industry paid-to-date
losses is multiplied by our paid-to-date losses to estimate our reserves. Specific considerations in the application of
this method include the completeness of our paid-to-date loss information, the potential acceleration or deceleration
in  our  payments  (relative  to  the  industry)  due  to  our  claims  handling  practices,  and  the  impact  of  large  individual
settlements. Each year, paid-to-date loss information is updated (for both us and the industry) and updates to industry
estimated reserves are reviewed. This method has the advantage of relying purely on paid loss data and so is not
influenced by subjectivity of case reserve loss estimates. A potential disadvantage is that the application to our portfolios
that do not have complete inception-to-date paid loss history could produce misleading results. To address this potential
disadvantage, a variation of the method is also considered by multiplying the ratio of estimated industry reserves to
industry losses paid during a recent period of time (e.g., 3 years) times our paid losses during that period.

100

Table of Contents

4. IBNR: Case Ratio Method.    In this method, the ratio of estimated industry IBNR reserves to industry case
reserves is multiplied by our case reserves to estimate our IBNR reserves. Specific considerations in the application
of this method include the presence of policies reserved at policy limits, changes in overall industry case reserve
adequacy and recent loss reporting history. Each year, our case reserves are updated, the estimate of industry reserves
is updated and the applicability of the industry IBNR: Case Ratio is reviewed. This method has the advantage that it
incorporates the most recent estimates of amounts needed to settle open cases included in current case reserves. A
potential disadvantage is that results could be misleading where our case reserve adequacy differs significantly from
overall industry case reserve adequacy. In these instances, the industry IBNR: Case Ratios were adjusted to reflect
our portfolio case reserve adequacy.

5. Ultimate-to-Incurred  Method.    In  this  method,  the  ratio  of  estimated  industry  ultimate  losses  to  industry
incurred-to-date losses is applied to our incurred-to-date losses to estimate our IBNR reserves. Specific considerations
in  the  application  of  this  method  include  the  completeness  of  our  incurred-to-date  loss  information,  the  potential
acceleration or deceleration in our incurred losses (relative to the industry) due to our claims handling practices and
the impact of large individual settlements. Each year incurred-to-date loss information is updated (for both us and the
industry)  and  updates  to  industry  estimated  ultimate  losses  are  reviewed.  This  method  has  the  advantage  that  it
incorporates both paid and case reserve information in projecting ultimate losses. A potential disadvantage is that
results could be misleading where cumulative paid loss data is incomplete or where our case reserve adequacy differs
significantly from overall industry case reserve adequacy. In these instances, the industry IBNR: Case Ratios were
adjusted to reflect our portfolio case reserve adequacy.

6. Decay Factor Method.    In this method, a decay factor is directly applied to our payment data to estimate
future payments. The decay factors were selected based on a review of our own decays and industry decays. This
method is most useful where our data shows a decreasing pattern and is credible enough to be reliable.

7. Asbestos Ground-up Exposure Analysis Using Frequency-Severity Method.    This method is used when we
have policy and claim data at the defendant or claimant level.  In a frequency-severity method there are two components
that need to be estimated, namely, (1) the number of claims that will ultimately be settled with payment and (2) the
severity of these claims including legal costs. The estimate of future settled claims is based on the historical claim
filing rates, claim dismissal rates, current pending claims and epidemiological forecasts of asbestos disease incident
for future claim filings. The average severity is based on historical average settlement amounts trended for inflation
to the expected year of settlement for claims that close with an indemnity payment. Loss adjustment expenses are
loaded on based on historical expense to indemnity ratios. Multiplying the number of expected future claims settled
with payments by the average severity results in an estimate of the ground-up losses at the defendant level.  At this
point, the defendant’s insurance coverage is considered to determine the allocation of the ground-up estimate to policy
years and policy within the insurance coverage as well as the amount retained by the defendant.

Atrium and StarStone

The reserve for losses and loss expenses includes reserves for unpaid reported losses and for IBNR reserves.
The reserves for unpaid reported losses and loss expenses are established by management based on reports from
brokers, ceding companies and insureds and represent the estimated ultimate cost of events or conditions that have
been reported to, or specifically identified by us. The reserve for incurred but not reported losses and loss expenses
is  established  by  management  based  on  actuarially  determined  estimates  of  ultimate  losses  and  loss  expenses.
Inherent in the estimate of ultimate losses and loss expenses are expected trends in claim severity and frequency and
other factors which may vary significantly as claims are settled. Accordingly, ultimate losses and loss expenses may
differ materially from the amounts recorded in the consolidated financial statements. These estimates are reviewed
regularly and, as experience develops and new information becomes known, the reserves are adjusted as necessary.
Such  adjustments,  if  any,  will  be  recorded  in  earnings  in  the  period  in  which  they  become  known.  Prior  period
development  arises  from  changes  to  loss  estimates  recognized  in  the  current  year  that  relate  to  loss  reserves
established in previous calendar years.

101

Table of Contents

The following tables provide a breakdown of the gross and net losses and LAE by line of business and the fair
value adjustments resulting from business combinations and ULAE as of December 31, 2019 and 2018 for the Atrium
segment:

Total

$

89,141 $

136,543 $

9,121

10,935

20,056

8,584

OLR

Gross

IBNR

2019

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

24,668 $
31,507

34,156 $
54,039

58,824 $
85,546

21,012 $
29,590

24,829 $
51,984

18,385

5,460

29,533

7,880

47,918

13,340

16,209

4,735

23,338

7,469

45,841

81,574

39,547

12,204

80,130 $

225,684 $
3,700

2,288

$

231,672

2018

9,637
117,257 $

18,221

197,387

3,181

2,288

$

202,856

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

32,999 $
28,512

36,011 $
59,302

69,010 $
87,814

21,460 $
26,601

24,207 $
57,016

18,547

4,972

27,653

6,348

46,200

11,320

15,180

4,225

24,823

5,837

45,667

83,617

40,003

10,062

Marine, Aviation and
Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and
Facultative

Fair value adjustments
ULAE

Total

Marine, Aviation and
Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and
Facultative

Fair value adjustments

ULAE

Total

Total

$

94,885 $

140,521 $

9,855

11,207

21,062

8,529

75,995 $

235,406 $
3,476

2,402

9,389
121,272 $

17,918

197,267

2,847

2,402

$

202,516

$

241,284

102

Table of Contents

The following tables provide a breakdown of the gross and net losses and LAE reserves by line of business and
the fair value adjustments resulting from business combinations and ULAE as of December 31, 2019 and 2018 for the
StarStone segment:

Total

578,272

300,659

250,811

70,658

92,655

22,862

74,661

111,334
750,950 $ 1,311,734
1,600

28,503
$ 1,341,837

Total

419,854

297,315

217,296

82,046

2019

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

$

191,317 $
195,068

481,473 $
173,319

672,790 $
368,387

156,086 $
162,073

422,186 $
138,586

Casualty

Marine

Property

Aerospace

Workers' Compensation

367,258

79,249

55,902

Total

$

888,794 $

Fair value adjustments

ULAE
Total

152,514

33,000

519,772

112,249

122,047
962,353 $ 1,851,147 $

177,949

158,156

47,796

36,673

560,784 $

(522)
28,503
$ 1,879,128

2018

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

$

177,432 $
185,084

331,432 $
182,453

508,864 $
367,537

137,828 $
163,889

282,026 $
133,426

123,511

40,416

440,613

107,619

110,082
787,894 $ 1,584,088 $

159,455

151,774

45,879

33,759

533,129 $

(467)
25,076
$ 1,608,697

65,522

36,167

68,969

102,728
586,110 $ 1,119,239
1,432

25,076
$ 1,145,747

Casualty

Marine

Property

Aerospace

Workers' Compensation

317,102

67,203

49,373

Total

$

796,194 $

Fair value adjustments

ULAE

Total

Quarterly Reserve Reviews

The reserve for losses and loss expenses is reviewed on a quarterly basis. Each quarter, paid and incurred loss
development  is  reviewed  to  determine  whether  it  is  consistent  with  expected  development.  Loss  development  is
examined separately by class of business, and large individual losses or loss events are examined separately from
regular  attritional  development.  Discussions  are  held  with  appropriate  personnel  including  underwriters,  claims
adjusters, actuaries, accountants and attorneys to fully understand quarterly loss development and implications for
the quarter-end reserve balances. Based on analysis of the loss development data and the associated discussions,
management determines whether any adjustment is necessary to quarter-end reserve balances.

103

Table of Contents

Defendant asbestos and environmental liabilities

Defendant asbestos and environmental liabilities as of December 31, 2019 and 2018 were as follows:

Defendant asbestos and environmental liabilities:

Defendant asbestos liabilities

Defendant environmental liabilities

Estimated future expenses

Fair value adjustments

Defendant asbestos and environmental liabilities

Other assets:

Insurance recoveries related to defendant asbestos and environmental liabilities

Fair value adjustments

Insurance balances recoverable

2019

2018

$

1,100,593 $
10,279

51,637
(314,824)
847,685

549,593
(100,738)
448,855

265,975

2,152

19,843
(84,650)
203,320

183,676
(47,868)
135,808

Net liabilities relating to defendant asbestos and environmental exposures

$

398,830 $

67,512

We  acquired  DCo  on  December  30,  2016,  and  Morse TEC  on  October  30,  2019,  as  described  in  Note  3  -
"Acquisitions". DCo and Morse TEC hold liabilities associated with personal injury asbestos claims and environmental
claims arising from their legacy manufacturing operations. These companies continue to process asbestos personal
injury claims in the normal course of business and are separately managed. Defendant asbestos liabilities on our
consolidated balance sheets include amounts for loss payments and defense costs for pending and future asbestos-
related  claims,  determined  using  standard  actuarial  techniques  for  asbestos  exposures.  Defendant  environmental
liabilities  include  estimated  clean-up  costs  associated  with  the  acquired  companies'  former  operations  based  on
engineering reports. 

Insurance balances recoverable on our consolidated balance sheets include estimated insurance recoveries
relating to these liabilities. The recorded asset represents our assessment of the capacity of the insurance agreements
to indemnify our subsidiaries for the anticipated defense and loss payments for pending claims and projected future
claims. The recognition of these recoveries is based on an assessment of the right to recover under the respective
contracts and on the financial strength of the insurers. The recorded asset does not represent the limits of our insurance
coverage, but rather the amount we would expect to recover if the accrued and projected loss and defense costs were
paid in full. 

Reinsurance Balances Recoverable on Paid and Unpaid Losses

Reinsurance balances recoverable on paid and unpaid losses as of December 31, 2019 and 2018 were as

follows:

Reinsurance balances recoverable on paid and unpaid losses

Reinsurance balances recoverable on paid and unpaid losses, fair value

Total reinsurance balances recoverable on paid and unpaid losses

2019

2018

(in thousands of U.S. dollars)

$

$

1,684,372 $

1,290,072

695,518

739,591

2,379,890 $

2,029,663

Our acquired insurance and reinsurance subsidiaries in all three of our operating segments use retrocessional
agreements to reduce their exposure to the risk of insurance and reinsurance they have assumed. Loss reserves
represent total gross losses, and reinsurance balances recoverables represent anticipated recoveries of a portion of
those loss reserves, as well as amounts receivable from reinsurers with respect to claims that have already been paid.
While reinsurance arrangements are designed to limit losses and to permit recovery of a portion of loss reserves,
reinsurance does not relieve us of our liabilities to our insureds or reinsureds. Therefore, we evaluate and monitor
concentration of credit risk among our reinsurers, including companies that are insolvent, in run-off or facing financial
difficulties.  Provisions  are  made  for  amounts  considered  potentially  uncollectible.  In  addition  to  the  acquired
retrocessional  agreements,  on  an  annual  basis,  our  active  underwriting  subsidiaries  purchase  tailored  outwards

104

Table of Contents

reinsurance programs designed to manage their risk profiles. The majority of the total third-party reinsurance cover
for our active underwriting subsidiaries is with Lloyd’s Syndicates or other reinsurers rated A- or better and reinsurers,
while not rated, provide collateral in the form of letters of credit, trust funds or funds withheld. 

Valuation Allowances on Reinsurance Balances Recoverable and Deferred Tax Assets

Valuation Allowances on Reinsurance Balances Recoverable 

To estimate the provision for uncollectible reinsurance balances recoverable on paid and unpaid losses, the
reinsurance balances recoverable on paid and unpaid losses is first allocated to applicable reinsurers. As part of this
process, ceded IBNR is allocated by reinsurer. We then use a detailed analysis to estimate uncollectible reinsurance.
The primary components of the analysis are reinsurance recoverable balances by reinsurer and bad debt provisions
applied to these balances to determine the portion of a reinsurer’s balance deemed to be uncollectible. These provisions
require considerable judgment and are determined using the current rating, or rating equivalent, of each reinsurer (in
order to determine its ability to settle the reinsurance balances) as well as other key considerations and assumptions,
such as claims and coverage issues.

Valuation Allowances on Deferred Tax Assets

Certain of our subsidiaries and branches operate in jurisdictions where they are subject to taxation. Current and
deferred tax expense or benefit is allocated to net earnings (loss), or, in certain cases, to discontinued operations or
other comprehensive income (loss). Current tax is recognized and measured based upon enacted tax laws and rates
applicable in the relevant jurisdiction in the period in which the income tax becomes accruable or realizable. Deferred
taxes are provided for temporary differences between the carrying amount of assets and liabilities used in the financial
statements and the tax basis used in the various jurisdictional tax returns. When our assessment indicates that all or
some portion of deferred tax assets will not be realized, a valuation allowance is recorded against the deferred tax
assets to reduce the assets to the amount more likely than not to be realized.

We recognize the benefit relating to tax positions only where the position is more likely than not to be sustained
assuming examination by tax authorities. A recognized tax benefit is measured as the largest amount that is greater
than 50 percent likely of being realized upon settlement. A liability or other adjustment is recognized for any tax benefit
(along  with  any  interest  and  penalty,  if  applicable)  claimed  in  a  tax  return  in  excess  of  the  amount  allowed  to  be
recognized in the financial statements under U.S. GAAP. Any changes in amounts recognized are recorded in the
period in which they are determined.

Goodwill

Goodwill as of December 31, 2019 and 2018 was as follows:

Goodwill

2019

2018

(in thousands of U.S. dollars)

$

114,807 $

114,807

Goodwill represents the excess of the purchase price over the fair value of the net assets acquired. We perform
an initial valuation of our goodwill assets and assess goodwill for impairment on an annual basis. If, as a result of the
assessment, we determine the value of our goodwill asset is impaired, goodwill is written down in the period in which
the determination is made.

Intangible Assets

Intangible assets as of December 31, 2019 and 2018 were as follows:

Intangible assets with a definite life

Intangible assets with an indefinite life

Total intangible assets

2019

2018

(in thousands of U.S. dollars)

$

$

14,630 $

87,031

16,887

87,031

101,661 $

103,918

Intangible assets represent the Lloyd’s syndicate capacity, customer relationships, management contract and
brand arising from the acquisition of Atrium and the syndicate capacity, U.S. insurance licenses and software, technology

105

Table of Contents

arising from the acquisition of StarStone. Definite-lived intangible assets are amortized over their estimated useful
lives. We recognize the amortization of all intangible assets in our consolidated statement of earnings. Indefinite-lived
intangible assets are not subject to amortization. The carrying values of indefinite-lived intangible assets are reviewed
for indicators of impairment on at least an annual basis or sooner whenever events or changes in circumstances
indicate that the assets may be impaired. Impairment is recognized if the carrying values of the intangible assets are
not recoverable from their undiscounted cash flows and is measured as the difference between the carrying value and
the fair value.

Deferred Charge Assets

Deferred charge assets as of December 31, 2019 and 2018 were as follows:

Deferred charge asset

2019

2018

(in thousands of U.S. dollars)

$

272,462 $

86,585

Retroactive reinsurance policies provide indemnification of losses and LAE with respect to past loss events. At
the inception of a contract, a deferred charge asset is recorded for the excess, if any, of the estimated ultimate losses
payable over the premiums received. The premium consideration that we charge the ceding companies may be lower
than the undiscounted estimated ultimate losses payable due to the "time value of money". After receiving the premium
consideration in full from our cedents at the inception of the contract, we invest the premium received over an extended
period of time thereby generating investment income. We expect to generate profits from these retroactive reinsurance
policies when taking into account the premium received and expected investment income, less contractual obligations
and expenses. Deferred charge assets, recorded in other assets, are amortized over the estimated claim payment
period of the related contract with the periodic amortization reflected in earnings as a component of losses and LAE.
Deferred charge assets amortization is adjusted periodically to reflect new estimates of the amount and timing of
remaining loss payments. Changes in the estimated amount and the timing of payments of unpaid losses may have
an effect on the unamortized deferred charge assets and the amount of periodic amortization.

Premium Revenue Recognition

Non-life Run-off, Atrium and StarStone

Our premiums written are earned on a pro-rata basis over the coverage period. Our reinsurance premiums are
recorded at the inception of the policy, unless policy language stipulates otherwise, and are estimated based upon
information in underlying contracts and information provided by clients and/or brokers. A change in reinsurance premium
estimates is made when additional information regarding changes in underlying exposures is obtained. Such changes
in estimates are expected and may result in significant adjustments in future periods. We record any adjustments as
premiums written in the period they are determined.

With respect to retrospectively rated contracts (where additional premium would be due should losses exceed
pre-determined contractual thresholds), any additional premiums are based upon contractual terms, and management
judgment is involved in estimating the amount of losses that we expect to be ceded. We would recognize additional
premiums at the time loss thresholds specified in the contract are exceeded and are earned over the coverage period,
or are earned immediately if the period of risk coverage has passed. Changes in estimates of losses recorded on
contracts with additional premium features would result in changes in additional premiums recognized.

Investments

Valuation of Investments

Our non-life run-off and active underwriting businesses invest in trading portfolios of fixed maturity and short-
term investments and equities, and an available-for-sale portfolio of fixed maturity and short-term investments. We
record both the trading and available-for-sale portfolios at fair value on our balance sheet. For our trading portfolios,
the  unrealized  gain  or  loss  associated  with  the  difference  between  the  fair  value  and  the  amortized  cost  of  the
investments is recorded in net earnings. For our available-for-sale portfolios, the unrealized gain or loss (other than
credit losses) is excluded from net earnings and reported as a separate component of accumulated other comprehensive
income.

106

Table of Contents

Our other investments comprise investments in various private equity funds, fixed income funds, hedge funds,
equity funds, private credit funds and CLO equity funds, as well as direct investments in CLO equities. All of these
other investments are recorded at fair value.

We  measure  fair  value  in  accordance  with  ASC  820,  Fair  Value  Measurements.  The  guidance  dictates  a
framework for measuring fair value and a fair value hierarchy based on the quality of inputs used to measure fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities
(Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of
the fair value hierarchy are described below: 

•

•

•

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities
that we have the ability to access. Valuation adjustments and block discounts are not applied to Level 1
instruments.

Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices
for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g. interest
rates,  yield  curves,  prepayment  speeds,  default  rates,  loss  severities,  etc.)  or  can  be  corroborated  by
observable market data

Level 3 - Valuations based on unobservable inputs where there is little or no market activity. Unadjusted
third party pricing sources or management's assumptions and internal valuation models may be used to
determine the fair values.

In addition, certain of our other investments are measured at fair value using net asset value ("NAV") per share
(or its equivalent) as a practical expedient and have not been classified within the fair value hierarchy above. When
the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value
measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its
entirety.  Thus,  a  Level  3  fair  value  measurement  may  include  inputs  that  are  observable  (Level  1  and  2)  and
unobservable (Level 3). 

The  use  of  valuation  techniques  may  require  a  significant  amount  of  judgment.  During  periods  of  market
disruption, including periods of rapidly widening credit spreads or illiquidity, it may be difficult to value certain of our
securities if trading becomes less frequent or market data becomes less observable.

Fixed Maturity Investments

Fixed maturity investments as of December 31, 2019 and 2018 were as follows:

Short-term investments, trading, at fair value

Short-term investments, available-for-sale, at fair value

Fixed maturities, trading, at fair value

Fixed maturities, available-for-sale, at fair value

Fixed maturity investments within funds held - directly managed

2019

2018

(in thousands of U.S. dollars)

$

51,490 $

114,116

128,335

6,346,329

1,913,389

1,173,345

—

7,248,793

151,609

1,183,374

8,697,892

Total fixed maturity investments

$

9,612,888 $

Fixed maturity investments are subject to fluctuations in fair value due to changes in interest rates, changes in
issuer-specific circumstances such as credit rating and changes in industry-specific circumstances such as movements
in credit spreads based on the market’s perception of industry risks. As a result of these potential fluctuations, it is
possible to have significant unrealized gains or losses on a security. At maturity, absent any credit loss, fixed maturity
investments’ amortized cost will equal their fair value and no realized gain or loss will be recognized in income. If, due
to an unforeseen change in loss payment patterns, we need to sell any available-for-sale investments before maturity,
we could realize significant gains or losses in any period, which could have a meaningful effect on reported net income
for such period.

107

Table of Contents

We perform regular reviews of our available-for-sale fixed maturities portfolios and utilize a process that considers
numerous indicators in order to identify investments that are showing signs of potential other-than-temporary impairment
losses. These indicators include the length of time and extent of the unrealized loss, any specific adverse conditions,
historic and implied volatility of the security, failure of the issuer of the security to make scheduled interest payments,
significant rating changes and recoveries or additional declines in fair value subsequent to the balance sheet date.
The consideration of these indicators and the estimation of credit losses involve significant management judgment.

Any other-than-temporary impairment loss, or OTTI, related to a credit loss would be recognized in earnings,
and  the  amount  of  the  OTTI  related  to  other  factors  (e.g.  interest  rates,  market  conditions,  etc.)  is  recorded  as  a
component of other comprehensive income. If no credit loss exists but either we have the intent to sell the fixed maturity
investment or it is more likely than not that we will be required to sell the fixed maturity investment before its anticipated
recovery, then the entire unrealized loss is recognized in earnings.

For the years ended December 31, 2019 and 2018, we did not recognize any other-than-temporary impairment

charges through earnings.

The  fair  values  for  all  fixed  maturity  securities  in  our  trading  and  funds  held  -  directly  managed  investment
portfolios  are  independently  provided  by  the  investment  accounting  service  providers,  investment  managers  and
investment custodians, each of which utilize internationally recognized independent pricing services. We record the
unadjusted  price  provided  by  the  investment  accounting  service  providers,  investment  managers  or  investment
custodians and validate this price through a process that includes, but is not limited to: (i) comparison of prices against
alternative pricing sources; (ii) quantitative analysis (e.g. comparing the quarterly return for each managed portfolio
to its target benchmark); (iii) evaluation of methodologies used by external parties to estimate fair value, including a
review of the inputs used for pricing; and (iv) comparing the price to our knowledge of the current investment market.
Our internal price validation procedures and review of fair value methodology documentation provided by independent
pricing services have not historically resulted in adjustment in the prices obtained from the pricing service.

The independent pricing services used by the investment accounting service providers, investment managers
and investment custodians obtain actual transaction prices for securities that have quoted prices in active markets.
Where we utilize single unadjusted broker-dealer quotes, they are generally provided by market makers or broker-
dealers who are recognized as market participants in the markets in which they are providing the quotes.  For determining
the fair value of securities that are not actively traded, in general, pricing services use "matrix pricing" in which the
independent pricing service uses observable market inputs including, but not limited to, reported trades, benchmark
yields, broker-dealer quotes, interest rates, prepayment speeds, default rates and such other inputs as are available
from market sources to determine a reasonable fair value. In addition, pricing services use valuation models, using
observable data, such as an Option Adjusted Spread model, to develop prepayment and interest rate scenarios. The
Option Adjusted Spread model is commonly used to estimate fair value for securities such as mortgage-backed and
asset-backed securities.

Where pricing is unavailable from pricing services, such as in periods of low trading activity or when transactions
are  not  orderly,  we  obtain  non-binding  quotes  from  broker-dealers.  Where  significant  inputs  are  unable  to  be
corroborated with market observable information, we classify the securities as Level 3.

Equities

Equity investments, trading as of December 31, 2019 and 2018 were as follows:

Publicly traded equity investments in common and preferred stocks

Exchange-traded funds

Privately held equity investments in common and preferred stocks

Total equity investments

2019

2018

(in thousands of U.S. dollars)

327,875 $

138,415

133,047

268,799

729,721 $

—

228,710

367,125

$

$

108

Table of Contents

Our  publicly  traded  equity  investments  in  common  and  preferred  stocks  predominantly  trade  on  the  major
exchanges and are managed by our external advisors. Our publicly traded equity investments are widely diversified
and there is no significant concentration in any specific industry. Our exchange-traded funds trade on major exchanges.
We  use  an  internationally  recognized  pricing  service  to  estimate  the  fair  value  of  our  publicly  traded  equities  and
exchange-traded funds. We have categorized the majority of our publicly traded equity investments, other than preferred
stock and our exchange-traded funds, as Level 1 investments because the fair values of these investments are based
on  unadjusted  quoted  prices  in  active  markets  for  identical  assets  or  liabilities.  The  fair  value  estimates  of  our
investments in publicly traded preferred stock and exchange-traded funds are based on observable market data and,
as a result, have been categorized as Level 2.

Our privately held equity investments in common and preferred stocks are direct investments in companies that
we believe offer attractive risk adjusted returns and/or offer other strategic advantages. Privately held equity investments
are another method by which we can invest in the run off or active underwriting markets. Each investment may have
its own unique terms and conditions and there may be restrictions on disposals. The market for these investments is
illiquid and there is no active market. We have categorized all of our privately held equity investments as Level 3
investments because the market for these investments is illiquid and there is no active market. The Company uses a
combination of internal models, reported values from co-investors/managers and observable inputs, such as capital
raises and capital transactions between new and existing shareholders, to calculate the fair value of the privately held
equity investments.

Other Investments, at fair value

Other investments as of December 31, 2019 and 2018 were as follows:

Hedge funds
Fixed income funds
Equity funds
Private equity funds
CLO equities
CLO equity funds
Other
Private credit funds
Total other investments

2019

2018

$

$

1,121,904 $
481,039
410,149
329,885
87,555
87,509
6,379
—

2,524,420 $

852,584
403,858
333,681
248,628
39,052
37,260
9,313
33,381
1,957,757

We have ongoing due diligence processes with respect to the other investments carried at fair value in which
we  invest  and  their  managers. These  processes  are  designed  to  assist  us  in  assessing  the  quality  of  information
provided by, or on behalf of, each fund and in determining whether such information continues to be reliable or whether
further review is warranted. Certain funds do not provide full transparency of their underlying holdings; however, we
obtain the audited financial statements for funds annually, and regularly review and discuss the fund performance with
the fund managers to corroborate the reasonableness of the reported net asset values ("NAV").

The use of NAV as an estimate of the fair value for investments in certain entities that calculate NAV is a permitted
practical expedient. Due to the time lag in the NAV reported by certain fund managers we adjust the valuation for
capital calls and distributions. Other investments measured at fair value using NAV as a practical expedient have not
been classified in the fair value hierarchy. Other investments for which we do not use NAV as a practical expedient
have been valued using prices from independent pricing services, investment managers and broker-dealers.

For our investments in private equity funds, we measure fair value by obtaining the most recently available NAV
from the external fund manager or third-party administrator. The fair values of these investments are measured using
the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.

Our  investments  in  fixed  income  funds  and  equity  funds  are  valued  based  on  a  combination  of  prices  from
independent pricing services, external fund managers or third-party administrators.  For the publicly available prices
we have classified the investments as Level 2. For the non-publicly available prices we are using NAV as a practical
expedient and therefore these have not been categorized within the fair value hierarchy.

109

Table of Contents

For our investments in hedge funds, we measure fair value by obtaining the most recently available NAV as
advised by the external fund manager or third-party administrator. The fair values of these investments are measured
using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy. 

We measure the fair value of our direct investment in CLO equities based on valuations provided by independent
pricing services, our external CLO equity manager, and valuations provided by the broker or lead underwriter of the
investment (the "broker"). Our CLO equity investments have been classified as Level 3 due to the use of unobservable
inputs in the valuation and the limited number of relevant trades in secondary markets. 

In  providing  valuations,  the  independent  pricing  service  providers,  CLO  equity  manager  and  brokers  use
observable and unobservable inputs. Of the significant unobservable market inputs used, the default and loss severity
rates involve the most judgment and create the most sensitivity. A significant increase or decrease in either of these
significant inputs in isolation would result in lower or higher fair value estimates for direct investments in CLO equities
and, in general, a change in default rate assumptions will be accompanied by a directionally similar change in loss
severity rate assumptions. Collateral spreads and estimated maturity dates are less subjective inputs because they
are based on the historical average of actual spreads and the weighted average life of the current underlying portfolios,
respectively. A significant increase or decrease in either of these significant inputs in isolation would result in higher
or  lower  fair  value  estimates  for  direct  investments  in  CLO  equities.  In  general,  these  inputs  have  no  significant
interrelationship with each other or with default and loss severity rates.

On a quarterly basis, we receive the valuation from the independent pricing providers, external CLO manager
and brokers and then review the underlying cash flows and key assumptions used by them. We review and update
the  significant  unobservable  inputs  based  on  information  obtained  from  secondary  markets. These  inputs  are  our
responsibility  and  we  assess  the  reasonableness  of  the  inputs  (and  if  necessary,  update  the  inputs)  through
communicating with industry participants, monitoring of the transactions in which we participate (for example, to evaluate
default and loss severity rate trends), and reviewing market conditions, historical results, and emerging trends that
may impact future cash flows.

If valuations from the independent pricing service providers, external CLO equity manager or brokers are not
available, we use an income approach based on certain observable and unobservable inputs to value these investments.
An income approach is also used to corroborate the reasonableness of the valuations provided by the pricing providers,
external  manager  and  brokers.  Where  an  income  approach  is  followed,  the  valuation  is  based  on  available  trade
information, such as expected cash flows and market assumptions on default and loss severity rates. Other inputs
used in the valuation process include asset spreads, loan prepayment speeds, collateral spreads and estimated maturity
dates.

For our investments in CLO equity funds, we measure fair value by obtaining the most recently available NAV
as advised by the external fund manager or third party administrator. The fair values of these investments are measured
using the NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy.

For our investments in private credit funds, we measure fair value by obtaining the most recently available NAV
from the external fund manager or third-party administrator. The fair values of these investments are measured using
NAV as a practical expedient and therefore have not been categorized within the fair value hierarchy. 

Certain funds are subject to gates or side-pockets, where redemptions are subject to the sale of underlying
investments. A gate is the ability to deny or delay a redemption request, whereas a side-pocket is a designated account
for which the investor loses its redemption rights. As of December 31, 2019, we had $51.8 million of fixed income
hedge funds subject to gates or side-pockets.

A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability
of valuation inputs may result in a reclassification for certain financial assets and liabilities. Reclassifications impacting
Level 3 of the fair value hierarchy are reported as transfers in/out of the Level 3 category as of the end of the quarter
in which the reclassifications occur.

Accounting for Business Combinations - Fair Value Measurement

The most significant liabilities and assets of an acquired company are typically the liability for losses and LAE,
and the assets related to cash, investments and any reinsurance balances recoverable on paid and unpaid losses that
may be contractually due to the acquired entity. The market for acquisition of run-off companies is not always sufficiently
active and transparent to enable us to identify reliable, market exit values for acquired assets and liabilities. Accordingly,
consistent with provisions of U.S. GAAP, we have developed internal models that we believe allow us to determine
fair values that are reasonable proxies for market exit values. We are familiar with the major participants in the acquisition

110

Table of Contents

run-off market and believe that the key assumptions we make in valuing acquired assets and liabilities are consistent
with the kinds of assumptions made by such market participants. Furthermore, in our negotiation of purchase prices
with sellers, it is frequently clear to us that other bidders in the market are using models and assumptions similar in
nature to ours during the competitive bid process. The majority of acquisitions are completed following a public tender
process whereby the seller invites market participants to provide bids for the target acquisition.

We  account  for  business  combinations  using  the  acquisition  method  of  accounting,  which  requires  that  the
acquirer record the assets and liabilities acquired at their estimated fair value. The fair values of each of the insurance
and reinsurance assets and liabilities acquired are derived from probability-weighted ranges of the associated projected
cash flows, based on actuarially prepared information and management’s run-off strategy. Our run-off strategy, as well
as that of other run-off market participants, is expected to be different from the seller’s as generally sellers are not
specialized in running off insurance and reinsurance liabilities whereas we and other market participants do specialize
in such run-offs.

The key assumptions used by us and, we believe, by other run-off market participants in the fair valuation of
acquired companies are (i) the projected payout, timing and amounts of claims liabilities; (ii) the related projected
timing  and  amount  of  reinsurance  collections;  (iii) an  appropriate  discount  rate,  which  is  applied  to  determine  the
present value of the future cash flows; (iv) the estimated ULAE to be incurred over the life of the run-off; (v) the impact
that any accelerated run-off strategy may have on the adequacy of acquired bad debt provisions; and (vi) an appropriate
risk margin.

The probability-weighted projected cash flows of the acquired company are based on projected claims payouts
provided by the seller predominantly in the form of the seller’s most recent independent actuarial reserve report. In
the absence of the seller’s actuarial reserve report, our actuaries will determine the estimated claims payout. In certain
jurisdictions, the local legislation provides for the possibility of pursuing strategies to achieve complete finality and
conclude the run-off of a company, such as solvent schemes of arrangement. If appropriate we may estimate the
probability of being able to complete a solvent scheme of arrangement and factor that into the claims payout projections.

On acquisition, we make a provision for ULAE liabilities. This provision considers the adequacy of the provision
maintained and recorded by the seller in light of our run-off strategy and estimated ULAE to be incurred over the life
of the acquired run-off as projected by the seller’s actuaries or, in their absence, our actuaries. To the extent that our
estimate of the total ULAE provision is different from the seller’s, an adjustment will be made. While our objective is
to accelerate the run-off by completing commutations of assumed and ceded business (which would have the effect
of shortening the life, and therefore the cost, of the run-off), the success of this strategy is far from certain. Therefore,
the estimates of ULAE are based on running off the liabilities and assets over the actuarially projected life of the run-
off.

We believe that providing for ULAE based on our run-off strategy is appropriate in determining the fair value of
the assets and liabilities acquired in an acquisition of a run-off company. We believe that other participants in the run-
off acquisition marketplace factor into the price to pay for an acquisition the estimated cost of running off the acquired
company based on how that participant expects to manage the assets and liabilities.

The difference between the carrying value of reserves acquired at the date of acquisition and the fair value is
the  Fair  Value  Adjustment,  ("FVA").  The  FVA  is  amortized  over  the  estimated  payout  period  and  adjusted  for
accelerations on commutation settlements or any other new information or subsequent change in circumstances after
the date of acquisition. To the extent the actual payout experience after the acquisition is materially faster or slower
than anticipated at the time of the acquisition, there is an adjustment to the estimated ultimate loss reserves, or there
are changes in bad debt provisions or in estimates of future run-off costs following accelerated payouts, then the
amortization of the FVA is accelerated or decelerated, as the case may be, to reflect such changes.

Fair Value Option - Insurance Contracts

In our Non-life Run-off segment we have elected to apply the fair value option for certain loss portfolio transfer
reinsurance transactions. This is an irrevocable election that applies to all balances under the insurance contract,
including funds held assets, reinsurance recoverable, and the liability for losses and loss adjustment expenses.

111

Table of Contents

The fair value of the liability for losses and LAE and reinsurance recoverable under these contracts is presented
separately in our consolidated balance sheet as of December 31, 2019 and 2018. Changes in the fair value of the
liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses are included in net incurred
losses and LAE in our consolidated statement of operations. The carrying value of our reinsurance recoverable and
liability for losses and LAE for which we elected the fair value option as of December 31, 2019 and 2018 was as follows:

Gross Losses and loss adjustment expenses, fair value

Reinsurance balances recoverable on paid and unpaid losses, fair value

Net losses and LAE, fair value

2019

2018

(in thousands of U.S. dollars)

2,621,122 $

2,874,055

695,518 $

739,591

1,925,604 $

2,134,464

$

$

$

We use an internal model to calculate the fair value of the liability for losses and loss adjustment expenses and
reinsurance recoverable asset for certain retroactive reinsurance contracts where we have elected the fair value option
in our Non-life Run-off segment. 

The fair value was calculated as the aggregate of discounted cash flows plus a risk margin:

•

•

The discounted cash flow approach uses (i) estimated nominal cash flows based upon an appropriate payment
pattern developed in accordance with standard actuarial techniques and (ii) a discount rate based upon a high
quality rated corporate bond plus a credit spread for non-performance risk. The model uses corporate bond
rates across the yield curve depending on the estimated timing of the future cash flows and specific to the
currency of the risk. 

The risk margin was calculated using the present value of the cost of capital. The cost of capital approach
uses (i) projected capital requirements, (ii) multiplied by the risk cost of capital representing the return required
for non-hedgeable risk based upon the weighted average cost of capital less investment income, and (iii)
discounted using the weighted average cost of capital. 

The observable and unobservable inputs used in the model are described in Note 12 - "Fair Value Measurements"

in the notes to our consolidated financial statements included within Item 8 of this Annual Report on Form 10-K.  

The fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses
may increase or decrease due to changes in the corporate bond rate, the credit spread for non-performance risk, the
risk cost of capital, the weighted average cost of capital and the estimated payment pattern:

•

•

•

•

An increase in the corporate bond rate or credit spread for non-performance risk would result in a decrease
in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid
losses. Conversely, a decrease in the corporate bond rate or credit spread for non-performance risk would
result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable
on paid and unpaid losses. 

An increase in the weighted average cost of capital would result in an increase in the fair value of the liability
for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease
in the weighted average cost of capital would result in a decrease in the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses. 

An increase in the risk cost of capital would result in an increase in the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease in the risk cost
of capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances
recoverable on paid and unpaid losses. 

An acceleration of the estimated payment pattern would result in an increase in the fair value of the liability
for  losses  and  LAE  and  reinsurance  balances  recoverable  on  paid  and  unpaid  losses.  Conversely,  a
deceleration of the estimated payment pattern would result in a decrease in the fair value of the liability for
losses and LAE and reinsurance balances recoverable on paid and unpaid losses. 

112

Table of Contents

In addition, the estimate of the capital required to support the liabilities is based upon current industry standards
for capital adequacy. If the required capital per unit of risk increases then the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses would increase. Conversely, a decrease in
required capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances
recoverable on paid and unpaid losses.

Redeemable Noncontrolling Interest

The redeemable noncontrolling interest as of December 31, 2019 and 2018 was as follows:

Redeemable noncontrolling interest

2019

2018

(in thousands of U.S. dollars)

$

438,791 $

458,543

In connection with the acquisitions of Arden, Atrium and StarStone, certain subsidiaries have issued shares to
noncontrolling interests. These shares provide certain redemption rights to the holder, which may be settled in Enstar’s
own shares or cash or a combination of cash and shares, at our option. We classify redeemable noncontrolling interests
with redemption features that are not solely within our control within temporary equity in our consolidated balance
sheets and carry them at the redemption value, which is fair value. We recognize changes in the fair value that exceed
the carrying value of redeemable noncontrolling interest through retained earnings as if the balance sheet date were
also the redemption date.

113

Table of Contents

ITEM 7A.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The  following  risk  management  discussion  and  the  estimated  amounts  generated  from  sensitivity  analysis
presented are forward-looking statements of market risk assuming certain market conditions occur. Future results may
differ materially from these estimated results due to, among other things, actual developments in the global financial
markets, changes in the composition of our investment portfolio, or changes in our business strategies. The results of
analysis we use to assess and mitigate risk are not projections of future events or losses. See "Cautionary Statement
Regarding Forward-Looking Statements" for additional information regarding our forward-looking statements.

We are principally exposed to four types of market risk: interest rate risk; credit risk; equity price risk and foreign
currency risk. Our policies to address these risks in 2019 were not materially different than those used in 2018 other
than  as  described  herein,  and,  based  on  our  current  knowledge  and  expectations,  we  do  not  currently  anticipate
significant changes in our market risk exposures or in how we will manage those exposures in future reporting periods.

Interest Rate and Credit Spread Risk

Interest rate risk is the price sensitivity of a security to changes in interest rates. Credit spread risk is the price
sensitivity of a security to changes in credit spreads. Our investment portfolio and funds held - directly managed include
fixed maturity and short-term investments, whose fair values will fluctuate with changes in interest rates and credit
spreads. We attempt to maintain adequate liquidity in our fixed maturity investments portfolio with a strategy designed
to emphasize the preservation of our invested assets and provide sufficient liquidity for the prompt payment of claims
and contract liabilities, as well as for settlement of commutation payments. We also monitor the duration and structure
of our investment portfolio.

The following table summarizes the aggregate hypothetical change in fair value from an immediate parallel shift
in the treasury yield curve, assuming credit spreads remain constant, in our fixed maturity and short-term investments
portfolio classified as trading and available-for-sale, our funds held directly managed portfolio, fixed income funds and
our fixed income exchange-traded funds:

As of December 31, 2019

-100

-50

—

+50

+100

Interest Rate Shift in Basis Points

Total Market Value

Market Value Change from Base

Change in Unrealized Value

As of December 31, 2018
Total Market Value

Market Value Change from Base

Change in Unrealized Value

(in millions of U.S. dollars)

$ 10,757

$ 10,490

5.2%
530

-100

9,555

5.0%
454

$

$

$

$

$

$

2.6%
263

-50

9,325

2.5%
224

$

$

$

$

10,227 $
—
— $

9,976

(2.5)%
(251)

—

9,101 $
—
— $

+50

8,885

(2.4)%
(216)

$

$

$

$

9,736

(4.8)%
(491)

+100

8,677

(4.7)%
(424)

Actual shifts in interest rates may not change by the same magnitude across the maturity spectrum or on an
individual security and, as a result, the impact on the fair value of our fixed maturity securities, short-term investments,
funds held - directly managed and fixed income exchange-traded fund may be materially different from the resulting
change in value indicated in the tables above.

114

Table of Contents

The following table summarizes the aggregate hypothetical change in fair value from an immediate parallel shift
in  credit  spreads  assuming  interest  rates  remain  fixed,  in  our  fixed  maturity  and  short-term  investments  portfolio
classified as trading and available-for-sale, our funds held directly managed portfolio, fixed income funds and our fixed
income exchange-traded funds:

As of December 31, 2019

Total Market Value

Market Value Change from Base

Change in Unrealized Value

As of December 31, 2018
Total Market Value

Market Value Change from Base

Change in Unrealized Value

Credit Risk

—

—

Credit Spread Shift in Basis Points

+50

+100

(in millions of U.S. dollars)

10,227 $

$

9,101 $

$

+50

9,999

(2.2)%
(228)

8,896

(2.3)%
(205)

$

$

$

$

+100

9,777

(4.4)%
(450)

8,699

(4.4)%
(402)

$

$

Credit risk relates to the uncertainty of a counterparty’s ability to make timely payments in accordance with
contractual terms of the instrument or contract. We are exposed to direct credit risk primarily within our portfolios of
fixed maturity and short-term investments, and through customers, brokers and reinsurers in the form of premiums
receivable and reinsurance balances recoverable on paid and unpaid losses, respectively, as discussed below.

Fixed Maturity and Short-Term Investments

As a holder of $9.6 billion of fixed maturity and short-term investments, we also have exposure to credit risk as
a result of investment ratings downgrades or issuer defaults. In an effort to mitigate this risk, our investment portfolio
consists primarily of investment grade-rated, liquid, fixed maturity investments of short-to-medium duration and mutual
funds. A table of credit ratings for our fixed maturity and short-term investments is in Note 6 - "Investments" in the
notes  to  our  consolidated  financial  statements  included  within  Item  8  of  this  Annual  Report  on  Form  10-K.  At
December 31, 2019, 40.0% of our fixed maturity and short-term investment portfolio was rated AA or higher by a major
rating agency (December 31, 2018: 42.6%) with 4.1% rated lower than BBB- (December 31, 2018: 3.6%). The portfolio
as a whole, including cash, restricted cash, fixed maturity and short term investments and funds held - directly managed,
had an average credit quality rating of A+ as of December 31, 2019 (December 31, 2018: A+). In addition, we manage
our portfolio pursuant to guidelines that follow what we believe are prudent standards of diversification. The guidelines
limit  the  allowable  holdings  of  a  single  issue  and  issuers  and,  as  a  result,  we  do  not  believe  we  have  significant
concentrations of credit risk. 

A  summary  of  our  fixed  maturity  and  short-term  investments  by  credit  rating  as  of  December 31,  2019  and

December 31, 2018 is as follows: 

Credit rating

2019

2018

Change

AAA

AA

A

BBB

Non-investment grade

Not rated

Total

Average credit rating

(1.1)%
(1.5)%
4.1 %
(2.0)%
0.5 %
— %

28.2%
14.4%
30.2%
23.4%
3.6%
0.2%
100.0%

A+

27.1%
12.9%
34.3%
21.4%
4.1%
0.2%
100.0%

A+

115

Table of Contents

Reinsurance Balances Recoverable on Paid and Unpaid Losses

We have exposure to credit risk as it relates to our reinsurance balances recoverable on paid and unpaid losses.
Our insurance subsidiaries remain liable to the extent that retrocessionaires do not meet their contractual obligations
and,  therefore,  we  evaluate  and  monitor  concentration  of  credit  risk  among  our  reinsurers.  A  discussion  of  our
reinsurance balances recoverable on paid and unpaid losses is in Note 8 - "Reinsurance Balances Recoverable on
Paid and Unpaid Losses" in the notes to our consolidated financial statements included within Item 8 of this Annual
Report on Form 10-K. 

Funds Held 

Under funds held arrangements, the reinsured company has retained funds that would otherwise have been
remitted to our reinsurance subsidiaries. The funds balance is credited with investment income and losses payable
are deducted. We are subject to credit risk if the reinsured company is unable to honor the value of the funds held
balances, such as in the event of insolvency. However, we generally have the contractual ability to offset any shortfall
in the payment of the funds held balances with amounts owed by us to the reinsured for losses payable and other
amounts contractually due. Our funds held are shown under two categories on the consolidated balance sheets, where
funds held upon which we receive the underlying portfolio economics are shown as "Funds held - directly managed",
and funds held where we receive a fixed crediting rate are shown as "Funds held by reinsured companies". Both types
of funds held are subject to credit risk. We routinely monitor the creditworthiness of reinsured companies with whom
we have funds held arrangements. As of December 31, 2019 we have a significant concentration of $1.0 billion with
one reinsured company, which has financial strength credit ratings of A+ from A.M. Best and AA from Standard &
Poor's.

Equity Price Risk

Our portfolio of equity investments, excluding our fixed income exchange-traded funds but including the equity
funds and call options on equities included in other investments (collectively, "equities at risk"), has exposure to equity
price risk, which is the risk of potential loss in fair value resulting from adverse changes in stock prices. Our fixed
income exchange-traded funds are excluded from the below analysis and have been included within the interest rate
and credit spread risk analysis, as the exchange-traded funds are part of our fixed income investment strategy. Our
global equity portfolio is correlated with a blend of the S&P 500 and MSCI World indices, and changes in this blend
of indices would approximate the impact on our portfolio. The following table summarizes the aggregate hypothetical
change in fair value from a 10% decline in the overall market prices of our equities at risk: 

Publicly traded equity investments in common and
preferred stocks

Privately held equity investments in common and
preferred stocks

Private equity funds

Equity funds

Call options on equity

Fair value of equities at risk

Impact of 10% decline in fair value

2019

2018

Change

(in millions of U.S. dollars)

$

327.9

$

138.4

$

189.5

268.8

329.9

410.1

0.1

$

$

1,336.8

133.7

$

$

228.7

248.6

333.7

—

949.4

94.9

$

$

40.1

81.3

76.4

0.1

387.4

38.8

In addition to the above, as of December 31, 2019, we had investments of $1,121.9 million (December 31, 2018:
$852.6 million) in hedge funds, included within our other investments, at fair value, that have exposure, among other
items, to equity price risk.

116

Table of Contents

Foreign Currency Risk

The table below summarizes our net exposures as of December 31, 2019 and 2018 to foreign currencies:

AUD

CAD

EUR

GBP

Other

Total

(in millions of U.S. dollars)

2019
Total net foreign currency exposure
Pre-tax impact of a 10% movement in USD(1)

2018
Total net foreign currency exposure
Pre-tax impact of a 10% movement in USD(1)

$

$

$

$

(1) Assumes 10% change in U.S. dollar relative to other currencies.

20.2 $ (10.6) $ 12.9 $ (11.9) $
(1.2) $

(1.1) $

1.3 $

2.0 $

17.5 $ 20.2 $ 17.2 $ (35.8) $
(3.6) $

1.7 $

2.0 $

1.8 $

0.6 $
0.1 $

11.2

1.1

1.7 $
0.2 $

20.7

2.1

Through our subsidiaries located in various jurisdictions, we conduct our insurance and reinsurance operations

in a variety of non-U.S. currencies. We have the following exposures to foreign currency risk:

•

•

•

•

Transaction Risk: The functional currency for the majority of our subsidiaries is the U.S. dollar. Within these
entities, any fluctuations in foreign currency exchange rates relative to the U.S. dollar has a direct impact on
the valuation of our assets and liabilities denominated in other currencies. All changes in foreign exchange
rates, with the exception of non-U.S. dollar available-for-sale investments, are recognized in our consolidated
statements  of  earnings.  Changes  in  foreign  exchange  rates  relating  to  non-U.S.  dollar  available-for-sale
investments  are  recorded  accumulated  other  comprehensive  income  (loss)  in  shareholders’  equity.  Our
subsidiaries with non-U.S. dollar functional currencies are also exposed to fluctuations in foreign currency
exchange rates relative to their own functional currency. 

Translation Risk: Our net investments in certain European, British, and Australian subsidiaries whose functional
currencies are the Euro, British pound and Australian dollar, respectively. The foreign exchange gain or loss
resulting from the translation of their financial statements from functional currency into U.S. dollars is recorded
in the cumulative translation adjustment account, which is a component of accumulated other comprehensive
income (loss) in shareholders’ equity. 

Our foreign currency policy is to broadly manage, where possible, our foreign currency risk by:

Seeking to match our liabilities under insurance and reinsurance policies that are payable in foreign currencies
with assets that are denominated in such currencies, subject to regulatory constraints. 

Selectively utilizing foreign currency forward contracts to mitigate foreign currency risk. 

• We may borrow to hedge the foreign currency exposure on our net investment in certain of our subsidiaries
whose functional currency is denominated in non-U.S. dollars. This is referred to as a non-derivative hedge. 

The instruments we use to manage foreign currency risk are discussed in Note 7 - "Derivatives and Hedging
Instruments" in the notes to our consolidated financial statements included within Item 8 of this Annual Report on Form
10-K. To the extent our foreign currency exposure is not matched or hedged, we may experience foreign exchange
losses or gains, which would be reflected in our consolidated results of operations and financial condition.

Effects of Inflation

Inflation may have a material effect on our consolidated results of operations by its effect on our assets and our
liabilities. Inflation could lead to higher interest rates, resulting in a decrease in the market value of our fixed maturity
portfolio. We may choose to hold our fixed maturity investments to maturity, which would result in the unrealized gains
or losses accreting back over time. Inflation may also affect the value of certain of our liabilities, primarily our estimate
for losses and LAE, such as our cost of claims which includes medical treatments, litigation costs and judicial awards.
Although our estimate for losses and LAE is established to reflect the likely payments in the future, we would be subject
to the risk that inflation could cause these amounts to be greater than the current estimate for losses and LAE. We
seek to take this into account when setting reserves and pricing new business.

117

Table of Contents

ITEM 8.   FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS AND SCHEDULES

CONSOLIDATED FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2019 and 2018

Consolidated Statements of Earnings for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Comprehensive Income for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Changes in Shareholders’ Equity for the years ended December 31, 2019, 2018 and 2017

Consolidated Statements of Cash Flows for the years ended December 31, 2019, 2018 and 2017

Notes to the Consolidated Financial Statements

Note 1 - Description of Business

Note 2 - Significant Accounting Policies

Note 3 - Acquisitions

Note 4 - Significant New Business

Note 5 - Divestitures, Held-for-Sale Businesses and Discontinued Operations

Note 6 - Investments

Note 7 - Derivatives and Hedging Instruments

Note 8 - Reinsurance Balances Recoverable on Paid and Unpaid Losses

Note 9 - Deferred Charge Assets

Note 10 - Losses and Loss Adjustment Expenses

Note 11 - Defendant Asbestos and Environmental Liabilities

Note 12 - Fair Value Measurements

Note 13 - Premiums Written and Earned

Note 14 - Goodwill and Intangible Assets

Note 15 - Debt Obligations and Credit Facilities 

Note 16 - Noncontrolling Interest

Note 17 - Share Capital

Note 18 - Earnings per Share

Note 19 - Share-Based Compensation and Pensions

Note 20 - Income Taxation

Note 21 - Related Party Transactions

Note 22 - Dividend Restrictions and Statutory Financial Information

Note 23 - Commitments and Contingencies

Note 24 - Segment Information

Note 25 - Unaudited Condensed Quarterly Financial Data

SCHEDULES

I. Summary of Investments Other than Investments in Related Parties

II. Condensed Financial Information of Registrant

III. Supplementary Insurance Information

IV. Reinsurance

V. Valuation and Qualifying Accounts

VI. Supplementary Information Concerning Property/Casualty Insurance Operations

Page
119

122

123

124

125
126

127

127

128

139

145

148

149

158

160

162

163

218

220

230

231

233

236

237

239

240

244

247

254

258

262

266

267

268

271

272

273

274

Schedules other than those listed above are omitted as they are not applicable or the information has been included in the

consolidated financial statements, notes thereto, or elsewhere herein. 

118

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors 

Enstar Group Limited:

Opinion on the Consolidated Financial Statements

We  have  audited  the  accompanying  consolidated  balance  sheets  of  Enstar  Group  Limited  and subsidiaries  (the
Company)  as  of  December 31,  2019  and  2018,  the  related  consolidated  statements  of  earnings,  comprehensive
income,  changes  in  shareholders’  equity,  and  cash  flows  for  each  of  the  years  in  the  three‑year  period  ended
December 31, 2019, and the related notes and financial statement schedules I to VI (collectively, the consolidated
financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the
financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash
flows  for  each  of  the  years  in  the  three‑year  period  ended  December 31,  2019,  in  conformity  with  U.S. generally
accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United
States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2019, based on criteria
established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations
of  the  Treadway  Commission,  and  our  report  dated  February 27,  2020  expressed  an  unqualified  opinion  on  the
effectiveness of the Company’s internal control over financial reporting.
Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to
express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm
registered with the PCAOB and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and
the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of
material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks
of  material  misstatement  of  the  consolidated  financial  statements,  whether  due  to  error  or  fraud,  and  performing
procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the
amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting
principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated
financial statements that were communicated or required to be communicated to the audit committee and that: (1)
relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially
challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way
our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical
audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which
they relate.
Assessment of the estimate of the loss reserves and asbestos and environmental liabilities 

As discussed in Notes 2 (c), 10 and 11 to the consolidated financial statements, the Company has recorded a liability
for loss and loss adjustment expenses (loss reserves) and defendant asbestos and environmental liabilities (asbestos
and environmental liabilities) of $7,808 million and $848 million, respectively, as of December 31, 2019. Included in
loss reserves are claims that have been received by the Company but not yet paid, in addition losses that have been
incurred, but not yet reported to the Company. Asbestos and environmental liabilities include amounts for indemnity
and defense costs for pending and future claims, as well as estimated clean-up costs based on engineering reports.
The Company established loss reserves and asbestos and environmental liabilities based on actuarially determined
estimates of ultimate claims payments, using generally accepted actuarial methods, with the assistance of actuarial
specialists.
We identified the assessment of the estimate of loss reserves and asbestos and environmental liabilities as a critical
audit matter. The evaluation of the estimate of loss reserves involved a high degree of auditor judgment due to the
inherent uncertainty that exists in the losses incurred but not yet reported amounts, the outcome of coverage litigation
on certain lines of business, and the significant amount of time that can lapse between the assumption of risk and
ultimate payment of the claim. Also, the evaluation of the estimate of asbestos and environmental liabilities involved

119

Table of Contents

a high degree of auditor judgment due to the inherent uncertainty that exists in estimating the number and potential
value of claims asserted, but unpaid and claims not yet asserted. The key assumptions used in the estimation process
for loss reserves included loss development factors, expected loss ratios, and expected trends in claim frequency and
severity.  The  key  assumptions  used  in  the  estimation  process  for  asbestos  and  environmental  liabilities  included
expected  trends  in  claim  frequency  and  severity.  Specialized  skills  and  knowledge  were  required  to  evaluate  the
actuarial methodologies and certain assumptions used to estimate loss reserves and asbestos and environmental
liabilities.

The primary procedures we performed to address this critical audit matter included the following. We tested certain
internal controls over the Company’s process to estimate the loss reserves and asbestos and environmental liabilities,
including controls over the assumptions listed above and actuarial methodologies used in the estimation of loss reserves
and asbestos and environmental liabilities. We involved actuarial professionals with specialized skills and knowledge,
who assisted in:

• Comparing the methodologies and assumptions used by the Company in estimating loss reserves and asbestos

and environmental liabilities with generally accepted actuarial methodologies; 

• Evaluating loss development factors, expected loss ratios, and expected trends in claim frequency and severity,

by comparing them to historical results and industry trends used in the estimation process of loss reserves;

• Evaluating expected trends in claim frequency and severity, by comparing them to historical results and industry

trends used in the estimation process of asbestos and environmental liabilities;

• Developing  an  independent  actuarial  estimate  of  loss  reserves  and  asbestos  and  environmental  liabilities  for

selected lines of business;

• Examining the Company’s internal or independent external actuarial analyses for the remaining lines of business
by  1)  analyzing  claims  development  in  the  current  year;  and  2)  evaluating  changes  in  methodologies  and
assumptions from the prior year; 

• Evaluating the Company’s overall recorded loss reserves by assessing the movement of the recorded loss reserves

within the Company’s range of actuarially determined reserves; and

• Evaluating the Company’s overall recorded asbestos and environmental liabilities by assessing the movement of
the recorded asbestos and environmental liabilities within the Company’s range of actuarially determined reserves.
Assessment of the estimate of the nominal loss reserve used to develop the liability for loss and loss adjustment
expenses, fair value

As discussed in Notes 2 (c), 2(p), 10 and 12 to the consolidated financial statements, the Company used a discounted
cash flow approach to estimate the liability for loss and loss adjustment expenses, fair value. The discounted cash
flow approach used estimated nominal cash flows based on a payment pattern developed in accordance with standard
actuarial techniques. Nominal loss reserves include claims that have been received by the Company but not yet paid,
in addition to losses that have been incurred, but not yet reported to the Company. The Company estimated the nominal
loss reserve based on actuarially determined estimates of ultimate loss and loss adjustment expenses, using generally
accepted actuarial methods, with the assistance of actuarial specialists. The Company has recorded a liability for loss
and loss adjustment expenses, fair value (loss reserves at fair value) of $2,621 million as of December 31, 2019. 

We identified the assessment of the estimate of the nominal loss reserve used to develop the loss reserves at fair
value as a critical audit matter. The evaluation of the estimate of the nominal loss reserves involved a high degree of
auditor judgment due to the inherent uncertainty that exists in the losses incurred but not yet reported amounts, the
outcome of coverage litigation on certain lines of business, and the significant amount of time that can lapse between
the assumption of risk and ultimate payment of the claim. The key assumptions used in the estimation process included
loss development factors and expected trends in claim frequency and severity. Specialized skills and knowledge were
required to 1) evaluate the actuarial methodologies and certain assumptions used to estimate the nominal loss reserves;
and 2) evaluate the projected payout, including timing, and amount of the nominal cash flows used in the fair value
estimate.

The primary procedures we performed to address this critical audit matter included the following. We tested certain
internal controls over the Company’s process to estimate nominal loss reserve, including controls over the assumptions
and actuarial methodologies used in the 1) estimation of the nominal loss reserves; and 2) the estimation of the projected
payout, including timing, and amount of the nominal cash flows used to develop the fair value. We involved actuarial
professionals with specialized skills and knowledge, who assisted in:

• Comparing the methodologies and assumptions used by the Company in estimating the nominal loss reserves

with generally accepted actuarial methodologies; 

• Evaluating loss development factors and expected trends in claim frequency and severity, by comparing them to

historical results and industry trends;

120

Table of Contents

• Developing an independent actuarial estimate of the nominal loss reserves for selected lines of business;

• Examining the Company’s internal and independent external actuarial analyses for the remaining lines of business
by  1)  analyzing  claims  development  in  the  current  year;  and  2)  evaluating  changes  in  methodologies  and
assumptions from the prior year; 

• Evaluating the Company’s overall nominal loss reserves and assessing the movement of the nominal loss reserves

within the Company’s range of actuarially determined reserves; and

• Evaluating the projected payout, including timing, and amount of the nominal cash flows used to develop the fair
value, by comparing the assumptions used with the assumptions applied in developing the nominal loss reserves.

Evaluation of the acquisition date fair value of asbestos liabilities acquired in the Morse TEC business combination

As discussed in Note 3 to the consolidated financial statements, on October 30, 2019, the Company acquired Morse
TEC. As a result of the transaction the Company recoded $0.663 billion in asbestos liabilities associated with personal
injury claims (asbestos liabilities). The Company determined the acquisition to be a business combination and applied
the acquisition method to account for the transaction. The acquisition date fair value of the acquired asbestos liabilities
are derived from projected cash flows, based on actuarially determined information. The key assumptions used by the
Company to determine the acquisition date fair value of the acquired asbestos liabilities are: 1) the projected payout,
including timing and amount of asbestos liabilities, which is derived from the actuarial estimate of nominal asbestos
liabilities; 2) a discount rate, which is applied to estimate the present value of the future cash flows; and 3) a risk margin.
The nominal asbestos liabilities include amounts for indemnity and defense costs for pending and future claims. The
Company  established  nominal  asbestos  liabilities  based  on  actuarially  determined  estimates  of  ultimate  claims
payments, using generally accepted actuarial methods, with the assistance of actuarial specialists.

We identified the determination of the acquisition date fair value of the asbestos liabilities acquired in the Morse TEC
business combination as a critical audit matter. The evaluation of the estimate of nominal asbestos liabilities involved
a high degree of auditor judgment due to the inherent uncertainty that exists in estimating the number and potential
value of claims asserted, but unpaid and claims not yet asserted. The key assumptions used in the fair value process
included: 1) the projected payout, including timing and amount of asbestos liabilities; 2) a discount rate; and 3) a risk
margin.  Specialized  skills  and  knowledge  were  required  to  1)  evaluate  the  actuarial  methodologies  and  certain
assumptions used to estimate the nominal asbestos liability; and 2) the acquisition date fair value of asbestos liabilities.

The primary procedures we performed to address this critical audit matter included the following. We tested certain
internal controls over the Company’s process to estimate the fair value of the asbestos liabilities, including controls
over the assumptions and actuarial methodologies used in the 1) estimation of the nominal asbestos liabilities; 2)
estimation of the projected payout, including timing, and amount of asbestos liabilities; and 3) the methodologies and
assumptions used in determining the discount rate and risk margin. We involved actuarial processionals with specialized
skills and knowledge, who assisted in:

• Comparing the methodologies and assumptions used by the Company in estimating the nominal asbestos liabilities

with generally accepted actuarial methodologies;

• Evaluating expected trends in claim frequency and severity, by comparing them to historical results and industry

trends;

• Developing an independent actuarial estimate of nominal asbestos liabilities for selected lines of - business;

• Examining  the  Company’s  internal  actuarial  analysis  for  the  remaining  lines  of  business  by  analyzing  claims

development in the current year;

• Developing independent actuarial estimates of the projected payout, including timing, and amount of asbestos

liabilities; and

• Evaluating the methodologies and assumptions used by the Company in determining the risk margin used in the

estimation of the fair value of the acquired asbestos liabilities.

In addition, we involved valuation professionals with specialized skills and knowledge, who assisted in:

• Evaluating the discount rate used in the estimation of the fair value of the asbestos liabilities by assessing the

inputs into the discount rate.

/s/ KPMG Audit Limited

KPMG Audit Limited

Hamilton, Bermuda

February 27, 2020

We have served as the Company’s auditor since 2012.

121

Table of Contents

ENSTAR GROUP LIMITED

CONSOLIDATED BALANCE SHEETS
As of December 31, 2019 and 2018 

ASSETS

Short-term investments, trading, at fair value

Short-term investments, available-for-sale, at fair value (amortized cost: 2019 — $128,311; 2018 — $nil)

Fixed maturities, trading, at fair value

Fixed maturities, available-for-sale, at fair value (amortized cost: 2019 — $1,914,143; 2018 — $151,433)

Funds held - directly managed

Equities, at fair value

Other investments, at fair value

Equity method investments

Total investments (Note 6 and Note 12)

Cash and cash equivalents

Restricted cash and cash equivalents

Premiums receivable

Deferred tax assets (Note 20)

Reinsurance balances recoverable on paid and unpaid losses (Note 8)

Reinsurance balances recoverable on paid and unpaid losses, fair value (Note 8 and Note 12)

Insurance balances recoverable (Note 11)

Funds held by reinsured companies

Deferred acquisition costs

Goodwill and intangible assets (Note 14)

Other assets

TOTAL ASSETS

LIABILITIES

Losses and loss adjustment expenses (Note 10)

Losses and loss adjustment expenses, fair value (Note 10 and Note 12)

Defendant asbestos and environmental liabilities (Note 11)

Unearned premiums

Insurance and reinsurance balances payable

Deferred tax liabilities (Note 20)

Debt obligations (Note 15)

Other liabilities

TOTAL LIABILITIES

COMMITMENTS AND CONTINGENCIES (Note 23)

2019

2018

(expressed in thousands of U.S.
dollars, except share data)

$

51,490

$

114,116

128,335

6,346,329

1,913,389

1,187,552

729,721

2,524,420

326,277

—

7,248,793

151,609

1,198,154

367,125

1,957,757

204,507

13,207,513

11,242,061

703,085

352,692

576,980

170,984

602,096

380,488

787,468

10,124

1,684,372

1,290,072

695,518

448,855

408,735

153,505

216,468

744,608

739,591

135,808

321,267

121,101

218,725

707,469

$

$

19,363,315

$

16,556,270

7,808,116

$

6,535,449

2,621,122

2,874,055

847,685

746,775

373,180

16,074

1,191,207

464,014

203,320

842,618

388,086

10,542

861,539

468,129

14,068,173

12,183,738

REDEEMABLE NONCONTROLLING INTEREST (Note 16)

438,791

458,543

SHAREHOLDERS’ EQUITY (Note 17)

Ordinary shares (par value $1 each, issued and outstanding 2019: 21,511,505; 2018: 21,459,997):

Voting Ordinary Shares (issued and outstanding 2019: 18,001,823; 2018: 17,950,315)

Non-voting convertible ordinary Series C Shares (issued and outstanding 2019 and 2018: 2,599,672)

Non-voting convertible ordinary Series E Shares (issued and outstanding 2019 and 2018: 910,010)

Preferred Shares:

Series C Preferred Shares (issued and held in treasury 2019 and 2018: 388,571)

Series D Preferred Shares (issued and outstanding 2019 and 2018: 16,000)

Series E Preferred Shares (issued and outstanding 2019 and 2018: 4,400)

Treasury shares, at cost (Series C Preferred Shares 2019 and 2018: 388,571)

Additional paid-in capital

Accumulated other comprehensive income

Retained earnings

Total Enstar Group Limited Shareholders’ Equity

Noncontrolling interest

TOTAL SHAREHOLDERS’ EQUITY

TOTAL LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND SHAREHOLDERS’ EQUITY

18,002

2,600

910

389

400,000

110,000

(421,559)

1,836,778

7,171

2,887,892

4,842,183

14,168

17,950

2,600

910

389

400,000

110,000

(421,559)

1,804,664

10,440

1,976,539

3,901,933

12,056

$

4,856,351

$

3,913,989

19,363,315

16,556,270

See accompanying notes to the consolidated financial statements

122

Table of Contents

ENSTAR GROUP LIMITED

CONSOLIDATED STATEMENTS OF EARNINGS 
For the Years Ended December 31, 2019, 2018 and 2017

INCOME

Net premiums earned

Fees and commission income

Net investment income

Net realized and unrealized gains (losses)

Other income

EXPENSES

Net incurred losses and loss adjustment expenses

Life and annuity policy benefits

Acquisition costs

General and administrative expenses

Interest expense

Net foreign exchange (gains) losses

Loss on sale of subsidiary

EARNINGS (LOSS) BEFORE INCOME TAXES

Income tax benefit (expense)

Earnings from equity method investments

2019

2018

2017

(expressed in thousands of U.S.
dollars, except share and per share data)

$

1,154,861 $

895,575 $

613,121

28,453

321,276

35,088

270,671

1,031,351

(412,884)

37,170

2,573,111

872,575

91

305,951

473,086

52,541

(7,879)

—

35,085

823,535

454,025

1,003

192,790

407,375

26,217

2,668

—

1,696,365

1,084,078

876,746

(260,543)

(4,437)

55,910

6,124

42,147

66,103

208,789

190,334

22,605

1,100,952

193,551

4,015

96,906

435,985

28,102

17,537

16,349

792,445

308,507

6,395

5,904

320,806

10,993

331,799

(20,341)

311,458

—

NET EARNINGS (LOSS) FROM CONTINUING OPERATIONS

928,219

(212,272)

Net earnings from discontinued operations, net of income taxes

NET EARNINGS (LOSS)

Net loss (earnings) attributable to noncontrolling interest

NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR GROUP LIMITED

Dividends on preferred shares

—

928,219

9,870

938,089

(35,914)

—

(212,272)

62,051

(150,221)

(12,133)

NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR GROUP LIMITED
ORDINARY SHAREHOLDERS

$

902,175 $

(162,354) $

311,458

Earnings per ordinary share attributable to Enstar Group Limited:

Basic:

Net earnings (loss) from continuing operations

Net earnings from discontinued operations, net of income taxes

Net earnings (loss) per ordinary share

Diluted:

Net earnings (loss) from continuing operations

Net earnings from discontinued operations, net of income taxes

Net earnings (loss) per ordinary share

Weighted average ordinary shares outstanding:

Basic

Diluted

$

$

$

$

42.00 $

(7.84) $

—

—

42.00 $

(7.84) $

41.43 $

(7.84) $

—

—

41.43 $

(7.84) $

15.50

0.56

16.06

15.39

0.56

15.95

21,482,617

20,698,310

19,388,621

21,775,066

20,904,176

19,527,591

See accompanying notes to the consolidated financial statements

123

Table of Contents

ENSTAR GROUP LIMITED

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
For the Years Ended December 31, 2019, 2018 and 2017 

NET EARNINGS (LOSS)

Other comprehensive income (loss), net of income taxes:

Unrealized holding gains (losses) on fixed income investments
arising during the year

Reclassification adjustment for net realized gains (losses)
included in net earnings

Unrealized gains (losses) arising during the year, net of
reclassification adjustment

Change in currency translation adjustment

Reclassification to earnings on disposal of subsidiary

Total cumulative translation adjustment

Decrease in defined benefit pension liability

Total other comprehensive gain (loss)

2019

2018

2017

(expressed in thousands of U.S. dollars)

$

928,219 $

(212,272) $

331,799

2,896

(2,284)

4,776

(3,894)

(998)
(2,428)
—
(2,428)
42
(3,384)

63

(491)

(2,221)
(202)
—
(202)
2,156
(267)

4,285

9,423

20,751

30,174

1,501

35,960

Comprehensive income (loss)

924,835

(212,539)

367,759

Comprehensive loss (income) attributable to noncontrolling
interest

9,985

62,291

(22,285)

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED

$

934,820 $

(150,248) $

345,474

See accompanying notes to the consolidated financial statements

124

 
Table of Contents

ENSTAR GROUP LIMITED

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
For the Years Ended December 31, 2019, 2018 and 2017

Share Capital — Voting Ordinary Shares

Balance, beginning of year

Issue of shares
Conversion of Series C Non-Voting Convertible Ordinary Shares

Balance, end of year

Share Capital — Non-Voting Convertible Ordinary Series C Shares

Balance, beginning of year

Conversion to Voting Ordinary Shares

Balance, end of year

Share Capital — Non-Voting Convertible Ordinary Series E Shares

Balance, beginning of year

Issue of shares
Balance, end of year

Share Capital - Series C Convertible Participating Non-Voting Preferred Shares

Balance, beginning and end of year

Share Capital - Series D Preferred Shares

Balance, beginning of year

Issue of shares
Balance, end of year

Share Capital - Series E Preferred Shares

Balance, beginning of year

Issue of shares
Balance, end of year

Treasury Shares (Series C Preferred Shares)
Balance, beginning and end of year

Additional Paid-in Capital

Balance, beginning of year

Issue of voting ordinary shares
Issuance costs of preferred shares
Amortization of share-based compensation

Balance, end of year

Accumulated Other Comprehensive Income (Loss)

Balance, beginning of year

Cumulative translation adjustment
Balance, beginning of year

Change in currency translation adjustment
Reclassification to earnings on disposal of subsidiary

Balance, end of year

Defined benefit pension liability
Balance, beginning of year

Change in defined benefit pension liability

Balance, end of year

Unrealized gains (losses) on investments

Balance, beginning of year

Change in unrealized gains (losses) on investments

Balance, end of year

Balance, end of year

Retained Earnings

Balance, beginning of year

Net earnings (loss) attributable to Enstar Group Limited ordinary shareholders
Net loss (earnings) attributable to noncontrolling interest
Dividends on preferred shares
Change in redemption value of redeemable noncontrolling interests
Cumulative effect of change in accounting principle

Balance, end of year

Noncontrolling Interest (excludes redeemable noncontrolling interests)

Balance, beginning of year

Purchase of noncontrolling shareholders' interest in subsidiaries
Contribution of capital
Net earnings attributable to noncontrolling interest

Balance, end of year

2019
2017
2018
(expressed in thousands of U.S. dollars)

17,950
52
—
18,002

2,600
—
2,600

910
—
910

389

400,000
—
400,000

110,000
—
110,000

(421,559)

1,804,664
583
—
31,531
1,836,778

10,440

10,986
(2,438)
—
8,548

(987)
42
(945)

441
(873)
(432)
7,171

1,976,539
928,219
9,870
(35,914)
9,178
—
2,887,892

12,056
(47)
—
2,159
14,168

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

16,402
1,548
—
17,950

2,600
—
2,600

405
505
910

389

$

$

$

$

$

$

$

— $

400,000
400,000

$

— $

110,000
110,000

(421,559)

1,395,067
413,141
(14,643)
11,099
1,804,664

10,468

11,171
(185)
—
10,986

(3,143)
2,156
(987)

2,440
(1,999)
441
10,440

2,132,912
(212,272)
62,051
(12,133)
7,554
(1,573)
1,976,539

9,264
—
49
2,743
12,056

$

$

$

$

$

$

$

$

$

$

16,175
35
192
16,402

2,792
(192)
2,600

405
—
405

389

—
—
—

—
—
—

(421,559)

1,380,109
450
—
14,508
1,395,067

(23,549)

(18,993)
9,413
20,751
11,171

(4,644)
1,501
(3,143)

88
2,352
2,440
10,468

1,847,550
331,799
(20,341)
—
(30,978)
4,882
2,132,912

8,520
—
22
722
9,264

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

See accompanying notes to the consolidated financial statements

125

  
Table of Contents

 ENSTAR GROUP LIMITED

CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Years Ended December 31, 2019, 2018 and 2017 

OPERATING ACTIVITIES:

Net earnings (loss)
Net earnings from discontinued operations, net of income taxes

Adjustments to reconcile net earnings to cash flows used in operating activities:

2019

2018

2017

(expressed in thousands of U.S. dollars)

$

928,219
—

$

(212,272) $

—

331,799
(10,993)

Realized losses (gains) on sale of investments
Unrealized losses (gains) on investments
Depreciation and other amortization
Earnings from equity method investments
Sales and maturities of trading securities
Purchases of trading securities
Net loss on sale of subsidiary
Other non-cash items
Changes in:

Reinsurance balances recoverable on paid and unpaid losses
Funds held by reinsured companies
Losses and loss adjustment expenses
Defendant asbestos and environmental liabilities
Policy benefits for life and annuity contracts
Insurance and reinsurance balances payable
Unearned premiums
Premiums receivable
Other operating assets and liabilities

Net cash flows provided by (used in) operating activities

INVESTING ACTIVITIES:

Acquisitions, net of cash acquired
Sale of subsidiary, net of cash sold
Sales and maturities of available-for-sale securities
Purchase of available-for-sale securities
Purchase of other investments
Proceeds from other investments
Purchase of equity method investments
Other investing activities

Net cash flows provided by (used in) investing activities

FINANCING ACTIVITIES:

Net proceeds from the issuance of preferred shares
Dividends on preferred shares
Contribution by noncontrolling interest
Contribution by redeemable noncontrolling interest
Dividends paid to noncontrolling interest
Purchase of noncontrolling interest in subsidiaries
Receipt of loans
Repayment of loans

Net cash flows provided by (used in) financing activities

EFFECT OF EXCHANGE RATE CHANGES ON FOREIGN CURRENCY CASH, CASH
EQUIVALENTS AND RESTRICTED CASH

(96,328)
(935,023)
35,583
(55,910)
5,829,277
(4,591,459)
—
33,857

(350,243)
(87,468)
1,021,175
(18,142)
(103,080)
(15,227)
(95,843)
210,493
53,635
1,763,516

$

172,482
—
344,325
(2,212,204)
(796,918)
582,662
(69,213)
(4,671)
(1,983,537)

$

— $

(35,914)
—
13,127
(11,556)
(47)
1,070,502
(742,574)
293,538

27,633
385,251
33,295
(42,147)
4,802,224
(5,592,311)
—
11,857

(268,039)
(126,897)
960,199
(15,844)
(6,776)
151,918
173,725
(212,423)
(229,465)
(160,072)

$

(245,151) $

—
58,219
(10,386)
(901,071)
436,396
(155,440)
(8,321)
(825,754)

495,357
(12,133)
49
55,377
(3,852)
—
1,132,507
(914,319)
752,986

$

(1,668)
(188,666)
36,115
(5,904)
6,111,607
(7,544,649)
16,349
41,087

(530,857)
(93,310)
1,363,032
(14,857)
(3,314)
(157,741)
34,854
(19,026)
293,035
(343,107)

(4,185)
126,611
86,359
(14,848)
(109,885)
232,827
—
(23,617)
293,262

—
—
22
—
(27,458)
—
874,100
(912,140)
(65,476)

(324)

2,588

9,512

NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR

73,193
982,584
$ 1,055,777

Supplemental Cash Flow Information:
Income taxes paid, net of refunds
Interest paid

Reconciliation to Consolidated Balance Sheets:
Cash and cash equivalents
Restricted cash and cash equivalents
Cash, cash equivalents and restricted cash

$
$

5,012
49,457

$

703,085
352,692
$ 1,055,777

(230,252)
1,212,836
982,584

(105,809)
1,318,645
$ 1,212,836

17,610
25,240

$
$

13,192
21,487

602,096
380,488
982,584

$

955,150
257,686
$ 1,212,836

$

$
$

$

$

See accompanying notes to the consolidated financial statements

126

Table of Contents

ENSTAR GROUP LIMITED

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2019, 2018 and 2017 

(Tabular information expressed in thousands of U.S. dollars except share and per share data) 

1. DESCRIPTION OF BUSINESS 

Enstar Group Limited ("Enstar") is a Bermuda-based holding company, formed in 2001. Enstar is a multi-faceted
insurance  group  that  offers  innovative  capital  release  solutions  and  specialty  underwriting  capabilities  through  its
network of group companies in Bermuda, the United States, the United Kingdom, Continental Europe, Australia, and
other international locations. Our ordinary shares are listed on the NASDAQ Global Select Market under the ticker
symbol "ESGR". Unless the context indicates otherwise, the terms "Enstar," "we," "us" or "our" mean Enstar Group
Limited and its consolidated subsidiaries and the term "Parent Company" means Enstar Group Limited and not any
of its consolidated subsidiaries.

Our business is organized into three segments:

(i) Non-life Run-off: This segment comprises the operations of our subsidiaries that are running off their property
and casualty and other non-life business. It also includes our management business, which manages the
run-off portfolios of third parties through our service companies; 

(ii) Atrium: Atrium Underwriters Ltd. is a managing general agent at Lloyd’s of London ("Lloyd's"), which manages
Syndicate  609.  Through  a  corporate  capital  vehicle,  Atrium  5  Ltd.,  we  provide  25%  of  the  syndicate’s
underwriting capacity and capital (with the balance provided by traditional Lloyd’s Names). Atrium specializes
in a wide range of industry classes, including marine, aviation and transit, property and casualty binding
authorities, reinsurance, accident and health and non-marine direct and facultative; and 

(iii) StarStone: StarStone is a global specialty insurer that underwrites a diverse range of property, casualty and
specialty  insurance  through  its  operations  in  Bermuda,  the  United  States,  the  United  Kingdom,  and
Continental  Europe.  Certain  business  of  StarStone  placed  into  run-off  at  the  time  of  our  acquisition  of
StarStone is recorded in our Non-life Run-off segment.

Atrium and StarStone, our active underwriting operations, are reported as separate segments because they are
managed and operated in separate and distinct manners. Atrium employees are not involved in the management or
strategy of StarStone, nor are StarStone employees involved in the management or strategy of Atrium. Atrium and
StarStone  are  monitored  and  reported  upon  separately  and  distinctly  and  their  strategies  and  business  plans  are
determined independently of each other.

 In addition to our three reportable segments, our other activities, which do not qualify as a reportable segment,
include our corporate expenses, debt servicing costs, holding company income and expenses, foreign exchange and
other miscellaneous items.

127

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

2. SIGNIFICANT ACCOUNTING POLICIES 

Basis of Preparation

The consolidated financial statements have been prepared in conformity with accounting principles generally
accepted in the United States of America ("U.S. GAAP"). The consolidated financial statements include our assets,
liabilities and results of operations as of December 31, 2019 and 2018 and for the years ended December 31, 2019,
2018 and 2017. Results of operations for acquired subsidiaries are included from the date of acquisition. All significant
intercompany transactions and balances have been eliminated. Certain prior period amounts have been reclassified
to conform to the current period presentation. These reclassifications had no impact on net earnings. 

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates
and  assumptions  that  affect  the  reported  amount  of  assets  and  liabilities  and  disclosure  of  contingent  assets  and
liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting
period.  Our  actual  results  could  differ  materially  from  our  estimates. Accounting  policies  that  we  believe  are  most
dependent on assumptions and estimates are considered to be our critical accounting policies and are related to the
determination of: 

•

•

•

•

•

•

•

•

•

•

liability for losses and loss adjustment expenses ("LAE");

reinsurance balances recoverable on paid and unpaid losses;

defendant asbestos and environmental liabilities and related insurance balances recoverable; 

valuation allowances on reinsurance balances recoverable and deferred tax assets;

impairment  charges,  including  other-than-temporary  impairments  on  investment  securities  classified  as
available-for-sale, and impairments on goodwill, intangible assets and deferred charge assets; 

gross and net premiums written and net premiums earned;

fair value measurements of investments; 

fair value estimates associated with accounting for acquisitions;

fair value estimates associated with loss portfolio transfer reinsurance agreements for which we have elected
the fair value option; and

redeemable noncontrolling interests.

 Significant Accounting Policies

(a) Premiums 

Non-Life

Non-life premiums written are earned on a pro-rata basis over the period the coverage is provided. Reinsurance
premiums are recorded at the inception of the policy, are based upon contractual terms and, for certain business, are
estimated  based  on  underlying  contracts  or  from  information  provided  by  insureds  and/or  brokers.  Changes  in
reinsurance  premium  estimates  are  expected  and  may  result  in  adjustments  in  future  periods.  Any  subsequent
differences arising on such estimates are recorded as premiums written in the period in which they are determined.

Certain non-life contracts are retrospectively rated and provide for a final adjustment to the premium based on
the  final  settlement  of  all  losses.  Premiums  on  such  contracts  are  adjusted  based  upon  contractual  terms,  and
management judgment is involved with respect to the estimate of the amount of losses that we expect to incur.  Additional
premiums are recognized at the time loss thresholds specified in the contract are exceeded and are earned over the
coverage period, or are earned immediately if the period of risk coverage has passed.

Premiums receivable

Premiums receivable represent amounts currently due and amounts not yet due on insurance and reinsurance
policies.  Premiums  for  insurance  policies  and  loss  portfolio  transfer  reinsurance  agreements  are  generally  due  at
inception. Premiums for other reinsurance policies generally become due over the period of coverage based on the

128

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

policy terms. We monitor the credit risk associated with premiums receivable, taking into consideration the impact of
our contractual right to offset loss obligations or unearned premiums against premiums receivable. Amounts deemed
uncollectible are charged to net earnings based on an expected loss approach. Changes in the estimates of premiums
written will result in an adjustment to premiums receivable in the period they are determined. 

Unearned premiums and prepaid reinsurance premiums

Unearned premiums represent the portion of premiums written that relate to the unexpired terms of policies in
force. Premiums ceded are similarly pro-rated over the period the coverage is provided with the unearned portion being
deferred as prepaid reinsurance premiums.

(b) Acquisition Costs 

Acquisition costs, consisting principally of commissions and brokerage expenses and certain premium taxes and
fees incurred at the time a contract or policy is issued and that vary with and are directly related to the successful
efforts of acquiring new insurance contracts or renewing existing insurance contracts, are deferred and amortized over
the period in which the related premiums are earned. Deferred acquisition costs are limited to their estimated realizable
value  by  line  of  business  based  on  the  related  unearned  premiums,  anticipated  claims  and  claim  expenses  and
anticipated investment income.

A premium deficiency occurs if the sum of anticipated losses and loss adjustment expenses exceed unearned
premiums, deferred acquisition costs and anticipated investment income. A premium deficiency is initially recognized
by charging any deferred acquisition costs to expense to the extent required in order to eliminate the deficiency. If the
premium deficiency exceeds the deferred acquisition costs then a liability is accrued for the excess deficiency.

(c) Losses and LAE 

Non-life Run-off

The liability for losses and LAE in the Non-life Run-off segment includes an amount determined from reported
claims and an amount, based on historical loss experience and industry statistics, for losses incurred but not reported
("IBNR") determined using a variety of actuarial methods. These estimates are continually reviewed and are necessarily
subject to the impact of future changes in factors such as claim severity and frequency, changes in economic conditions
including the impact of inflation, legal and judicial developments, and medical cost trends. Our estimates, at inception
and  on  an  ongoing  basis,  do  not  include  an  estimate  for  potential  future  commutations  and  policy  buybacks.
Commutations and policy buybacks are often unique, and each commutation or policy buyback is separately negotiated.
Therefore, the successful execution of one commutation or policy buyback does not necessarily impact the likelihood
of other commutations or policy buybacks occurring in the future. We therefore exclude the impact of potential future
commutations and policy buybacks in determining the liability for losses and LAE. While we believe that the liability
for  losses  and  LAE  is  adequate,  the  ultimate  amount  may  be  in  excess  of,  or  less  than,  the  amounts  provided.
Adjustments will be reflected as part of the net increase or reduction in losses and LAE liabilities in the periods in which
they become known. Premium and commission adjustments may be triggered by incurred losses, and any amounts
are recorded in the same period that the related incurred loss is recognized.

Commutations of acquired companies’ exposures have the effect of accelerating the payout of claims compared
to the probability-weighted ranges of actuarially projected cash flows that we applied when estimating the fair values
of assets and liabilities at the time of acquisition. Commutations and policy buybacks provide an opportunity for us to
exit exposures to certain policies and insureds generally at a discount to our estimate of the ultimate liability and provide
us with the ability to eliminate exposure to further losses. Commutations and policy buybacks can be beneficial to us
as they legally extinguish liabilities in full, reduce the potential for future adverse loss development, and reduce future
claims handling costs. Any material acceleration of payout together with the impact of any material loss reserve savings
in any period will also accelerate the amortization of fair value adjustments and deferred charge assets in that period.
Commutations are only executed directly with insureds or reinsureds and any gains realized or losses incurred on the
settlement of losses and LAE liabilities through commutations or policy buybacks are recognized upon the execution
of a commutation or policy buyback with the insured or reinsured. Our estimate of the liability for losses and LAE does
not consider historical commutations and policy buybacks and also does not include an estimate for potential future
commutations and policy buybacks. 

129

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Our insurance and reinsurance subsidiaries also establish provisions for LAE relating to run-off costs for the
estimated duration of the run-off, which are included in the liability for losses and LAE. These provisions are assessed
at each reporting date, and provisions relating to future periods are adjusted to reflect any changes in estimates of the
periodic run-off costs or the duration of the run-off, including the impact of any acceleration of the run-off period that
may be caused by commutations. Provisions relating to the current period together with any adjustment to future run-
off provisions are included in net incurred losses and LAE in the consolidated statements of earnings.

Atrium and StarStone

The reserves for losses and LAE in the Atrium and StarStone segments include reserves for unpaid reported
losses and for IBNR loss reserves. The reserves for unpaid reported losses and loss expenses are established by
management based on reports from brokers, ceding companies and insureds and represent the estimated ultimate
cost of events or conditions that have been reported to or specifically identified by us. The reserve for IBNR losses is
established by us based on actuarially determined estimates of ultimate losses and loss expenses. Inherent in the
estimate of ultimate losses and loss expenses are expected trends in claim severity and frequency and other factors
which may vary significantly as claims are settled. Accordingly, ultimate losses and loss expenses may differ from the
amounts recorded in the consolidated financial statements. These estimates are reviewed regularly and, as experience
develops and new information becomes known, the reserves are adjusted as necessary. Such adjustments, if any, will
be recorded in earnings in the period in which they become known. Prior period development arises from changes to
loss estimates recognized in the current year that relate to loss reserves established in previous calendar years.

Components of Net Incurred Losses and LAE

Included within the total net incurred losses and LAE on our consolidated statement of earnings are the following

items:

•

•

•

•

•

•

•

•

•

Net losses paid: paid losses and LAE, net of related reinsurance recoveries.

Net  change  in  case  and  LAE  reserves:  the  change  in  case  reserves  and  associated  LAE,  net  of  related
reinsurance recoveries.

Net change in IBNR reserves: the change in IBNR reserves, net of related reinsurance recoveries.

Increase (reduction) in estimates of net ultimate losses: the total of net losses paid, net change in case and
LAE reserves and the net change in IBNR. This includes the net impact of commutations and policy buybacks
on the liability for losses and LAE reserves and reinsurance recoveries.

Increase (reduction) in provisions for unallocated LAE: the net change in our provision for unallocated LAE.

Amortization of deferred charge assets: the amortization of the deferred charge assets associated with assumed
retroactive reinsurance contracts, where the estimated ultimate losses assumed at the inception of the contracts
is greater than the premium consideration received.

Amortization of fair value adjustments: the amortization of the fair value adjustments associated with acquired
companies, where the assumed losses and LAE reserves and the acquired reinsurance recoveries are fair
valued on acquisition.

Changes in fair value - fair value option: the changes in the fair value for reinsurance agreements where we
have elected the fair value option. The change in fair value component includes the changes in the discounted
cash flows and risk margin. The underlying net losses paid, net change in case and LAE reserves and the net
change in IBNR reserves relating to these reinsurance agreements for which we have elected the fair value
option are included within the appropriate line items described above.

Net incurred losses and LAE: the total of increase (reduction) in estimates of net ultimate losses, increase
(reduction) in provisions for unallocated LAE, amortization of deferred charge assets, amortization of fair value
adjustments and changes in fair value - fair value option. 

130

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

(d) Defendant Asbestos and Environmental Liabilities 

We  acquired  DCo  on  December  30,  2016,  and  Morse TEC  on  October  30,  2019,  as  described  in  Note  3  -
"Acquisitions". DCo and Morse TEC hold liabilities associated with personal injury asbestos claims and environmental
claims arising from their legacy manufacturing operations. DCo and Morse TEC continue to process asbestos personal
injury claims.

Defendant  asbestos  and  environmental  liabilities  on  our  consolidated  balance  sheets  include  amounts  for
indemnity  and  defense  costs  for  pending  and  future  claims,  determined  using  standard  actuarial  techniques  for
asbestos-related exposures. Defendant asbestos and environmental liabilities also include amounts for environmental
liabilities associated with DCo's and Morse TEC's properties. 

(e) Reinsurance Balances Recoverable on Paid and Unpaid Losses 

Amounts  billed  to,  and  due  from,  reinsurers  resulting  from  paid  movements  in  the  underlying  business  are
calculated  in  accordance  with  the  terms  of  the  individual  reinsurance  contracts.  Similarly,  reinsurance  balances
recoverable  on  paid  and  unpaid  losses  related  to  our  case  reserves  are  calculated  by  applying  the  terms  of  any
applicable reinsurance coverage to movements in the underlying case reserves. Our estimate of reinsurance balances
recoverable on paid and unpaid losses related to IBNR reserves is recognized on a basis consistent with the underlying
IBNR reserves.

Our reinsurance balances recoverable on paid and unpaid losses are presented net of a provision for uncollectible
amounts, reflecting the amount deemed not collectible due to credit quality, collection problems due to the location of
the reinsurer, contractual disputes with reinsurers over individual contentious claims, contract language or coverage
issues.

(f) Insurance Balances Recoverable 

Amounts billed to and due from insurers providing coverage for our defendant asbestos liabilities are calculated

in accordance with the terms of the individual insurance contracts.

The insurance balances recoverable related to our defendant asbestos liabilities are presented net of a provision
for uncollectible amounts, reflecting the amount deemed not collectible primarily due to credit quality and contractual
disputes with insurers over coverage issues.

(g) Investments, Cash and Cash Equivalents 

Short-term investments and fixed maturity investments

Short-term investments comprise investments with a maturity greater than three months up to one year from the
date of purchase. Fixed maturities comprise investments with a maturity of greater than one year from the date of
purchase.

 Short-term  and  fixed  maturity  investments  classified  as  trading  are  carried  at  fair  value,  with  realized  and
unrealized holding gains and losses included in net earnings and reported as net realized and unrealized gains and
losses.

Short-term and fixed maturity investments classified as available-for-sale are carried at fair value, with unrealized
gains  and  losses  excluded  from  net  earnings  and  reported  as  a  separate  component  of  accumulated  other
comprehensive income (loss) ("AOCI"). Realized gains and losses on sales of investments classified as available-for-
sale are recognized in the consolidated statements of earnings.

The costs of short-term and fixed maturity investments are adjusted for amortization of premiums and accretion
of discounts, recognized using the effective yield method and included in net investment income. For mortgage-backed
and asset-backed investments, and any other holdings for which there is a prepayment risk, prepayment assumptions
are evaluated and reviewed on a regular basis.

Investment purchases and sales are recorded on a trade-date basis. Realized gains and losses on the sale of

investments are based upon specific identification of the cost of investments.

131

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Other-Than-Temporary Impairments

Fixed  maturity  investments  classified  as  available-for-sale  are  reviewed  quarterly  to  determine  if  they  have
sustained an impairment of value that is, based on our judgment, considered to be other than temporary. The process
includes reviewing each fixed maturity investment whose fair value is below amortized cost and: (1) determining if we
have the intent to sell the fixed maturity investment; (2) determining if it is more likely than not that we will be required
to sell the fixed maturity investment before its anticipated recovery; and (3) assessing whether a credit loss exists, that
is, whether we expect that the present value of the cash flows expected to be collected from the fixed maturity investment
is less than the amortized cost basis of the investment. 

In assessing whether it is more likely than not that we will be required to sell a fixed maturity investment before
its anticipated recovery, we consider various factors including our future cash flow requirements, legal and regulatory
requirements, the level of our cash, cash equivalents, short-term investments and fixed maturity investments available-
for-sale in an unrealized gain position, and other relevant factors. 

In evaluating credit losses, we consider a variety of factors in the assessment of a fixed maturity investment
including: (1) the time period during which there has been a significant decline below cost; (2) the extent of the decline
below cost and par; (3) the potential for the investment to recover in value; (4) an analysis of the financial condition of
the issuer; (5) the rating of the issuer; and (6) failure of the issuer of the investment to make scheduled interest or
principal payments. 

If we conclude that an investment is other-than-temporarily impaired ("OTTI"), then the difference between the
fair value and the amortized cost of the investment is presented as an OTTI charge in the consolidated statements of
earnings,  with  an  offset  for  any  non-credit  related  loss  component  of  the  OTTI  charge  to  be  recognized  in  other
comprehensive income. Accordingly, only the credit loss component of the OTTI amount would have an impact on our
earnings.

Equities

We hold investments in publicly traded equities and exchange-traded funds as well as in privately held equities.
Our equity investments are carried at fair value with realized and unrealized holding gains and losses included in net
earnings and reported as net realized and unrealized gains and losses.

Other investments, at fair value

Other investments include investments in limited partnerships and limited liability companies (collectively "private
equities") and fixed income funds, hedge funds, equity funds, private credit funds and collateralized loan obligation
("CLO") equity funds that carry their investments at fair value, as well as direct investments in CLO equities. These
other investments are stated at fair value, which ordinarily will be the most recently reported net asset value as advised
by the fund manager or administrator. Many of our fund investments publish net asset values on a daily basis and
provide daily liquidity; others report on a monthly basis. Private equities typically report quarterly. The change in fair
value is included in net realized and unrealized gains and losses on investments and recognized in net earnings.

Equity method investments

Investments  in  which  the  Company  has  significant  influence  over  the  operating  and  financial  policies  of  the
investee are classified as equity method investments and are accounted for using the equity method of accounting. In
applying the equity method of accounting, investments are initially recorded at cost and are subsequently adjusted
based on the Company's proportionate share of net income or loss of the investee, net of any distributions received
from  the  investee. Adjustments  are  based  on  the  most  recently  available  financial  information  from  the  investee.
Changes in the carrying value of such investments are recorded in our consolidated statements of earnings as earnings
(losses) from equity method investments. Any decline in the value of our equity method investments considered by
management to be other-than-temporary is reflected in our consolidated statements of earnings in the period in which
it is determined. 

Cash and cash equivalents

Cash equivalents includes money market funds, fixed interest deposits and all highly liquid debt instruments

purchased with an original maturity of three months or less.

132

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

(h) Funds Held 

Under funds held arrangements, the reinsured company has retained funds that would otherwise have been
remitted to our reinsurance subsidiaries. The funds balance is credited with investment income and losses payable
are deducted. Funds held are shown under two categories on the consolidated balance sheets, where funds held upon
which we receive the underlying portfolio economics are shown as "Funds held - directly managed", and funds held
where we receive a fixed crediting rate are shown as "Funds held by reinsured companies". Funds held by reinsured
companies are carried at cost. Funds held - directly managed, carried at fair value, represents the aggregate of funds
held at cost and the value of an embedded derivative. The embedded derivative relates to our contractual right to
receive the return on the underlying investment portfolio economics. The investment returns on both categories of
funds held are recognized in net investment income and net realized and unrealized gains (losses). The revaluation
of the embedded derivative is included in net unrealized gains (losses). 

(i) Fees and Commission Income 

Fees and commission income primarily includes profit commissions earned from managed Lloyd's syndicates
as well as fees earned under fronting and consulting arrangements with third-party clients, which are recorded on an
accrual basis. 

(j) Foreign Exchange 

Our reporting currency is the U.S. dollar. Assets and liabilities of entities whose functional currency is not the
U.S. dollar are translated at period end exchange rates. Revenues and expenses of such foreign entities are translated
at average exchange rates during the year. The effect of the currency translation adjustments for these foreign entities
is included in accumulated other comprehensive income (loss).

Other foreign currency assets and liabilities that are considered monetary items are translated at exchange rates
in effect at the balance sheet date. Foreign currency revenues and expenses are translated either at transaction date
exchange rates or using an appropriately weighted average exchange rate for the reporting period. These exchange
gains and losses are recognized in net earnings.

(k) Share-based Compensation 

We primarily use three types of share-based compensation arrangements: (i) restricted shares, restricted share
units and performance share units, (ii) cash-settled stock appreciation rights ("SARs") and (iii) shares issued under
our employee share purchase plans. With the exception of SARs and the incentive plan awards issued to certain
employees of Atrium and StarStone, our share-based compensation awards qualify for equity classification. The fair
value of the compensation cost is measured at the grant date and is expensed over the service period of the award.
The SARs, the Atrium and StarStone incentive plan awards are classified as liability awards. Liability classified awards
are recorded at fair value within other liabilities in the consolidated balance sheet with changes in fair value relating to
the vested portion of the award recorded within general and administrative expenses in the consolidated statements
of earnings.

(l) Derivative Instruments 

We  utilize  derivative  instruments  in  our  foreign  currency  and  interest  rate  risk  management  strategies  and
recognize all derivatives as either assets or liabilities in the consolidated balance sheets and carry them at the fair
value of the specific instrument utilized. Changes in the fair value as well as realized gains or losses on derivative
instruments are recognized in net earnings if they are not designated as qualifying hedging instruments or if the criteria
for establishing a perfectly effective designated hedging relationship for our net investment hedges has not been met.
However, if a designated net investment hedge is deemed to be perfectly effective, then we recognize the changes in
the  fair  value  of  the  underlying  hedging  instrument  in  accumulated  other  comprehensive  income  (loss)  until  the
application of hedge accounting is discontinued. Any cumulative gains or losses arising on designated net investment
hedges are deferred in accumulated other comprehensive income (loss) until the cumulative translation adjustment
("CTA") from the underlying hedged net investment is recognized in net earnings due to a disposal, deconsolidation
or substantial liquidation.

Certain of our funds held arrangements also contain embedded derivatives as described above, which are carried

at fair value. In addition, we also hold equity call options carried at fair value, as part of our investment strategy.

133

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

(m) Income Taxes 

Certain of our subsidiaries and branches operate in jurisdictions where they are subject to taxation. Current and
deferred tax expense or benefit is allocated to net earnings (loss), or, in certain cases, to discontinued operations or
other comprehensive income (loss). Current tax is recognized and measured upon enacted tax laws and rates applicable
in the relevant jurisdiction in the period in which the income tax becomes accruable or realizable. Deferred taxes are
provided for temporary differences between the carrying amount of assets and liabilities used in the financial statements
and the tax basis used in the various jurisdictional tax returns. When our assessment indicates that all or some portion
of deferred tax assets will not be realized, a valuation allowance is recorded against the deferred tax assets to reduce
the assets to the amount more likely than not to be realized.

We recognize the benefit relating to tax positions only where the position is more likely than not to be sustained
assuming examination by tax authorities. A recognized tax benefit is measured as the largest amount that is greater
than 50 percent likely of being realized upon settlement. A liability or other adjustment is recognized for any tax benefit
(along  with  any  interest  and  penalty,  if  applicable)  claimed  in  a  tax  return  in  excess  of  the  amount  allowed  to  be
recognized in the financial statements under U.S. GAAP. Any changes in amounts recognized are recorded in the
period in which they are determined.

(n) Earnings Per Share 

Basic earnings per share is based on the weighted average number of ordinary shares outstanding and excludes
potentially  dilutive  securities  such  as  restricted  shares,  restricted  share  units,  warrants,  options  and  convertible
securities.  Diluted  earnings  per  share  is  based  on  the  weighted  average  number  of  ordinary  and  ordinary  share
equivalents outstanding calculated using the treasury stock method for all potentially dilutive securities. When the effect
of dilutive securities would be anti-dilutive, these securities are excluded from the calculation of diluted earnings per
share.

(o) Acquisitions, Goodwill and Intangible Assets 

The acquisition method is used to account for all business acquisitions. This method requires that we record the
acquired assets and liabilities at their estimated fair value. The fair values of each of the acquired reinsurance assets
and liabilities are derived from probability-weighted ranges of the associated projected cash flows, based on actuarially
prepared information and management’s run-off strategy. Our run-off strategy, as well as that of other run-off market
participants, is expected to be different from the seller's as generally sellers are not specialized in running off insurance
and reinsurance liabilities whereas we and other market participants do specialize in such run-offs.

The key assumptions used by us and, we believe, by other run-off market participants in the valuation of acquired
companies are (i) the projected payout, timing and amount of claims liabilities; (ii) the related projected timing and
amount of reinsurance collections; (iii) an appropriate discount rate, which is applied to determine the present value
of the future cash flows; (iv) the estimated unallocated LAE to be incurred over the life of the run-off; (v) the impact of
any accelerated run-off strategy; and (vi) an appropriate risk margin.

The difference between the nominal carrying values of the acquired reinsurance liabilities and assets as of the
acquisition date and their fair value is recorded as a fair value adjustment ("FVA") on the consolidated balance sheet.
The FVA is amortized over the estimated payout period of the acquired outstanding losses and LAE and reinsurance
balances recoverable. To the extent the actual payout experience after the acquisition is materially faster or slower
than anticipated at the time of the acquisition as a result of (i) our active claims management strategies, which include
commutations and policy buybacks, (ii) an adjustment to the estimated ultimate loss reserves, (iii) changes in bad debt
provisions, or (iv) changes in estimates of future run-off costs following accelerated payouts, then the amortization of
the FVA is adjusted to reflect such changes.

The difference between the fair value of net assets acquired and the purchase price is recorded as goodwill and
included  as  an  asset  on  the  consolidated  balance  sheet  or  as  a  gain  from  bargain  purchase  in  the  consolidated
statements of earnings. Goodwill is established initially upon acquisition and assessed at least annually for impairment.
If the goodwill asset is determined to be impaired it is written down in the period in which the determination is made.

134

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Intangible  assets  represent  both  the  definite-lived  and  indefinite-lived  intangible  assets  arising  from  the
acquisitions of Atrium and StarStone. Definite-lived intangible assets are amortized over their useful lives with the
amortization expense being recognized in the consolidated statements of earnings. Indefinite-lived intangible assets
are not subject to amortization. The carrying values of intangible assets are reviewed for indicators of impairment at
least annually. Impairment is recognized if the carrying values of the definite-lived intangible assets are not recoverable
from their undiscounted cash flows and is measured as the amount by which the carrying value exceeds the fair value.
Similarly, for indefinite-lived intangible assets, if the carrying value of the asset exceeds its fair value, then an impairment
loss is recognized in an amount equal to the excess.

(p) Retroactive Reinsurance 

Retroactive reinsurance policies provide indemnification for losses and LAE with respect to past loss events. In
our Non-life Run-off segment we use the balance sheet accounting approach for assumed loss portfolio transfers,
whereby at the inception of the contract there are no premiums or losses recorded in earnings.

Deferred Charge Assets

If, at the inception of a Non-life Run-off retroactive reinsurance contract, the estimated undiscounted ultimate
losses  payable  are  in  excess  of  the  premiums  received,  a  deferred  charge  asset  is  recorded  for  the  excess. The
premium consideration that we charge the ceding companies may be lower than the undiscounted estimated ultimate
losses payable due to the time value of money. After receiving the premium consideration in full from our cedents at
the inception of the contract, we invest the premium received over an extended period of time, thereby generating
investment income. We expect to generate profits from these retroactive reinsurance policies when taking into account
the premium received and expected investment income, less contractual obligations and expenses. Deferred charge
assets, recorded in other assets, are amortized over the estimated claim payment period of the related contract with
the periodic amortization reflected in earnings as a component of losses and LAE. The amortization of deferred charge
assets is adjusted at each reporting period to reflect new estimates of the amount and timing of remaining loss ad LAE
payments. Changes in the estimated amount and the timing of payments of unpaid losses may have an effect on the
unamortized deferred charge assets and the amount of periodic amortization. When liabilities for losses and LAE are
extinguished through commutations and policy buybacks, they are removed from our estimates for the remaining loss
and LAE payments, and this will generally result in an acceleration of the amortization of the deferred charge assets.
Deferred charge assets are assessed at each reporting period for impairment and if the asset is determined to be
impaired, then it is written down in the period in which the determination is made.

Fair Value Option

In our Non-life Run-off segment, we have elected to apply the fair value option for certain loss portfolio transfer
reinsurance transactions. This is an irrevocable election that applies to all balances under the insurance contract,
including funds held assets, reinsurance balances recoverable on paid and unpaid losses, and the liability for losses
and loss adjustment expenses. 

We use an internal model to calculate the fair value of the liability for losses and loss adjustment expenses and
the reinsurance balances recoverable on paid and unpaid losses. Note 12 - "Fair Value Measurements" describes the
internal model, including the observable and unobservable inputs used in the model.

(q) Redeemable Noncontrolling Interest 

In  connection  with  the  acquisitions  of  Arden,  Atrium  and  StarStone,  certain  subsidiaries  issued  shares  to
noncontrolling interests. These shares provide certain redemption rights to the holders, which may be settled in our
own shares or cash or a combination of cash and shares, at our option. Redeemable noncontrolling interests with
redemption features that are not solely within our control are classified within temporary equity in the consolidated
balance sheets and carried at their redemption value, which is fair value. Change in the fair value is recognized through
retained earnings as if the balance sheet date were also the redemption date.

135

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

(r) Internal-use Software 

Direct internal and external costs to acquire or develop internal-use software have been capitalized. We only
capitalize costs incurred after the preliminary project stage has been completed, and when management has authorized
and committed to funding the project and it is probable that the project will be completed and the software will be used
to perform the functions intended. Capitalized costs related to internal-use software are amortized on a straight-line
basis over the estimated useful lives of the assets. These capitalized costs are also assessed for impairment when
impairment indicators exist. 

(s) Held-for-sale Business and Discontinued Operations 

We report a business as held-for-sale when certain criteria are met, which include (1) management has either
approved the sale or is in the process of obtaining approval to sell the business and is committed to a formal plan to
sell the business, (2) the business is available for immediate sale in its present condition, (3) the business is being
actively marketed for sale at a price that is reasonable in relation to its current fair value, and (4) the sale is anticipated
to occur within the next 12 months, among other specified criteria. A business classified as held for sale is recorded
at the lower of its carrying amount or estimated fair value less costs to sell. If the carrying amount of the business
exceeds its estimated fair value, a loss is recognized. Assets and liabilities related to the businesses classified as held-
for-sale are separately reported in our Consolidated Balance Sheets beginning in the period in which the business is
classified as held-for-sale. Refer to Note 5 - "Divestitures, Held-for-Sale Businesses and Discontinued Operations" for
further information regarding our held-for-sale business.

Disposals that represent strategic shifts that have or will have a major effect on our operations and financial

results are reported as discontinued operations.

New Accounting Standards Adopted in 2019 

Accounting Standards Update ("ASU") 2019-07 - Codification Updates to SEC Sections

In July 2019, the Financial Accounting Standards Board (the "FASB") issued ASU 2019-07 in response to the
Securities and Exchange Commission's ("SEC's") disclosure update and simplification initiative. The ASU clarifies or
improves the disclosure and presentation requirements of a variety of Codification Topics by aligning them with the
SEC’s regulations, thereby eliminating redundancies and making the Codification easier to apply. The adoption of the
disclosure and presentation amendments included in this ASU and which are to be applied prospectively, did not have
a material impact on our consolidated financial statements and disclosures.

ASU 2018-13, Changes to the Disclosure Requirements for Fair Value Measurements

In  August  2018,  the  FASB  issued  ASU  2018-13,  which  amended  the  fair  value  measurement  guidance  in
Accounting Standards Codification ("ASC") 820 - Fair Value Measurement, by removing and modifying certain existing
disclosure requirements, while also adding some new disclosure requirements. We adopted the new standard as of
December  31,  2019  however  these  new  or  modified  disclosures  did  not  have  a  material  impact  on  the  fair  value
measurement disclosures included in our consolidated financial statements.

ASU 2018-02, Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income

In February 2018, the FASB issued ASU 2018-02, which gives entities the option to reclassify to retained earnings
tax effects related to items in accumulated other comprehensive income (“AOCI”) that are deemed stranded in AOCI
as a result of the Tax Cuts and Jobs Act (the "Tax Act") enacted in the United States at the end of 2017. The amendments
in  this  guidance  eliminate  the  stranded  tax  effects  resulting  from  the  Tax  Act  and  will  improve  the usefulness  of
information reported to financial statement users. We adopted the new standard on January 1, 2019, and that adoption
did not have a material impact on our consolidated financial statements and related disclosures.

ASUs 2016-02, 2018-10, 2018-11 and 2019-01, Leases

In February 2016, the FASB issued ASU 2016-02, which is codified in ASC 842 - Leases, amending the guidance
on the classification, measurement and disclosure of leases for both lessors and lessees. The ASU requires lessees
to recognize a right-of-use asset and an offsetting lease liability on the balance sheet and to disclose qualitative and
quantitative information about leasing arrangements. Subsequently, in July 2018, the FASB issued ASU 2018-10, which
clarifies how to apply certain aspects of ASC 842. The amendments in the ASU address a number of issues in the new
leases guidance, including (1) the rate implicit in the lease, (2) impairment of the net investment in the lease, (3) lessee

136

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

reassessment of lease classification, (4) lessor reassessment of lease term and purchase options, (5) variable payments
that depend on an index or rate, and (6) certain transition adjustments.

In July 2018, the FASB also issued ASU 2018-11, which adds a transition option for all entities and a practical
expedient only for lessors, to ASU 2016-02. The transition option, which we elected on adoption of the guidance, allows
entities not to apply the new leases standard in the comparative periods they present in their financial statements in
the year of adoption. Under the transition option, entities can instead opt to continue to apply the legacy guidance in
ASC 840 - Leases, including its disclosure requirements, in the comparative periods presented in the year they adopt
the new leases standard. This means that entities that elect this option will only provide annual disclosures for the
comparative periods because ASC 840 does not require interim disclosures. Entities that elect this transition option
are still required to adopt the new leases standard using the modified retrospective transition method, but they will
recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption rather
than in the earliest period presented. The practical expedient provides lessors with an option to not separate the non-
lease components from the associated lease components when certain criteria are met and requires them to account
for the combined component in accordance with the revenue recognition standard in ASC 606 if the associated non-
lease components are the predominant components.

In addition, in March 2019, the FASB issued ASU 2019-01 to clarify that in the year of initial adoption of ASC
842, entities are not subject to the transition disclosure requirements in ASC 250-10-50-3 related to the effect of an
accounting change on certain interim period financial information. Prior to this clarification, the transition guidance in
ASC 842 only excluded the annual disclosures required in ASC 250-10-50-1(b)(2).

We adopted ASU 2016-02 and the related amendments on January 1, 2019 using the modified retrospective
transition method as required by the standard and recognized a right-of-use asset and an associated lease liability of
$51.6 million on our consolidated balance sheet, relating primarily to office space and facilities that we have leased to
conduct our business operations. Refer to Note 23 - "Commitments and Contingencies" for further details.

Recently Issued Accounting Pronouncements Not Yet Adopted

ASU 2020-01 - Clarifying the Interactions between ASC 321, ASC 323 and ASC 815

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities
under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting
for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions
between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that
require it to either apply or discontinue the equity method of accounting when applying the measurement alternative
in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward
contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in
ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise
of the purchased option, individually or with existing investments, the underlying securities would be accounted for
under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for
interim and annual reporting periods beginning after December 15, 2020, although early adoption is permitted, including
adoption  in  any  interim  period.  We  do  not  expect  the  adoption  of  this  standard  to  have  a  material  impact  on  our
consolidated financial statements and disclosures.

ASU 2019-12 - Simplifying the Accounting for Income Taxes

In December 2019, the FASB issued ASU 2019-12 which removes certain exceptions for (1) recognizing deferred
taxes for investments, (2) performing intraperiod tax allocation, and (3) calculating income taxes in interim periods.
The ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill
and allocating income taxes to a legal entity that is not subject to income taxes. The ASU is effective for interim and
annual reporting periods beginning after December 15, 2020, although early adoption is permitted, including adoption
in any interim period. We are currently assessing the impact of adopting this guidance however we do not expect that
the adoption will have a material impact on our consolidated financial statements and disclosures.

137

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

ASUs  2016-13,  2018-19,  2019-04,  2019-05,  2019-10  and  2019-11,  Financial  Instruments  -  Credit  Losses  -
Measurement of Credit Losses on Financial Instruments

In June 2016, the FASB issued ASU 2016-13, which is codified in ASC 326, amending the guidance on the
impairment of financial instruments and significantly changing how entities measure credit losses for most financial
assets and certain other financial instruments including reinsurance balances recoverable on paid and unpaid losses
that are not measured at fair value through net income. The ASU will replace the existing “incurred loss” approach,
with an “expected loss” model for instruments measured at amortized cost and require entities to record allowances
for available-for-sale ("AFS") debt securities rather than reduce the carrying amount under the existing OTTI model.
The ASU also simplifies the accounting model for purchased credit-impaired debt securities and loans.

In November 2018, the FASB then issued ASU 2018-19 covering targeted improvements to ASU 2016-13, which
clarifies that receivables arising from operating leases are not within the scope of ASC 326-20 and that instead, the
impairment of such receivables should be accounted for in accordance with ASC 842 - Leases.

In April 2019, the FASB also issued ASU 2019-04, which amends (1) ASU 2016-13 as codified in ASC 326, (2)
ASU 2017-12 on hedging activities as codified in ASC 815, and (3) ASU 2016-01 on recognizing and measuring financial
instruments as codified in ASC 825-10. Specifically with respect to ASC 326, the amendments in ASU 2019-04 clarify
the scope of the credit losses standard and address issues related to accrued interest receivable balances, recoveries,
variable interest rates and prepayments.

In May 2019, the FASB then issued ASU 2019-05, which amends ASU 2016-13 to provide entities with an option
to irrevocably elect the fair value option for certain financial assets previously measured on an amortized cost basis.
Entities that avail themselves of this transition relief will have the option to irrevocably elect the fair value option in ASC
825-10 on an instrument-by-instrument basis for eligible instruments, upon the adoption of ASC 326. The fair value
option election, however, does not apply to held-to-maturity debt securities. An entity that elects the fair value option
should subsequently apply the guidance in ASC 820-10 and ASC 825-10 to the eligible instruments for which it has
elected the fair value option.

In November 2019, the FASB also issued ASU 2019-10 deferring the effective dates for ASU 2016-13; ASU
2017-12  and ASU  2016-02  for  non-public  business  entities.  With  respect  to ASU  2016-13,  this  deferral  was  also
extended to entities that meet the smaller reporting company eligibility criteria.

Finally, in November 2019, the FASB issued ASU 2019-11 which clarified the following specific issues related
to the amendments in ASU 2016-13: (1) the treatment for expected recoveries for purchased financial assets with
credit deterioration or PCD assets, (2) application of the transition relief provided for troubled debt restructuring ("TDRs"),
(3) disclosures related to accrued interest receivables, and (4) the application of the practical expedient related to
financial assets secured by collateral maintenance provisions.

We adopted ASU 2016-13 and all the related amendments on January 1, 2020 using the modified retrospective
approach and recorded a cumulative effect adjustment of approximately $1.6 million to increase opening retained
earnings with respect to our financial instruments carried at amortized cost, which primarily relate to our reinsurance
balances recoverable. As disclosed in Note 8 - Reinsurance Balances Recoverable on Paids and Unpaid Losses, we
already carry significant specific provisions for bad debts amounting to $147.6 million on our reinsurance balances
recoverable, relating primarily to our Non-life Run-off segment. Therefore, the adoption of ASU 2016-13 and the related
amendments  did  not  have  a  material  quantitative  impact  on  the  overall  credit  allowance  established  against  our
reinsurance balances recoverable. As a result of adopting ASU 2016-13 and the related amendments, we also recorded
a credit allowance of approximately $3.1 million related to our AFS debt securities whose fair values were less than
their amortized cost basis. 

In  addition  to  the  estimated  quantitative  impact  of  adopting ASU  2016-13  and  the  related  amendments,  as
illustrated above, the guidance will also require us to amend and in certain cases, significantly enhance the qualitative
disclosures included in our consolidated financial statements around the following specific items: (1) the credit risk
inherent within our portfolios of financial assets and how we monitor credit quality, (2) how we determine the estimation
of expected credit losses, (3) changes in the estimate of expected credit losses that have occurred during each reporting
period, and (4) providing a roll-forward analysis of our allowance for credit losses.

138

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

3. ACQUISITIONS 

2019

Morse TEC

Overview

On October 30, 2019, we completed the acquisition of Morse TEC LLC ("Morse TEC") through our subsidiary,
Enstar Holdings (US) LLC for $nil purchase price. Morse TEC holds approximately $0.7 billion in liabilities associated
with  personal  injury  asbestos  claims  and  environmental  claims  arising  from  BorgWarner's  legacy  manufacturing
operations. We applied the acquisition method to account for the Morse TEC transaction as required by ASC 805 -
Business Combinations, with no goodwill or gain from bargain purchase being recorded on the acquisition. In addition,
no intangible assets were identified for recognition on the acquisition.

Fair Value of Net Assets Acquired and Liabilities Assumed

The following table summarizes the fair values of the assets acquired and liabilities assumed in the Morse TEC

transaction at the acquisition date, which have all been allocated to the Non-life Run-off segment.

ASSETS

Cash and cash equivalents

Deferred tax assets

Other assets - insurance balances receivable

TOTAL ASSETS

LIABILITIES

Defendant asbestos and environmental liabilities

Other liabilities

TOTAL LIABILITIES

NET ASSETS ACQUIRED AT FAIR VALUE

$ 171,412
140,000

371,116

682,528

662,507

20,021
$ 682,528
—

Morse TEC's Results Included in the Consolidated Statement of Earnings

The table below summarizes the results of the Morse TEC operations, which are included in our consolidated

statement of earnings from the acquisition date to December 31, 2019:

Net investment income

General and administrative expenses

Other expenses

Net loss

$

$

488
(1,459)
(1,512)
(2,483)

Supplemental Pro Forma Financial Information

The following unaudited pro forma condensed combined statement of earnings for the years ended December
31, 2019 and 2018 combines our historical consolidated statements of earnings with those of Morse TEC, giving effect
to the business combination transaction as if it had occurred on January 1, 2019 and 2018, respectively. The unaudited
pro forma financial information presented below is for informational purposes only and is not necessarily indicative of
the results of operations that would have been achieved if the acquisition of Morse TEC had taken place at the beginning
of each period presented, nor is it indicative of future results.

139

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

2019

Total income

Total expenses

Total noncontrolling interest

Enstar Group
Limited

$

2,629,021 $
(1,700,802)
9,870

Morse TEC

Pro Forma
Adjustments

Enstar Group
Limited - Pro
forma

76,480 $
(8,918)
—

(488) $

1,459

—

2,705,013
(1,708,261)
9,870

Net earnings (loss) attributable to Enstar Group
Limited

$

938,089 $

67,562 $

971 $

1,006,622

The following table summarizes the pro-forma adjustments in the table above:

Income

(a) Total income for the period subsequent to the acquisition of Morse TEC already included
within Enstar's full year results

$

(488)

Expenses

(a) Total expenses for the period subsequent to the acquisition of Morse TEC already
included within Enstar's full year results

$

1,459

2018

Total income

Total expenses

Total noncontrolling interest

Enstar Group
Limited

$

865,682 $

(1,077,954)
62,051

Morse TEC

Enstar Group
Limited - Pro
forma

42,766 $
(30,187)
—

908,448
(1,108,141)
62,051

Net earnings (loss) attributable to Enstar Group
Limited

$

(150,221) $

12,579 $

(137,642)

2018

Maiden Re North America

Overview

On December 27, 2018, we completed the acquisition of Maiden Reinsurance North America, Inc. (“Maiden Re
North America”)  from  a  subsidiary  of Maiden  Holdings,  Ltd.  ("Maiden  Holdings"). Maiden  Re  North America is  an
insurance company domiciled in Missouri that provides property and casualty treaty reinsurance, casualty facultative
reinsurance and accident and health treaty reinsurance.  As part of the transaction, we also novated and assumed
certain reinsurance agreements from Maiden Holdings' Bermuda reinsurer, including certain reinsurance agreements
with Maiden Re North America. Refer to Note 4 - "Significant New Business" for additional information relating to these
reinsurance agreements. We have operated the business in run-off since we acquired it.

Purchase Price

The  total  cash  paid  in  the  transaction  was $286.4  million,  subject  to  certain  post-closing  adjustments.  The
components of the consideration paid to acquire all of the outstanding shares of Maiden Re North America were as
follows:

Cash paid

Adjustment for the fair value of preexisting relationships
Total purchase price

Net assets acquired at fair value (excluding preexisting relationships)

Excess of purchase price over fair value of net assets acquired

$

$

$

$

286,375

10,273
296,648

296,648

—

140

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The purchase price was allocated to the acquired assets and liabilities of Maiden Re North America based on

their estimated fair values at the acquisition date.

Adjustment for the Fair Value of Preexisting Relationships

Enstar  had  contractual  preexisting  relationships  with  Maiden  Re  North America,  which  were  deemed  to  be
effectively settled at fair value on the acquisition date. The differences between the carrying value and the fair value
of the preexisting relationships was included as part of the purchase price in accordance with ASC 805 - Business
Combinations. The fair value of the balances relating to preexisting reinsurance relationships with Maiden Re North
America were deemed to equal their carrying values given their short-term nature and the expectation that they would
all be settled within twelve months following acquisition.

Fair Value of Net Assets Acquired and Liabilities Assumed

The  following  table  summarizes  the  fair  values  of  the  assets  acquired  and  liabilities  assumed  (excluding
preexisting relationships and net of the intercompany cession assumed as part of the transaction) in the Maiden Re
North America transaction at the acquisition date, which have all been allocated to the Non-life Run-off segment.

ASSETS

Fixed maturities, trading, at fair value

Short-term investments, trading, at fair value

Total investments

Cash and cash equivalents

Restricted cash and cash equivalents

Premiums receivable

Prepaid reinsurance premiums

Reinsurance balances recoverable

Other assets

TOTAL ASSETS

LIABILITIES

Losses and LAE

Unearned premiums

Other liabilities

TOTAL LIABILITIES

NET ASSETS ACQUIRED AT FAIR VALUE

$1,098,593
3,508

1,102,101

12,035

26,871

138,378

3,257

87,018

96,669
$1,466,329

$1,027,367
85,696

56,618

1,169,681
$ 296,648

Maiden Re North America's Results Included in the Consolidated Statement of Earnings

The table below summarizes the results of the Maiden Re North America operations, which are included in

our consolidated statement of earnings from the acquisition date to December 31, 2018:

Net investment income

Net unrealized gains

General and administrative expenses

Net earnings

$

$

675

3,749
(435)
3,989

141

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Table of Contents

KaylaRe

Overview

On May 14, 2018, the Company acquired all of the outstanding shares and warrants of KaylaRe Holdings, Ltd.
("KaylaRe"). In consideration for the acquired shares and warrants of KaylaRe, the Company issued an aggregate of
2,007,017 ordinary shares to the shareholders of KaylaRe, comprising 1,501,778 voting ordinary shares and 505,239
Series E non-voting ordinary shares. Effective May 14, 2018, we consolidated KaylaRe into our consolidated financial
statements,  and  any  balances  between  KaylaRe  and  Enstar  are  now  eliminated  upon  consolidation.  Effective
September  30,  2019,  KaylaRe  and  KaylaRe  Ltd.  merged  with  Cavello  Bay  Reinsurance  Limited,  a  wholly  owned
subsidiary of the Company, with Cavello Bay Reinsurance Limited as the surviving company. Refer to Note 21 - "Related
Party Transactions" for additional information relating to KaylaRe.

Purchase Price

The components of the consideration paid to acquire all of the outstanding shares and warrants of KaylaRe

were as follows:

Fair value of Enstar ordinary shares issued

Fair value of previously held equity method investment

Adjustment for the fair value of preexisting relationships

Total purchase price

Net assets acquired at fair value (excluding preexisting relationships)

Excess of purchase price over fair value of net assets acquired

$

$

$

$

414,750

336,137

37,169

788,056

746,320

41,736

The purchase price was allocated to the acquired assets and liabilities of KaylaRe based on their estimated fair
values at the acquisition date. We recognized goodwill of $41.7 million on the transaction, primarily attributable to (i)
the capital synergies from integrating KaylaRe into our group capital structure, (ii) investment management capabilities
on a total return basis, and (iii) the incremental acquired capital to be utilized for future non-life run-off transactions. 

Fair Value of Enstar Ordinary Shares Issued

The fair value of the Enstar ordinary shares issued was based on the closing price of Enstar's voting ordinary
shares  of  $206.65  as  of  May 14,  2018,  the  date  the  transaction  closed.  Enstar's  non-voting  ordinary  shares  are
economically equivalent to Enstar's voting ordinary shares.

Number of Enstar ordinary shares issued

Closing price of Enstar voting ordinary shares as of May 14, 2018

Fair value of Enstar ordinary shares issued to shareholders of KaylaRe

2,007,017

206.65

414,750

$

$

Fair Value of Previously Held Equity Method Investment

Prior to the close of the transaction, Enstar held a 48.2% interest in KaylaRe, which was accounted for as an
equity method investment in accordance with ASC 323 - Investments - Equity Method and Joint Ventures. The acquisition
of the remaining 51.8% equity interest in KaylaRe was considered a step acquisition, whereby the Company remeasured
the previously held equity method investment to fair value. The Company considered multiple factors in determining
the  fair  value  of  the  previously  held  equity  method  investment,  including  (i)  the  price  negotiated  with  the  selling
shareholders for the 51.8% equity interest in KaylaRe, (ii) recent market transactions for similar companies, and (iii)
current trading multiples for comparable companies. Based on this analysis, a valuation multiple of 1.05 to KaylaRe's
carrying book value was determined to be appropriate to remeasure the previously held equity method investment at
fair value. This resulted in the recognition of a gain of $16.0 million on completion of the step acquisition of KaylaRe,
which was recorded in earnings (losses) from equity method investments for the three and six months ended June 30,
2018. 

142

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Carrying value of previously held equity method investment prior to the close of the transaction

Price-to-book multiple

Fair value of previously held equity method investment prior to the close of the transaction

Gain recognized on remeasurement of previously held equity method investment to fair value

$

$

$

320,130

1.05

336,137

16,007

Adjustment for the Fair Value of Preexisting Relationships

Enstar had contractual preexisting relationships with KaylaRe, which were deemed to be effectively settled at
fair value on the acquisition date. The differences between the carrying value and the fair value of the preexisting
relationships was included as part of the purchase price in accordance with ASC 805 - Business Combinations. The
fair  value  of  the  balances  relating  to  preexisting  reinsurance  relationships  with  KaylaRe  was  determined  using  a
discounted  cash  flow  approach  and,  where  applicable,  consideration  was  given  to  stated  contractual  settlement
provisions, when determining the loss to be recorded on the deemed settlement of these preexisting relationships.
The fair values of the balances arising from the non-reinsurance preexisting relationships with KaylaRe were deemed
to equal their carrying values given their short-term nature and the expectation that they would all be settled within the
next twelve months.

As  a  result  of  effectively  settling  all  the  contractual  preexisting  relationships  with  KaylaRe,  the  Company
recognized a loss of $15.6 million, which was recorded in other income (loss) in the three and six months ended June
30, 2018, as summarized below:

ASSETS

Carrying value

Fair value

Funds held by reinsured companies

$

386,793 $

386,793 $

Deferred acquisition costs/Value of business acquired

TOTAL ASSETS

LIABILITIES

Losses and LAE

Unearned premiums

Insurance and reinsurance balances payable

Other liabilities

TOTAL LIABILITIES

NET ASSETS (LIABILITIES)

33,549

420,342

339,747

105,602

25,897

1,864

40,268

427,061

333,205

105,602

23,559

1,864

473,110
(52,768) $

464,230
(37,169) $

$

Loss on
deemed
settlement

—

6,719

6,719

(6,542)
—
(2,338)
—
(8,880)
15,599

143

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Fair Value of Net Assets Acquired and Liabilities Assumed

The  following  table  summarizes  the  fair  values  of  the  assets  acquired  and  liabilities  assumed  (excluding
preexisting relationships) in the KaylaRe transaction at the acquisition date, which have all been allocated to the Non-
life Run-off segment.

ASSETS

Fixed maturities, trading, at fair value

Other investments, at fair value

Total investments

Cash and cash equivalents

Premiums receivable

Deferred acquisition costs

Other assets

TOTAL ASSETS

LIABILITIES

Losses and LAE

Unearned premiums

Insurance and reinsurance balances payable

Other liabilities

TOTAL LIABILITIES

NET ASSETS ACQUIRED AT FAIR VALUE

$ 126,393
626,476

752,869

5,657

10,965

275

614
$ 770,380

$

4,059

10,984

13

9,004

24,060
$ 746,320

KaylaRe's Results Included in the Consolidated Statement of Earnings

The table below summarizes the results of the KaylaRe operations, which are included in our consolidated

statement of earnings from the acquisition date to December 31, 2018:

Premiums earned

Incurred losses and LAE

Acquisition costs

Underwriting income

Net investment income

Net unrealized gains

General and administrative expenses

Net loss

$

$

13,627
(12,364)
(341)
922

3,096
(47,769)
(2,164)
(45,915)

144

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

4. SIGNIFICANT NEW BUSINESS 

2020

AXA Group

On February 24, 2020, we entered into a loss portfolio transfer reinsurance agreement with AXA XL, a division
of AXA,  to  reinsure  specified  legacy  construction  general  liability  multi-year  policies.  We  will  assume  reinsurance
reserves of approximately $225.0 million in the transaction. Completion of the transaction is subject to, among other
things, regulatory approvals and satisfaction of various closing conditions. The transaction is expected to close in the
first half of 2020.

Munich Re

On  September 10,  2019,  we  signed  an  agreement  with  Great  Lakes  Insurance  SE  and  HSB  Engineering
Insurance Limited, both subsidiaries of Munich Reinsurance Company ("Munich Re"), pursuant to which we will acquire
certain portfolios from their Australian branches. In the transaction, which is subject to regulatory and Federal Court
of Australia approval, we will receive total assets of approximately AUD$228.2 million (approximately $160.3 million)
for assuming the associated net insurance reserves, which primarily relate to long tail insurance business. We are
pursuing a portfolio transfer of the insurance business under Division 3A of Part III of Australia’s Insurance Act 1973
(Cth), which would provide legal finality for Munich Re and its subsidiaries. This transaction is expected to close in
2020.

2019

Zurich

On October 1, 2019, we completed a reinsurance transaction with Zurich Insurance Group ("Zurich"), pursuant
to  which  we  reinsured  certain  of  Zurich's  U.S.  asbestos  and  environmental  liability  insurance  portfolios.  In  the
transaction, we assumed $622.9 million of gross reserves, relating to 1986 and prior year business, for reinsurance
premium of $465.5 million and recorded a deferred charge of $115.8 million. We have ceded 10% of this transaction
to Enhanzed Reinsurance Ltd. ("Enhanzed Re"), in which we have an investment, on the same terms and conditions
as those received by Enstar. 

Maiden ADC

On August 5, 2019, we and Maiden Reinsurance Ltd. (“Maiden Re Bermuda”) completed a transaction pursuant
to a Master Agreement with Maiden Holdings, Ltd. and Maiden Re Bermuda to provide adverse development cover
reinsurance to Maiden Re Bermuda, effective January 1, 2019. In the transaction, Maiden Re Bermuda ceded and we
assumed  as  retrocessionaire  Maiden  Re  Bermuda's  liability  under  its  quota  share  agreement  with  the  Bermuda
subsidiary  ("AmTrust  Bermuda")  of AmTrust  Financial  Services,  Inc.  (“AmTrust”). The  adverse  development  cover
reinsurance is for losses incurred on or prior to December 31, 2018 in excess of a $2.2 billion retention up to a $600.0
million limit, in exchange for a premium of $445.0 million. We assumed total gross reserves of $530.2 million and
recorded  a  deferred  charge  of  $85.2  million.  Enstar's  reinsurance  performance  obligations  in  the  transaction  are
collateralized in accordance with a Master Collateral Agreement among Enstar, Maiden Re Bermuda, AmTrust and
certain subsidiaries of AmTrust. 

Amerisure

On April 11, 2019, we completed a loss portfolio transfer reinsurance agreement with Amerisure Mutual Insurance
Company ("Amerisure") and Allianz Risk Transfer (Bermuda) Limited (“ART Bermuda”). In the transaction, Amerisure
ceded, and each of Enstar and ART Bermuda severally assumed, a 50% quota share of the construction defect losses
incurred by Amerisure and certain of its subsidiaries on or before December 31, 2012. Under the agreement, which
was effective as of January 1, 2019, we assumed $48.3 million of gross reserves in exchange for consideration of
$45.5 million and recorded a deferred charge asset of $2.9 million. 

145

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

AmTrust RITC Transactions

On  February 14,  2019,  we  completed  four  RITC  transactions  with  Syndicates  1206,  1861,  2526  and  5820
(collectively the "AmTrust RITC Transactions"), managed by AmTrust Syndicates Limited, under which we reinsured
to close the 2016 and prior underwriting years. We assumed, among other items, gross loss reserves of £703.8 million
($897.1  million)  and  net  loss  reserves  of  £486.8  million  ($620.4  million)  relating  to  the  portfolios  in  exchange  for
consideration of £539.9 million ($688.2 million) and recorded a deferred charge asset of $20.6 million. We have an
investment in AmTrust, as described further in Note 21 - "Related Party Transactions".

2018

Allianz 

Effective December 31, 2018, we and Allianz SE ("Allianz") amended the January 1, 2016 reinsurance agreement
between our subsidiary and Allianz, which related to our reinsurance of certain U.S. workers' compensation, construction
defect, and asbestos, pollution and toxic tort business originally held by Fireman's Fund Insurance Company. The
amendment increased the original sub-limit related to asbestos & environmental (“A&E”) liabilities in exchange for a
premium of $70.0 million. This additional business is also covered by the consulting agreement that we entered into
with San Francisco Reinsurance Company, an affiliate of Allianz, in connection with our 2016 transaction with Allianz
discussed below. 

Maiden LPT

On  December 27,  2018,  as  part  of  the  acquisition  of  Maiden  Re  North  America  as  discussed  in  Note  3  -
"Acquisitions", we also novated and assumed certain reinsurance agreements from Maiden Re Bermuda, including
certain affiliate reinsurance agreements with Maiden Re North America. We assumed total gross unaffiliated reserves
of $72.1 million for total assets of $70.4 million on a funds held basis and recorded a deferred charge asset of $1.7
million.

Coca-Cola

On August 1, 2018, we entered into a reinsurance transaction with The Coca-Cola Company and its subsidiaries
("Coca-Cola"),  pursuant  to  which  we  reinsured  certain  of  Coca-Cola's  retention  and  deductible  risks  under  its
subsidiaries' U.S. workers' compensation, auto liability, general liability and product liability insurance coverage. We
assumed total gross reserves of $120.8 million for cash consideration of $103.6 million and recorded a deferred charge
asset of $17.2 million. We transferred the cash consideration received of $103.6 million into a trust to support our
obligations under the reinsurance agreement.

Zurich Australia

On February 23, 2018, we entered into a reinsurance agreement with Zurich Australian Insurance Limited, a
subsidiary of Zurich Insurance Group ("Zurich"), to reinsure its New South Wales Vehicle Compulsory Third Party
("CTP") insurance business. Under the agreement, which was effective as of January 1, 2018, we assumed gross loss
reserves of AUD$359.4 million ($280.8 million) in exchange for consideration of AUD$343.9 million ($268.7 million).
We elected the fair value option for this reinsurance contract and recorded an initial fair value adjustment of AUD$15.5
million  ($12.1  million)  on  the  assumed  gross  loss  reserves.  Refer  to  Note  12  -  "Fair  Value  Measurements"  for  a
description of the fair value process and the assumptions made.

Following the initial reinsurance transaction, which transferred the economics of the CTP insurance business,
we and Zurich also completed a portfolio transfer of the CTP insurance business under Division 3A Part III of Australia's
Insurance Act 1973 (Cth), effective December 31, 2018, which provided legal finality for Zurich's obligations. 

146

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Neon RITC Transaction

On February 16, 2018, we completed a reinsurance-to-close (“RITC”) transaction with Neon Underwriting Limited
("Neon"), under which we reinsured to close the 2015 and prior underwriting years of account (comprising underwriting
years 2008 to 2015) of Neon's Syndicate 2468, with effect from January 1, 2018. We assumed gross loss reserves of
£403.9 million ($546.3 million) and net loss reserves of £342.1 million ($462.6 million) relating to the portfolio in exchange
for consideration of £329.1 million ($445.1 million). We elected the fair value option for this reinsurance contract and
recorded initial fair value adjustments of $20.6 million and $17.5 million on the gross and net loss reserves assumed,
respectively. Refer to Note 12 - "Fair Value Measurements" for a description of the fair value process and the assumptions
made.

Novae RITC Transaction

On January 29, 2018, we completed an RITC transaction with AXIS Managing Agency Limited, under which we
reinsured to close the 2015 and prior underwriting years of account of Novae Syndicate 2007 ("Novae"), with effect
from January 1, 2018. We assumed gross loss reserves of £860.1 million ($1,163.2 million) and net loss reserves of
£630.7 million ($853.0 million) relating to the portfolio in exchange for consideration of £594.1 million ($803.5 million)
and recorded initial fair value adjustments of $67.5 million and $49.5 million on the gross and net loss reserves assumed,
respectively. Refer to Note 12 - "Fair Value Measurements" for a description of the fair value process and the assumptions
made.

2017

Allianz 

On December 28, 2017, we entered into a reinsurance agreement with Allianz to reinsure a portfolio of Allianz’s
run-off business, effective December 31, 2017. Pursuant to the reinsurance agreement, we reinsured 50% of certain
U.S. workers' compensation, asbestos, and toxic tort business originally held by San Francisco Reinsurance Company,
an affiliate of Allianz, and in the process assumed net reinsurance reserves of $81.4 million. Affiliates of Allianz retained
$81.4 million of reinsurance premium as funds withheld collateral for the obligations under the reinsurance agreement
and  we  transferred  $8.1  million  to  a  reinsurance  trust  to  further  support  our  obligations.  We  also  provide  ongoing
consulting services with respect to the entire $162.8 million portfolio, including the 50% share retained by affiliates of
Allianz.

RSA

On February 7, 2017, we entered into an agreement to reinsure the U.K. employers' liability legacy business of
RSA Insurance Group PLC ("RSA"). Pursuant to the transaction, our subsidiary assumed gross insurance reserves of
£1,046.4 million ($1,301.8 million), relating to 2005 and prior year business. Net insurance reserves assumed were
£927.5 million ($1,153.9 million) and the reinsurance premium received was £801.6 million ($997.2 million). We elected
the fair value option for this reinsurance contract. The initial fair value adjustment on the gross reserves was $174.1
million, and on the net reserves was $156.7 million. Refer to Note 12 - "Fair Value Measurements" for a description of
the fair value process and assumptions.

In addition to the initial reinsurance transaction, which transferred the economics of the portfolio up to the policy's
limits, we and RSA completed a portfolio transfer of the business under Part VII of the Financial Services and Markets
Act 2000 on July 1, 2019, which provided legal finality for RSA's obligations.

QBE

On January 11, 2017, we closed a transaction to reinsure multi-line property and casualty business of QBE
Insurance Group Limited ("QBE"). We assumed gross reinsurance reserves of approximately $1,019.0 million (net
reserves of $447.0 million) relating to the portfolio, which primarily includes workers' compensation, construction defect,
and general liability discontinued lines of business. The reinsurance premium received was $403.8 million, comprised
of $227.6 million in restricted cash and $176.2 million in funds held. We elected the fair value option for this reinsurance
contract. The initial fair value adjustment was $180.0 million on the gross reserves and $43.2 million on the net reserves.
Refer to Note 12 - "Fair Value Measurements" for a description of the fair value process and assumptions. In addition,
we pledged a portion of the premium as collateral to a subsidiary of QBE, and we have provided additional collateral
and a limited parental guarantee.

147

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

5. DIVESTITURES, HELD-FOR-SALE BUSINESSES AND DISCONTINUED OPERATIONS 

Policy Benefits for Life Contracts held by Alpha Insurance

On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-owned
subsidiary Alpha  Insurance  SA  to  a  subsidiary  of  Monument  Insurance  Group  Limited  ("Monument").  Our  life  and
annuities operations do not qualify for inclusion in our reportable segments and are therefore included within other
activities. The related assets, as well as the results from these operations, were not significant to our consolidated
operations and therefore were not classified as a discontinued operation. In addition, our transfer of these life assurance
polices to Monument was not classified as a held-for-sale business transaction since the underlying contracts did not
meet the definition of a business. We have an equity method investment in Monument, as described further in Note
21 - "Related Party Transactions".

Life assurance polices subjected us to mortality, longevity and morbidity risks and were accounted for as life and
annuity premiums earned. Life benefit reserves were established using assumptions for investment yields, mortality,
morbidity,  lapse  and  expenses,  including  a  provision  for  adverse  deviation.  We  established  and  reviewed  our  life
reserves regularly based upon cash flow projections. We established and maintained our life reinsurance reserves at
a level that we estimated would, when taken together with future premium payments and investment income expected
to be earned on associated premiums, be sufficient to support all future cash flow benefit obligations and third-party
servicing obligations as they become payable. Policy benefits for life contracts as of December 31, 2018 were $105.1
million.

Pavonia

On December 29, 2017, we completed the sale of our subsidiary, Pavonia Holdings (US), Inc. (“Pavonia”), to
Southland National Holdings, Inc. (“Southland”), a Delaware corporation and a subsidiary of Global Bankers Insurance
Group, LLC. The aggregate purchase price was $120.0 million. We used the proceeds to make repayments under our
revolving credit facility. Pavonia was a substantial portion of our previously reported Life and Annuities segment. Pavonia
was classified as held-for-sale prior to its sale during 2017. 

The Pavonia business qualified as a discontinued operation. Net earnings from discontinued operations from
Pavonia recorded in the consolidated statement of earnings were $11.0 million for the year ended December 31, 2017.
The change in cash of businesses held for sale on the consolidated cash flow statement from Pavonia was $118.3
million whilst under our ownership for the year ended December 31, 2017. The cash, cash equivalents and restricted
cash carried on the balance sheet of Pavonia on December 29, 2017, the date of disposal, were $135.1 million.

A sale of one subsidiary, Pavonia Life Insurance Company of New York ("PLIC NY"), has not yet been agreed
or completed. As of December 31, 2019 and 2018, included within other assets and other liabilities on our consolidated
balance sheet were amounts of $20.6 million and $11.7 million, and $24.0 million and $11.3 million, respectively, relating
to PLIC NY.

Laguna 

On August 29, 2017, we closed the previously-announced sale of our wholly-owned subsidiary Laguna Life DAC
(“Laguna”) to a subsidiary of Monument, for a total consideration of €25.6 million (approximately $30.8 million). We
have an equity method investment in Monument, as described further in Note 21 - "Related Party Transactions". Laguna
was classified as held-for-sale during 2017 prior to its sale. 

Following the closing of the sale of Laguna, we recorded a loss on sale of $16.3 million for the year ended
December 31, 2017, which was included in earnings from continuing operations before income taxes in our consolidated
statement of earnings. This loss included a cumulative currency translation adjustment balance of $6.3 million, which
was reclassified from accumulated other comprehensive income and included in earnings as a component of the loss
on sale of Laguna during the year ended December 31, 2017, following the closing of the sale. Excluding the loss on
sale, the net losses relating to Laguna for the year ended December 31, 2017 were $1.2 million. These amounts were
not significant to our consolidated operations and therefore Laguna was not classified as a discontinued operation.

148

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

6. INVESTMENTS 

We hold: (i) trading portfolios of fixed maturity investments, short-term investments and equities, carried at fair
value;  (ii)  available-for-sale  portfolios  of  fixed  maturity  and  short-term  investments,  carried  at  fair  value;  (iii)  other
investments carried at fair value; (iv) equity method investments; and (v) funds held - directly managed.

Fixed Maturity Investments

Asset Types

The  fair  values  of  the  underlying  asset  types  of  our  short-term  investments  and  fixed  maturity  investments,
classified as trading and available-for-sale, and the fixed maturity investments included within our funds held - directly
managed balance were as follows as of December 31, 2019 and 2018:

2019

Short-term
investments,
trading

Short-term
investments,
available-for-
sale

Fixed
maturities,
trading

Fixed
maturities,
available-
for-sale

Fixed
maturities,
funds held -
directly
managed

Total

U.S. government and agency

$

— $

111,583 $

219,194 $

298,729

$

106,537 $

736,043

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Total fixed maturity and short-
term investments

24,411

21,958

5,121

—

—

—

—

1,069

387

122,012

575,018

14,280

84,760

—

20,734

161,772

702,857

13,915

4,007,386

1,067,256

603,389

5,697,067

1,381

—

—

—

102,554

258,412

571,129

490,624

14,491

127,219

98,557

208,097

49,456

86,205

230,343

76,681

167,882

471,836

900,029

775,402

$

51,490 $

128,335 $ 6,346,329 $ 1,913,389

$ 1,173,345 $ 9,612,888

Short-term
investments,
trading

Fixed
maturities,
trading

2018

Fixed
maturities,
available-for-
sale

Fixed
maturities,
funds held -
directly
managed

$

45,885 $

2,275
19,064
44,900
—
—
—
1,992

389,735 $
298,356
679,525
4,081,793
73,856
682,962
488,598
553,968

$

573
—
73,185
75,359
2,480
12
—
—

74,052 $
—
22,036
637,788
53,929
90,583
224,465
80,521

Total

510,245
300,631
793,810
4,839,840
130,265
773,557
713,063
636,481

$

114,116 $

7,248,793 $

151,609

$

1,183,374 $

8,697,892

U.S. government and agency
U.K. government
Other government
Corporate
Municipal
Residential mortgage-backed
Commercial mortgage-backed
Asset-backed

Total fixed maturity and short-
term investments

Included within residential and commercial mortgage-backed securities as of December 31, 2019 were securities
issued by U.S. governmental agencies with a fair value of $356.9 million (as of December 31, 2018: $656.6 million).
Included  within  corporate  securities  as  of  December 31,  2019  were  senior  secured  loans  of  $31.4  million  (as  of
December 31, 2018: $20.4 million).

149

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Contractual Maturities

The contractual maturities of our short-term investments and fixed maturity investments, classified as trading
and available-for-sale, and the fixed maturity investments included within our funds held - directly managed balance
are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call
or prepay obligations with or without call or prepayment penalties.

As of December 31, 2019
One year or less

More than one year through two years

More than two years through five years

More than five years through ten years

More than ten years

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Credit Ratings

Amortized
Cost

Fair Value

$

537,944 $

536,156

801,473

808,071

2,175,547

2,212,834

2,108,172

2,198,505

1,584,345

1,710,055

466,932

882,603

779,279

471,836

900,029

775,402

% of Total
Fair
Value

5.6%

8.4%

23.0%

22.9%

17.8%

4.9%

9.4%

8.0%

$ 9,336,295 $ 9,612,888

100.0%

The following table sets forth the credit ratings of our short-term investments and fixed maturity investments,
classified as trading and available-for-sale, and the fixed maturity investments included within our funds held - directly
managed balance as of December 31, 2019: 

Amortized
Cost

Fair Value

% of Total

AAA
Rated

AA Rated

A Rated

BBB
Rated

Non-
Investment
Grade

Not Rated

$

730,396

$ 736,043

7.7% $ 736,043

$

— $

— $

— $

— $

155,261

161,772

1.7%

—

161,772

—

—

—

684,117

702,857

7.3%

316,151

154,072

63,270

144,557

24,807

—

—

—

5,479,839

5,697,067

59.2%

149,108

619,707

2,911,867

1,703,328

311,167

1,890

157,868

466,932

167,882

471,836

1.7%

4.9%

16,381

381,502

77,291

47,489

50,938

2,295

23,272

1,882

—

34,055

—

4,613

882,603

900,029

9.4%

632,461

89,347

95,508

66,573

6,224

9,916

U.S.
government and
agency

U.K.
government

Other
government

Corporate

Municipal

Residential
mortgage-
backed

Commercial
mortgage-
backed

Asset-backed

779,279

775,402

8.1%

378,116

89,418

174,118

117,275

15,694

781

Total

$ 9,336,295

$9,612,888

100.0% $2,609,762

$1,239,096

$3,297,996

$2,056,887

$ 391,947

$ 17,200

% of total fair
value

27.1%

12.9%

34.3%

21.4%

4.1%

0.2%

150

 
Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Unrealized Gains and Losses on Available-for-sale Fixed Maturity Investments

The amortized cost and fair values of our fixed maturity investments classified as available-for-sale were as

follows as of December 31, 2019 and 2018:

2019
U.S. government and agency

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

2018
U.S. government and agency

Other government

Corporate

Municipal

Residential mortgage-backed

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized
Losses
Non-OTTI

Fair
Value

$

410,842 $

77 $

(607) $

410,312

15,067

84,116

1,081,713

15,963

127,704

98,928

208,121

282

1,119

4,026

20

240

38

169

—

(88)

15,349

85,147

(4,568)

1,081,171

(111)

(725)

(409)

(193)

15,872

127,219

98,557

208,097

$

2,042,454 $

5,971 $

(6,701) $

2,041,724

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized
Losses
Non-OTTI

$

576 $

— $

(3) $

72,811

75,535

2,499

12

1,219

1,006

—

—

(845)

(1,182)

(19)

—

Fair
Value

573

73,185

75,359

2,480

12

$

151,433 $

2,225 $

(2,049) $

151,609

Gross Unrealized Losses on Available-for-sale Fixed Maturity Investments

The following tables summarize our fixed maturity and short-term investments classified as available-for-sale in a
gross unrealized loss position, as of December 31, 2019 and 2018:

2019
Fixed maturity investments, at fair
value

12 Months or Greater

Less Than 12 Months

Total

Fair
Value

Gross
Unrealized
Losses

Fair
Value

Gross
Unrealized
Losses

Fair
Value

Gross
Unrealized
Losses

U.S. government and agency

$

— $

— $ 222,643 $

(607) $ 222,643 $

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Total fixed maturity and short-term
investments

1,080

2,754

128

—

—

—

(23)

(306)

—

—

—

—

37,796

461,772

12,046

65,992

79,606

129,014

(607)

(88)

(65)

38,876

(4,262)

464,526

(4,568)

(111)

(725)

(409)

(193)

12,174

65,992

79,606

129,014

(111)

(725)

(409)

(193)

$

3,962 $

(329) $ 1,008,869 $

(6,372) $ 1,012,831 $

(6,701)

151

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

2018
Fixed maturity and short-term
investments, at fair value

12 Months or Greater

Less Than 12 Months

Total

Fair
Value

Gross
Unrealized
Losses

Fair
Value

Gross
Unrealized
Losses

Fair
Value

Gross
Unrealized
Losses

U.S. government and agency

$

573 $

(3) $

— $

— $

573 $

Other government

Corporate

Municipal

Residential mortgage-backed

Total fixed maturity and short-term
investments

7,351

11,888

1,783

12

(345)

(629)

(18)

—

11,000

25,227

283

—

(500)

(553)

(1)

—

18,351

37,115

2,066

12

(3)

(845)

(1,182)

(19)

—

$

21,607 $

(995) $

36,510 $

(1,054) $

58,117 $

(2,049)

As of December 31, 2019 and 2018, the number of securities classified as available-for-sale in an unrealized
loss position was 563 and 88, respectively. Of these securities, the number of securities that had been in an unrealized
loss  position  for  twelve  months  or  longer  was  12  and  42,  respectively.    From  October  1,  2019  we  elected  to  use
available-for-sale accounting for all new acquisitions and where permissible, as trading fixed maturity securities mature,
we are reinvesting the proceeds into available-for-sale securities for the Non-Life Run-off and StarStone segments.

Other-Than-Temporary Impairment on Available-for-sale Fixed Maturity Investments

For  the  years  ended  December 31,  2019,  2018  and  2017,  we  did  not  recognize  any  other-than-temporary
impairment losses on our available-for-sale securities. We determined that no credit losses existed as of December 31,
2019 and 2018.  A description of our other-than-temporary impairment process is included in Note 2 - "Significant
Accounting Policies". There were no changes to our process in the years ended December 31, 2019 and 2018.

Equity Investments

The following table summarizes our equity investments classified as trading as of December 31, 2019 and 2018:

Publicly traded equity investments in common and preferred stocks
Exchange-traded funds
Privately held equity investments in common and preferred stocks

2019

2018

$

$

327,875 $
133,047
268,799
729,721 $

138,415
—
228,710
367,125

Equity investments include publicly traded common and preferred stocks, exchange-traded funds and privately
held  common  and  preferred  stocks.  Our  publicly  traded  equity  investments  in  common  and  preferred  stocks
predominantly trade on major exchanges and are managed by our external advisors. Our investments in exchange-
traded funds trade on a major exchange.

Our privately held equity investments in common and preferred stocks are direct investments in companies that
we believe offer attractive risk adjusted returns and/or offer other strategic advantages. Each investment may have its
own unique terms and conditions and there may be restrictions on disposals. The market for these investments is
illiquid and there is no active market. Included within the above balance as of December 31, 2019 is an investment in
the parent company of AmTrust Financial Services, Inc. ("AmTrust"), with a fair value of $240.1 million. Refer to Note
21 - "Related Party Transactions" for further information. 

152

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Other Investments, at fair value

The following table summarizes our other investments carried at fair value as of December 31, 2019 and

2018:

Hedge funds
Fixed income funds
Equity funds
Private equity funds
CLO equity funds
CLO equities
Private credit funds
Others

2019

2018

$

$

1,121,904 $
481,039
410,149
329,885
87,509
87,555
—
6,379
2,524,420 $

852,584
403,858
333,681
248,628
37,260
39,052
33,381
9,313
1,957,757

The valuation of our other investments is described in Note 12 - "Fair Value Measurements". Due to a lag in the
valuations of certain funds reported by the managers, we may record changes in valuation with up to a three-month
lag. We regularly review and discuss fund performance with the fund managers to corroborate the reasonableness of
the reported net asset values and to assess whether any events have occurred within the lag period that would affect
the valuation of the investments. The following is a description of the nature of each of these investment categories:

•

•

•

•

•

•

•

Hedge funds may invest in a wide range of instruments, including debt and equity securities, and utilize various
sophisticated strategies to achieve their objectives. We invest in a mixture of fixed income, equity and multi-
strategy hedge funds. 

Fixed income funds comprise a number of positions in diversified fixed income funds that are managed by
third-party managers. Underlying investments vary from high-grade corporate bonds to non-investment grade
senior secured loans and bonds, but are generally invested in liquid fixed income markets. These funds have
regularly published prices. 

Equity funds invest in a diversified portfolio of U.S. and international publicly-traded equity securities. 

Private equity funds invest primarily in the financial services industry. 

CLO equity funds invest primarily in the equity tranches of term-financed securitizations of diversified pools of
corporate bank loans. 

CLO equities comprise investments in the equity tranches of term-financed securitizations of diversified pools
of corporate bank loans. 

Private credit funds invest in direct senior or collateralized loans. 

• Others comprise of various investments including a real estate debt fund that invests primarily in European
commercial real estate equity, call options on equities and a fund that provides loans to educational institutions
throughout the United States and its territories.

The increase in our other investments carried at fair value between December 31, 2019 and December 31, 2018
was primarily attributable to unrealized gains of $441.6 million and net additional subscriptions of $214.3 million to
CLO equity, CLO equity funds, fixed income funds and private equity funds.

As of December 31, 2019, we had unfunded commitments of $482.3 million to private equity funds.

Certain of our other investments are subject to restrictions on redemptions and sales that are determined by the
governing documents, which limits our ability to liquidate those investments. These restrictions may include lock-ups,
redemption gates, restricted share classes or side pockets, restrictions on the frequency of redemption and notice
periods. A gate is the ability to deny or delay a redemption request, whereas a side-pocket is a designated account for
which the investor loses its redemption rights. Certain other investments may not have any restrictions governing their
sale, but there is no active market and no guarantee that we will be able to execute a sale in a timely manner. In

153

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

addition, even if certain other investments are not eligible for redemption or sales are restricted, we may still receive
income distributions from those other investments. The table below details the estimated date by which proceeds would
be received if we had provided notice of our intent to redeem or initiated a sales process as of December 31, 2019:

Less than
1 Year

1-2 years

2-3 years

More than
3 years

Not
Eligible/
Restricted

Total

Hedge funds

$ 343,005 $ 624,233 $

— $ 102,600 $

52,066 $ 1,121,904

Fixed income funds

477,935

Equity funds

410,149

Private equity funds

CLO equity funds

CLO equities

Other

60,735

87,555

34

—

—

—

—

—

—

—

—

—

26,774

—

—

—

—

—

—

—

—

3,104

481,039

—

329,885

410,149

329,885

—

—

6,345

87,509

87,555

6,379

$ 1,379,413 $ 624,233 $

26,774 $ 102,600 $ 391,400 $ 2,524,420

Equity Method Investments

The table below shows our equity method investments as of December 31, 2019 and 2018:

Redemption
Frequency

Monthly to Bi-
annually

Daily to
Quarterly

Daily to
Quarterly

N/A

Quarterly to Bi-
annually

N/A

N/A

2019

2018

Investment

Ownership
%

Carrying
Value

Investment

Ownership
%

Carrying
Value

Enhanzed Re

$

154,050

Citco

Monument

Clear Spring

Other

50,000

26,600

11,210

24,963

47.4% $
31.9%
26.6%
20.0% $
~30%

182,856 $

51,742

60,598

10,645

20,436

94,800

50,000

26,600

11,210

15,250

47.4% $
31.9%
26.6%
20.0%
~30%

94,800

50,812

42,193

10,070

6,632

$

266,823

$

326,277 $

197,860

$

204,507

Refer to Note 21 - "Related Party Transactions" for further information regarding our investments in Clear Spring,

Citco, Monument and Enhanzed Re.

As of December 31, 2019, we had unfunded commitments of $93.1 million related to equity method investments.

Funds Held

Under funds held arrangements, the reinsured company has retained funds that would otherwise have been
remitted to our reinsurance subsidiaries. We either have (i) funds held by reinsured companies, which are carried at
amortized cost and on which we receive a fixed crediting rate, or (ii) funds held - directly managed, which are carried
at fair value and on which we receive the underlying return on the portfolio. The investment returns on both categories
of funds held are recognized in net investment income and net realized and unrealized gains (losses). The funds held
balance is credited with investment income and losses payable are deducted. 

154

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Funds Held - Directly Managed

Funds held - directly managed, where we receive the underlying return on the investment portfolio, are carried
at fair value, either because we elected the fair value option at the inception of the reinsurance contract, or because
it represents the aggregate of funds held at amortized cost and the fair value of an embedded derivative. The embedded
derivative relates to our contractual right to receive the return on the underlying investment portfolio supporting the
reinsurance contract. We include the estimated fair value of these embedded derivatives in the consolidated balance
sheets with the host contract in order to reflect the expected settlement of these features with the host contract. The
change in the fair value of the embedded derivative is included in net unrealized gains (losses). The following table
summarizes the components of the funds held - directly managed as of December 31, 2019 and 2018:

Fixed maturity investments, trading
Other assets

2019
1,173,345 $
14,207
1,187,552 $

2018
1,183,374
14,780
1,198,154

$

$

The following table summarizes the fixed maturity investment components of funds held - directly managed as

of December 31, 2019 and 2018:

Funds held
- Directly
Managed -
Fair Value
Option

2019

Funds held
- Directly
Managed -
Variable
Return

Funds held
- Directly
Managed -
Fair Value
Option

2018

Funds held
- Directly
Managed -
Variable
Return

Total

Total

$

185,859 $

940,194 $ 1,126,053 $

179,670 $ 1,044,377 $ 1,224,047

5,438

—

5,438

(2,733)

—

(2,733)

—

41,854

41,854

—

(37,940)

(37,940)

$

191,297 $

982,048 $ 1,173,345 $

176,937 $ 1,006,437 $ 1,183,374

Fixed maturity investments, at
amortized cost

Net unrealized gains (losses):

Change in fair value - fair value
option accounting

Change in fair value - embedded
derivative accounting

Fixed maturity investments within
funds held - directly managed, at fair
value

Refer to the sections above for details of the fixed maturity investments within our funds held - directly managed

portfolios.

Funds Held by Reinsured Companies 

Funds  held  by  reinsured  companies,  where  we  received  a  fixed  crediting  rate,  are  carried  at  cost  on  our
consolidated balance sheets. As of December 31, 2019 and 2018, we had funds held by reinsured companies of $408.7
million and $321.3 million, respectively.

155

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Net Investment Income

Major  categories  of  net  investment  income  for  the  years  ended  December  31,  2019,  2018  and  2017  are

summarized as follows: 

Fixed maturity investments

Short-term investments and cash and cash equivalents

Funds held

Funds held – directly managed

Investment income from fixed maturities and cash and cash
equivalents

Equity investments

Other investments

Life settlements and other

Investment income from equities and other investments

Gross investment income

Investment expenses

Net investment income

Net Realized and Unrealized Gains (Losses)

2019
233,310 $

2018
189,000 $

2017
144,367

$

16,607

19,981

38,173

308,071

16,671

11,792

—

28,463

12,117

10,041

37,623

9,314

601

32,479

248,781

186,761

5,397

19,703

6,511

31,611

4,355

14,337

14,370

33,062

336,534
(15,258)
321,276 $

280,392
(9,721)
270,671 $

219,823
(11,034)
208,789

$

Components of net realized and unrealized gains (losses) for the years ended December 31, 2019, 2018 and

2017 were as follows:

Net realized gains (losses) on sale:

Gross realized gains on fixed maturity securities, available-for-sale
securities (1)
Gross realized losses on fixed maturity securities, available-for-sale
securities (1)
Net realized gains (losses) on fixed maturity securities, trading

Net realized gains (losses) on fixed maturity securities in funds held -
directly managed portfolios

Net realized gains (losses) on equity investments, trading

Total net realized gains (losses) on sale

Net unrealized gains (losses):

Fixed maturity securities, trading

Fixed maturity securities in funds held - directly managed portfolios

Equity investments, trading

Other investments

Total net unrealized gains (losses)

Net realized and unrealized gains (losses)

2019

2018

2017

$

4,856 $

27 $

616

(962)

91,313

1,495

(374)

96,328

349,975

88,053

55,359

441,636

935,023

(90)

(27,646)

(3,940)

4,016

(27,633)

(165,187)

(46,257)

(9,831)

(163,976)

(385,251)

$

1,031,351 $

(412,884) $

(125)

4,695

(4,219)

701

1,668

35,878

33,902

16,498

102,388

188,666

190,334

(1)The gross realized gains and losses on available-for-sale investments included in the table above resulted from sales of $310.4 million, $11.4

million and $40.8 million for the years ended December 31, 2019, 2018 and 2017, respectively.

156

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Restricted Assets  

We utilize trust accounts to collateralize business with our insurance and reinsurance counterparties. We are
also required to maintain investments and cash and cash equivalents on deposit with regulatory authorities and Lloyd's
to support our insurance and reinsurance operations. The investments and cash and cash equivalents on deposit are
available to settle insurance and reinsurance liabilities. Collateral generally takes the form of assets held in trust, letters
of credit or funds held. The assets used as collateral are primarily highly rated fixed maturity securities. The carrying
value of our restricted assets, including restricted cash of $352.7 million and $380.5 million, as of December 31, 2019
and 2018, respectively, was as follows: 

Collateral in trust for third party agreements

Assets on deposit with regulatory authorities

Collateral for secured letter of credit facilities
Funds at Lloyd's (1)

2019
4,104,093 $
445,626

133,238

639,316
5,322,273 $

$

$

2018

4,336,752

579,048

127,841

354,589

5,398,230

(1)  Our businesses include three Lloyd's syndicates. Lloyd's determines the required capital principally through the annual business plan of each
syndicate. This capital is referred to as "Funds at Lloyd's" and will be drawn upon in the event that a syndicate has a loss that cannot be funded
from  other  sources.  We  also  utilize  unsecured  letters  of  credit  for  Funds  at  Lloyd's,  as  described  in  Note  15  -  "Debt  Obligations  and  Credit
Facilities".  Funds at Lloyd's increased primarily due to reinsurance to close ("RITC") transactions, during 2019.

157

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

7. DERIVATIVES AND HEDGING INSTRUMENTS 

Foreign Currency Hedging of Net Investments in Foreign Operations

We use foreign currency forward exchange rate contracts in qualifying hedging relationships to hedge the foreign
currency exchange rate risk associated with certain of our net investments in foreign operations. As of December 31,
2019 and 2018, we had forward foreign currency contracts in place which we had designated as hedges of our net
investments in foreign operations. 

The following table presents the gross notional amounts and the estimated fair values recorded within other
assets and liabilities related to our qualifying foreign currency forward exchange rate contracts as of December 31,
2019 and 2018: 

2019

Fair Value

2018

Fair Value

Gross Notional
Amount

Assets

Liabilities

Gross Notional
Amount

Assets

Liabilities

Foreign exchange forward - AUD

$

64,620

$

52

$

2,033

$

42,258

$

1,377

$

Foreign exchange forward - EUR

Foreign exchange forward - GBP

112,284

318,387

Total qualifying hedges

$

495,291

$

246

344

642

1,635

7,784

66,422

—

238

—

$

11,452

$

108,680

$

1,615

$

—

300

—

300

The following table presents the amounts of the net gains and losses deferred in the cumulative translation
adjustment ("CTA") account, which is a component of accumulated other comprehensive income (loss) ("AOCI"), in
shareholders' equity, relating to our foreign currency forward exchange rate contracts for the years ended December 31,
2019, 2018 and 2017:

Foreign exchange forward - AUD

Foreign exchange forward - EUR

Foreign exchange forward - GBP

Total qualifying hedges

Amount of Gains (Losses) Deferred in AOCI

2019

2018

2017

$

$

(722) $

1,817

(16,423)

(15,328) $

3,438

$

1,000

—

4,438

$

(1,247)

—

—

(1,247)

Non-derivative Hedging Instruments of Net Investments in Foreign Operations 

From time to time, we may also use non-derivative instruments such as foreign currency denominated borrowings
under our credit facilities to hedge certain of our net investments in foreign operations in designated qualifying non-
derivative hedging arrangements. While there were no foreign currency denominated borrowings outstanding under
our credit facilities as of December 31, 2019 and 2018, the following table presents the amounts of the net gains and
losses deferred in the CTA account in AOCI relating to these qualifying non-derivative hedging instruments for the
years ended December 31, 2018 and 2017:

Amount of Gains (Losses) Deferred in AOCI

2018

2017

Net gains (losses) on qualifying non-derivative hedges

3,144

(9,375)

Derivatives Not Designated or Not Qualifying as Hedging Instruments

From time to time, we may also utilize foreign currency forward contracts as part of our overall foreign currency
risk management strategy or to obtain exposure to a particular financial market, as well as for yield enhancement in
non-qualifying hedging relationships. We may also utilize equity call option instruments either to obtain exposure to a
particular equity instrument or for yield enhancement in non-qualifying hedging relationships.

158

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Foreign Currency Forward Contracts

The following table presents the gross notional amounts and the estimated fair values recorded within other
assets and liabilities as of December 31, 2019 and 2018 and the gains and losses during the years ended December 31,
2019 and 2018, related to our non-qualifying foreign currency forward exchange rate hedging relationships: 

December 31, 2019

Fair Value

2019

Gross Notional
Amount

Assets

Liabilities

Gains (losses) on non-
qualifying hedges charged to
earnings

Foreign exchange forward - AUD

$

913

$

839

$

892

$

Foreign exchange forward - CAD

Foreign exchange forward - EUR

Foreign exchange forward - GBP

66,266

74,444

11,940

10

507

13

1,482

1,440

292

Total non-qualifying hedges

$

153,563

$

1,369

$

4,106

$

1,523

(2,079)

1,759

12,004

13,207

December 31, 2018

Fair Value

2018

Gross Notional
Amount

Assets

Liabilities

Gains (losses) on non-
qualifying hedges charged to
earnings

Foreign exchange forward - AUD

$

45,427

$

1,952

$

310

$

Foreign exchange forward - CAD

Foreign exchange forward - EUR

Foreign exchange forward - GBP

55,050

54,282

256,959

1,441

139

1,554

—

301

72

Total non-qualifying hedges

$

411,718

$

5,086

$

683

$

4,958

9,311

2,296

15,078

31,643

Investments in Call Options on Equities

During the years ended December 31, 2019 and 2018, we recorded unrealized gains of approximately $0.5
million and unrealized losses of $9.4 million respectively, within net earnings, on the call options on equities which we
purchased in 2018 at a cost of $10.0 million. These call options on equities had a fair value of less than $0.1 million
and $0.6 million as of December 31, 2019 and 2018, respectively.

Other Derivatives

In 2019 we entered into a forward interest rate swap, with a notional amount of AUD$120.0 million, to partially
mitigate  the  risk  associated  with  declining  interest  rates  until  the  receipt  of  the  assets  related  to  the  Munich  Re
transaction, as discussed in Note 3 - "Significant New Business", which is expected to close in 2020.  The carrying
value of the forward interest rate swap, recorded in other liabilities, was $0.3 million as of December 31, 2019. We
recorded unrealized losses in net earnings of $0.3 million on the instrument for the year ended December 31, 2019.

159

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

8. REINSURANCE BALANCES RECOVERABLE ON PAID AND UNPAID LOSSES 

The  following  table  provides  the  total  reinsurance  balances  recoverable  on  paid  and  unpaid  losses  as  of

December 31, 2019 and 2018: 

Recoverable from reinsurers on unpaid:

Outstanding losses

IBNR

Fair value adjustments - acquired companies

Fair value adjustments - fair value option

Total reinsurance reserves recoverable

Paid losses recoverable

Total

Non-life
Run-off

Atrium

StarStone

Total

2019

$

972,293 $

9,011 $

328,009 $

1,309,313

673,059

(13,652)

(88,086)

1,543,614

181,375

19,286

519

—

28,816

1,541

211,404

(2,122)

—

537,291

87,253

903,749

(15,255)

(88,086)

2,109,721

270,169

$

1,724,989 $

30,357 $

624,544 $

2,379,890

Reconciliation to Consolidated Balance Sheet:

Reinsurance balances recoverable on paid and
unpaid losses

Reinsurance balances recoverable on paid and
unpaid losses - fair value option

Total

$

$

1,029,471 $

30,357 $

624,544 $

1,684,372

695,518

—

—

695,518

1,724,989 $

30,357 $

624,544 $

2,379,890

Recoverable from reinsurers on unpaid:

Outstanding losses

IBNR

Fair value adjustments - acquired companies

Fair value adjustments - fair value option

Total reinsurance reserves recoverable

Paid losses recoverable

Total

Non-life
Run-off

Atrium

StarStone

Total

2018

$

901,772 $

18,891 $

263,065 $

1,183,728

609,434

(14,344)

(130,739)

1,366,123

138,265

19,247

630

—

38,768

(256)

201,784

(1,899)

—

462,950

23,813

830,465

(15,613)

(130,739)

1,867,841

161,822

$

1,504,388 $

38,512 $

486,763 $

2,029,663

Reconciliation to Consolidated Balance Sheet:

Reinsurance balances recoverable on paid and
unpaid losses

Reinsurance balances recoverable on paid and
unpaid losses - fair value option

Total

$

$

764,797 $

38,512 $

486,763 $

1,290,072

739,591

—

—

739,591

1,504,388 $

38,512 $

486,763 $

2,029,663

Our  insurance  and  reinsurance  run-off  subsidiaries  and  assumed  portfolios,  prior  to  acquisition,  used
retrocessional agreements to reduce their exposure to the risk of insurance and reinsurance assumed. On an annual
basis, both Atrium and StarStone purchase a tailored outwards reinsurance program designed to manage their risk
profiles. The majority of Atrium’s and StarStone's third-party reinsurance cover is with highly rated reinsurers or is
collateralized by pledged assets or letters of credit.

160

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The fair value adjustments, determined on acquisition of insurance and reinsurance subsidiaries, are based on
the estimated timing of loss and LAE recoveries and an assumed interest rate equivalent to a risk free rate for securities
with similar duration to the acquired reinsurance balances recoverable on paid and unpaid losses plus a spread to
reflect credit risk, and are amortized over the estimated recovery period, as adjusted for accelerations in timing of
payments as a result of commutation settlements. The determination of the fair value adjustments on the retroactive
reinsurance  contracts  for  which  we  have  elected  the  fair  value  option  is  described  in  Note  12  -  "Fair  Value
Measurements".

As of December 31, 2019 and 2018, we had reinsurance balances recoverable on paid and unpaid losses of
approximately $2,379.9 million and $2,029.7 million, respectively. The increase of $350.2 million in reinsurance balances
recoverable on paid and unpaid losses was primarily due to the AmTrust RITC and Zurich reinsurance transactions,
which closed during the first and fourth quarters of 2019, respectively, and reserve increases in StarStone and our
non-life run-off segment, offset by commutations and cash collections made during the year ended December 31,
2019.

Top Ten Reinsurers

December 31, 2019

December 31, 2018

Top ten reinsurers

Other reinsurers > $1
million

Other reinsurers < $1
million

Total

Non-life
Run-off

Atrium

StarStone

Total

% of
Total

Non-life
Run-off

Atrium

StarStone

Total

% of
Total

$

1,154,110

$

22,051

$

388,171

$

1,564,332

65.7% $

1,124,079

$

25,239

$

263,192

$

1,412,510

69.6%

551,636

7,761

233,871

793,268

33.4%

364,098

12,091

220,123

596,312

29.4%

19,243

545

2,502

22,290

0.9%

16,211

1,182

3,448

20,841

1.0%

$

1,724,989

$

30,357

$

624,544

$

2,379,890

100.0% $

1,504,388

$

38,512

$

486,763

$

2,029,663

100.0%

Information regarding top ten reinsurers:

Number of top 10 reinsurers rated A- or better
Number of top 10 non-rated reinsurers (1)

Recoverables rated A- or better in top 10
Collaterized non-rated reinsurers recoverables in top 10 (1)

Single reinsurers that represent 10% or more of total reinsurance
balance recoverables as of December 31, 2019:

Hannover Ruck SE (2)
Lloyd's Syndicates (3)

December 31, 2019 December 31, 2018

8

2

1,292,207 $
272,125
1,564,332 $

7

3

1,096,272

316,238

1,412,510

261,295 $
411,030 $

279,723

334,509

$

$

$

$

(1) For the two non-rated reinsurers as of December 31, 2019 and three non-rated reinsurers as at December 31, 2018, we hold security in the form

of pledged assets in trust or letters of credit issued to us in the full amount of the recoverable.

(2) Hannover Ruck SE is rated AA- by Standard & Poor’s and A+ by A.M. Best.

(3)  Lloyd's Syndicates are rated A+ by Standard & Poor's and A by A.M. Best.

161

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

 Provisions for Uncollectible Reinsurance Balances Recoverable on Paid and Unpaid Losses

We evaluate and monitor concentration of credit risk among our reinsurers. Provisions are made for amounts

considered potentially uncollectible. 

The following table shows our reinsurance balances recoverable on paid and unpaid losses by rating of reinsurer
and our provisions for uncollectible reinsurance balances recoverable on paid and unpaid losses ("provisions for bad
debt") as of December 31, 2019 and 2018. The majority of the provisions for bad debt relate to the Non-life Run-off
segment.

2019

2018

Gross

Provisions
for Bad
Debt

Provisions
as a 
% of Gross

Net

Gross

Provisions
for Bad
Debt

Provisions
as a 
% of Gross

Net

Reinsurers rated A- or above

$ 1,904,268

$

43,427

$ 1,860,841

2.3% $ 1,612,464

$

51,519

$ 1,560,945

Reinsurers rated below A-,
secured

Reinsurers rated below A-,
unsecured

Total

487,608

—

487,608

—%

430,852

—

430,852

135,653

104,212

31,441

76.8%

143,079

105,213

37,866

$ 2,527,529

$

147,639

$ 2,379,890

5.8% $ 2,186,395

$

156,732

$ 2,029,663

3.2%

—%

73.5%

7.2%

9. DEFERRED CHARGE ASSETS

Deferred charge assets relate to retroactive reinsurance policies providing indemnification of losses and LAE
with respect to past loss events in the Non-life Run-off segment. For insurance and reinsurance contracts for which
we do not elect the fair value option, a deferred charge asset is recorded for the excess, if any, of the estimated ultimate
losses payable over the premiums received at the initial measurement. The premium consideration that we charge the
ceding companies may be lower than the undiscounted estimated ultimate losses payable due to the time value of
money. After receiving the premium consideration in full from our cedents at the inception of the contract, we invest
the premium received over an extended period of time thereby generating investment income. We expect to generate
profits  from  these  retroactive  reinsurance  policies  when  taking  into  account  the  premium  received  and  expected
investment income, less contractual obligations and expenses. Further information on deferred charge assets recorded
during the years ended December 31, 2019, 2018 and 2017 is included in Note 4 - "Significant New Business". 

Deferred charge assets are included in other assets on our consolidated balance sheets. The following table

presents a reconciliation of the deferred charge assets for the years ended December 31, 2019, 2018 and 2017:

Beginning carrying value

Recorded during the year

Amortization
Ending carrying value

2019

2018

2017

$

$

86,585 $

224,504
(38,627)
272,462 $

80,192 $
20,174
(13,781)
86,585 $

94,551

—
(14,359)
80,192

Deferred charge assets are amortized over the estimated claim payment period of the related contract with the
periodic amortization reflected in earnings as a component of losses and LAE. Deferred charge assets amortization
is  adjusted  at  each  reporting  period  to  reflect  new  estimates  of  the  amount  and  timing  of  remaining  loss
payments. Changes in the estimated amount and the timing of payments of unpaid losses may have an effect on the
unamortized deferred charge assets and the amount of periodic amortization. When liabilities for losses and LAE are
commuted or bought back, they are removed from the estimates for the remaining loss payments, and this will generally
result in an acceleration of the amortization of the deferred charge assets. Deferred charge assets are assessed at
each reporting period for impairment. If the asset is determined to be impaired, it is written down in the period in which
the determination is made. For the year ended December 31, 2019, we completed our assessment for impairment of
deferred  charge  assets  and  concluded  that  there  had  been  $nil  impairment  of  our  carried  deferred  charge  assets
amount.

162

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

10. LOSSES AND LOSS ADJUSTMENT EXPENSES 

The liability for losses and loss adjustment expenses ("LAE"), also referred to as loss reserves, represents our gross
estimates before reinsurance for unpaid reported losses and losses that have been incurred but not reported ("IBNR") for
our Non-life Run-off, Atrium and StarStone segments using a variety of actuarial methods. We recognize an asset for the
portion of the liability that we expect to recover from reinsurers. LAE reserves include allocated loss adjustment expenses
("ALAE"), and unallocated loss adjustment expenses ("ULAE"). ALAE are linked to the settlement of an individual claim or
loss, whereas ULAE are based on our estimates of future costs to administer the claims. IBNR represents reserves for
losses and LAE that have been incurred but not yet reported to us.  This includes amounts for unreported claims, development
on known claims and reopened claims. 

The following table summarizes the liability for losses and LAE by segment and for our other activities as of

December 31, 2019 and 2018:

Non-life
Run-off

Atrium

StarStone

Other

Total

2019

Outstanding losses
IBNR
Fair value adjustments - acquired companies
Fair value adjustments - fair value option
ULAE
Total

$

$

89,141 $ 888,794 $

4,407,082 $
3,945,407
(170,689)
(217,933)
331,494

9,512 $ 5,394,529
5,057,868
(167,511)
(217,933)
362,285
8,295,361 $ 231,672 $ 1,879,128 $ 23,077 $ 10,429,238

962,353
(522)
—
28,503

136,543
3,700
—
2,288

13,565
—
—
—

Reconciliation to Consolidated Balance Sheet:
Losses and loss adjustment expenses
Losses and loss adjustment expenses, at fair
value

Total

$

$

5,674,239 $ 231,672 $ 1,879,128 $ 23,077 $ 7,808,116

2,621,122
2,621,122
8,295,361 $ 231,672 $ 1,879,128 $ 23,077 $ 10,429,238

—

—

—

2018

Non-life
Run-off

Atrium

StarStone

Other

Total

$

4,271,769 $

94,885 $ 796,194 $ 6,052 $ 5,168,900

3,527,767

140,521

787,894

12,809

4,468,991

(217,527)

(374,752)

333,405

3,476

—

2,402

(467)

—

25,076

—

—

—

(214,518)

(374,752)

360,883

$

7,540,662 $ 241,284 $ 1,608,697 $ 18,861 $ 9,409,504

Outstanding losses

IBNR

Fair value adjustments- acquired companies

Fair value adjustments - fair value option

ULAE

Total

Reconciliation to Consolidated Balance Sheet:

Losses and loss adjustment expenses

$

4,666,607 $ 241,284 $ 1,608,697 $ 18,861 $ 6,535,449

Losses and loss adjustment expenses, at fair
value

Total

2,874,055

—

—

—

2,874,055

$

7,540,662 $ 241,284 $ 1,608,697 $ 18,861 $ 9,409,504

The overall increase in the liability for losses and LAE between December 31, 2018 and December 31, 2019
was primarily attributable to the assumed reinsurance agreements with Zurich, Maiden Re Bermuda, Amerisure and
AmTrust, as described in Note 4 - "Significant New Business" in our Non-life Run-off segment.

163

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The table below provides a consolidated reconciliation of the beginning and ending liability for losses and LAE

for the years ended December 31, 2019, 2018 and 2017:

Balance as at January 1

Less: reinsurance reserves recoverable

Less: deferred charge assets on retroactive reinsurance

Net balance as at January 1

Net incurred losses and LAE:

  Current period

  Prior periods

  Total net incurred losses and LAE

Net paid losses:

  Current period

  Prior periods

  Total net paid losses

Effect of exchange rate movement

Acquired on purchase of subsidiaries

Assumed business

Ceded business

Net balance as at December 31

Plus: reinsurance reserves recoverable

Plus: deferred charge assets on retroactive reinsurance

2019

2018

2017

$

9,409,504 $

7,398,088 $

1,867,841

86,585

7,455,078

823,658

48,917

872,575

(200,264)

(1,669,004)

(1,869,268)

48,695

686

1,586,307

(47,018)

8,047,055

2,109,721

272,462

1,870,033

80,192

5,447,863

689,782

(235,757)

454,025

(189,560)

(1,194,985)

(1,384,545)

(145,243)

1,310,874

1,772,104

—

7,455,078

1,867,841

86,585

5,987,867

1,388,193

94,551

4,505,123

437,853

(244,302)

193,551

(82,273)

(862,921)

(945,194)

158,429

10,251

1,525,703

—

5,447,863

1,870,033

80,192

Balance as at December 31

$

10,429,238 $

9,409,504 $

7,398,088

The tables below provide the components of net incurred losses and LAE by segment and for our other activities

for the years ended December 31, 2019, 2018 and 2017:  

Net losses paid

Net change in case and LAE reserves

Net change in IBNR reserves

Increase (reduction) in estimates of net ultimate losses

Increase (reduction) in provisions for unallocated LAE

Amortization of deferred charge assets

Amortization of fair value adjustments

Changes in fair value - fair value option

Net incurred losses and LAE

2019

Non-life
Run-off

Atrium

StarStone

Other

Total

$ 1,247,624 $

78,189 $ 531,633 $

11,822 $ 1,869,268

(530,891)

(813,582)

(96,849)

(57,404)

38,627

50,070

117,181

3,534

(4,782)

76,941

—

—

335

—

25,967

166,427

724,027

3,441

—

168

—

3,460

756

(497,930)

(651,181)

16,038

720,157

—

—

—

—

(53,963)

38,627

50,573

117,181

$

51,625 $

77,276 $ 727,636 $

16,038 $ 872,575

164

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Non-life
Run-off

Atrium

StarStone

Other

Total

2018

Net losses paid

Net change in case and LAE reserves

Net change in IBNR reserves

$

838,817 $

64,506 $

477,130 $

4,092 $ 1,384,545

(547,420)

(565,385)

6,331

4,091

75,887

113,879

4,808

7,999

(460,394)

(439,416)

Increase (reduction) in estimates of net ultimate
losses

Increase (reduction) in provisions for unallocated
LAE

Amortization of deferred charge assets

Amortization of fair value adjustments

Changes in fair value - fair value option

(273,988)

74,928

666,896

16,899

484,735

(65,401)

13,781

12,877

6,664

—

—

(5,118)

—

6,753

—

(266)

—

—

—

—

—

(58,648)

13,781

7,493

6,664

Net incurred losses and LAE

$

(306,067) $

69,810 $

673,383 $

16,899 $

454,025

Net losses paid

Net change in case and LAE reserves

Net change in IBNR reserves

Increase (reduction) in estimates of net ultimate
losses

Increase (reduction) in provisions for bad debt

Increase (reduction) in provisions for unallocated
LAE

Amortization of deferred charge assets

Amortization of fair value adjustments

Changes in fair value - fair value option

2017

Non-life
Run-off

Atrium

StarStone

Total

$

581,723 $

55,678 $

307,793 $

945,194

(381,053)

(390,727)

(190,057)

(1,536)

(53,810)

14,359

10,114

30,256

8,338

7,679

31,685

(23,540)

(341,030)

(406,588)

71,695

315,938

197,576

159

285

—

(2,720)

—

—

(1,377)

(187)

—

(945)

—

(53,712)

14,359

6,449

30,256

Net incurred losses and LAE

$

(190,674) $

69,419 $

314,806 $

193,551

Loss Development Information

Methodology for Establishing Reserves

The liability for losses and LAE includes an amount determined from reported claims and an amount based on
historical loss experience and industry statistics for IBNR using a variety of actuarial methods. Our loss reserves cover
multiple lines of business, which include workers' compensation, general casualty, asbestos and environmental, marine,
aviation  and  transit,  construction  defects  and  other  non-life  lines  of  business.  Our  management,  through  our  loss
reserving committees, considers the reasonableness of loss reserves recommended by our actuaries, including actual
loss development during the year. 

Case reserves are recognized for known claims (including the cost of related litigation) when sufficient information
has been reported to us to indicate the involvement of a specific insurance policy. We use considerable judgment in
estimating losses for reported claims on an individual claim basis based upon our knowledge of the circumstances
surrounding the claim, the severity of the injury or damage, the jurisdiction of the occurrence, the potential for ultimate
exposure, the type of loss, and our experience with the line of business and policy provisions relating to the particular
type of claim. The reserves for unpaid reported losses and LAE are established by management based on reports
from brokers, ceding companies and insureds and represent the estimated ultimate cost of events or conditions that
have been reported to, or specifically identified, by us. We also consider facts currently known and the current state
of the law and coverage litigation.

165

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

IBNR reserves are established by management based on actuarially determined estimates of ultimate losses
and loss expenses. We use generally accepted actuarial methodologies to estimate ultimate losses and LAE and those
estimates are reviewed by management. In addition, the routine settlement of claims, at either below or above the
carried advised loss reserve, updates historical loss development information to which actuarial methodologies are
applied, often resulting in revised estimates of ultimate liabilities. On an annual basis, independent actuarial firms are
retained by management to provide their estimates of ultimate losses and to review the estimates developed by our
actuaries.

Within the annual loss reserve studies produced by either our actuaries or independent actuaries, exposures
for each subsidiary are separated into homogeneous reserving categories for the purpose of estimating IBNR. Each
reserving category contains either direct insurance or assumed reinsurance reserves and groups relatively similar
types of risks and exposures (for example, asbestos, environmental, casualty, property) and lines of business written
(for example, marine, aviation, non-marine). Based on the exposure characteristics and the nature of available data
for each individual reserving category, a number of methodologies are applied. Recorded reserves for each category
are selected from the actuarial indications produced by the various methodologies after consideration of exposure
characteristics, data limitations and strengths and weaknesses of each method applied. This approach to estimating
IBNR has been consistently adopted in the annual loss reserve studies for each period presented.

The estimation of unpaid claim liabilities at any given point in time is subject to a high degree of uncertainty for
a number of reasons. A significant amount of time can lapse between the assumption of risk, the occurrence of a loss
event, the reporting of the event to an insurance or reinsurance company and the ultimate payment of the claim on
the  loss  event.  Our  actuarial  methodologies  include  industry  benchmarking  which,  under  certain  methodologies,
compares the trend of our loss development to that of the industry. To the extent that the trend of our loss development
compared to the industry changes in any period, it is likely to have an impact on the estimate of ultimate liabilities.
Unpaid claim liabilities for property and casualty exposures in general are impacted by changes in the legal environment,
jury awards, medical cost trends and general inflation. Certain estimates for unpaid claim liabilities involve considerable
uncertainty  due  to  significant  coverage  litigation,  and  it  can  be  unclear  whether  past  claim  experience  will  be
representative  of  future  claim  experience.  Ultimate  values  for  such  claims  cannot  be  estimated  using  reserving
techniques  that  extrapolate  losses  to  an  ultimate  basis  using  loss  development  factors,  and  the  uncertainties
surrounding the estimation of unpaid claim liabilities are not likely to be resolved in the near future. In addition, reserves
are established to cover loss development related to both known and unasserted claims. Consequently, our subsequent
estimates of ultimate losses and LAE, and our liability for losses and LAE, may differ materially from the amounts
recorded in the consolidated financial statements.

These estimates are reviewed regularly and, as experience develops and new information becomes known, the
reserves are adjusted as necessary. Such adjustments, if any, will be recorded in earnings in the period in which they
become known. Prior period development arises from changes to loss estimates recognized in the current year that
relate to loss reserves established in previous calendar years.

Asbestos and Environmental 

In establishing the reserves for losses and LAE related to asbestos and environmental claims, management
considers facts currently known and the current state of the law and coverage litigation. Liabilities are recognized for
known claims (including the cost of related litigation) when sufficient information has been developed to indicate the
involvement of a specific insurance policy, and management can reasonably estimate its liability. In addition, reserves
have been established to cover additional exposures on both known and unreported claims. Estimates of the reserves
are  reviewed  and  updated  continually.  Developed  case  law  and  claim  histories  are  still  evolving  for  such  claims,
especially  because  significant  uncertainty  exists  about  the  outcome  of  coverage  litigation  and  whether  past  claim
experience will be representative of future claim experience. In view of the changes in the legal and tort environment
that affect the development of such claims, the uncertainties inherent in valuing asbestos and environmental claims
are not likely to be resolved in the near future. Ultimate values for such claims cannot be estimated using traditional
reserving techniques and there are significant uncertainties in estimating the amount of our potential losses for these
claims. There can be no assurance that the reserves established by us will be adequate or will not be adversely affected
by the development of other latent exposures. The net liability for unpaid losses and LAE as of December 31, 2019
and 2018 included $2,078.3 million and $1,703.6 million, respectively, which represented an estimate of the net ultimate
liability for asbestos and environmental claims. The gross liability for such claims as of December 31, 2019 and 2018
was $2,259.6 million and $1,839.7 million, respectively. For the years ended December 31, 2019 and 2018, our reserves
for asbestos and environmental liabilities increased by $419.9 million and decreased by $152.4 million on a gross

166

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

basis, respectively, and increased by $374.7 million and decreased by $159.6 million on a net basis, respectively. The
increase in 2019 was primarily due to acquisition activity and the decrease in 2018 was primarily due to net paid losses,
foreign exchange and net favorable development, partially offset by acquisition activity.

Disclosures of Incurred and Paid Loss Development, IBNR, Claims Counts and Payout Percentages

The loss development tables disclosed below, sets forth our historic incurred and paid loss development by
accident year through December 31, 2019, net of reinsurance, as well as the cumulative number of reported claims,
IBNR balances, and other supplementary information.

The loss development tables disclosed below are presented as follows:

•

•

•

Non-Life Run-off - Presented by acquisition year, if significant, and further disaggregated, if significant, by
line of business within that acquisition year. The disaggregated lines of business include General Casualty,
Workers’ Compensation, Marine, Aviation and Transportation, Professional Indemnity / Directors & Officers
and Motor.

Atrium - The loss development disclosures for our Atrium segment have not been disaggregated further by
line of business as the segment comprised approximately only 2% of our total consolidated liability for losses
and LAE as of December 31, 2019 and was, therefore, not considered material for further disaggregation.

StarStone - All the lines of business related to the StarStone segment have been included within the loss
development disclosures below, namely, Casualty, Marine, Property, Aerospace and Workers’ Compensation.

Incurred and Paid Loss Development and IBNR Disclosures

For  each  acquisition  year  and/or  line  of  business  for  which  incurred  losses  and  allocated  loss  adjustment
expenses, net of reinsurance tables have been provided below, the disclosure approach and format adopted reflects
the following:

•

•

•

•

•

•

•

The incurred loss development tables include both reported case reserves and IBNR liabilities, as well as
cumulative paid losses;

Both the incurred and cumulative paid loss development tables include allocated LAE (i.e. claims handling
costs allocated to specific individual claims) but exclude unallocated LAE (i.e. the costs associated with internal
claims staff and third party administrators as well as consultants that cannot be allocated to specific individual
claims);

The fair value adjustments related to business acquisitions are excluded from the loss development tables,
however  the  undiscounted  incurred  losses,  cumulative  paid  losses  and  allocated  LAE  related  to  business
acquisitions are included in the loss development tables;

The fair value adjustments related to retroactive reinsurance agreements for which we have elected the fair
value  option  are  excluded  from  the  loss  development  tables,  however  the  undiscounted  incurred  losses,
cumulative paid losses and allocated LAE related to retroactive reinsurance agreements for which we have
elected the fair value option are included in the loss development tables;

The amounts relating to the amortization of deferred charge assets are excluded from the loss development
tables;

The amounts relating to the increase (reduction) in provisions for unallocated LAE are excluded from the loss
development tables;

In the incurred loss development tables, the incurred effect of agreeing a commutation or policy buyback is
included in the period in which the commutation or policy buyback is contractually agreed. We reflect the net
incurred  loss  development  arising  from  a  commutation  or  policy  buyback  in  the  fiscal  year  in  which  a
commutation or policy buyback is contractually agreed, and the net incurred loss development is allocated to
the  appropriate  accident  year. The  claim  will  generally  have  been  adjusted  throughout  its  lifetime  and  the
amounts recorded in prior years (supplementary information) remain unchanged in our tables, such that the
incurred amount that we recognize in the year in which a commutation or policy buyback is contractually agreed
represents the effect of the commutation or policy buyback settlement compared to the carried net loss and
LAE reserve balance in the prior year. We do not recast prior years to remove commuted or bought back

167

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

claims,  as  such  practice  would  eliminate  any  historical  favorable  or  adverse  development  we  may  have
experienced on our commuted loss and LAE reserves. Reserves that have been commuted or bought back
are not adjusted in future years but the commuted or bought back value remains in our total incurred losses;

In the cumulative paid losses tables, we reflect the amount of the commutation or policy buyback settlements
in the year in which they are actually paid or received, and the net payment is allocated to the appropriate
accident year. The claim or recoverable may have recorded payments or receipts throughout its lifetime and
amounts recorded in prior years (supplementary information) remain unchanged in our tables, such that the
amounts paid or received that we recognize in the year in which a commutation or policy buyback is paid or
received represents the amount actually paid or received. We do not recast prior years to remove payments
or receipts related to commutations or policy buybacks, as we consider commutations and policy buybacks a
key component of our business and reflective of our ability to effectively manage acquired losses and LAE
liabilities. Payments relating to commutations and policy buybacks are not adjusted in future years but the
payments remain in our total cumulative paid losses;

The amounts included within the loss development tables for the years ended December 31, 2010 through to
December 31, 2018 (April 1, 2014 through to December 31, 2018 in the case of StarStone since its date of
acquisition), as well as the historical average annual percentage payout ratios as of December 31, 2019, are
presented as supplementary information and are therefore unaudited;

All data presented within the loss development tables is net of reinsurance recoveries, excluding provisions
for uncollectible reinsurance recoverables; 

All data presented within the loss development tables is net of intercompany activity, including the Intra-Group
Cessions  within  the  StarStone  segment.  On  May  14,  2018,  we  completed  the  acquisition  of  KaylaRe  and
subsequently eliminated all the related intercompany balances. In the loss development disclosures provided
in our Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended
December 31, 2017, the StarStone loss triangles were presented net of the external reinsurance provided by
KaylaRe since it was not a consolidated subsidiary at that time. However, after the acquisition of KaylaRe in
May  2018,  the  reinsurance  arrangement  with  StarStone  became  an  intercompany  transaction  and  was
eliminated on consolidation. In addition, the StarStone loss development disclosures relating to the prior years
(supplementary  information)  were  retrospectively  recast  as  if  KaylaRe  had  always  been  a  consolidated
subsidiary, to allow for comparability between fiscal years;

The IBNR reserves included within each incurred loss development table by accident year, reflect the net IBNR
recorded as of December 31, 2019, including expected development on reported losses;

For the Non-life Run-off segment loss development tables, all information for both acquisitions and retroactive
reinsurance agreements is presented prospectively. As the reserves are effectively re-underwritten at the date
the reserves are acquired or assumed, we believe that the historical loss development prior to being acquired
is not relevant to our own experience managing these reserves. In addition, the information required to prepare
the loss development disclosures on a retrospective basis is not always available to us and a mixed approach
would result in loss development tables that are not entirely reflective of the actual loss development;

For the Non-life Run-off segment we have also presented the net incurred and paid losses and ALAE information
by calendar year as well as IBNR and claim counts for accident years older than 10 years on a single row
within the loss development tables. This presentation differs from the typical approach where only the net
outstanding losses and LAE reserves are presented as a reconciling item at the bottom of the loss development
tables. The additional detailed disclosures are provided on a voluntary basis and the inclusion of the disclosures
is to provide additional information to the users of our financial statements and to also enable the reconciliation
of our total loss reserves by acquisition year and by significant line of business.

For the StarStone segment loss development tables, all information has been presented on a prospective
basis  from  the  date  of  our  acquisition  of  StarStone,  which  was  effective  on April  1,  2014.  Providing  pre-
acquisition incurred and paid losses by accident year for years prior to 2014 was determined to be impracticable
due to significant data limitations; and

•

•

•

•

•

•

•

•

•

For the Atrium segment loss development tables, all information has been presented on a retrospective basis.

The historical amounts disclosed within the loss development tables for all lines of business presented below

168

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

are on a constant-currency basis, which is achieved by using constant foreign exchange rates between periods in the
loss development tables, and translating prior period amounts denominated in currencies other than the U.S. dollar,
which is our reporting currency, using the closing exchange rates as of December 31, 2019.

The impact of this exchange rate conversion is to show the change between periods exclusive of the effect of
exchange rate fluctuations, which would otherwise distort the change in incurred losses and the cash flow patterns
associated with those incurred losses shown within the loss development tables. The change in net incurred losses
shown within the loss development tables will, however, differ from other U.S. GAAP disclosures of incurred current
and prior period reserve development amounts, which include the effect of exchange rate fluctuations.

Establishing an estimate for loss reserves involves various assumptions and judgments, therefore, the information
contained within the loss development disclosures only allows readers or users of our consolidated financial statements
to understand, at the summary level presented in the development tables, the change over time in our reported incurred
loss estimates as well as the nature and patterns of the cash flows associated with those estimates. We, therefore,
believe that the information provided within the loss development tables disclosed below is of limited use for independent
analysis or application of standard actuarial estimations, and any results obtained from doing so should be interpreted
with caution.

Cumulative Number of Reported Claims

Reported claim counts, on a cumulative basis, are provided as supplemental information to each incurred loss
development table by accident year. We measure claim frequency information on an individual claim count basis within
each of our segments as follows:

•

•

Non-Life Run-off - The claim frequency information for the exposures included within our Non-life Run-off
lines of business includes direct and assumed open and closed claims by accident year at the claimant level.
Reported claims that are closed without a payment are included within our cumulative number of reported
claims because we typically incur claim adjustment expenses on them prior to their closure. The claim count
numbers exclude counts related to claims within policy deductibles where the insured is responsible for the
payment of losses within the deductible layer. Individual claim counts related to certain assumed reinsurance
contracts such as excess-of-loss and quota share treaties are not available to us, and the losses arising from
these treaties have been treated as single claims for the purposes of determining claim counts. Therefore,
each treaty year within the reinsurance contract is deemed a single claim because the detailed underlying
individual claim information is generally not reported to us by our cedents; and

StarStone and Atrium - The claim frequency information is determined at the claimant level for the exposures
within the lines of business related to these segments. Our claims system assigns a unique claim identifier to
each reported claim we receive. Each unique claim identifier is deemed to be a single claim, irrespective of
whether the claim remains open or has been closed with or without payment. For certain insurance facilities
and business produced or managed by managing general agents, coverholders and third party administrators
where  the  underlying  claims  data  is  reported  to  us  in  an  aggregated  format,  the  information  necessary  to
provide cumulative claims frequency is not available. In such cases, we typically record a “block” claim in our
system. This also applies to a small amount of assumed reinsurance business that we write where, similarly,
the  underlying  claims  data  is  reported  to  us  in  an  aggregated  format.  In  such  instances,  each  assumed
reinsurance contract is deemed a single claim.

The cumulative number of reported claims for our Atrium segment includes all claim counts for Syndicate 609.
Our Atrium segment represents our 25% share of Syndicate 609's underwriting capacity and capital, however, the
claims count is the same whether viewed at the 100% Syndicate level or for our 25% share. 

Our reported claim frequency information is subject to the following inherent limitations when analyzing our loss

experience and severity:

•

Claim counts are presented only on a reported and not on an ultimate basis. Therefore, reported claim counts
include open claims which have outstanding reserves but exclude IBNR claims. As such the reported claims
are consistent with reported losses, which can be calculated by subtracting IBNR losses from incurred losses.
However, the reported claim counts are inconsistent with the losses in the incurred loss development tables,
which include IBNR losses, and to losses in the paid loss development tables, which exclude outstanding
reserves;

169

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

•

•

•

•

•

Reported claim counts have not been adjusted for ceded reinsurance, which may distort any measures of
frequency or severity;

For lines of business that have a mix of primary and excess layer exposures, such as our general casualty
and workers’ compensation lines of business, the reported claim counts may fluctuate from period to period
between exposure layers, thereby distorting any measure of frequency and severity; and

The use of our reported claim frequency information to project ultimate loss payouts by disaggregated disclosure
category or line of business may not be as meaningful as claim count information related to individual contracts
at a more granular level.

Payout Percentages 

Non-life Run-off - The annual percentage payout disclosures for our Non-life Run-off segment are based on
the payout of incurred claims by age, net of reinsurance. For our Non-life Run-off segment, claims aging reflects
the number of years that have lapsed since the original acquisition of the related net liability for losses and
LAE reserves to the date the claim is paid. There may be occasions where, due to our claims management
strategies (including commutations and policy buy-backs) or due to the timing of claims payments relative to
the associated recovery, the cash received from reinsurance recoveries is greater than the cash paid out to
our claimants, (i.e. a net recovery rather than a net payout for a particular calendar year), thereby resulting in
a negative annual percentage payout for that calendar year.

Atrium and StarStone - The average annual percentage payout disclosures for our Atrium and StarStone
segments are based on the payout of incurred claims by age, net of reinsurance.

170

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Non-Life Run-off Segment 

The table below provides a reconciliation of the beginning and ending reserves for losses and LAE for the years

ended December 31, 2019, 2018 and 2017 for the Non-life Run-off segment:

2019

2018

2017

Balance as at January 1

$

7,540,662 $

5,949,472 $

Less: reinsurance reserves recoverable

Less: deferred charge assets on retroactive reinsurance

Net balance as at January 1

Net incurred losses and LAE:

  Current period

  Prior periods

  Total net incurred losses and LAE

Net paid losses:

  Current period

  Prior periods

  Total net paid losses

Effect of exchange rate movement

Acquired on purchase of subsidiaries

Assumed business

Ceded business

Net balance as at December 31

Plus: reinsurance reserves recoverable

Plus: deferred charge assets on retroactive reinsurance

1,366,123

86,585

6,087,954

123,559

(71,934)

51,625

(64,820)

(1,182,804)

(1,247,624)

47,355

686

1,586,307

(47,018)

6,479,285

1,543,614

272,462

1,377,485

80,192

4,491,795

12,451

(318,518)

(306,067)

(5)

(838,812)

(838,817)

(132,632)

1,111,839

1,761,836

—

6,087,954

1,366,123

86,585

Balance as at December 31

$

8,295,361 $

7,540,662 $

4,716,363

1,000,953

94,551

3,620,859

5,866

(196,540)

(190,674)

(2,835)

(578,888)

(581,723)

138,772

10,251

1,494,310

—

4,491,795

1,377,485

80,192

5,949,472

171

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Net incurred losses and LAE in the Non-life Run-off segment for the years ended December 31, 2019, 2018 and

2017 were as follows:

2019

2018

2017

Prior
Period

Current
Period

Total

Prior
Period

Current
Period

Total

Prior
Period

Current
Period

Total

$ 1,182,804

$

64,820

$ 1,247,624

$ 838,812

$

5

$ 838,817

$ 578,888

$

2,835

$ 581,723

(553,996)

23,105

(530,891)

(552,124)

4,704

(547,420)

(381,450)

397

(381,053)

Net losses paid

Net change in case and LAE
reserves

Net change in IBNR reserves

(848,776)

35,194

(813,582)

(573,127)

7,742

(565,385)

(393,100)

(219,968)

123,119

(96,849)

(286,439)

12,451

(273,988)

(195,662)

2,373

5,605

(390,727)

(190,057)

Increase (reduction) in estimates
of net ultimate losses

Reduction in provisions for bad
debt

Increase (reduction) in provisions
for unallocated LAE

Amortization of deferred charge
assets

Amortization of fair value
adjustments

Changes in fair value - fair value
option

—

—

—

—

(57,844)

440

(57,404)

(65,401)

38,627

50,070

117,181

—

—

—

38,627

13,781

50,070

12,877

117,181

6,664

—

—

—

—

—

—

(1,536)

—

(1,536)

(65,401)

(54,071)

261

(53,810)

13,781

14,359

12,877

10,114

6,664

30,256

—

—

—

14,359

10,114

30,256

Net incurred losses and LAE

$

(71,934) $ 123,559

$

51,625

$ (318,518) $ 12,451

$ (306,067) $ (196,540) $

5,866

$ (190,674)

Net change in case and LAE reserves comprises the movement during the year in specific case reserve liabilities
as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case
reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable.

Year Ended December 31, 2019 

The increase in net incurred losses and LAE for the year ended December 31, 2019 of $51.6 million included
net incurred losses and LAE of $123.6 million related to current period net earned premium. Excluding current period
net incurred losses and LAE of $123.6 million, the reduction in net incurred losses and LAE liabilities relating to prior
periods was $71.9 million, which was attributable to a reduction in estimates of net ultimate losses of $220.0 million,
a reduction in provisions for unallocated LAE of $57.8 million relating to 2019 run-off activity, partially offset by the
amortization of the deferred charge assets of $38.6 million, amortization of fair value adjustments of $50.1 million and
an increase in the fair value of liabilities of $117.2 million related to our assumed retroactive reinsurance agreements
for which we have elected the fair value option. 

Drivers of the change in estimates of net ultimate losses:

The reduction in estimates of prior period net ultimate losses of $220.0 million for the year ended December 31,
2019 included a net reduction in case and IBNR reserves of $1,402.8 million, partially offset by net losses paid of
$1,182.8 million. For the year ended December 31, 2019, the overall change in our estimates of net ultimate losses
related to prior periods by line of business within our Non-life Run-off was as presented in the table below:

172

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Net losses paid

Net change in case
and LAE reserves

Net change in
IBNR reserves

Increase (reduction) in
estimates of net
ultimate losses

Asbestos

$

118,557 $

Environmental

General Casualty

Workers' Compensation

Marine, aviation and
transit

Construction defect

Professional indemnity/
Directors & Officers

Motor

Property

All Other

Total

16,899

175,044

208,961

82,058

32,078

103,413

276,563

94,093

75,138
1,182,804 $

$

35,003 $
13,796
(89,968)
(156,435)

(77,958)
(8,313)

(36,986)
(134,127)
(73,259)
(25,749)
(553,996) $

(146,749) $
(15,707)
(91,818)
(188,944)

(24,508)
(25,025)

(104,984)
(179,887)
(7,358)
(63,796)
(848,776) $

The significant drivers of the results in the table above are explained below.

Workers' Compensation

6,811

14,988
(6,742)
(136,418)

(20,408)
(1,260)

(38,557)
(37,451)
13,476
(14,407)
(219,968)

A $136.4 million reduction in estimates of net ultimate losses in our workers' compensation line of business arose
across multiple portfolios, where reported loss development was generally significantly less than expected development.
The  lower  than  expected  actual  development  was  driven  by  significant  proactive  settlement  activity  on  individual
claimants where we were able to settle claims lower than the case reserve estimates.  For example, in two of our
portfolios we observed favorable reported loss development, where we paid $39.3 million in loss payments to release
a corresponding $53.6 million of associated case reserves for $14.3 million in favorable reported loss development.
These settlement activities and the favorable actual loss development versus expected loss development, lead to a
change in the actuarial assumptions in the annual reserve study that reflect this favorable loss development.  For
workers compensation, we paid $209.0 million offset by a reduction in case reserves of $156.4 million and reduction
in IBNR reserve of $188.9 million.

We also continue to actively seek to commute policies when possible, and where the commutation of the policy
is settled at a level below the carried value of the loss reserves, we record a reduction in our estimates of net ultimate
losses.  During  the  year  ended  December 31,  2019,  we  completed  6  commutations  across  several  portfolios  that
contributed to a $6.1 million reduction in estimates of net ultimate losses.

Professional Indemnity/Directors & Officers

A $38.6 million reduction in estimates of net ultimate losses in our professional indemnity/directors’ & officers’
line of business arose based on the annual actuarial analysis which reflected the better than expected loss development
during 2019.  As part of the reserve analysis, an in-depth review of recently acquired portfolios’ ceded reinsurance
program led to an increase in the ceded reinsurance asset of $13.5 million, which is a reduction in net ultimate losses.

Asbestos

A $6.8 million increase in estimates of net ultimate losses in our asbestos line of business arose primarily due
to changes in our actuarial assumptions related to dismissal rates.  During 2019, the number of new defendants and
filed claims was less than expected but this was offset by a lowering of the dismissal rate.  In asbestos, the dismissal
rates are extremely high as many of the claims do not have merit against the insured.  However, we have seen a trend
in both US and UK exposure of the dismissal rate trending down in the range of 2 to 3 percentage points.  

Similar  to  workers’  compensation  business,  during  the  year  ended  December  31,  2019,  we  completed  6
commutations across several portfolios that contributed to a $9.8 million reduction in estimates of net ultimate losses.

173

Table of Contents

All Other

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

All other line of business changes in estimates of net ultimate losses were primarily due to the application of our

reserving methodologies, favorable actual versus expected loss development and proactive claim management.

Other Components of Net incurred Losses and LAE

The reduction of $57.8 million in provisions for unallocated LAE was due to a reduction in our estimate of the

total future costs to administer the claims.

The increase in the fair value of liabilities for which we have elected the fair value option of $117.2 million was
primarily due to changes in the discount rate and the application of the discount rate to the updated expected cash
flow patterns.

The amortization of fair value adjustments of $50.1 million was related to the fair value adjustments associated
with the acquisition of companies. On acquisition, we are required to fair value the net assets acquired, including the
reinsurance balances recoverable and the liability for losses and LAE. The resulting fair value adjustments are then
amortized over the expected life of the reinsurance balances recoverable and the liability for losses and LAE.

The amortization of deferred charge assets of $38.6 million was associated with retroactive reinsurance contracts
where, at the inception of the contract, the estimated ultimate losses payable was in excess of premium received.
Deferred charge assets are amortized over the estimated claim payment period of the related contract and are adjusted
periodically to reflect new estimates of the amount and timing of the remaining loss payments.

Year Ended December 31, 2018 

The reduction in net incurred losses and LAE for the year ended December 31, 2018 of $306.1 million included
net incurred losses and LAE of $12.5 million related to current period net earned premium from previously acquired
businesses that renewed certain policies while being run-off. Excluding current period net incurred losses and LAE of
$12.5 million, the reduction in net incurred losses and LAE liabilities relating to prior periods was $318.5 million, which
was attributable to a reduction in estimates of net ultimate losses of $286.4 million, and a reduction in provisions for
unallocated LAE of $65.4 million, relating to 2018 run-off activity, partially offset by an increase in the fair value of
liabilities of $6.7 million related to our assumed retroactive reinsurance agreements for which we have elected the fair
value  option,  the  amortization  of  the  deferred  charge  assets  of  $13.8  million  and  the  amortization  of  fair  value
adjustments over the estimated payout period relating to companies acquired amounting to $12.9 million.

174

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Drivers of the change in estimates of net ultimate losses:

The reduction in estimates of prior period net ultimate losses of $286.4 million for the year ended December 31,
2018 included a net reduction in case and IBNR reserves of $1,125.3 million, partially offset by net losses paid of
$838.8 million. For the year ended December 31, 2018, the overall change in our estimates of net ultimate losses
related to prior periods by line of business within our Non-life Run-off was as presented in the table below:

Net losses paid

Net change in case
and LAE reserves

Net change in
IBNR reserves

Increase (reduction) in
estimates of net
ultimate losses

Asbestos

$

108,248 $

Environmental

General Casualty

Workers' Compensation

Marine, aviation and
transit

Construction defect

Professional indemnity/
Directors & Officers

Motor

Property

All Other

Total

21,273

141,624

139,226

67,831

22,182

161,797

104,182

22,178

50,271

$

838,812 $

(21,535) $
479
(115,240)
(178,138)

(151,662) $
(7,599)
(60,828)
(115,648)

(44,200)
(7,257)

(21,188)
(33,146)

(11,159)
(109,962)
(24,271)
(40,841)
(552,124) $

(130,957)
(34,215)
(11,497)
(6,387)
(573,127) $

The significant drivers of the results in the table above are explained below.

Workers' Compensation

(64,949)
14,153
(34,444)
(154,560)

2,443
(18,221)

19,681
(39,995)
(13,590)
3,043
(286,439)

The $154.6 million reduction in estimates of net ultimate losses in our workers' compensation line of business
in 2018 arose across multiple portfolios, where reported incurred loss development was generally significantly less
than expected. When actual development is less than expected for a sustained period of time across a significant
volume of exposures, an updated actuarial analysis tends to indicate reductions in IBNR reserves. Updates to actuarial
analysis, factoring in the less-than-expected reported incurred loss development for the year, is the primary driver of
the $154.6 million reduction to Workers' Compensation net ultimate loss estimates.

For certain of our portfolios, the lower than expected actual development was driven by significant proactive
settlement activity on individual claimants where we were able to close open claims earlier than was indicated by the
original payout pattern, and in other portfolios, based on the review of recent loss development activity we revised our
actuarial development "tail factor" assumption, which led to a reduction in net ultimate losses. For example, in one
portfolio we observed favorable incurred loss development, primarily relating to accident years 1995 through 2005
where we paid $22.7 million in loss payments to release a corresponding $37.0 million of associated case reserves
for $14.3 million in favorable incurred loss development. 

For recently acquired portfolios of workers' compensation business, we have utilized our subsidiary, Paladin
Managed Care Services ("Paladin"), to assist us in reviewing claims. Paladin generally produces savings related to
medical expense liabilities over and above savings achieved by prior vendors of such services, and the savings lead
to actual development that is less than expected, thereby driving reductions to the estimates of net ultimate losses. In
one  particular  program,  our  claims  personnel  pursued  a  proactive  strategy  of  settling  with  numerous  workers'
compensation claimants whose injuries arose in recent accident years. For this portfolio, the claims team reduced the
open inventory of claims by 78% during 2018. This reduction in exposure, when incorporated into an updated actuarial
analysis, led to a reduction in our estimate of ultimate net losses of $30.2 million, primarily relating to accident years
2010 through 2014.

We also continue to actively seek to commute policies when possible, and where the commutation of the policy
is settled at a level below the carried value of the loss reserves, we record a reduction in our estimates of net ultimate
losses.  During  the  year  ended  December 31,  2018,  we  completed  7  commutations  across  several  portfolios  that
contributed to an $11.2 million the reduction in estimates of net ultimate losses. 

175

Table of Contents

Asbestos

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The $64.9 million reduction in estimates of net ultimate losses in our asbestos line of business arose primarily
due to one asbestos portfolio where lower than expected volume of claims reported and a lower than expected severity
on claims settled in the period, when projected to net ultimate losses through actuarial methodologies, resulted in a
significant reduction in estimates of net ultimate losses. The volume of claims reported was 3% less than expected
and the average cost per claim was 5% less than expected. Across our other asbestos portfolios, we completed 8
commutations and 2 policy buy-backs contributing to a $9.5 million reduction in estimates of net ultimate losses. 

All Other 

All other line of business changes in estimates of net ultimate losses were primarily due to the application of our
reserving methodologies, favorable actual versus expected loss development, claim management and commutations.

Other Components of Net incurred Losses and LAE

The reduction of $65.4 million in provisions for unallocated LAE was due to a reduction in our estimate of the

total future costs to administer the claims.

The amortization of deferred charge assets of $13.8 million was associated with retroactive reinsurance contracts

where, at the inception of the contract, the estimated ultimate losses payable were in excess of premium received. 

The amortization of fair value adjustments of $12.9 million was related to the fair value adjustments associated
with the acquisition of companies. On acquisition, we are required to fair value the net assets acquired, including the
reinsurance balances recoverable and the liability for losses and LAE. 

The increase in the fair value of liabilities for which we have elected the fair value option of $6.7 million was
primarily due to decreases in the estimated duration of the net liabilities, partially offset by changes in the corporate
bond yield.

Year Ended December 31, 2017 

The reduction in net incurred losses and LAE for the year ended December 31, 2017 of $190.7 million included
net incurred losses and LAE of $5.9 million related to current period net earned premium from previously acquired
businesses that renewed certain policies while being run-off. Excluding current period net incurred losses and LAE of
$5.9 million, the reduction in net incurred losses and LAE liabilities relating to prior periods was $196.5 million, which
was attributable to a reduction in estimates of net ultimate losses of $195.7 million, and a reduction in provisions for
unallocated LAE of $54.1 million, relating to 2017 run-off activity, partially offset by an increase in the fair value of
unallocated liabilities of $30.3 million  related to our assumed retroactive reinsurance agreements for which we have
elected the fair value option, the amortization of the deferred charge assets of $14.4 million and the amortization of
fair value adjustments over the estimated payout period relating to companies acquired amounting to $10.1 million. 

Drivers of the change in estimates of net ultimate losses:

The reduction in estimates of prior period net ultimate losses of $195.7 million for the year ended December 31,
2017 included a net reduction in case and IBNR reserves of $774.6 million, partially offset by net losses paid of $578.9
million. For the year ended December 31, 2017, the overall change in our estimates of net ultimate losses related to
prior periods by line of business within our Non-life Run-off was as presented in the table below:

176

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Net losses paid

Net change in case
and LAE reserves

Net change in
IBNR reserves

Increase (reduction) in
estimates of net
ultimate losses

Asbestos

$

105,731 $

Environmental

General Casualty

Workers' Compensation

Marine, aviation and
transit

Construction defect

Professional indemnity/
Directors & Officers

Motor

Property

All Other

Total

26,542

94,526

187,712

18,272

33,802

33,402

24,391

13,440

41,070

$

578,888 $

(1,865) $
(9,438)
(54,292)
(190,924)

(76,837) $
(7,748)
(49,025)
(151,797)

(9,322)
(24,023)

(11,517)
(42,804)

(19,054)
(15,990)
(11,196)
(45,346)
(381,450) $

(24,559)
(8,513)
(5,162)
(15,138)
(393,100) $

The significant drivers of the results in the table above are explained below.

Workers' Compensation

27,029

9,356
(8,791)
(155,009)

(2,567)
(33,025)

(10,211)
(112)
(2,918)
(19,414)
(195,662)

The $155.0 million reduction in estimates of net ultimate losses in our workers' compensation line of business
arose primarily in five separate portfolios. Across these five portfolios, the reported incurred loss development was
generally significantly lower than expected. When actual development is less than expected for a sustained period of
time, across a significant volume of exposures, an updated actuarial analysis tends to indicate reductions in IBNR
reserves.  In  addition,  we  continue  to  proactively  manage  and  settle  claims  where  possible,  commute  policies  if
appropriate and, through Paladin, we are able to achieve significant savings on medical costs through active claims
management strategies over the life of the reported claims. All of these items reduce the estimates of net ultimate
losses. 

Construction Defect

The $33.0 million reduction in estimates of net ultimate losses in our construction defect line of business arose
primarily due to lower than expected actual incurred development in one portfolio. The active claims management
approach that our claims team adopted for the assumed exposures within this portfolio led to a significant reduction
loss in the inventory of the assumed open claims of 73% during 2017. This reduction in exposure, when incorporated
into our updated actuarial analysis, resulted in a reduction in estimates of net ultimate losses for this line of business.

Asbestos 

The $27.0 million increase in estimates of net ultimate losses in our asbestos line of business resulted from a
ground-up study performed by a consulting actuarial firm on one of our portfolios. This study resulted in the recording
of additional reserves of $60.5 million due to a small number of accounts that experienced an increase in the notification
of claims which are expected to attach to the excess policies that we reinsure. This increase was partially offset by
favorable development of $33.5 million in our other portfolios of asbestos exposures arising primarily from lower than
expected claim notifications

All Other

All other line of business changes in estimates of net ultimate losses were primarily due to the application of our
reserving methodologies, favorable actual versus expected loss development, claim management and commutations.

Other Components of Net incurred Losses and LAE

The reduction in provisions for bad debt of $1.5 million was a result of the favorable recoveries from reinsurers,
the reduction in bad debt provisions for insolvent reinsurers as a result of distributions received and the reduction of
specific provisions held for certain reinsurers. 

177

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reduction of $54.1 million in provisions for unallocated LAE was due to a reduction in our estimate of the

total future costs to administer the claims.

The amortization of deferred charge assets of $14.4 million was associated with retroactive reinsurance contracts
where, at the inception of the contract, the estimated ultimate losses payable were in excess of premium received.
Deferred charge assets are amortized over the estimated claim payment period of the related contract and are adjusted
periodically to reflect new estimates of the amount and timing of the remaining loss payments.

The amortization of fair value adjustment of $10.1 million was related to the fair value adjustments associated
with the acquisition of companies. On acquisition, we are required to fair value the net assets acquired, including the
reinsurance balances recoverable and the liability for losses and LAE. The resulting fair value adjustments are then
amortized over the expected life of the reinsurance balances recoverable and the liability for losses and LAE.

The increase in the fair value of liabilities for which we have elected the fair value option of $30.3 million was
primarily due to decreases in the estimated duration of the net liabilities, partially offset by changes in the corporate
bond yield.

Disclosures of Incurred and Paid Loss Development, IBNR, Claims Counts and Payout Percentages 

The following tables provides a breakdown of gross and net losses and LAE reserves, consisting of Outstanding
Loss Reserve ("OLR") and IBNR by line of business and adjustments for fair value resulting from business combinations,
adjustments for where we elected the fair value option, deferred charge assets and ULAE, as of December 31, 2019
and 2018:

Asbestos

Environmental

General casualty

Workers' compensation/personal accident

Marine, aviation and transit

Construction defect

Professional indemnity/Directors & Officers

Motor

Property

Other

Fair value adjustments

Fair value adjustments - fair value option

Deferred charge on retroactive reinsurance

ULAE

Total

OLR

Gross

IBNR

2019

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

542,681

$ 1,373,678

$ 1,916,359

$

490,117

$ 1,271,982

$ 1,762,099

187,165

501,863

1,270,530

290,067

29,772

693,760

480,668

140,620

269,956

156,121

489,129

977,808

121,577

98,312

265,490

233,806

63,604

165,882

343,286

990,992

2,248,338

411,644

128,084

959,250

714,474

204,224

435,838

173,878

399,396

963,578

244,611

29,245

485,478

317,829

122,010

208,647

142,351

421,426

751,074

100,135

94,888

170,926

165,543

56,450

97,573

316,229

820,822

1,714,652

344,746

124,133

656,404

483,372

178,460

306,220

$

4,407,082

$ 3,945,407

$ 8,352,489

$ 3,434,789

$ 3,272,348

$ 6,707,137

(170,689)

(217,933)

—

331,494

$ 8,295,361

(157,036)

(129,848)

(272,462)

331,494

$ 6,479,285

178

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Asbestos

Environmental

General casualty

Workers' compensation/personal accident

Marine, aviation and transit

Construction defect

Professional indemnity/Directors & Officers

Motor

Property

Other

Fair value adjustments

Fair value adjustments - fair value option

Deferred charge on retroactive reinsurance

ULAE

Total

OLR

Gross

IBNR

2018

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

341,544

$ 1,275,476

$ 1,617,020

$

321,356

$ 1,171,754

$ 1,493,110

96,665

500,033

1,454,178

301,783

20,712

603,665

564,307

168,267

220,615

126,035

379,484

832,615

72,888

99,288

216,839

321,992

37,631

165,519

222,700

879,517

93,095

416,097

2,286,793

1,115,116

374,671

120,000

820,504

886,299

205,898

386,134

227,994

19,310

426,020

414,847

160,873

175,289

117,384

298,612

537,782

78,023

94,736

166,898

304,874

36,817

111,453

210,479

714,709

1,652,898

306,017

114,046

592,918

719,721

197,690

286,742

$

4,271,769

$ 3,527,767

$ 7,799,536

$ 3,369,997

$ 2,918,333

$ 6,288,330

(217,527)

(374,752)

—

333,405

$ 7,540,662

(203,183)

(244,013)

(86,585)

333,405

$ 6,087,954

In addition to the breakdown of our non-life run-off reserves by line of business we also monitor our reserves by
acquisition year. The acquisition year is the year in which the net reserves were acquired via a business acquisition or
assumed via a retroactive reinsurance agreement. By analyzing the loss development tables by acquisition year on a
prospective basis, the impact of the take-on positions from year to year does not distort the loss development tables. 

The following table provides a summary of our net loss reserves, prior to provisions for bad debt, fair value adjustments,

deferred charge assets and ULAE as of December 31, 2019, by year of acquisition and by significant line of business:

2009
and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total

Asbestos

$ 180,887 $ 36,371 $

Environmental

44,461

10,364

— $

—

— $

7,973 $

— $

673 $ 387,808 $ 729,749 $

60,424 $ 336,925 $ 1,740,810

—

—

—

—

101,649

26,798

17,247

108,094

308,613

Acquisition Year

General
casualty

Workers'
compensation/
personal
accident

Marine,
aviation and
transit

Construction
defect

Professional
indemnity/
Directors &
Officers

Motor

Property

All Other

Total

60,400

13,409

24,072

12,082

14,695

30,313

46,838

5,389

59,432

305,370

241,541

813,541

3,362

49,828

145,975

3,986

58,316

— 331,383

266,932

73,069

385,223

392,454

1,710,528

8,890

2,638

3,256

—

18

55

—

—

9,438

25,131

3,957

5,021

5,756

4,058

17,889

13,843

8,619

28,274

217

298

422

500

6,199

6,295

—

—

—

660

—

3,361

13,762

1,589

—

81,037

139,908

91,909

342,989

—

46,906

18,982

22,973

—

35,198

124,132

35,795

—

77,685

—

326,157

164,271

655,260

250

14,785

14,127

5,587

3,581

7,600

203

—

4,453

406,545

455

66,755

16,562

22,099

78,785

84,344

480,599

178,215

301,410

26,528

118,979

$ 354,415 $ 141,306 $ 182,914 $ 57,336 $ 85,005 $ 99,834 $ 453,355 $ 885,176 $ 1,116,945 $ 1,724,191 $ 1,555,620 $ 6,656,097

179

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The table below reconciles the net loss reserves, prior to provisions for bad debt, fair value adjustments, deferred
charge assets and ULAE as of December 31, 2019, by significant line of business to the line of business table presented
above:

Asbestos

Environmental

General casualty

Workers' compensation/personal accident

Marine, aviation and transit

Construction defect

Professional indemnity/Directors & Officers

Motor

Property

All Other

Total

2019

Total Net
Reserves per all
Acquisition
Years

Provision for
Bad Debt

Total Net
Reserves

$

1,740,810 $

21,289 $

1,762,099

308,613

813,541

1,710,528

342,989

124,132

655,260

480,599

178,215

301,410

7,616

7,281

4,124

1,757

1

1,144

2,773

245

4,810

316,229

820,822

1,714,652

344,746

124,133

656,404

483,372

178,460

306,220

$

6,656,097 $

51,040 $

6,707,137

Loss development tables have been provided for acquisition years 2010 through 2019. In addition, the workers'
compensation  line  of  business  in  the  2015  acquisition  year;  the  workers'  compensation  line  of  business  in  the  2016
acquisition year; the general casualty, workers' compensation, marine, aviation & transit, professional indemnity/directors
& officers and motor lines of business in the 2018 acquisition year; and the general casualty, workers' compensation and
professional indemnity/directors & officers lines of business in the 2019 acquisition year are significant and we have provided
additional loss development tables for those lines of business within those acquisition years.

Our non-life run-off segment is unique within the insurance industry in that legacy reserves are continuously being
acquired  and  added  to  this  segment  through  business  acquisitions  or  through  retroactive  reinsurance  agreements.
Accordingly, it would not be appropriate to extrapolate redundancies or deficiencies into the future from the loss development
tables provided below. Acquired and assumed reserves arising from business acquisitions and retroactive reinsurance
agreements are presented on a full prospective basis.

The  following  tables  set  forth  information  about  incurred  and  paid  loss  development,  total  IBNR  reserves  and
cumulative loss frequency related to our 2010 through 2019 acquisition years within the Non-Life Run-off segment as of
December 31, 2019. In addition, we have also presented loss development tables for the significant lines of business within
certain acquisition years. The information related to incurred and paid loss development for the years ended December
31, 2010 through 2018 is presented as supplementary information and is therefore unaudited.

180

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2010 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December
31, 2019

Accident
Year

Total Net
Reserves
Acquired

2010
(unaudited)

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

Cumulative
Number of
Claims

2009
and
Prior

Accident
Year

2009
and
Prior

$ 1,092,197 $ 1,086,671 $ 1,044,111 $ 1,058,458 $1,012,046 $ 929,888 $ 903,954 $ 839,798 $ 800,104 $ 800,341 $ 788,475

$ 42,290

163,994

$ 1,092,197

$ 788,475

$ 42,290

163,994

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

2010
(unaudited)

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$

102,123 $

261,446 $

428,312 $ 511,054 $ 553,769 $ 567,605 $ 584,306 $ 612,530 $ 630,627 $ 647,169

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$ 647,169

$ 141,306

181

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2011 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December
31, 2019

Accident
Year

Total Net
Reserves
Acquired

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

Cumulative
Number of
Claims

2009
and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$ 596,121 $621,742 $586,636 $490,822 $424,001 $370,995 $315,912 $270,905 $256,864 $ 235,348

$23,721

112,787

285

—

—

—

—

—

—

—

—

—

412

102

449

36

121

141

140

140

140

142

142

142

45

10

23

54

10

43

1

61

10

15

3

—

71

10

15

3

(2)

2

79

17

15

3

(2)

86

18

15

18

32

93

17

15

15

24

(139)

(110)

(99)

—

21

7

15

8

—

—

—

—

—

3

5

8

2

2

—

26

19

7

16

14

1

2

2

1

—

$ 596,406

$ 235,578

$23,741

112,875

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

For The Years Ended December 31,

2009
and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$ 59,906 $ 97,414 $ 92,129 $ 21,874 $ 15,512 $ 24,434 $ 16,751 $ 27,013 $

52,483

140

140

140

140

142

142

142

$

91

27

115

36

6

45

10

6

54

10

10

1

61

10

15

3

—

71

10

15

3

(2)

2

79

17

15

3

(2)

86

17

15

4

3

93

17

15

7

11

(153)

(124)

(114)

—

3

1

6

4

—

$

52,664

$ 182,914

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

182

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2012 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total Net
Reserves
Acquired

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

Cumulative
Number of
Claims

$ 315,850 $ 314,772 $ 306,078 $ 297,612 $ 283,244 $ 273,273 $ 266,124 $ 257,947 $ 252,794

$

18,173

47,708

920

1,341

74

3,068

1,222

45

866

2,788

1,081

332

109

2,736

2,400

1,002

315

390

2,843

667

831

1,360

50

—

—

—

—

—

—

—

$ 318,091

2,468

1,368

1,242

1,208

981

371

396

1,420

1,388

61

960

363

385

1,189

676

1,158

69

944

152

124

1,093

676

1,019

153

—

944

152

124

1,048

676

969

91

141

251

64

—

—

—

23

—

139

—

18

37

6

5

6

5

7

5

2

4

1

4

$ 258,398

$

18,454

47,753

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

2,754 $ 67,858 $ 108,965 $ 139,542 $ 163,845 $ 173,921 $ 187,091 $ 197,236

$

$

167

110

28

463

454

45

100

618

679

45

109

62

685

792

47

124

205

103

712

849

152

124

420

107

2

748

905

152

124

617

676

51

12

776

944

152

124

791

676

89

39

—

801

944

152

124

905

676

89

91

27

17

$ 201,062

$ 57,336

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

183

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2013 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total Net
Reserves
Acquired

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

$

207,452 $ 227,635 $ 233,644 $ 225,478 $ 218,082 $ 212,039 $ 200,034 $ 188,416

$ 15,864

110,795

118,652

117,915

133,289

135,364

125,148

123,802

122,441

96,929

102,288

100,482

100,243

95,848

87,913

86,403

85,920

131,119

127,323

121,364

118,085

114,772

110,045

107,853

108,025

13,062

90,739

—

—

—

—

—

—

91,634

4,514

88,920

3,714

265

85,791

3,425

280

103

81,732

16,800

982

71

30

80,036

16,225

329

70

13

22

80,091

16,304

250

69

13

17

13

4,635

2,218

2,090

1,277

90

54

2

—

—

3

Cumulative
Number of
Claims

44,881

11,537

11,175

10,420

5,649

175

2

1

1

1

1

$

559,357

$ 601,559

$ 26,233

83,843

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

$

$

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

48,802 $

84,422 $ 109,918 $ 128,474 $ 129,803 $ 136,898 $ 140,814

24,752

30,323

33,361

17,022

48,783

52,455

59,095

37,653

993

75,351

63,952

74,663

52,638

1,747

43

92,782

70,498

86,916

62,876

2,256

102

34

98,341

75,055

92,445

68,866

15,804

112

64

9

105,023

105,873

77,290

96,780

71,487

15,959

165

65

13

13

79,113

99,781

74,556

16,123

190

66

13

17

8

$ 516,554

$

85,005

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

184

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2014 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

Total Net Reserves
Acquired

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

Cumulative
Number of Claims

For the Years Ended December 31,

As of December 31, 2019

2009 and
Prior

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

37,554 $

33,315 $

23,192 $

20,933 $

22,105 $

21,089 $

19,229

$

104,408

100,017

100,345

133,784

119,430

115,341

122,063

73,942

128,979

153,910

133,521

135,540

140,845

143,664

140,683

146,060

177,122

185,261

178,247

165,223

162,068

75,762

12,826

93,936

9,503

33,545

82,344

13,817

15,529

330

86,798

7,420

20,709

1,075

5,074

86,920

—

—

—

—

—

—

86,393

5,765

18,616

4,607

3,920

6

84,590

5,589

17,799

773

8,196

5

—

72

10,628

9,369

11,175

13,971

1,731

73

89

423

—

899

6,363

6,454

6,693

5,086

3,171

1,113

186

44

37

17

5

$

443,507

$ 563,976

$

48,430

29,169

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

$

$

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

7,044 $

13,090 $

15,652 $

16,337 $

16,884 $

16,934

69,414

87,233

102,138

102,128

103,753

109,574

110,338

113,406

120,564

126,650

119,807

128,692

127,958

132,508

29,424

84,042

47,495

21,752

1,462

89,618

40,237

2,494

1,739

47,537

3,280

4,295

20

55,882

3,975

11,465

556

537

63,256

5,994

13,487

571

1,553

5

62,009

7,671

12,774

601

1,237

5

—

$ 464,142

$

99,834

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

185

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2015 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

Total Net Reserves
Acquired

2015 
(unaudited)

2016 
(unaudited)

2017 
(unaudited)

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

For the Years Ended December 31,

As of December 31, 2019

2009 and
Prior

$

953,149 $

877,641 $

585,616 $

536,452 $

508,471 $

467,530

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

53,914

137,102

187,288

189,430

142,425

69,067

52,889

130,994

197,716

196,205

137,061

68,034

14,172

49,049

124,400

178,936

229,182

143,623

22,540

—

—

—

—

55,761

129,386

200,749

199,593

142,332

65,243

12,504

4,056

51,348

127,098

192,896

188,572

136,403

63,776

12,750

4,497

2,965

49,031

127,673

192,338

184,189

151,243

68,388

13,837

5,194

1,845

1,804

$

1,700,879

$ 1,263,072

$

51,305

6,860

18,940

23,706

16,027

18,617

5,125

2,053

453

997

1,775

145,858

11,285

2,349

5,379

4,714

5,182

10,707

21,014

3,365

900

270

3

65,168

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

$

$

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2015 
(unaudited)

2016 
(unaudited)

2017 
(unaudited)

2018 
(unaudited)

2019

23,605 $

67,899 $

114,682 $

140,691 $

165,931

9,191

33,826

52,728

46,761

30,747

20,653

15,301

55,077

94,767

89,868

64,353

38,193

5,325

19,665

70,975

119,382

120,429

90,738

46,067

7,038

2,311

25,625

86,324

142,165

145,659

109,149

51,315

8,298

3,909

558

28,455

97,842

158,417

159,626

125,226

59,247

9,405

4,691

835

42

$

$

809,717

453,355

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

186

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2015 - Workers' Compensation

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December 31, 2019

Accident
Year

Total Net Reserves
Acquired

2015 (unaudited)

2016 (unaudited)

2017 (unaudited)

2018 (unaudited)

2019

IBNR

Cumulative Number
of Claims

2009 and
Prior

$

921,259 $

834,148 $

538,290 $

488,356 $

462,612 $

418,931

$

43,677

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

34,360

73,723

110,007

124,726

86,852

18,647

31,402

69,009

108,251

122,238

82,038

12,623

873

31,919

76,789

120,298

146,237

82,141

4,089

—

—

—

—

30,407

68,013

106,625

121,010

83,095

13,488

955

358

27,922

66,781

100,187

113,056

78,389

12,295

583

61

—

26,913

67,236

98,532

112,199

78,457

11,125

536

41

5

1

1,877

5,836

5,774

6,789

2,633

545

72

21

3

—

8,129

471

1,238

1,804

2,379

3,680

2,900

38

10

1

1

$

1,382,732

$

813,976

$

67,228

20,651

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2015 (unaudited)

2016 (unaudited)

2017 (unaudited)

2018 (unaudited)

2019

16,278 $

56,563 $

96,000 $

115,884 $

137,417

$

$

4,352

16,032

25,103

27,737

17,824

3,034

8,446

30,462

52,851

55,675

38,051

5,672

134

11,906

39,635

66,092

75,065

53,308

7,917

363

2

16,141

50,470

79,367

91,559

65,561

9,169

417

10

—

17,912

55,595

88,369

100,890

72,696

9,248

447

18

1

—

$

$

482,593

331,383

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

187

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2016

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

Total Net Reserves
Acquired

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

Cumulative Number
of Claims

For the Years Ended December 31,

As of December 31, 2019

2009 and
Prior

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

1,263,726 $

1,274,524 $

1,302,307 $

1,282,385 $

1,287,000

$

303,592

22,892

32,451

17,291

13,717

373

391

—

—

32,866

19,920

17,020

1,312

1,380

—

—

—

32,571

17,291

13,717

373

391

—

—

—

—

—

28,093

19,754

14,765

1,237

1,056

—

—

—

—

25,710

18,829

12,717

1,120

869

—

—

—

—

—

5,047

2,830

2,012

827

485

—

—

—

—

—

706

789

776

112

50

—

—

—

—

—

$

1,328,069

$

1,346,245

$

314,793

25,325

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Years Ended December 31,

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$

$

96,937 $

213,509 $

317,309 $

2,757

2,758

2,734

145

178

—

—

7,111

6,647

5,206

191

207

—

—

—

10,001

8,218

6,461

278

284

—

—

—

—

428,904

14,236

9,691

7,587

285

366

—

—

—

—

—

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

461,069

885,176

188

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2016 - Workers' Compensation

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December 31, 2019

Accident Year

Total Net Reserves
Acquired

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR

2009 and Prior $

413,381 $

412,474 $

377,285 $

369,093 $

362,905

$

26,747

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

25,330

15,376

13,074

—

—

—

—

26,034

16,399

15,465

—

—

—

—

—

24,075

15,376

13,074

—

—

—

—

—

—

—

22,383

16,501

13,276

19,541

16,327

11,379

—

—

—

—

—

—

—

—

—

—

—

—

—

3,660

1,456

1,093

—

—

—

—

—

—

—

Cumulative
Number of
Claims

9,092

323

476

608

—

—

—

—

—

—

—

$

465,906

$

410,152

$

32,956

10,499

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

33,610 $

59,725 $

83,273 $

117,191

$

$

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

1,908

2,631

2,638

—

—

—

—

5,539

5,871

5,028

—

—

—

—

—

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

7,326

7,305

6,247

—

—

—

—

—

—

9,891

8,756

7,382

—

—

—

—

—

—

—

$

$

143,220

266,932

189

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2017 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year

Total Net Reserves
Acquired

For the Years Ended December 31,
2018
2017
(unaudited)
(unaudited)

2019

As of December 31, 2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

1,449,663 $

1,374,191 $

1,304,002 $

1,313,517

$

776,522

11,481

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

34,561

36,184

39,449

36,320

31,474

9,207

1,484

95

—

—

28,737

29,273

35,467

30,335

20,315

6,494

(4)

174

18,908

25,390

31,240

28,140

16,984

7,002

125

—

—

21,021

27,315

29,452

24,703

15,996

6,295

919

—

—

—

8,209

8,573

6,389

1,242

2,195

931

86

416

—

—

36

7

11

11

20

8

3

1

—

—

$

1,638,437

$

1,439,218

$

804,563

11,578

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

$

$

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Years Ended December 31,
2018
2017
(unaudited)
(unaudited)

2019

80,189 $

165,471 $

243,621

4,287

4,125

10,348

9,508

6,482

1,361

(56)

4

7,394

9,257

15,371

15,711

8,987

3,720

66

—

—

9,121

12,971

18,603

21,277

11,559

4,687

434

—

—

—

$

$

322,273

1,116,945

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

190

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2018 

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year Total Net Reserves Acquired

For the Year Ended December 31,

As of December 31, 2019

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

559,105 $

383,948 $

355,392

$

106,822

209,846

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

88,147

159,362

225,177

263,008

408,726

354,692

170,311

207,035

315,659

—

108,810

147,341

219,807

267,132

453,181

474,678

172,245

207,172

315,659

94,273

142,391

211,156

255,973

423,289

467,650

174,845

205,460

285,038

68,271

23,039

21,380

20,218

54,609

90,111

97,189

55,384

79,430

88,411

19,774

13,799

14,100

14,055

16,251

18,887

23,421

2,094

4,163

4,929

1,634

$

2,751,222

$

2,683,738

$

656,367

323,179

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Year Ended December 31,

2018 
(unaudited)

2019

$

$

41,953 $

11,109

26,998

31,845

42,312

93,536

100,598

6,258

52

—

36,359

23,761

47,261

74,768

90,716

181,166

191,150

62,658

72,794

139,815

39,099

959,547

1,724,191

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

191

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2018 - General Casualty

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year Total Net Reserves Acquired

For the Year Ended December 31,

As of December 31, 2019

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

97,189 $

48,898 $

42,901

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

30,895

17,518

36,536

42,528

65,355

77,011

28,825

37,209

39,888

—

23,086

15,854

31,901

54,061

80,316

91,825

28,825

37,209

39,888

23,059

15,532

27,774

44,782

72,333

102,399

36,585

41,664

40,753

6,767

3,969

7,004

2,086

3,716

5,123

16,793

28,926

14,377

20,392

20,480

2,802

45,895

1,885

1,404

1,567

1,571

2,210

3,430

253

230

182

34

$

472,954

$

454,549

$

125,668

58,661

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Year Ended December 31,

2018 
(unaudited)

2019

$

$

3,496 $

5,345

2,236

1,104

10,015

13,427

15,163

—

—

—

7,146

7,835

6,621

11,097

19,756

28,071

32,244

14,109

11,048

8,879

2,373

149,179

305,370

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

192

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2018 - Workers' Compensation

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Year Ended December 31,

As of December 31, 2019

Accident Year Total Net Reserves Acquired

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

106,230 $

101,016 $

108,435

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

24,838

29,795

28,788

37,716

65,000

38,734

44,686

52,360

65,075

—

25,149

24,877

29,174

38,309

66,305

39,336

44,686

52,360

65,075

24,102

26,179

27,723

37,866

57,128

34,649

38,945

49,156

60,923

20,889

30,391

8,642

12,202

12,633

16,786

24,865

16,909

21,267

28,222

24,137

5,472

$

493,222

$

485,995

$

201,526

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

1,742

355

401

468

866

1,335

1,437

892

998

886

383

9,763

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Year Ended December 31,

2018 
(unaudited)

2019

$

$

3,633 $

317

(1,517)

521

1,532

3,248

1,355

—

—

—

10,643

4,542

1,825

5,513

7,743

14,666

4,066

3,666

5,900

28,725

13,483

100,772

385,223

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

193

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2018 - Marine, Aviation & Transit

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year Total Net Reserves Acquired

For the Year Ended December 31,

As of December 31, 2019

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

26,321 $

28,798 $

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

3,324

8,676

16,069

43,798

62,766

26,007

—

—

—

—

2,062

9,472

12,297

35,462

81,126

65,209

—

—

—

20,641

$

(6,710)

10,345

10,151

29,464

82,479

72,055

—

—

—

—

(1,842)

(1,049)

1,486

(6,037)

2,404

14,668

8,758

—

—

—

—

57,002

3,243

3,966

4,280

5,720

5,862

6,606

—

—

—

—

$

186,961

$

218,425

$

18,388

86,679

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Year Ended December 31,

2018 
(unaudited)

2019

$

$

3,211 $

(3,689)

4,953

1,180

5,642

22,990

21,956

—

—

—

(3,789)

(7,715)

5,901

3,482

11,734

40,926

27,978

—

—

—

—

78,517

139,908

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

194

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired  and  Contracts  Incepting  in  the  Year  Ended  December  31,  2018  -  Professional  Indemnity/
Directors & Officers

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year Total Net Reserves Acquired

For the Year Ended December 31,

As of December 31, 2019

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

200,658 $

92,577 $

100,687

$

(1,316)

52,393

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

25,474

44,476

55,366

56,251

84,795

45,515

—

—

—

—

39,710

50,663

68,004

60,010

106,888

97,288

—

—

—

33,765

46,111

65,180

74,018

101,771

79,028

—

—

—

—

8,220

2,837

12,943

9,407

16,922

19,285

—

—

—

—

4,259

3,745

3,263

3,223

3,563

3,903

—

—

—

—

$

512,535

$

500,560

$

68,298

74,349

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For the Year Ended December 31,

2018 
(unaudited)

2019

$

$

24,232 $

3,644

12,453

15,706

10,599

21,640

13,696

—

—

—

33,585

12,243

19,732

22,837

18,601

40,189

27,216

—

—

—

—

174,403

326,157

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

195

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2018 - Motor

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident Year Total Net Reserves Acquired

For the Year Ended December 31,

As of December 31, 2019

2018 
(unaudited)

2019

IBNR

Cumulative
Number of Claims

2009 and Prior $

17,648 $

15,490 $

10,781

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$

23,548

46,015

62,432

74,615

111,418

129,271

90,166

100,316

180,471

—

835,900

13,937

36,282

55,338

68,022

99,140

127,187

92,100

100,453

180,471

15,187

35,843

60,620

61,396

86,887

126,345

93,824

99,129

157,556

39,757

(291)

1,015

1,477

6,949

14,105

10,440

15,912

19,439

30,312

42,546

11,457

356

922

1,209

1,594

626

1,140

1,274

644

2,797

3,731

1,200

$

787,325

$

153,361

15,493

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For the Year Ended December 31,

2018 
(unaudited)

2019

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$

$

2,398 $

4,437

5,631

11,520

10,226

20,746

19,857

6,258

52

—

5,112

6,911

12,112

23,284

27,839

46,359

58,433

42,527

48,655

86,861

22,687

380,780

406,545

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$

$

196

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2019

Incurred Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

Total Net Reserves Acquired

2019

IBNR

Cumulative Number
of Claims

For the Year Ended December 31,

As of December 31, 2019

2009 and Prior $

604,631 $

598,841

$

330,575

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

35,515

47,718

70,661

110,426

135,465

182,991

238,798

116,386

162,744

—

24,353

38,961

51,937

87,708

131,000

186,727

308,254

116,386

162,744

54,601

3,586

1,506

27,520

36,879

76,169

99,838

179,237

116,386

162,744

12,706

81,869

21,945

21,380

15,532

19,223

21,224

35,276

39,815

2

2

85

$

1,705,335 $

1,761,512

$

1,047,146

256,353

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

For the Year Ended December 31,

2019

$

$

$

21,678

4,923

4,649

6,455

12,893

26,910

34,610

68,179

—

—

25,595

205,892

1,555,620

197

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2019 - General Casualty

Incurred Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For the Year Ended December 31,

As of December 31, 2019

Accident Year

Total Net Reserves Acquired

2019

2009 and Prior $

4,396 $

4,415

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

7,704

11,381

16,910

22,355

32,883

58,563

50,518

32,188

45,010

—

5,426

8,817

13,592

16,934

30,337

45,594

62,866

32,188

45,010

1,709

IBNR

Cumulative Number
of Claims

670

1,509

2,347

5,262

7,515

15,387

30,556

44,899

32,188

45,010

475

693

1,213

1,148

688

448

456

346

475

1

1

3

$

281,908 $

266,888

$

185,818

5,472

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

For the Year Ended December 31,

2019

$

$

$

1,163

1,031

896

3,136

3,472

4,103

4,552

6,193

—

—

801

25,347

241,541

198

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired and Contracts Incepting in the Year Ended December 31, 2019 - Workers' Compensation

Incurred Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For the Year Ended December 31,

As of December 31, 2019

Accident Year

Total Net Reserves Acquired

2019

2009 and Prior $

5,143 $

3,609

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$

713

2,470

6,274

16,686

34,945

57,027

84,171

84,197

117,734

—

409,360 $

726

2,410

6,173

16,223

35,252

56,158

85,396

84,197

117,734

—

407,878

$

IBNR

Cumulative Number
of Claims

1,270

642

2,334

6,090

14,578

30,998

48,794

73,087

84,197

117,734

—

379,724

11,136

1,352

1,476

2,102

3,726

3,956

6,158

6,612

1

1

—

36,520

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

For the Year Ended December 31,

2019

$

$

$

577

38

24

24

451

3,076

3,635

7,599

—

—

—

15,424

392,454

199

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Business Acquired  and  Contracts  Incepting  in  the  Year  Ended  December  31,  2019  -  Professional  Indemnity/
Directors & Officers

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Year Ended December 31,

As of December 31, 2019

Accident Year

Total Net Reserves Acquired

2019

2009 and Prior $

6,696 $

4,052

$

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

7,245

18,093

30,127

46,758

46,557

29,527

2,892

—

—

—

4,448

10,292

18,012

35,881

46,982

32,577

52,708

—

—

3,251

IBNR

Cumulative Number
of Claims

812

838

1,947

4,348

9,945

17,975

7,665

28,916

—

—

961

10,399

5,300

6,511

3,472

4,411

5,361

5,856

5,053

—

—

3

$

187,895 $

208,203

$

73,407

46,366

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

Accident Year

2009 and Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

Total outstanding liabilities for unpaid losses and LAE,
net of reinsurance

For the Year Ended December 31,

2019

$

$

$

1,323

326

3,403

3,216

3,924

14,955

7,193

8,067

—

—

1,525

43,932

164,271

200

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Annual Historical Duration of Claims

The following is unaudited supplementary information, which presents the annual percentage payout since the

year of acquisition, by year of acquisition and significant line of business within each acquisition year: 

Annual Percentage Payout of Incurred Losses since Year of Acquisition, Net of Reinsurance

Year of Acquisition

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

2010 - All lines of business

12.95% 20.21 % 21.16 % 10.49 %

5.42% 1.75 % 2.12 %

3.58%

2.30%

2.10%

2011 - All lines of business

25.48% 15.94 % (2.22)% (29.82)% (2.70)% 3.79 % (3.32)%

4.38% 10.83%

2012 - All lines of business

1.18% 25.49 % 16.08 % 12.00 %

9.56% 4.26 % 5.22 %

4.02%

2013 - All lines of business

25.64% 21.47 % 15.78 % 10.91 %

6.08% 3.86 % 2.14 %

2014 - All lines of business

33.91% 23.93 % 10.99 % 7.95 %

3.44% 2.08 %

2015 - All lines of business

17.22% 16.89 % 12.71 % 9.69 %

2015 - Workers' compensation

13.56% 16.89 % 12.58 % 9.62 %

7.60%

6.64%

2016 - All lines of business

7.84% 9.46 % 8.15 % 8.80 %

2016 - Workers' Compensation

9.94% 8.63 % 6.82 % 9.53 %

2017 - All lines of business

8.08% 7.62 % 6.69 %

2018 - All lines of business

2018 - General Casualty

13.22% 22.54 %

11.17% 21.65 %

2018 - Workers' Compensation

1.87% 18.87 %

2018 - Marine, Aviation & Transit

25.75% 10.20 %

2018 - Professional Indemnity/
Directors & Officers

2018 - Motor

2019 - All lines of business

2019 - General Casualty

2019 - Workers' Compensation

2019 - Professional Indemnity/
Directors & Officers

20.37% 14.47 %

10.30% 38.06 %

11.69%

9.50%

3.78%

21.10%

The negative payout percentages in the table above for years 3, 4, 5 and 7 within the 2011 year of acquisition
line were primarily due to ceded paid losses exceeding the assumed paid losses as a result of commutations completed
with several reinsurers covering the exposures assumed by one of our reinsurance subsidiaries that we acquired in
2011. For the specific years referenced above, we collected more paid recoveries from our reinsurers than the losses
we paid on the assumed exposures, and as such, the calculated annual payout percentages were negative.

201

Table of Contents

Atrium 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The table below provides a reconciliation of the beginning and ending liability for losses and LAE for the years

ended December 31, 2019, 2018 and 2017:

2019

2018

2017

Balance as at January 1

$

241,284 $

240,873 $

Less: reinsurance reserves recoverable

Net balance as at January 1

Net incurred losses and LAE:

  Current period

  Prior periods

  Total net incurred losses and LAE

Net paid losses:

  Current period

  Prior periods

  Total net paid losses

Effect of exchange rate movement

Net balance as at December 31

Plus: reinsurance reserves recoverable

38,768

202,516

85,027
(7,751)
77,276

(34,617)
(43,572)
(78,189)
1,253

202,856

28,816

40,531

200,342

83,627
(13,817)
69,810

(35,537)
(28,969)
(64,506)
(3,130)
202,516

38,768

Balance as at December 31

$

231,672 $

241,284 $

212,122

30,009

182,113

90,359
(20,940)
69,419

(24,571)
(31,107)
(55,678)
4,488

200,342

40,531

240,873

Net incurred losses and LAE in the Atrium segment for the years ended December 31, 2019, 2018 and 2017

were as follows:

Prior
Period

2019

Current
Period

Total

Prior
Period

2018

Current
Period

Total

Prior
Period

2017

Current
Period

Total

Net losses paid

$ 43,572

$ 34,617

$ 78,189

$ 28,969

$ 35,537

$ 64,506

$ 31,107

$ 24,571

$ 55,678

Net change in case and LAE
reserves

Net change in IBNR reserves

Increase (reduction) in
estimates of net ultimate losses

Increase in provisions for bad
debt

Increase (reduction) in
provisions for unallocated LAE

Amortization of fair value
adjustments

(13,278)

(38,380)

16,812

33,598

3,534

(10,161)

(4,782)

(27,507)

16,492

31,598

6,331

4,091

(13,324)

(35,650)

21,662

43,329

8,338

7,679

(8,086)

85,027

76,941

(8,699)

83,627

74,928

(17,867)

89,562

71,695

—

—

335

—

—

—

—

—

—

—

335

(5,118)

—

—

—

—

—

89

(442)

70

727

159

285

(5,118)

(2,720)

—

(2,720)

Net incurred losses and LAE

$ (7,751) $ 85,027

$ 77,276

$ (13,817) $ 83,627

$ 69,810

$ (20,940) $ 90,359

$ 69,419

202

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Disclosures of Incurred and Paid Loss Development, IBNR, Claims Counts and Payout Percentages 

The following tables provide a breakdown of the gross and net losses and LAE by line of business and the fair
value adjustments resulting from business acquisitions and ULAE as of December 31, 2019 and 2018 for the Atrium
segment:

Total

$

89,141 $

136,543 $

9,121

10,935

20,056

8,584

OLR

Gross

IBNR

2019

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

24,668 $
31,507

34,156 $
54,039

58,824 $
85,546

21,012 $
29,590

24,829 $
51,984

18,385

5,460

29,533

7,880

47,918

13,340

16,209

4,735

23,338

7,469

45,841

81,574

39,547

12,204

80,130 $

225,684 $
3,700

2,288

$

231,672

2018

9,637
117,257 $

18,221

197,387

3,181

2,288

$

202,856

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

Total

$

32,999 $
28,512

36,011 $
59,302

69,010 $
87,814

21,460 $
26,601

24,207 $
57,016

18,547

4,972

27,653

6,348

46,200

11,320

15,180

4,225

24,823

5,837

45,667

83,617

40,003

10,062

Marine, Aviation and
Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and
Facultative

Fair value adjustments

ULAE

Total

Marine, Aviation and
Transit

Binding Authorities

Reinsurance

Accident and Health

Non-Marine Direct and
Facultative

Fair value adjustments

ULAE

Total

Total

$

94,885 $

140,521 $

9,855

11,207

21,062

8,529

75,995 $

235,406 $
3,476

2,402

$

241,284

9,389
121,272 $

17,918

197,267

2,847

2,402

$

202,516

The  Atrium  segment  comprises  only  2%  of  the  total  consolidated  gross  liability  for  losses  and  LAE  as  of
December 31, 2019 and therefore has not been disaggregated further for purposes of presenting the accident year
disclosures below.

203

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The following tables set forth information about incurred and paid loss development information for the Atrium
segment as of December 31, 2019. The information related to incurred and paid loss development for the years ended
December 31, 2010 through 2018 is presented as supplementary information and is therefore unaudited. Information
about total IBNR reserves and cumulative loss frequency as of December 31, 2019, including expected development
on reported losses included within the net incurred losses and allocated LAE amounts for the Atrium segment, are set
forth in the table below.

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For the Years Ended December 31,

As of December
31, 2019

Accident
Year

2010
(unaudited)

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR(1)

Cumulative
Number of
Claims

2009
and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

546,446

609,275

593,467

573,576

569,959

564,128

560,524

558,768

556,252

553,325

2,839

1,381

26,782

64,985

57,835

51,698

47,558

46,024

45,540

44,289

43,739

86,326

84,661

72,898

71,104

69,385

68,083

67,358

66,904

70,259

57,279

55,903

53,723

51,930

51,012

50,541

58,326

63,710

57,798

54,472

51,706

52,049

69,253

69,500

66,104

60,542

57,667

69,646

71,498

63,530

60,210

43,723

66,534

50,352

50,638

56,737

58,785

518

991

601

1,441

3,104

6,018

73,190

75,318

70,179

67,031

10,449

90,247

94,984

91,109

20,400

85,044

91,621

37,297

86,269

33,598

201

252

385

566

932

1,515

2,803

5,053

6,644

5,362

(1) Total of IBNR plus expected development on reported losses.

Total $ 1,216,124

$ 117,257

25,094

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

Accident
Year

2010
(unaudited)

2011
(unaudited)

2012
(unaudited)

2013
(unaudited)

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

2009
and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

$491,683 $510,113 $521,740 $531,928 $536,706 $541,597 $543,591 $544,954 $543,253 $ 544,625

11,442

25,127

32,223

36,530

39,022

40,049

40,650

41,223

41,386

17,138

39,997

52,450

58,627

62,560

63,914

65,199

64,669

11,228

31,474

37,991

42,152

44,430

45,321

46,901

14,579

32,064

40,443

43,511

45,387

46,099

17,596

34,368

41,595

46,879

48,542

12,029

29,687

38,987

44,544

13,729

34,606

44,273

14,371

47,723

13,130

41,631

65,040

47,598

46,637

51,263

47,704

47,962

56,057

34,166

36,054

Total outstanding liabilities for unpaid losses and LAE, net of reinsurance

$ 197,387

Total $1,018,737

204

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the Atrium segment for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and
fair value adjustments

$

$

2019

197,387
28,297

225,684

The following is unaudited supplementary information for average annual historical duration of claims within the

Atrium segment:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

Atrium

24.69% 32.30%

14.57%

8.25%

4.69%

2.47%

1.88%

0.63%

0.47%

0.56%

StarStone 

The table below provides a reconciliation of the beginning and ending liability for losses and LAE for the years

ended December 31, 2019, 2018 and 2017:

Balance as at January 1

Less: reinsurance reserves recoverable

Net balance as at January 1

Net incurred losses and LAE:

  Current period

  Prior periods

  Total net incurred losses and LAE

Net paid losses:

  Current period

  Prior periods

  Total net paid losses

Effect of exchange rate movement

Acquired on purchase of subsidiaries

Assumed business

Ceded business

Net balance as at December 31

Plus: reinsurance reserves recoverable

Balance as at December 31

2019

2018

2017

$

1,608,697 $
462,950

1,145,747

1,207,743 $
452,017

755,726

1,059,382

357,231

702,151

598,468

129,168

727,636

(96,261)
(435,372)
(531,633)
87

—

—

—

578,892

94,491

673,383

(150,778)
(326,352)
(477,130)
(9,481)
192,981

10,268

—

1,341,837

1,145,747

537,291
1,879,128 $

462,950
1,608,697 $

$

341,628
(26,822)
314,806

(54,867)
(252,926)
(307,793)
15,169

—

31,393

—

755,726

452,017

1,207,743

205

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Net incurred losses and LAE in the StarStone segment for the years ended December 31, 2019, 2018 and 2017

were as follows:

Prior
Period

2019

Current
Period

Total

Prior
Period

2018

Current
Period

Total

Prior
Period

2017

Current
Period

Total

Net losses paid

$ 435,372

$ 96,261

$ 531,633

$ 326,352

$ 150,778

$ 477,130

$ 252,926

$ 54,867

$ 307,793

Net change in case and
LAE reserves

Net change in IBNR
reserves

Increase (reduction) in
estimates of net ultimate
losses

Increase (reduction) in
provisions for unallocated
LAE

Amortization of fair value
adjustments

Net incurred losses and
LAE

(85,983)

111,950

25,967

(81,491)

157,378

75,887

(63,785)

95,470

31,685

(214,787)

381,214

166,427

(144,212)

258,091

113,879

(208,244)

184,704

(23,540)

134,602

589,425

724,027

100,649

566,247

666,896

(19,103)

335,041

315,938

(5,602)

9,043

3,441

(5,892)

12,645

6,753

(6,774)

6,587

(187)

168

—

168

(266)

—

(266)

(945)

—

(945)

$ 129,168

$ 598,468

$ 727,636

$ 94,491

$ 578,892

$ 673,383

$ (26,822) $ 341,628

$ 314,806

Net change in case and LAE reserves comprises the movement during the year in specific case reserve liabilities
as a result of claims settlements or changes advised to us by our policyholders and attorneys, less changes in case
reserves recoverable advised by us to our reinsurers as a result of the settlement or movement of assumed claims.
Net change in IBNR represents the gross change in our actuarial estimates of IBNR, less amounts recoverable.

Disclosures of Incurred and Paid Loss Development, IBNR, Claims Counts and Payout Percentages 

The following tables provide a breakdown of the gross and net losses and LAE reserves by line of business and

the fair value adjustments resulting from business acquisitions and ULAE as of December 31, 2019 and 2018:

2019

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

$

191,317 $
195,068

481,473 $
173,319

672,790 $
368,387

156,086 $
162,073

422,186 $
138,586

Casualty

Marine

Property

Aerospace

Workers' Compensation

367,258

79,249

55,902

Total

$

888,794 $

Fair value adjustments

ULAE

Total

Total

578,272

300,659

250,811

70,658

92,655

22,862

74,661

111,334
750,950 $ 1,311,734
1,600

28,503
$ 1,341,837

152,514

33,000

519,772

112,249

122,047
962,353 $ 1,851,147 $

177,949

158,156

47,796

36,673

560,784 $

(522)
28,503
$ 1,879,128

206

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

2018

OLR

Gross

IBNR

Total

OLR

(in thousands of U.S. dollars)

Net

IBNR

$

177,432 $
185,084

331,432 $
182,453

508,864 $
367,537

137,828 $
163,889

282,026 $
133,426

Casualty

Marine

Property

Aerospace

Workers' Compensation

317,102

67,203

49,373

Total

$

796,194 $

Fair value adjustments

ULAE

Total

123,511

40,416

440,613

107,619

110,082
787,894 $ 1,584,088 $

159,455

151,774

45,879

33,759

533,129 $

(467)
25,076
$ 1,608,697

65,522

36,167

68,969

102,728
586,110 $ 1,119,239
1,432

25,076
$ 1,145,747

Total

419,854

297,315

217,296

82,046

The following tables set forth information about incurred and paid loss development, total IBNR reserves and
cumulative loss frequency related to all the individual lines of business within the StarStone segment as of December 31,
2019. The information related to incurred and paid loss development for the years ended December 31, 2014 through
2018 is presented as supplementary information and is therefore unaudited. The information within the tables below
is presented on a prospective basis from the date of our acquisition of StarStone on April 1, 2014 since providing pre-
acquisition incurred and paid losses by accident year for years prior to 2014 was determined to be impracticable due
to significant data limitations.

207

Table of Contents

Casualty

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(Unaudited)

2015
(Unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR(1)

$ 82,278 $ 82,329 $ 82,400 $ 82,324 $ 82,535 $
17,856

18,538

18,556

17,769

16,623

21,101

56,891

72,771

91,369

25,435

48,251

66,888

92,793

105,135

25,745

43,936

77,756

92,812

111,067

125,367

24,971

40,095

76,172

90,335

110,179

129,130

137,614

25,422

39,477

78,788

90,588

123,208

140,601

162,599

159,324

82,574 $
18,612

26,159

42,055

87,575

101,748

131,156

169,207

194,259

181,499

—

119

765

3,059

9,817

19,074

22,056

39,548

64,639

90,672

198,218

172,437
Total $1,233,062 $ 422,186

Cumulative
Number of
Claims

2,543

729

2,035

3,128

4,998

5,734

4,744

4,467

4,830

3,902

2,780

39,890

(1) Total of IBNR plus expected development on reported losses.

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For The Years Ended December 31,

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(Unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$ 82,257 $ 82,319 $ 82,395 $ 82,318 $ 82,534 $
17,855

18,537

18,555

17,768

15,555

15,745

18,412

23,054

5,769

21,088

29,503

30,448

21,911

8,088

23,731

32,694

50,137

37,607

27,292

4,642

24,294

33,943

54,688

50,767

49,014

42,935

9,997

24,925

36,162

60,389

64,672

68,194

74,921

50,705

20,649

82,546

18,466

25,389

36,076

69,703

68,827

92,327

97,715

107,625

47,973

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

$ 578,272

8,143
Total $ 654,790

208

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and fair value
adjustments

$

$

2019

578,272
94,518

672,790

The following is unaudited supplementary information for average annual historical duration of claims:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

Casualty

5.87% 17.83% 17.73% 17.98% 13.06%

5.94%

3.72%

1.44%

0.71% (0.23)%

209

Table of Contents

Marine

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR(1)

$ 27,070 $ 27,002 $ 27,018 $ 27,050 $ 27,076 $ 27,100 $

22,347

29,527

47,957

62,904

50,079

19,270

27,753

51,418

55,154

53,452

71,004

19,114

27,330

51,074

52,938

48,450

70,033

82,486

19,176

27,371

49,813

53,913

54,958

79,494

83,070

130,700

19,040

27,715

50,618

57,224

50,576

81,088

87,169

19,050

33,538

59,597

46,309

50,026

82,698

86,774

158,785

167,902

166,042

167,565

—

144

514

405

243

833

1,082

4,214

10,802

33,836

163,412

86,513
Total $ 902,111 $ 138,586

(1) Total of IBNR plus expected development on reported losses.

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For The Years Ended December 31,

Cumulative
Number of
Claims

1,991

1,029

1,961

2,422

2,226

4,003

5,742

6,904

8,524

9,881

5,219

49,902

Accident
Year

2008 and
Prior

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$ 26,939 $ 26,990 $ 27,015 $ 27,042 $ 27,077 $ 27,092
18,539

18,437

18,403

18,372

16,300

18,324

29,395

49,727

12,529

10,878

31,152

53,711

21,213

24,813

10,871

32,397

55,446

25,135

32,332

30,562

12,131

32,643

56,589

27,237

36,773

50,062

41,696

25,258

32,803

57,206

29,071

42,420

56,154

57,265

68,952

41,427

32,558

57,711

38,733

43,789

59,478

72,475

108,000

104,825

38,252
Total $ 601,452

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

$ 300,659

210

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and
fair value adjustments

$

$

2019

300,659
67,728

368,387

The following is unaudited supplementary information for average annual historical duration of claims:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

Marine

18.70% 29.98% 19.76%

9.79%

5.60%

3.86%

4.63%

0.32% (0.09)%

0.30%

211

Table of Contents

Property

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR(1)

$ 113,828 $ 113,118 $ 113,206 $ 113,696 $ 114,633 $ 114,991 $

74,893

91,161

65,824

78,145

58,975

73,437

89,708

61,707

65,152

43,848

78,993

72,072

89,752

60,683

64,804

43,169

76,550

87,562

72,134

89,441

61,637

63,959

43,603

70,359

95,557

155,484

72,146

89,359

58,721

62,177

41,563

70,244

95,151

72,088

89,708

58,985

60,582

40,818

71,189

95,038

171,665

165,311

183,584

178,800

—

—

4

12

13

1,082

3,964

2,672

6,554

8,433

122,118
69,922
Total $1,087,901 $ 92,656

(1) Total of IBNR plus expected development on reported losses.

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of
Reinsurance

For The Years Ended December 31,

Cumulative
Number of
Claims

2,901

1,557

1,621

1,501

1,959

2,094

5,720

6,791

8,034

6,653

3,277

42,108

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$ 112,693 $ 112,957 $ 112,987 $ 113,237 $ 113,143 $ 113,338
71,969

72,131

72,148

72,069

71,958

69,070

87,411

48,103

30,880

5,500

88,608

52,168

46,285

18,830

10,433

89,113

54,308

51,086

31,617

28,652

26,838

89,366

55,274

53,172

34,563

55,372

58,035

37,410

89,345

55,474

59,277

36,106

63,880

75,387

98,267

59,187

89,387

57,753

60,416

37,240

64,764

85,023

139,555

98,065

19,580
Total $ 837,090

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

$ 250,811

212

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and
fair value adjustments

$

$

2019

250,811
268,961

519,772

The following is unaudited supplementary information for average annual historical duration of claims:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

Property

20.98% 29.19% 27.01%

8.82%

2.69%

3.22%

0.54%

1.04%

— %

0.20%

213

Table of Contents

Aerospace

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

As of December 31,
2019

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

IBNR(1)

Cumulative
Number of
Claims

$

— $

— $

— $

— $

— $

— $

18,441

58,786

55,675

72,098

65,208

18,073

57,257

55,370

70,180

53,541

66,335

18,382

57,681

56,212

70,511

53,553

69,499

37,741

18,896

58,114

56,159

74,900

52,341

72,519

45,019

31,380

18,970

59,647

57,450

77,393

54,408

73,183

48,180

35,075

59,498

18,772

58,770

57,185

76,964

48,657

71,196

45,380

56,354

55,986

—

17

61

125

274

464

1,318

1,714

3,142

3,980

45,483
11,766
Total $ 534,747 $ 22,861

—

579

2,197

2,421

2,568

2,861

2,975

2,880

3,100

2,891

1,232

23,704

(1) Total of IBNR plus expected development on reported losses

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2014
(unaudited)

2015
(unaudited)

2016
(unaudited)

2017
(unaudited)

2018
(unaudited)

2019

$

— $

— $

— $

— $

— $

—

15,396

53,821

45,897

50,842

17,297

16,539

55,179

49,332

59,850

31,147

32,388

17,145

55,858

52,142

63,439

38,426

52,185

11,815

18,209

56,435

53,622

68,775

40,678

60,820

31,858

10,398

18,494

57,028

54,812

72,770

43,801

64,000

37,037

28,221

25,552

18,548

57,555

55,585

73,511

43,779

66,293

39,361

45,946

40,304

23,207
Total $ 464,089

Total outstanding liabilities for unpaid losses and
LAE, net of reinsurance

$ 70,658

214

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and
fair value adjustments

$

$

2019

70,658
41,591

112,249

The  following  is  unaudited  supplementary  information  for  average  annual  historical  duration  of  claims:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5

Year 6

Year 7

Year 8

Year 9

Year 10

Aerospace

37.03% 31.40% 16.33%

4.98%

4.76%

3.00%

1.81%

2.68%

1.21%

0.29%

215

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Workers' Compensation

Incurred Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

For The Years Ended December 31,

As of December 31,
2019

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2014
(unaudited)

2015 
(unaudited)

2016 
(unaudited)

2017 
(unaudited)

2018 
(unaudited)

2019

IBNR(1)

$

— $
—

—

—

—

— $
—

—

—

—

— $
—

—

—

—

— $
—

—

—

—

— $
—

—

—

—

— $
—

—

—

—

15,607

17,199

54,977

18,290

55,505

62,942

15,662

50,103

54,121

43,366

15,203

47,338

54,793

39,089

44,615

14,873

45,812

55,150

29,676

39,247

—

—

—

—

—

1,421

4,905

9,101

6,037

13,672

56,754
39,525
Total $ 241,512 $ 74,661

(1) Total of IBNR plus expected development on reported losses.

Cumulative Paid Losses and Allocated Loss Adjustment Expenses, Net of Reinsurance

Cumulative
Number of
Claims

—

—

—

—

—

1,062

2,522

2,507

2,110

2,820

2,860

13,881

Accident
Year

2009 and
Prior

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

For The Years Ended December 31,

2014
(unaudited)

2015 
(unaudited)

2016 
(unaudited)

2017 
(unaudited)

2018 
(unaudited)

2019

$

— $
—

— $
—

—

—

—

1,491

—

—

—

6,079

6,361

— $
—

—

—

—

— $
—

—

—

—

— $
—

—

—

—

9,279

20,194

7,953

11,431

30,439

23,428

5,477

12,243

35,311

32,739

13,509

4,508

—

—

—

—

—

12,617

37,385

39,333

18,899

15,064

6,880
Total $ 130,178

Total outstanding liabilities for unpaid
losses and LAE, net of reinsurance

$ 111,334

The reconciliation of incurred and paid loss development to the liability for unpaid losses and LAE as presented

in the tables above for the year ended December 31, 2019 is set forth below:

Liabilities for unpaid losses and allocated LAE, net of reinsurance
Reinsurance recoverable on unpaid losses
Gross liability for unpaid losses and LAE before unallocated loss adjustment expenses and
fair value adjustments

$

$

2019

111,334
66,615

177,949

216

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The following is unaudited supplementary information for average annual historical duration of claims:

Average Annual Percentage Payout of Incurred Losses by Age, Net of Reinsurance

Year 1

Year 2

Year 3

Year 4

Year 5 Year 6 Year 7 Year 8 Year 9 Year 10

Workers' compensation

13.40% 28.61% 19.73% 12.35% 4.99% 2.51%

—%

—%

—%

—%

217

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

11. DEFENDANT ASBESTOS AND ENVIRONMENTAL LIABILITIES 

We  acquired  DCo  on  December  30,  2016,  and  Morse TEC  on  October  30,  2019,  as  described  in  Note  3  -
"Acquisitions". DCo and Morse TEC hold liabilities associated with personal injury asbestos claims and environmental
claims arising from their legacy manufacturing operations. These companies continue to process asbestos personal
injury  claims  in  the  normal  course  of  business.  Defendant  asbestos  liabilities  on  our  consolidated  balance  sheets
include amounts for loss payments and defense costs for pending and future asbestos-related claims, determined
using  standard  actuarial  techniques  for  asbestos  exposures.  Defendant  environmental  liabilities  include  estimated
clean-up costs associated with the acquired companies' former operations based on engineering reports. 

Insurance balances recoverable on our consolidated balance sheets include estimated insurance recoveries
relating to these liabilities. The recorded asset represents our assessment of the capacity of the insurance agreements
to indemnify our subsidiaries for the anticipated defense and loss payments for pending claims and projected future
claims. The recognition of these recoveries is based on an assessment of the right to recover under the respective
contracts and on the financial strength of the insurers. The recorded asset does not represent the limits of our insurance
coverage, but rather the amount we would expect to recover if the accrued and projected loss and defense costs were
paid in full. 

Included within insurance balances recoverable and defendant asbestos and environmental liabilities are the
fair value adjustments that were initially recognized upon acquisition. These fair value adjustments are amortized in
proportion to the actual payout of  claims and recoveries. The carrying value of the asbestos and environmental liabilities,
insurance recoveries, future estimated expenses and the fair value adjustments related to DCo and Morse TEC as of
December 31, 2019 and 2018 was as follows:

Defendant asbestos and environmental liabilities:

Defendant asbestos liabilities

Defendant environmental liabilities

Estimated future expenses

Fair value adjustments

Defendant asbestos and environmental liabilities

Insurance balances recoverable:

Insurance recoveries related to defendant asbestos and environmental liabilities

Fair value adjustments

Insurance balances recoverable

2019

2018

$

1,100,593 $
10,279

51,637
(314,824)
847,685

549,593
(100,738)
448,855

265,975

2,152

19,843
(84,650)
203,320

183,676
(47,868)
135,808

Net liabilities relating to defendant asbestos and environmental exposures

$

398,830 $

67,512

218

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The table below provides a consolidated reconciliation of the beginning and ending liability for defendant asbestos

and environmental exposures for the years ended December 31, 2019, 2018 and 2017:

Balance as at January 1

Less: Insurance balances recoverable

Net balance as at January 1

Total net paid claims

Amounts recorded in other income (expense):

Net change in actuarial estimates

Amortization of fair value adjustments

Total other expense (income)

Acquired on purchase of subsidiaries

Net balance as at December 31

Plus: Insurance balances recoverable

Balance as at December 31

Methodologies for determining liabilities

Defendant Asbestos Liabilities

2019

2018

2017

203,320

135,808

67,512

(13,708)

(4,263)

13,500

9,237

335,789

398,830

448,855

847,685

219,164

122,326

96,838

(6,351)

(23,221)

246

(22,975)

—

67,512

135,808

203,320

234,020

133,032

100,988

(6,927)

2,800

(23)

2,777

—

96,838

122,326

219,164

DCo and Morse TEC review, on an ongoing basis, their own experience in handling asbestos-related claims and
trends affecting asbestos-related claims in the U.S. tort system generally, for the purposes of assessing the value of
pending asbestos-related claims and the number and value of those that may be asserted in the future, as well as
potential recoveries from DCo and Morse TEC’s insurance carriers with respect to such claims and defense costs. The
actuarial analysis for these asbestos-related exposures utilizes data resulting from the claim review process, including
input from national coordinating counsel and local counsel, and includes the development of an estimate of the potential
value of asbestos-related claims asserted but not yet resolved as well as the number and potential value of asbestos-
related claims not yet asserted. In developing the estimate of liability for potential future claims, the actuarial analysis
projects the potential number of future claims based on DCo and Morse TEC’s historical claim filings and epidemiological
studies. The actuarial analysis also utilizes assumptions based on the DCo and Morse TEC’s historical proportion of
claims resolved without payment, historical claim resolution costs for those claims that result in a payment, and historical
defense costs. The liabilities are then estimated by multiplying the pending and projected future claim filings by projected
payments rates and average claim resolution amounts and then adding an estimate for defense costs.

DCo and Morse TEC determine, based on the factors described above, including the actuarial analysis, that
their best estimate of the aggregate liability both for asbestos-related claims asserted but not yet resolved and potential
asbestos-related claims not yet asserted, including estimated defense costs, was $1,100.6 million and $266.0 million
as of December 31, 2019 and 2018, respectively. This liability reflects the actuarial central estimate, which is intended
to represent an expected value of the most probable outcome.

Defendant Environmental Liabilities

As a result of our acquisition of DCo and Morse TEC, we have been identified by the United States Environmental
Protection Agency and certain U.S. state environmental agencies and private parties as potentially responsible parties
("PRP") at various hazardous waste disposal sites under the Comprehensive Environmental Response, Compensation
and Liability Act ("Superfund") and equivalent U.S. state laws. The PRPs may currently be liable for the cost of clean-
up and other remedial activities at 22 such sites. Responsibility for clean-up and other remedial activities at a Superfund
site is typically shared among PRPs based on an allocation formula.  

We have a liability for defendant environmental liabilities of $10.3 million and $2.2 million as of December 31,
2019 and 2018, respectively. The estimate for defendant environmental liabilities is based on information available to
us, including an estimate of the allocation of liability among PRPs, the probability that other PRPs will pay the cost
apportioned  to  them,  currently  available  information  from  PRPs  and/or  federal  or  state  environmental  agencies
concerning the scope of contamination and estimated remediation and consulting costs, and remediation alternatives.

219

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

12. FAIR VALUE MEASUREMENTS 

Fair Value Hierarchy

Fair value is defined as the price at which to sell an asset or transfer a liability (i.e. the "exit price") in an orderly
transaction between market participants. We use a fair value hierarchy that gives the highest priority to quoted prices
in active markets and the lowest priority to unobservable data. The hierarchy is broken down into three levels as follows:

•

•

•

Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities
that we have the ability to access. Valuation adjustments and block discounts are not applied to Level 1
instruments.

Level 2 - Valuations based on quoted prices in active markets for similar assets or liabilities, quoted prices
for identical assets or liabilities in inactive markets, or for which significant inputs are observable (e.g. interest
rates,  yield  curves,  prepayment  speeds,  default  rates,  loss  severities,  etc.)  or  can  be  corroborated  by
observable market data.

Level 3 - Valuations based on unobservable inputs where there is little or no market activity. Unadjusted third
party pricing sources or management's assumptions and internal valuation models may be used to determine
the fair values.

In addition, certain of our other investments are measured at fair value using net asset value ("NAV") per share
(or its equivalent) as a practical expedient and have not been classified within the fair value hierarchy above. We have
categorized our assets and liabilities that are recorded at fair value on a recurring basis among levels based on the
observability of inputs, or at fair value using NAV per share (or its equivalent) as follows:

220

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

December 31, 2019

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant
Other Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Fair Value
Based on NAV
as Practical
Expedient

Total Fair
Value

Investments:

Fixed maturity investments:

U.S. government and agency

$

— $

736,043

$

— $

— $

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Other assets included within funds held
- directly managed

Equities:

Publicly traded equity investments

Exchange-traded funds

Privately held equity investments

Other investments:

Hedge funds

Fixed income funds

Equity funds

Private equity funds

CLO equities

CLO equity funds

Other

Total Investments

Cash and cash equivalents

Reinsurance balances recoverable
on paid and unpaid losses:

Other Assets:

Derivatives qualifying as hedging

Derivatives not qualifying as hedges

Derivative instruments

Losses and LAE:

Other Liabilities:

Derivatives qualifying as hedging

Derivatives not qualifying as hedges

Derivative instruments

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

—

—

—

—

—

—

—

161,772

702,857

5,697,067

167,882

471,836

900,029

775,402

—

—

—

—

—

—

—

—

—

—

—

—

—

—

736,043

161,772

702,857

5,697,067

167,882

471,836

900,029

775,402

— $

9,612,888

$

— $

— $

9,612,888

—

14,207

—

—

14,207

297,310

$

30,565

$

133,047

—

—

—

— $

—

268,799

— $

—

—

430,357

$

30,565

$

268,799

$

— $

327,875

133,047

268,799

729,721

— $

— $

— $

1,121,904

$

1,121,904

—

—

—

—

—

—

398,143

111,040

—

—

—

34

—

—

—

87,555

—

314

82,896

299,109

329,885

—

87,509

6,031

481,039

410,149

329,885

87,555

87,509

6,379

— $

509,217

430,357

$

10,166,877

$

$

87,869

356,668

$

$

1,927,334

1,927,334

$

$

2,524,420

12,881,236

173,892

$

222,191

$

— $

— $

396,083

— $

— $

695,518

$

— $

695,518

— $

— $

— $

— $

— $

— $

— $

642

1,369

2,011

$

$

$

— $

— $

— $

— $

— $

— $

642

1,369

2,011

— $

2,621,122

$

— $

2,621,122

11,452

4,106

15,558

$

$

$

— $

— $

— $

— $

— $

— $

11,452

4,106

15,558

221

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

December 31, 2018

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

Significant
Other Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Fair Value
Based on NAV
as Practical
Expedient

Total Fair
Value

Investments:

Fixed maturity investments:

U.S. government and agency

U.K government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Other assets included within funds held
- directly managed

Equities:

Publicly traded equity investments

Privately held equity investments

Other investments:

Hedge funds

Fixed income funds

Equity funds

Private equity funds

CLO equities

CLO equity funds

Private credit funds

Other

Total Investments

Cash and cash equivalents

Reinsurance recoverable:

Other Assets:

Derivatives qualifying as hedging

Derivatives not qualifying as hedges

Derivative instruments

Losses and LAE:

Other Liabilities:

Derivatives qualifying as hedging

Derivatives not qualifying as hedges

Derivative instruments

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

— $

510,245

$

— $

— $

—

—

—

—

—

—

—

300,631

793,810

—

—

4,802,454

37,386

130,265

773,557

705,674

627,360

—

—

7,389

9,121

—

—

—

—

—

—

—

510,245

300,631

793,810

4,839,840

130,265

773,557

713,063

636,481

— $

8,643,996

— $

14,780

$

$

53,896

$

— $

8,697,892

— $

— $

14,780

102,102

$

36,313

$

— $

—

—

228,710

102,102

$

36,313

$

228,710

$

— $

—

— $

138,415

228,710

367,125

— $

— $

— $

852,584

$

—

—

—

—

—

—

—

290,864

100,440

—

—

—

—

578

—

—

—

39,052

—

—

315

112,994

233,241

248,628

—

37,260

33,381

8,420

852,584

403,858

333,681

248,628

39,052

37,260

33,381

9,313

— $

391,882

102,102

$

9,086,971

$

$

39,367

321,973

$

$

1,526,508

1,526,508

$

$

1,957,757

11,037,554

243,839

$

21,146

$

— $

— $

264,985

— $

— $

739,591

$

— $

739,591

1,615

$

5,086

6,701

$

— $

—

— $

— $

—

— $

1,615

5,086

6,701

— $

2,874,055

$

— $

2,874,055

300

$

683

983

$

— $

—

— $

— $

—

— $

300

683

983

— $

—

— $

— $

— $

—

— $

222

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Valuation Methodologies of Financial Instruments Measured at Fair Value

Fixed Maturity Investments

The fair values for all securities in the fixed maturity investments and funds held - directly managed portfolios
are independently provided by the investment accounting service providers, investment managers and investment
custodians, each of which utilize internationally recognized independent pricing services. We record the unadjusted
price provided by the investment accounting service providers, investment managers or investment custodians and
validate this price through a process that includes, but is not limited to: (i) comparison of prices against alternative
pricing sources; (ii) quantitative analysis (e.g. comparing the quarterly return for each managed portfolio to its target
benchmark); (iii) evaluation of methodologies used by external parties to estimate fair value, including a review of the
inputs used for pricing; and (iv) comparing the price to our knowledge of the current investment market. Our internal
price  validation  procedures  and  review  of  fair  value  methodology  documentation  provided  by  independent  pricing
services have not historically resulted in adjustment in the prices obtained from the pricing service. 

The independent pricing services used by the investment accounting service providers, investment managers
and investment custodians obtain actual transaction prices for securities that have quoted prices in active markets.
Where we utilize single unadjusted broker-dealer quotes, they are generally provided by market makers or broker-
dealers  who  are  recognized  as  market  participants  in  the  markets  for  which  they  are  providing  the  quotes.    For
determining the fair value of securities that are not actively traded, in general, pricing services use "matrix pricing" in
which the independent pricing service uses observable market inputs including, but not limited to, reported trades,
benchmark yields, broker-dealer quotes, interest rates, prepayment speeds, default rates and other such inputs as
are available from market sources to determine a reasonable fair value. In addition, pricing services use valuation
models, using observable data, such as an Option Adjusted Spread model, to develop prepayment and interest rate
scenarios. The Option Adjusted Spread model is commonly used to estimate fair value for securities such as mortgage-
backed and asset-backed securities.

The following describes the techniques generally used to determine the fair value of our fixed maturity investments

by asset class, including the investments underlying the funds held - directly managed.

•

•

U.S. government and agency securities consist of securities issued by the U.S. Treasury and mortgage pass-
through agencies such as the Federal National Mortgage Association, the Federal Home Loan Mortgage
Corporation  and  other  agencies.  Non-U.S.  government  securities  consist  of  bonds  issued  by  non-U.S.
governments and agencies along with supranational organizations. The significant inputs used to determine
the fair value of these securities include the spread above the risk-free yield curve, reported trades and
broker-dealer quotes. These are considered to be observable market inputs and, therefore, the fair values
of these securities are classified as Level 2. 

Corporate securities consist primarily of investment-grade debt of a wide variety of corporate issuers and
industries. The fair values of these securities are determined using the spread above the risk-free yield curve,
reported trades, broker-dealer quotes, benchmark yields, and industry and market indicators. These are
considered observable market inputs and, therefore, the fair values of these securities are classified as Level
2.  Where  pricing  is  unavailable  from  pricing  services,  such  as  in  periods  of  low  trading  activity  or  when
transactions are not orderly, we obtain non-binding quotes from broker-dealers. Where significant inputs are
unable to be corroborated with market observable information, we classify the securities as Level 3. 

• Municipal securities consist primarily of bonds issued by U.S.-domiciled state and municipal entities. The
fair values of these securities are determined using the spread above the risk-free yield curve, reported
trades, broker-dealer quotes and benchmark yields. These are considered observable market inputs and,
therefore, the fair values of these securities are classified as Level 2.

•

Asset-backed securities consist primarily of investment-grade bonds backed by pools of loans with a variety
of underlying collateral. Residential and commercial mortgage-backed securities include both agency and
non-agency originated securities. Where pricing is unavailable from pricing services, we obtain non-binding
quotes from broker-dealers. This is generally the case when there is a low volume of trading activity and
current transactions are not orderly. The significant inputs used to determine the fair value of these securities
include the spread above the risk-free yield curve, reported trades, benchmark yields, prepayment speeds
and default rates. The fair values of these securities are classified as Level 2 if the significant inputs are

223

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

market  observable.  Where  significant  inputs  are  unable  to  be  corroborated  with  market  observable
information, we classify the securities as Level 3.

Equities

Our investments in equities consist of a combination of publicly and privately traded investments. Our publicly
traded equity investments in common and preferred stocks predominantly trade on major exchanges and are managed
by our external advisors. Our publicly traded equities are widely diversified and there is no significant concentration in
any specific industry. Our exchange-traded funds trade on major exchanges. We use an internationally recognized
pricing service to estimate the fair value of our publicly traded equities and exchange-traded funds. We have categorized
the majority of our publicly traded equity investments, other than preferred stock, and our exchange-traded funds as
Level 1 investments because the fair values of these investments are based on unadjusted quoted prices in active
markets for identical assets. One equity security is trading in an inactive market and, as a result has been classified
as Level 2. The fair value estimates of our investments in publicly traded preferred stock are based on observable
market data and, as a result, have been categorized as Level 2.

Our privately held equity investments in common and preferred stocks are direct investments in companies that
we believe offer attractive risk adjusted returns and/or offer other strategic advantages. Each investment may have its
own unique terms and conditions and there may be restrictions on disposals. The market for these investments is
illiquid and there is no active market. We use a combination of cost, internal models, reported values from co-investors/
managers and observable inputs, such as capital raises and capital transactions between new and existing shareholders
to calculate the fair value of the privately held equity investments. The fair value estimates of our investments in privately
held equities are based on unobservable market data and, as a result, have been categorized as Level 3. 

Other investments, at fair value

We have ongoing due diligence processes with respect to the other investments carried at fair value in which
we  invest  and  their  managers. These  processes  are  designed  to  assist  us  in  assessing  the  quality  of  information
provided by, or on behalf of, each fund and in determining whether such information continues to be reliable or whether
further review is warranted. Certain funds do not provide full transparency of their underlying holdings; however, we
obtain the audited financial statements for funds annually, and regularly review and discuss the fund performance with
the fund managers to corroborate the reasonableness of the reported net asset values ("NAV"). 

The use of NAV as an estimate of the fair value for investments in certain entities that calculate NAV is a permitted
practical expedient. Due to the time lag in the NAV reported by certain fund managers we adjust the valuation for capital
calls and distributions. Other investments measured at fair value using NAV as a practical expedient have not been
classified in the fair value hierarchy. Other investments for which we do not use NAV as a practical expedient have
been valued using prices from independent pricing services, investment managers and broker-dealers. 

The following describes the techniques generally used to determine the fair value of our other investments.

•

For our investments in hedge funds, we measure fair value by obtaining the most recently available NAV as
advised by the external fund manager or third-party administrator. The fair values of these investments are
measured using the NAV as a practical expedient and therefore have not been categorized within the fair value
hierarchy. 

• Our investments in fixed income funds and equity funds are valued based on a combination of prices from
independent pricing services, external fund managers or third-party administrators. For the publicly available
prices we have classified the investments as Level 2. For the non-publicly available prices we are using NAV
as a practical expedient and therefore these have not been categorized within the fair value hierarchy.

•

For our investments in private equity funds, we measure fair value by obtaining the most recently available
NAV from the external fund manager or third-party administrator. The fair values of these investments are
measured using the NAV as a practical expedient and therefore have not been categorized within the fair value
hierarchy. 

• We measure the fair value of our direct investment in CLO equities based on valuations provided by independent
pricing services, our external CLO equity manager, and valuations provided by the broker or lead underwriter
of the investment (the "broker"). Our CLO equity investments have been classified as Level 3 due to the use
of unobservable inputs in the valuation and the limited number of relevant trades in secondary markets. 

224

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

In  providing  valuations,  the  independent  pricing  service  providers,  CLO  equity  manager  and  brokers  use
observable and unobservable inputs. Of the significant unobservable market inputs used, the default and loss
severity rates involve the most judgment and create the most sensitivity. A significant increase or decrease in
either  of  these  significant  inputs  in  isolation  would  result  in  lower  or  higher  fair  value  estimates  for  direct
investments in CLO equities and, in general, a change in default rate assumptions will be accompanied by a
directionally similar change in loss severity rate assumptions. Collateral spreads and estimated maturity dates
are less subjective inputs because they are based on the historical average of actual spreads and the weighted
average life of the current underlying portfolios, respectively. A significant increase or decrease in either of
these significant inputs in isolation would result in higher or lower fair value estimates for direct investments
in CLO equities. In general, these inputs have no significant interrelationship with each other or with default
and loss severity rates.

On a quarterly basis, we receive the valuation from the independent pricing providers, external CLO manager
and brokers and then review the underlying cash flows and key assumptions used by them. We review and
update the significant unobservable inputs based on information obtained from secondary markets. These
inputs are our responsibility and we assess the reasonableness of the inputs (and if necessary, update the
inputs) through communicating with industry participants, monitoring of the transactions in which we participate
(for example, to evaluate default and loss severity rate trends), and reviewing market conditions, historical
results, and emerging trends that may impact future cash flows.

If valuations from the independent pricing service providers, external CLO equity manager or brokers are not
available, we use an income approach based on certain observable and unobservable inputs to value these
investments. An income approach is also used to corroborate the reasonableness of the valuations provided
by the pricing providers, external manager and brokers. Where an income approach is followed, the valuation
is based on available trade information, such as expected cash flows and market assumptions on default and
loss severity rates. Other inputs used in the valuation process include asset spreads, loan prepayment speeds,
collateral spreads and estimated maturity dates.

For our investments in the CLO equity funds, we measure fair value by obtaining the most recently available
NAV as advised by the external fund manager or third party administrator. The fair value of these investments
is measured using the NAV as a practical expedient and therefore have not been categorized within the fair
value hierarchy.

For our investments in private credit funds, we measure fair value by obtaining the most recently available
NAV from the external fund manager or third-party administrator. The fair values of these investments are
measured using the NAV as a practical expedient and therefore have not been categorized within the fair value
hierarchy.

Included within other is an investment in a real estate debt fund, for which we measure fair value by obtaining
the most recently available NAV from the external fund manager or third-party administrator. The fair value of
this investment is measured using the NAV as a practical expedient and therefore has not been categorized
within the fair value hierarchy.

•

•

•

Insurance Contracts - Fair Value Option

The Company uses an internal model to calculate the fair value of the liability for losses and loss adjustment
expenses and reinsurance balances recoverable on paid and unpaid losses for certain retroactive reinsurance contracts
where we have elected the fair value option in our Non-life Run-off segment. The fair value was calculated as the
aggregate of discounted cash flows plus a risk margin. The discounted cash flow approach uses (i) estimated nominal
cash flows based upon an appropriate payment pattern developed in accordance with standard actuarial techniques
and (ii) a discount rate based upon a high quality rated corporate bond plus a credit spread for non-performance risk.
The model uses corporate bond rates across the yield curve depending on the estimated timing of the future cash
flows and specific to the currency of the risk. The risk margin was calculated using the present value of the cost of
capital. The cost of capital approach uses (i) projected capital requirements, (ii) multiplied by the risk cost of capital
representing the return required for non-hedgeable risk based upon the weighted average cost of capital less investment
income and (iii) discounted using the weighted average cost of capital.

225

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Derivative Instruments

The fair values of our foreign currency exchange contracts, as described in Note 7 - "Derivatives and Hedging
Instruments" are classified as Level 2. The fair values are based upon prices in active markets for identical contracts.

Level 3 Measurements and Changes in Leveling

Transfers into or out of levels are recorded at their fair values as of the end of the reporting period, consistent

with the date of determination of fair value.

Investments

The following table presents a reconciliation of the beginning and ending balances for all investments measured

at fair value on a recurring basis using Level 3 inputs during the years ended December 31, 2019 and 2018:

Fixed maturity investments

Residential
mortgage-
backed

Commercial
mortgage-
backed

Corporate

Asset-
backed

Privately-
held
Equities

Other
Investments

Total

2019

Beginning fair value

$

37,386

$

— $

7,389

$

9,121

$

228,710

$

39,367

$ 321,973

Purchases

Sales

Total realized and unrealized gains
(losses)

Transfer into Level 3 from Level 2

Transfer out of Level 3 into Level 2

184

(3,520)

90

3,535

(37,675)

—

—

(1)

102

(101)

—

(784)

64

—

(5,088)

241

1,515

(8,184)

22,771

(27,045)

33,713

(2,016)

8,392

—

—

56,908

90,805

(590)

(11,998)

(7,816)

970

—

—

27,923

(73,005)

Ending fair value

$

— $

— $

— $

— $

268,799

$

87,869

$ 356,668

Fixed maturity investments

Residential
mortgage-
backed

Commercial
mortgage-
backed

Corporate

Asset-
backed

Privately-
held
Equities

Other
Investments

Total

2018

Beginning fair value

$

67,178

$

3,080

$

21,494

$

27,892

$

— $

57,079

$ 176,723

Purchases

Sales

Total realized and unrealized
losses

Transfer into Level 3 from Level 2

Transfer out of Level 3 into Level 2

14,391

(65,700)

(57)

28,339

(6,765)

—

(1,184)

(28)

1,795

(3,663)

3,749

(5,781)

(645)

46,074

(49,020)

(1,843)

227,000

13,173

304,387

—

(2)

(12,091)

(133,776)

(18,794)

(21,369)

4,897

9,890

(16,325)

(23,872)

1,712

—

—

—

46,633

(50,625)

Ending fair value

$

37,386

$

— $

7,389

$

9,121

$

228,710

$

39,367

$ 321,973

Net realized and unrealized gains related to Level 3 assets in the table above are included in net realized and

unrealized (losses) gains in our consolidated statements of earnings.

The securities transferred from Level 2 to Level 3 were transferred due to insufficient market observable inputs
for  the  valuation  of  the  specific  assets. The  transfers  from  Level  3  to  Level  2  were  based  upon  obtaining  market
observable information regarding the valuations of the specific assets.

226

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Valuations Techniques and Inputs

The table below presents the quantitative information related to the fair value measurements for investments

measured at fair value on a recurring basis using Level 3 inputs for the year ended December 31, 2019:

Qualitative Information about Level 3 Fair Value Measurements

Fair Value at
December 31,
2019

(in millions of
U.S. dollars)
$87.6

CLO equities

Privately held equity
investments

268.8

Valuation
Techniques

Unobservable Input

Range (Average) (1)

Consensus pricing Offered quotes

14-87 (48)

Discounted Cash
Flow method

Transactional
value

Cost as
approximation of
fair value

Discount rate (%) (2)
Recovery rate (3)
Prepayment rate (4)
Collateral reinvestment coupon
floor (5)
Implied price at recent purchase
transaction

Cost as approximation of fair value

10%-30% (19.5%)
50%-70% (60%)
20%-30% (25%)
1%

13.50 - 13.85

(1) The average represents the arithmetic average of the inputs and is not weighted by the relative fair value.

(2) Implied yields were determined from recent market color of comparable subordinated notes, as well as unique characteristics for each investment.

(3) For collateral which has already defaulted, a recovery rate equal to the current market value of the collateral was assumed.

(4) An assumed constant prepayment rate (CPR) was applied to the CLOs. CPRs are the annualized percentage of loans in the collateral pool that

prepay. 

(5) It was assumed that the collateral manager would reinvest into collateral with a similar weighted-average spread and a similar ratings composition

to the current collateral pool.

Insurance Contracts - Fair Value Option

The following table presents a reconciliation of the beginning and ending balances for all insurance contracts
measured at fair value on a recurring basis using Level 3 inputs during the years ended December 31, 2019 and 2018:

2019

Reinsurance
balances
recoverable
on paid and
unpaid
losses

Liability for
losses and
LAE

2018

Reinsurance
balances
recoverable
on paid and
unpaid
losses

Net

Liability for
losses and
LAE

Net

$

2,874,055

$

739,591

$

2,134,464

$

1,794,669

$

542,224

$

1,252,445

9,218

—

9,218

1,890,061

372,780

1,517,281

(32,690)

(19,915)

160,630

108,025

(416,770)

46,594

(2,958)

—

43,449

40,491

(92,145)

7,581

(29,732)

(19,915)

117,181

67,534

(324,625)

39,013

(108,429)

(20,656)

27,845

(101,240)

(576,949)

(132,486)

(30,041)

—

21,181

(8,860)

(148,175)

(18,378)

(78,388)

(20,656)

6,664

(92,380)

(428,774)

(114,108)

Beginning fair value

Assumed business

Incurred losses and LAE:

Reduction in estimates of ultimate
losses

Reduction in unallocated LAE

Change in fair value

Total incurred losses and LAE

Paid losses

Effect of exchange rate movements

Ending fair value

$

2,621,122

$

695,518

$

1,925,604

$

2,874,055

$

739,591

$

2,134,464

227

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Changes in fair value in the table above are included in net incurred losses and LAE in our consolidated statements

of earnings.

The following table presents the components of the net change in fair value for the years ended December 31,

2019, 2018 and 2017:

Changes in fair value due to changes in:

Duration

Corporate bond yield

Risk cost of capital

Change in fair value

2019

2018

2017

$

$

22,719 $
94,462

—

117,181 $

74,011 $
(71,031)
3,684
6,664 $

41,332
(11,076)
—

30,256

Below is a summary of the quantitative information regarding the significant observable and unobservable inputs

used in the internal model to determine fair value on a recurring basis as of December 31, 2019 and 2018:

Valuation
Technique

Unobservable (U) and Observable (O) Inputs

Internal model

Corporate bond yield (O)

Internal model

Credit spread for non-performance risk (U)

Internal model

Risk cost of capital (U)

Internal model

Weighted average cost of capital (U)

Internal model

Duration - liability (U)

Internal model

Duration - reinsurance balances recoverable on paid
and unpaid losses (U)

2019
Weighted
Average

A rated

0.2%

5.1%

8.5%

2018
Weighted
Average

A rated

0.2%

5.0%

8.5%

7.82 years

8.68 years

7.33 years

7.98 years

The fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid losses
may increase or decrease due to changes in the corporate bond rate, the credit spread for non-performance risk, the
risk cost of capital, the weighted average cost of capital and the estimated payment pattern as described below:

•

•

•

•

An increase in the corporate bond rate or credit spread for non-performance risk would result in a decrease
in the fair value of the liability for losses and LAE and reinsurance balances recoverable on paid and unpaid
losses. Conversely, a decrease in the corporate bond rate or credit spread for non-performance risk would
result in an increase in the fair value of the liability for losses and LAE and reinsurance balances recoverable
on paid and unpaid losses.

An increase in the weighted average cost of capital would result in an increase in the fair value of the liability
for losses and LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease
in the weighted average cost of capital would result in a decrease in the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses.

An increase in the risk cost of capital would result in an increase in the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses. Conversely, a decrease in the risk cost
of capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances
recoverable on paid and unpaid losses.

The duration of the liability and recoverable is adjusted every period to reflect actual net payments during the
period and expected future payments. An acceleration of the estimated payment pattern, a decrease in duration,
would  result  in  an  increase  in  the  fair  value  of  the  liability  for  losses  and  LAE  and  reinsurance  balances
recoverable  on  paid  and  unpaid  losses.  Conversely,  a  deceleration  of  the  estimated  payment  pattern,  an
increase in duration, would result in a decrease in the fair value of the liability for losses and LAE and reinsurance
balances recoverable on paid and unpaid losses.

228

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

In addition, the estimate of the capital required to support the liabilities is based upon current industry standards
for capital adequacy. If the required capital per unit of risk increases, then the fair value of the liability for losses and
LAE and reinsurance balances recoverable on paid and unpaid losses would increase. Conversely, a decrease in
required capital would result in a decrease in the fair value of the liability for losses and LAE and reinsurance balances
recoverable on paid and unpaid losses.

Disclosure of Fair Values for Financial Instruments Carried at Cost

Senior Notes

As of December 31, 2019, our 4.50% Senior Notes due 2022 (the "2022 Senior Notes") and our 4.95% Senior
Notes due 2029 (the "2029 Senior Notes" and, together with the 2022 Senior Notes, the "Senior Notes") were carried
at amortized cost of $348.6 million and $493.6 million, respectively, while the fair value based on observable market
pricing from a third party pricing service was $362.5 million and $537.4 million, respectively. The Senior Notes are
classified as Level 2.

Insurance Contracts

Disclosure of fair value of amounts relating to insurance contracts is not required, except those for which we

elected the fair value option, as described above. 

Remaining Assets and Liabilities

Our remaining assets and liabilities were generally carried at cost or amortized cost, which due to their short-

term nature approximates fair value as of December 31, 2019 and 2018.

229

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

13. PREMIUMS WRITTEN AND EARNED 

The following tables provide a summary of net premiums written and earned for the years ended December 31,

2019, 2018 and 2017:

2019

2018

2017

Premiums
Written

Premiums
Earned

Premiums
Written

Premiums
Earned

Premiums
Written

Premiums
Earned

Non-life Run-off
Gross
Ceded
Net
Atrium
Gross
Ceded
Net
StarStone
Gross
Ceded
Net
Other

Gross
Ceded
Net
Total

Gross

Ceded

Net

$

$

$

$

$

$

$

$

(25,069) $
(269)
(25,338) $

197,009 $
(28,513)
168,496 $

(8,910) $
(307)
(9,217) $

25,230 $
(15,803)

9,427 $

14,102 $
(7,620)
6,482 $

23,950
(9,788)
14,162

192,373 $
(20,017)
172,356 $

182,678 $
(18,619)
164,059 $

171,494 $
(18,006)
153,488 $

164,428 $
(18,113)
146,315 $

153,472 $
(19,258)
134,214 $

152,278
(17,531)
134,747

917,555 $ 1,021,827 $ 1,121,135 $ 1,010,816 $
(182,126)
735,429 $

(219,901)
801,926 $

(295,857)
714,959 $

(315,573)
805,562 $

895,160 $
(430,259)
464,901 $

865,159
(405,756)
459,403

18,534 $
(22)
18,512 $

20,544 $
(164)
20,380 $

32,378 $
(311)
32,067 $

25,237 $
(363)
24,874 $

5,719 $
(926)
4,793 $

5,900
(1,091)
4,809

$ 1,103,393 $ 1,422,058 $ 1,316,097 $ 1,225,711 $ 1,068,453 $ 1,047,287
(434,166)
613,121

(202,434)
900,959 $ 1,154,861 $

(458,063)
610,390 $

(334,197)
981,900 $

(330,136)
895,575 $

(267,197)

$

Gross premiums written for the year ended December 31, 2019 and 2018 were $1,103.4 million and $1,316.1
million, respectively, a decrease of $212.7 million. The decrease was primarily due to a decrease in gross written
premiums in our StarStone segment due to our strategy to exit certain lines of business, and reductions in gross written
premiums in our Non-life Run-off segment due to unearned premium acquired in various transactions.

230

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

14. GOODWILL AND INTANGIBLE ASSETS 

The following table presents a reconciliation of the beginning and ending goodwill and intangible assets for the

years ended December 31, 2019 and 2018:

Goodwill

Intangible
assets with
a definite life

Intangible assets

Intangible 
assets with
an indefinite
life

Total

Total

Balance as of December 31, 2017

Acquired during the year

Amortization

Balance as of December 31, 2018

Amortization

Balance as of December 31, 2019

$

$

$

73,071 $

20,487 $

87,031 $

107,518 $

180,589

41,736

—

—

(3,600)

—

—

—

(3,600)

41,736

(3,600)

114,807 $

16,887 $

87,031 $

103,918 $

218,725

—

(2,257)

—

(2,257)

(2,257)

114,807 $

14,630 $

87,031 $

101,661 $

216,468

Goodwill

Goodwill as of December 31, 2019 and 2018, related to our Non-life Run-off, Atrium and StarStone segments,

was as follows:

Non-life Run-Off

Atrium

StarStone

2019

2018

$

$

62,959 $
38,848

13,000

114,807 $

62,959

38,848

13,000

114,807

For the year ended December 31, 2019, we completed our assessment for impairment of goodwill and concluded
that there had been no impairment of our carried goodwill amount. For the year ended December 31, 2018 the increase
in the goodwill balance in the Non-life Run-off segment was due to the acquisition of KaylaRe as discussed in Note 3
- "Acquisitions", which resulted in the recognition of goodwill of $41.7 million, none of which is amortizable for tax
purposes.

Intangible Assets

Intangible  assets  with  a  definite  life  includes  the  distribution  channel,  technology  and  brand  related  to  our
acquisitions of Atrium and StarStone. These assets are amortized on a straight-line basis over a period ranging from
four to fifteen years. The following table provides a summary of the amortization recorded on the intangible assets for
the years ended December 31, 2019, 2018 and 2017:

Intangible asset amortization

$

2,257 $

3,600 $

4,266

2019

2018

2017

Intangible assets with an indefinite life includes assets associated with the Lloyd’s syndicate capacity for StarStone
and Atrium, StarStone's U.S. insurance licenses, and Atrium’s management contract with Syndicate 609 in relation to
underwriting, actuarial and support services it provides.

231

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The gross carrying value, accumulated amortization and net carrying value of intangible assets by type as of

December 31, 2019 and 2018 was as follows:

Intangible assets with a definite life:

Distribution channel

Technology

Brand

Total

Intangible assets with an indefinite
life:

Lloyd’s syndicate capacity

Licenses

Management contract

Total

$

$

$

$

Gross
Carrying
Value

2019

Accumulated
Amortization

Net
Carrying
Value

Gross
Carrying
Value

2018

Accumulated
Amortization

Net
Carrying
Value

20,000

$

(8,111) $

11,889

$

20,000

$

(6,776) $

13,224

15,000

7,000

(15,000)

(4,259)

—

2,741

15,000

7,000

(14,778)

(3,559)

222

3,441

42,000

$

(27,370) $

14,630

$

42,000

$

(25,113) $

16,887

37,031

$

— $

37,031

$

37,031

$

— $

19,900

30,100

—

—

19,900

30,100

19,900

30,100

—

—

87,031

$

— $

87,031

$

87,031

$

— $

37,031

19,900

30,100

87,031

The net carrying value of intangible assets by segment and by type as of December 31, 2019 and 2018 was as

follows:

Intangible assets with a definite life:

Distribution channel

Technology

Brand

Total

Intangible assets with an indefinite
life:

Lloyd’s syndicate capacity

Licenses

Management contract

Total

Total intangible assets

$

$

$

$

$

2019

2018

Atrium

StarStone

Total

Atrium

StarStone

Total

11,889

$

— $

11,889

$

13,224

$

— $

13,224

—

2,741

—

—

—

2,741

—

3,441

222

—

222

3,441

14,630

$

— $

14,630

$

16,665

$

222

$

16,887

33,031

$

4,000

$

37,031

$

33,031

$

4,000

$

—

30,100

19,900

—

19,900

30,100

—

30,100

19,900

—

63,131

$

23,900

$

87,031

$

63,131

$

23,900

$

37,031

19,900

30,100

87,031

77,761

$

23,900

$

101,661

$

79,796

$

24,122

$

103,918

The estimated future amortization expense related to our intangible assets with a definite life is as follows:

Year
2020

2021

2022

2023

2024

2025 and thereafter

Total amortization

Atrium

StarStone

Total

2,033

2,033

2,033

1,975

1,333

5,223

$

— $

—

—

—

—

—

2,033

2,033

2,033

1,975

1,333

5,223

14,630

$

— $

14,630

$

$

232

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

15. DEBT OBLIGATIONS AND CREDIT FACILITIES 

We primarily utilize debt facilities for funding acquisitions and significant new business, investment activities and,

from time to time, for general corporate purposes. Our debt obligations are as follows:

Facility

4.50% Senior Notes due 2022

4.95% Senior Notes due 2029

Total senior notes

EGL Revolving Credit Facility

2018 EGL Term Loan Facility

Total debt obligations

Origination Date

Term

December 31, 
 2019

December 31, 
 2018

March 10, 2017

5 years

$

348,616 $

348,054

May 28, 2019

10 years

August 16, 2018

December 27, 2018

5 years

3 years

493,600

842,216

—

348,991

$

1,191,207 $

—

348,054

15,000

498,485

861,539

During the year ended December 31, 2019, we utilized $1,070.5 million and repaid $742.6 million under our
facilities. The facilities were primarily utilized for funding acquisitions as described in Note 3 - "Acquisitions", significant
new business as described in Note 4 - "Significant New Business", and investing activities.

The table below provides a summary of the total interest expense for the years ended December 31, 2019, 2018

and 2017:

Interest expense on debt obligations

Amortization of debt issuance costs

Funds withheld balances and other

Total interest expense

Senior Notes

4.50% Senior Notes due 2022

2019

2018

2017

$

$

51,245 $
953

343
52,541 $

25,205 $
537

475
26,217 $

25,619

416

2,067

28,102

On March 10, 2017, we issued the 2022 Senior Notes for an aggregate principal amount of $350.0 million. The
2022  Senior  Notes  pay  4.5%  interest  semi-annually  and  mature  on  March  10,  2022.  The  2022  Senior  Notes  are
unsecured  and  unsubordinated  obligations  that  rank  equal  to  any  of  our  other  unsecured  and  unsubordinated
obligations,  senior  to  any  future  obligations  that  are  expressly  subordinated  to  the  2022  Senior  Notes,  effectively
subordinate to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness,
and structurally subordinate to all liabilities of our subsidiaries.

The 2022 Senior Notes are rated BBB- and are redeemable at our option on a make whole basis at any time
prior to the date that is one month prior to the maturity of the 2022 Senior Notes. On or after the date that is one month
prior to the maturity of the 2022 Senior Notes, the notes are redeemable at a redemption price equal to 100% of the
principal amount of the 2022 Senior Notes to be redeemed. 

We incurred costs of $2.9 million in issuing the 2022 Senior Notes. These costs included underwriters’ fees,
legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the principal
amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of the 2022
Senior Notes and are included in interest expense in our consolidated statements of earnings. The unamortized costs
as of December 31, 2019 and 2018 were $1.4 million and $1.9 million, respectively. 

233

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

4.95% Senior Notes due 2029

On May 28, 2019, we issued the 2029 Senior Notes for an aggregate principal amount of $500.0 million. The
2029 Senior Notes pay 4.95% interest semi-annually and mature on June 1, 2029. The 2029 Senior Notes are unsecured
and unsubordinated obligations that rank equal to any of our other unsecured and unsubordinated obligations, senior
to any future obligations that are expressly subordinated to the 2029 Senior Notes, effectively subordinate to any of
our  secured  indebtedness  to  the  extent  of  the  value  of  the  assets  securing  such  indebtedness,  and  contractually
subordinate to all liabilities of our subsidiaries.

The 2029 Senior Notes are rated BBB- and are redeemable at our option on a make whole basis at any time
prior to the date that is three months prior to the maturity of the 2029 Senior Notes. On or after the date that is three
months prior to the maturity of the 2029 Senior Notes, the notes are redeemable at a redemption price equal to 100%
of the principal amount of the notes to be redeemed. 

We incurred costs of $6.8 million in issuing the 2029 Senior Notes. These costs included underwriters’ fees,
legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the principal
amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of the 2029
Senior Notes and are included in interest expense in our consolidated statements of earnings. The unamortized costs
as of December 31, 2019 were $6.4 million.

EGL Revolving Credit Facility

On August 16, 2018, we and certain of our subsidiaries, as borrowers and guarantors, entered into a new five-
year unsecured $600.0 million revolving credit agreement. The revolving credit agreement expires in August 2023 and
we have the option to increase the commitments under the facility by up to an aggregate amount of $400.0 million
from the existing lenders, or through the addition of new lenders subject to the terms of the agreement. Borrowings
under the facility will bear interest at a rate based on the Company's long term senior unsecured debt ratings.

As of December 31, 2019, we were permitted to borrow up to an aggregate of $600.0 million under the facility.
As of December 31, 2019, there was $600.0 million of available unutilized capacity under the facility. Subsequent to
December 31, 2019, we drew down $5.0 million bringing the unutilized capacity under this facility to $595.0 million.

 Interest is payable at least every three months at either the alternate base rate ("ABR") or LIBOR plus a margin
as set forth in the revolving credit agreement. The margin could vary based upon any change in our long term senior
unsecured debt rating assigned by S&P or Fitch. We also pay a commitment fee based on the average daily unutilized
portion of the facility. If an event of default occurs, the interest rate may increase and the agent may, and at the request
of the required lenders shall, cancel lender commitments and demand early repayment.

Financial and business covenants imposed on us in relation to the new revolving credit facility include certain
limitations on mergers and consolidations, acquisitions, indebtedness and guarantees, restrictions as to dispositions
of stock and assets, and limitations on liens. Generally, the financial covenants require us to maintain a gearing ratio
of consolidated indebtedness to total capitalization of not greater than 0.35 to 1.0 and to maintain a consolidated net
worth of not less than the aggregate of (i) $2.3 billion, (ii) 50% of net income available for distribution to our ordinary
shareholders at any time after August 16, 2018, and (iii) 50% of the proceeds of any common stock issuance made
after August 16, 2018. In addition, we must maintain eligible capital in excess of the enhanced capital requirement
imposed  on  us  by  the  Bermuda  Monetary Authority  pursuant  to  the  Insurance  (Group  Supervision)  Rules  2011  of
Bermuda. We are in compliance with the covenants of the EGL Revolving Credit Facility.

2018 EGL Term Loan Facility

On December 27, 2018, we entered into and fully utilized a three-year $500.0 million unsecured term loan (the
"2018 EGL Term Loan Facility"). The proceeds were partially used to fund the acquisition of Maiden Re North America.
We have the option to increase the principal amount of the term loan credit facility up to an aggregate amount of $150.0
million from the existing lenders or through the addition of new lenders, subject to the terms of the term loan credit
agreement. During 2019, we repaid $150.0 million of principal on the facility, bringing the outstanding loan amount to
$349.0 million, which includes unamortized issuance costs of $1.0 million, as of December 31, 2019.

234

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Interest is payable at least every three months at either ABR or LIBOR plus a margin set forth in the term loan
credit agreement. The margin could vary based upon any change in our long term senior unsecured debt rating assigned
by S&P or Fitch. During the existence of an event of default, the interest rate may increase and the agent may, and at
the request of the required lenders shall, demand early repayment. 

Financial and business covenants relating to this facility are similar to the EGL revolving credit facility. We are

in compliance with the covenants of the 2018 EGL Term Loan Facility.

We incurred costs of $1.5 million associated with closing the 2018 EGL Term Loan Facility. These costs included
bank, legal and accounting fees, and other fees, and are capitalized and presented as a direct deduction from the
principal amount of debt obligations in the consolidated balance sheets. These costs are amortized over the term of
the facility and are included in interest expense in our consolidated statements of earnings. The unamortized costs as
of December 31, 2019 and December 31, 2018 were $1.0 million and $1.5 million, respectively.

Unsecured Letters of Credit

We utilize unsecured letters of credit to support certain of our insurance and reinsurance performance obligations.

Funds at Lloyd's

We have an unsecured letter of credit agreement for Funds at Lloyd's ("FAL Facility") to issue up to $375.0 million
of letters of credit, with provision to increase the facility by an additional $25.0 million up to an aggregate amount of
$400.0 million, subject to lenders approval. On November 6, 2019, we amended and restated the FAL Facility to extend
its term by one year. The FAL Facility is available to satisfy our Funds at Lloyd's requirements and expires in 2023. As
of December 31, 2019, our combined Funds at Lloyd's were comprised of cash and investments of $639.3 million and
unsecured letters of credit of $252.0 million.

$120.0 million Letter of Credit Facility

We use this facility to support certain reinsurance collateral obligations of our subsidiaries. On December 6,
2019, we reduced the facility size from $170.0 million to $120.0 million. Pursuant to the facility agreement, we have
the option to increase commitments under the facility by an additional $60.0 million. As of December 31, 2019 and
December 31, 2018, we had issued an aggregate amount of letters of credit under this facility of $115.3 million and
$78.4 million, respectively. 

$760.0 million Syndicated Letter of Credit Facility 

During  2019,  we  entered  into  an  unsecured  $760.0  million  letter  of  credit  facility  agreement,  most  recently
amended on December 9, 2019. We may increase the commitments by an aggregate amount of $40.0 million. The
facility is used to post letters of credit to collateralize reinsurance performance obligations to various parties, including
$445.0 million relating to the reinsurance transaction with Maiden Re Bermuda, as described in Note 4 - "Significant
New Business". As of December 31, 2019, we had issued an aggregate amount of letters of credit under this facility
of $608.0 million.  

235

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

16. NONCONTROLLING INTEREST 

We have both redeemable noncontrolling interest and noncontrolling interest on our consolidated balance sheets.
Redeemable noncontrolling interest with redemption features that are not solely within our control are classified within
temporary equity in the consolidated balance sheets and carried at redemption value, which is fair value. The change
in fair value is recognized through retained earnings as if the balance sheet date were also the redemption date. In
addition, we also have noncontrolling interest, which does not have redemption features and is classified within equity
in the consolidated balance sheets.

Redeemable Noncontrolling Interest

Redeemable  noncontrolling  interest  ("RNCI")  as  of  December 31,  2019  and  2018  comprises  the  ownership
interests held by the Trident V Funds ("Trident") (39.3%) and Dowling Capital Partners, L.P. ("Dowling") (1.7%) in our
subsidiary North Bay Holdings Limited ("North Bay"). North Bay owns our investments in Atrium and StarStone. 

The following is a reconciliation of the beginning and ending carrying amount of the equity attributable to the

RNCI for the years ended December 31, 2019 and 2018: 

Balance at beginning of year

Capital contributions

Dividends paid

Net loss attributable to RNCI

Accumulated other comprehensive income (loss) attributable to RNCI

Change in redemption value of RNCI

Balance at end of year

2019
458,543 $

$

13,127
(11,556)
(12,029)
(116)
(9,178)
438,791 $

$

2018

479,606

55,377
(3,852)
(64,794)
(240)
(7,554)
458,543

We carried the RNCI at its estimated redemption value, which is fair value, as of December 31, 2019. The fair
value is based on tangible book value and a valuation multiple derived from a combination of comparable company
market valuations, recent comparable transaction multiples and discounted cash flow models. The decrease in the fair
value of the RNCI during 2019 was primarily attributable to a decrease in tangible net assets due to net losses relating
to StarStone during 2019 and the distribution of Atrium dividends during the year ended December 31, 2019, which
were partially offset by net earnings from Atrium. The valuation multiples did not change significantly.

Refer  to  Note  2  -  "Significant  Accounting  Policies",  Note  21  -  "Related  Party  Transactions"  and  Note  23  -

"Commitments and Contingencies" for additional information regarding RNCI. 

Noncontrolling Interest

As  of  December 31,  2019  and  2018,  we  had  $14.2  million  and  $12.1  million,  respectively,  of  noncontrolling
interest ("NCI") primarily related to an external interest in two of our non-life run-off subsidiaries. A reconciliation of the
beginning and ending carrying amount of the equity attributable to NCI is included in the Consolidated Statement of
Changes in Shareholders Equity. 

236

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

17. SHARE CAPITAL 

As of December 31, 2019 and 2018, the authorized share capital was 111,000,000 ordinary shares ("Voting
Ordinary Shares") and non-voting convertible ordinary shares ("Non-Voting Ordinary Shares"), each of par value $1.00
per share, and 45,000,000 preferred shares of par value $1.00 per share. 

Voting Ordinary Shares

Our Voting Ordinary Shares are listed and trade on the NASDAQ Global Select Market. Each Voting Ordinary

Share entitles the holder thereof to one vote. 

On May 14, 2018, 1,501,778 Voting Ordinary Shares were issued as consideration for the acquisition of KaylaRe

Holdings Ltd, as described in Note 3 - "Acquisitions". 

On January 21, 2020, 565,630 Voting Ordinary Shares were issued to the trustee of the Enstar Group Limited
Employee Benefit Trust (the "EB Trust"). Shares held in the EB Trust are classified as treasury shares. The EB Trust
supports awards made under the Joint Share Ownership Plan, a sub-plan to our Amended and Restated 2016 Equity
Incentive Plan (the "JSOP"). Voting rights in respect of shares held in the EB Trust have been contractually waived.

Non-Voting Ordinary Shares

The Non-Voting Ordinary Shares are comprised of several different series as of December 31, 2019: 

•

•

•

•

the Series A shares were canceled in June 2016 in an internal reorganization as described below.

the Series C shares were originally issued in connection with investment transactions in April and December
of  2011.  In  addition,  there  were  66,520  Series  C  Non-Voting  Ordinary  Shares  issued  in  March  2017  in
connection with the exercise of warrants as described below. The Series C shares: (i) have all of the economic
rights (including dividend rights) attaching to Voting Ordinary Shares but are non-voting except in certain
limited circumstances; (ii) will automatically convert at a one-for-one exchange ratio (subject to adjustment
for  share  splits,  dividends,  recapitalizations,  consolidations  or  similar  transactions)  into  Voting  Ordinary
Shares if the registered holder transfers them in a widely dispersed offering; (iii) may only vote on certain
limited matters that would constitute a variation of class rights and as required under Bermuda law, provided
that  the  aggregate  voting  power  of  the  Series  C  shares  with  respect  to  any  merger,  consolidation  or
amalgamation will not exceed 0.01% of the aggregate voting power of our issued share capital; and (iv)
require the registered holders’ written consent in order to vary the rights of the shares in a significant and
adverse manner. During the three months ended March 31, 2017, 192,485 Series C Non-Voting Ordinary
Shares were converted into Voting Ordinary Shares in a widely dispersed offering by their registered holders.

the Series B and Series D shares were created in connection with the 2011 investment transactions, but no
shares in these series are issued and outstanding. Holders of the Series C shares have the right to convert
such shares, on a share-for-share basis, subject to certain adjustments, into Series D shares at their option.
There is no economic difference in Series B, C or D shares, but there are slight differences in the conversion
rights and the limited voting rights of each series.

there were 910,010 Series E shares issued and outstanding as of December 31, 2019. On May 14, 2018,
505,239 Series E non-voting shares were issued as consideration for the acquisition of KaylaRe Holdings
Ltd, as described in Note 3 - "Acquisitions". The Series E shares have substantially the same rights as the
Series C shares, except that (i) they are convertible only into Voting Ordinary Shares and (ii) they may only
vote as required under Bermuda law. The Series E shares include all other Non-Voting Ordinary Shares
authorized under our bye-laws but not classified as Series A, B, C or D Non-Voting Ordinary Shares.

Warrants

As of December 31, 2019, there were warrants outstanding to acquire 175,901 Series C Non-Voting Ordinary
Shares for an exercise price of $115.00 per share, subject to certain adjustments (the "Warrants").  The Warrants were
issued in April 2011 and expire in April 2021. The Warrant holder may, at its election, satisfy the exercise price of the
Warrants on a cashless basis by surrender of shares otherwise issuable upon exercise of the Warrants in accordance
with a formula set forth in the Warrants. 

237

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Series C Preferred Shares

As of December 31, 2019, there were 388,571 Series C Participating Non-Voting Perpetual Preferred Shares
("Series C Preferred Shares") issued and held by one of our wholly-owned subsidiaries. The Series C Preferred Shares
were issued in June 2016 in an internal reorganization transaction that resulted in the cancellation of all of the Series
A Shares. The Series C Preferred Shares (i) upon liquidation, dissolution or winding up of the Company, entitle their
holders to a preference over holders of our ordinary voting and non-voting shares of an amount equal to $0.001 per
share with respect to surplus assets and (ii) are non-voting except in certain limited circumstances. The Series C
Preferred shares have dividend rights equal to those of the ordinary voting shares, subject to certain limitations and
in an amount determined by a "participation rate" that is generally reflective of the reduction in the number of Series
C Preferred Shares issued in exchange for the previously outstanding Series A Shares. The Series C Preferred Shares
otherwise rank on parity with the ordinary voting and non-voting shares, and they rank senior to each other class or
series of share capital, unless the terms of any such class or series shall expressly provide otherwise.

Series D Preferred Shares

On June 28, 2018, the Company raised $400.0 million of gross proceeds through the public offering of 16,000
shares of its 7.00% non-cumulative fixed-to-floating rate Series D perpetual preferred shares ("Series D Preferred
Shares") (equivalent to 16,000,000 depositary shares, each of which represents a 1/1,000th interest in a Series D
Preferred  Share),  $1.00  par  value  and  $25,000  liquidation  preference  (the  "Liquidation  Preference")  per  share
(equivalent to $25.00 per depositary share). The Company received net proceeds of $389.2 million which was used
to repay debt obligations. The depositary shares are listed and trade on the NASDAQ Global Select Market. The Series
D Preferred Shares are not redeemable prior to September 1, 2028, except in specified circumstances relating to
certain tax, corporate, capital or rating agency events as described in the prospectus supplement relating to the offering.
On  and  after  September 1,  2028,  the  Series  D  Preferred  Shares,  represented  by  the  depositary  shares,  will  be
redeemable at the Company’s option, in whole or from time to time in part, at a redemption price equal to $25,000 per
Series D Preferred Share (equivalent to $25.00 per depositary share), plus any declared and unpaid dividends. 

Series E Preferred Shares

On November 21, 2018, the Company raised $110.0 million of gross proceeds through the public offering of
4,400 shares of its 7.00% fixed rate non-cumulative Series E perpetual preferred shares ("Series E Preferred Shares")
(equivalent to 4,400,000 depositary shares, each of which represents a 1/1,000th interest in a Series E Preferred
Share), $1.00 par value and $25,000 liquidation preference (the "Series E Liquidation Preference") per share (equivalent
to  $25.00  per  depositary  share).  The  Company  received  net  proceeds  of  $106.1  million  which  was  used  to  fund
operations within our Non-life Run-off segment. The depositary shares are listed and trade on the NASDAQ Global
Select  Market.  The  Series  E  Preferred  Shares  are  not  redeemable  prior  to  March 1,  2024,  except  in  specified
circumstances  relating  to  certain  tax,  corporate,  capital  or  rating  agency  events  as  described  in  the  prospectus
supplement relating to the offering. On and after March 1, 2024, the Series E Preferred Shares, represented by the
depositary shares, will be redeemable at the Company’s option, in whole or from time to time in part, at a redemption
price equal to $25,000 per Series E Preferred Share (equivalent to $25.00 per depositary share), plus any declared
and unpaid dividends. 

Dividends on Preferred Shares

Holders of Series D and Series E Preferred Shares are entitled to receive, only when, as and if declared, non-
cumulative cash dividends, paid quarterly in arrears on the 1st day of March, June, September and December of each
year,  commencing  on  September  1,  2018  for  the  Series  D  Preferred  Shares  and  March  1,  2019  for  the  Series  E
Preferred Shares, of 7.00% per annum. Commencing on September 1, 2028, the Series D Preferred Shares will convert
to a floating rate basis and dividends will be payable on a non-cumulative basis, when, as and if declared, at three-
month LIBOR plus 4.015% per annum. Dividends that are not declared will not accumulate and will not be payable.
During 2019, we declared and paid $28.0 million of dividends on the Series D Preferred Shares, and declared and
paid $7.9 million of dividends on the Series E Preferred Shares. During 2018, we declared and paid $12.1 million of
dividends  on  the  Series  D  Preferred  Shares.  During  February  2020,  we  declared  $7.0  million  and  $1.9  million  of
dividends on the Series D and E Preferred Shares, respectively, to be paid on March 2, 2020 to shareholders of record
as of February 15, 2020.    

Any payment of dividends must be approved by our Board of Directors. Our ability to pay dividends is subject

to certain restrictions, as described in Note 22 - "Dividend Restrictions and Statutory Financial Information".

238

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

18. EARNINGS PER SHARE 

The  following  table  sets  forth  the  computation  of  basic  and  diluted  earnings  per  share  for  the  years  ended

December 31, 2019, 2018 and 2017:

Numerator:

Net earnings (loss) from continuing operations
Net earnings from discontinued operations, net of income taxes
Net earnings (loss) attributable to Enstar Group Limited

Denominator:

Weighted-average ordinary shares outstanding — basic
Effect of dilutive securities:

Share-based compensation plans
Warrants

Weighted-average ordinary shares outstanding — diluted
Earnings per share attributable to Enstar Group Limited:
Basic:

Net earnings (loss) from continuing operations
Net earnings from discontinued operations, net of income taxes
Net earnings (loss) per ordinary share
Diluted(1):
Net earnings (loss) from continuing operations
Net earnings from discontinued operations, net of income taxes
Net earnings (loss) per ordinary share

$

$

$

$

$

$

2019

2018

2017

902,175 $ (162,354) $

—

—

902,175 $ (162,354) $

300,465
10,993
311,458

21,482,617

20,698,310

19,388,621

227,878
64,571
21,775,066

129,746
76,120
20,904,176

62,732
76,238
19,527,591

42.00 $
—
42.00 $

41.43 $
—
41.43 $

(7.84) $
—
(7.84) $

(7.84) $
—
(7.84) $

15.50
0.56
16.06

15.39
0.56
15.95

(1) During a period of loss, the basic weighted average ordinary shares outstanding is used in the denominator of the diluted loss per ordinary share

computation as the effect of including potentially dilutive securities would be anti-dilutive.

239

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

19. SHARE-BASED COMPENSATION AND PENSIONS 

Share-based compensation 

The 2016 and 2006 Equity Incentive Plans are our primary share-based compensation plans. We also maintain
other share-based compensation plans as discussed below. The table below provides a summary of the compensation
costs for all of our share-based compensation plans for the years ended December 31, 2019, 2018 and 2017:

Share-based compensation plans:

Restricted shares and restricted share units

Performance share units

Cash-settled stock appreciation rights

Other share-based compensation plans:

Northshore incentive plan

StarStone incentive plan

Deferred compensation and ordinary share plan for non-employee directors

Employee share purchase plan

Total share-based compensation

Restricted Shares and Restricted Share Units

2019

2018

2017

$

6,564

$

7,641

$

23,582

2,575

3,652

223

992

411

1,968

(3,316)

2,792

—

1,155

430

7,302

5,832

8,875

3,156

—

758

403

$

37,999

$

10,670

$

26,326

Restricted shares and restricted share units are service awards that typically vest over three years. These awards
are share-settled and are recorded in additional paid-in capital on the consolidated balance sheets. The fair value of
these awards is measured at the grant date and expensed over the service period. The following table summarizes
the activity related to restricted shares and restricted share awards during 2019:

Number of
Shares

Weighted-Average
Share Price

Nonvested — January 1

Granted

Vested

Forfeited

Nonvested — December 31

59,936

50,054

(42,462)

(2,956)

64,572

$191.89

176.16

189.98

206.85

180.49

The unrecognized compensation cost related to our unvested restricted share and restricted share unit awards
as of December 31, 2019 was $6.0 million. This cost is recognizable over the next 2.10 years, which is the weighted
average contractual life. 

Performance Share Units ("PSUs")

PSUs are share-settled and vest on the third anniversary of the grant date. The number of shares to vest will be
determined by a performance adjustment based on either (i) the change in fully diluted book value per share ("FDBVPS")
over three years, or (ii) average annual non-GAAP operating income return on equity, excluding StarStone.

Performance Share Units based on FDBVPS

The following table summarizes the awards granted, the unvested PSU awards at December 31, 2019,  and the

performance criteria and associated performance multipliers at various levels of achievement.  

Inception-to-date Activity Roll-forward

Performance Criteria:
Change in FDBVPS (3 year) 

Performance Multiplier 
Levels Per Award Agreements

Grant
Year

2017

2017

2018

2019

PSUs
Granted 
at Target 

36,321

91,875

39,682

18,308

Forfeited

(12,176)

—

(11,414)

(798)

Estimated
Change in
Multiplier

Nonvested at
December 31,
2019

9,560

18,081

—

—

33,705

109,956

28,268

17,510

189,439

186,186

(24,388)

27,641

Threshold

Target Maximum

Threshold

Target

Maximum

20.00% 30.00%

30.30% 35.65%

25.00% 32.50%

20.00% 30.00%

40.00%

41.00%

40.00%

40.00%

50.00% 100.00%

150.00%

50.00% 100.00%

150.00%

50.00% 100.00%

150.00%

60.00% 100.00%

150.00%

240

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

An increase of Target to Maximum or more in FDBVPS results in a settlement of 100% to a maximum of 150%
of the units granted, respectively. An increase of Threshold to Target in FDBVPS results in a settlement of 50% to 100%
of the units granted, respectively for 2017 and 2018 awards, and settlement of 60% to 100% for the 2019 awards.
Straight-line interpolation applies within these ranges, and no settlement occurs if the increase in FDBVPS is less than
the Threshold. 

Performance Share Units based on Average Annual Non-GAAP Operating Income Return on Equity ("Operating
ROE")

The  following  table  summarizes  the  awards  granted,  the  unvested  units  at  December 31,  2019,  and  the

performance criteria and associated performance multipliers at various levels of achievement.  

Inception-to-date Activity Roll-forward

Performance Criteria:
Average Annual Operating ROE 

Performance Multiplier 
Levels Per Award Agreements

Grant
Year

2019

PSUs
Granted 
at Target 

Forfeited

Estimated
Change in
Multiplier

Nonvested at
December 31,
2019

Threshold

Target Maximum

Threshold

Target

Maximum

18,308

(798)

—

17,510

9.60% 12.00%

14.40%

60.00% 100.00%

150.00%

Annual Operating ROE is calculated based upon the non-GAAP operating income return on opening shareholder's
equity, excluding StarStone. Average Annual Operating ROE is the sum of the three individual year annual operating
ROE %'s divided by three. An Average Annual Operating ROE of Target to Maximum or more results in a settlement
of 100% to a maximum of 150% of the units granted, respectively. An Average Annual Operating ROE of Threshold to
Target results in a settlement of 60% to 100%. Straight-line interpolation applies within these ranges and no settlement
occurs if the Average Annual Operating ROE is less than the Threshold. 

Performance Multipliers

For expense purposes we assume a Target vesting at the initial time of award. At the end of each reporting

period, we estimate the expected performance multiplier, as shown in the table below: 

Award Description

2017 FDBVPS Type I (30.00% Target Change)

2017 FDBVPS Type II (35.65% Target Change)

2018 FDBVPS

2019 FDBVPS

2019 Average Operating ROE

2019

139%

120%

100%

100%

100%

2018

50%

50%

50%

n/a

n/a

2017

100%

100%

n/a

n/a

n/a

The unrecognized compensation cost related to our unvested PSU share awards as of December 31, 2019 was

$7.9 million. This cost is recognizable over the next 1.51 years, which is the weighted average contractual life. 

Roll-forward of Performance Share Units 

The following table summarizes the activity related to PSUs during 2019:

Nonvested — January 1

Granted

Increase for above target vest

Vested

Forfeited

Nonvested — December 31

Number of
Shares

Weighted-Average
Share Price

159,168

36,616

27,641

(2,631)

(13,845)

206,949

$190.77

166.42

188.62

195.60

198.37

185.61

241

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Cash-Settled Stock Appreciation Rights

 Cash-settled stock appreciation right awards ("SARs") give the holder the right, upon exercise, to receive in
cash the difference between the market price per share of our ordinary shares at the time of exercise and the exercise
price of the SARs. The exercise price of each SAR is equal to the market price of our ordinary shares on the date of
the grant. Vested SARs are exercisable for periods not to exceed either 4 years or 10 years from the date of grant.
We have not granted any new SAR awards since 2015. 

The following table summarizes the activity related to SARs during 2019:

Number of
SARs

Weighted-Average
Exercise
Price of SARs

Weighted-Average
Expected Term
(in years)

Aggregate
Intrinsic
Value(1)

Balance, beginning of year

109,081

$

Exercised

Balance, end of year

(19,854)

89,227

142.37

138.07

143.33

2.39

$

6,133

(1) The aggregate intrinsic value is calculated as the pre-tax difference between the exercise price of the underlying share awards
and the closing price per share of our ordinary shares of $206.86 on December 31, 2019.

Compensation expense for SARs is based on the estimated fair value on the date of grant using the Black-
Scholes valuation model, which requires the use of subjective assumptions related to the expected stock price volatility,
expected  term,  expected  dividend  yield  and  risk-free  interest  rate.  SARs  are  liability-classified  awards  for  which
compensation expense and the liability are re-measured using the then-current Black Scholes assumptions at each
interim reporting date based upon the portion of the requisite service period rendered. The unrecognized compensation
cost related to our SARs as of December 31, 2019 was less than $0.1 million. 

The following table sets forth the assumptions used to estimate the fair value of the SARs using the Black-

Scholes option valuation model as of December 31, 2019, 2018 and 2017:

Weighted-average fair value per SAR

$

76.03

$

45.85

$

Weighted-average volatility

Weighted-average risk-free interest rate

Dividend yield

19.75%

1.64%

0.00%

18.94%

2.72%

0.00%

75.38

19.44%

1.65%

0.00%

2019

2018

2017

Joint Share Ownership Plan

Under the JSOP, we have the ability to make equity awards to our U.K.-based staff through which a recipient
acquires jointly held interests in a set number of our Voting Ordinary Shares together with the independent trustee of
the EB Trust at fair market value, pursuant to the terms of a joint ownership agreement. The Voting Ordinary Shares
underlying any JSOP award remain in the EB Trust, and the recipient ultimately receives the value of the appreciation
above a threshold on those shares, measured between date of grant and a pre-set measuring date that follows a
vesting period (typically three years). JSOP awards are generally settled in Voting Ordinary Shares and may include
performance and other conditions, typically related to share price appreciation above a hurdle, that must be met in
order for the award to vest. Voting rights in respect of shares held in the EB Trust are contractually waived. Shares
held in the EB Trust are classified as treasury shares.

No  awards  under  the  JSOP  were  made  during  2019.  Subsequent  to  December  31,  2019,  a  JSOP  award
comprising 565,630 underlying Voting Ordinary Shares was made to our Chief Executive Officer (the "CEO JSOP
Award"). The CEO JSOP Award was granted on January 21, 2020 and cliff-vests after 3 years. The ultimate value of
the CEO JSOP Award at vesting, if any, is determined based on the price of a Voting Ordinary Share appreciating
above a certain threshold between the date of grant and the vesting date. If the higher of the closing price per Share
on January 20, 2023 and the 10-day volume weighted average price per Share for the ten consecutive trading days
ending on January 20, 2023 (each, the "Market Price") is $266.00 or greater (the "Hurdle"), the award will have a value
equal to the applicable Market Price per Share, less $205.89, multiplied by 565,630. If the higher of the Market Price
per Voting Ordinary Share is less than $266.00 on such date, the award will have no value. Subject to the terms of the
agreement  governing  the  award,  20%  of  the  ultimate  value  of  the  CEO  JSOP Award  is  subject  to  a  performance
condition to vesting, in addition to the Hurdle, based on growth in our fully diluted book value per share between January

242

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

1, 2020 and December 31, 2022. The grant date fair value of the award was approximately $13.6 million.

Other share-based compensation plans

Northshore Incentive Plan

Our subsidiary, Northshore, has long-term incentive plans that award time-based restricted shares of Northshore
to certain Atrium employees. Shares generally vest over two to three years. These share awards have been classified
as liability awards. The unrecognized compensation cost related to the Northshore incentive plan at December 31,
2019 was $0.9 million. This cost is expected to be recognized over the next 0.36 years, which is the weighted average
contractual life of the awards. 

StarStone Incentive Plan

Our subsidiary, StarStone, has long-term incentive plans that are cash-settled plans for StarStone employees.
The awards are based on StarStone's performance over two to three years. These share awards have been classified
as liability awards. The unrecognized compensation cost related to the StarStone incentive plan at December 31, 2019
was $1.8 million. This cost is expected to be recognized over the next 2 years. 

Deferred Compensation and Ordinary Share Plan for Non-Employee Directors

The following table summarizes the number of units outstanding for the years ended December 31, 2019, 2018
and 2017 under the Enstar Group Limited Deferred Compensation and Ordinary Share Plan for Non-Employee Directors
(the "Deferred Compensation Plan"):

Restricted share units credited to the accounts
of non-employee directors

5,976

5,691

3,852

2019

2018

2017

Employee Share Purchase Plan

We provide an Employee Share Purchase Plan whereby eligible employees may purchase Enstar shares at a
15% discount to market price, in an amount of share value limited to the lower of $21,250 or 15% of the employee's
base salary. The 15% discount is expensed as compensation cost. 

The following table summarizes the number of shares issued to employees under the Employee Share Purchase

Plan for the years ended December 31, 2019, 2018 and 2017:

Number of shares issued to employees

15,269

14,183

12,401

2019

2018

2017

Pension Plans

We provide retirement benefits to eligible employees through various plans that we sponsor. Pension expense
can be affected by changes in our employee headcount. The table below summarizes the pension expenses related
to our Defined Contribution Plans and our Defined Benefit Plan for the years ended December 31, 2019, 2018 and
2017.

Defined contribution plans

Defined benefit plan

Total pension expense

2019

2018

2017

$

$

11,798

684

12,482

$

$

11,434

2,243

13,677

$

$

12,247

1,988

14,235

Defined Benefit Plan

During 2019, an actuarial review was performed on the defined benefit plan, which determined that the plan’s
unfunded liability, as of December 31, 2019 and 2018 was $8.9 million and $8.4 million, respectively. As of December 31,
2019 and 2018, we had an accrued liability of $8.9 million and $8.4 million, respectively, for this plan. 

243

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

20. INCOME TAXATION 

Enstar Group Limited is incorporated under the laws of Bermuda and under Bermuda law is not required to pay
taxes in Bermuda based upon income or capital gains. The Company, under the Exempted Undertakings Tax Protection
Act of 1966, is protected against any legislation that may be enacted in Bermuda which would impose any tax on
profits, income, or gain until March 31, 2035.

We have foreign operating subsidiaries and branch operations principally located in the United States, United
Kingdom, Continental Europe and Australia that are subject to federal, foreign, state and local taxes in those jurisdictions.
Deferred tax liabilities have not been accrued with respect to the undistributed earnings of our foreign subsidiaries. If
the earnings were to be distributed, as dividends or other distributions, withholding taxes may be imposed by the
jurisdiction of the paying subsidiary. For our U.S. subsidiaries, we have not currently accrued any withholding taxes
with respect to unremitted earnings as management has indefinitely reinvested these earnings. For our United Kingdom
subsidiaries, there are no withholding taxes imposed. For our other foreign subsidiaries, it would not be practicable to
compute  such  amounts  due  to  a  variety  of  factors,  including  the  amount,  timing,  and  manner  of  any  repatriation.
Because we operate in many jurisdictions, our net earnings are subject to risk due to changing tax laws and tax rates
around  the  world. The  current,  rapidly  changing  economic  environment  may  increase  the  likelihood  of  substantial
changes to tax laws in the jurisdictions in which we operate.

The  following  table  presents  earnings  (loss)  before  income  taxes  by  jurisdiction  from  continuing  operations,
including earnings (loss) from equity method investments, for the years ended December 31, 2019, 2018 and 2017:

Domestic (Bermuda)

Foreign

Total earnings (loss) before income tax on continuing operations

2019

2018

2017

$

$

576,339

356,317

932,656

$

$

(232,743) $

14,347

(218,396) $

167,263

147,148

314,411

The following table presents our current and deferred income tax expense (benefit) from continuing operations

by jurisdiction for the years ended December 31, 2019, 2018 and 2017:

2019

2018

2017

Current:

Domestic (Bermuda)

Foreign

Deferred:

Domestic (Bermuda)

Foreign

$

— $

— $

18,433

18,433

—

(13,996)

(13,996)

(3,632)

(3,632)

—

(2,492)

(2,492)

Total income tax expense (benefit) on continuing operations

$

4,437

$

(6,124) $

—

10,299

10,299

—

(16,694)

(16,694)

(6,395)

The actual effective income tax rate differs from the statutory rate of 0% under Bermuda law to earnings (loss)
from continuing operations before income taxes, including earnings (loss) from equity method investments for the years
ended December 31, 2019, 2018 and 2017 as shown in the following reconciliation:

Earnings (loss) before income tax

Bermuda income taxes at statutory rate

Foreign income tax rate differential

Change in valuation allowance

Effect of change in foreign (U.S.) tax rate

U.S. base erosion and anti-abuse tax

Other
Effective tax rate

2019

2018

2017

$

932,656

$

(218,396)

$

314,411

0.0 %

8.6 %

(8.2)%

— %

0.5 %

(0.4)%
0.5 %

0.0 %

0.7 %

(0.3)%

— %

(0.6)%

3.0 %
2.8 %

0.0 %

13.1 %

(34.9)%

20.3 %

— %

(0.5)%
(2.0)%

Our effective tax rate is generally driven by the geographical distribution of our pre-tax net earnings between

our taxable and non-taxable jurisdictions.

244

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities reflect the tax effect of the differences between the financial statement carrying
amount and the income tax bases of assets and liabilities. Significant components of the deferred tax assets and
deferred tax liabilities as of December 31, 2019 and 2018 were as follows:

Deferred tax assets:

Net operating loss carryforwards

Insurance reserves

Unearned premiums

Lloyd's underwriting losses taxable in future periods

Provisions for bad debt

Unrealized losses on investments
Defendant asbestos and environmental liabilities (1)
Other deferred tax assets

Gross deferred tax assets

Valuation allowance

Deferred tax assets

Deferred tax liabilities:

Unrealized gains on investments

Lloyd's underwriting profit taxable in future periods

Deferred policy acquisition cost

Other deferred tax liabilities

Deferred tax liabilities

2019

2018

$

159,436

$

14,104

7,131

—

6,172

—

140,000

—

326,843

(117,390)

209,453

(10,107)

(8,852)

(8,267)

(27,317)

(54,543)

183,633

18,677

11,314

6,201

2,594

5,160

—

183

227,762

(212,113)

15,649

—

—

—

(16,067)

(16,067)

Net deferred tax asset (liability)

$

154,910

$

(418)

(1) Relates to the Morse TEC acquisition as described in Note 3 - "Acquisitions".

Net Deferred Tax Asset (Liability) Balance by Major Jurisdiction:

December 31,

2019

Net Deferred Tax 
Asset

2018

Net Deferred Tax 
Liability

United States

United Kingdom

Other

Total

$

$

169,891

$

(16,074)

1,093

154,910

$

5,151

(8,377)

2,808

(418)

Net Operating Loss Carryforwards:

As of December 31, 2019, we had net operating loss carryforwards that could be available to offset future taxable

income, as follows:

Tax Jurisdiction

Loss Carryforwards

Tax effect

Expiration

Operating and Capital Loss Carryforwards:

United States - Net operating loss

$

513,476

$

United Kingdom

Other

224,150

52,484

107,830

38,106

13,500

2024-2038

Indefinitely

Various

The U.S. net operating loss carryforwards are also subject to certain utilization limitations based upon their nature

and the specific legal entity that holds them.

245

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Assessment of Valuation Allowance on Deferred Tax Assets

As of December 31, 2019 and 2018, we had deferred tax asset valuation allowances of $117.4 million and $212.1
million, respectively, related to foreign subsidiaries. We recorded a decrease of $94.7 million in our deferred tax valuation
allowance primarily due to utilization of deferred tax asset in the amount of $69.7 million as well as a partial deferred
tax asset valuation allowance release in the amount of $25.0 million during 2019. 

The realization of deferred tax assets is dependent on generating sufficient taxable income in future periods in
which the tax benefits are deductible or creditable. The amount of the deferred tax asset considered realizable, however,
could  be  revised  in  the  future  if  estimates  of  future  taxable  income  change.  Taxes  are  determined  and  assessed
jurisdictionally by legal entity or by filing group. Certain jurisdictions require or allow combined or consolidated tax
filings. We have estimated future taxable income of our foreign subsidiaries and provided a valuation allowance in
respect of those assets where we do not expect to realize a benefit. We have considered all available evidence using
a “more likely than not” standard in determining the amount of the valuation allowance. We considered the following
evidence: (i) net earnings or losses in recent years; (ii) the future sustainability and likelihood of positive net earnings
of our subsidiaries; (iii) the carryforward periods of tax losses including the effect of reversing temporary differences;
and (iv) tax planning strategies, in making our determination. The assumptions used in determining future taxable
income require significant judgment and any changes in these assumptions could have an impact on earnings.

Unrecognized Tax Benefits

During the years ended December 31, 2019, 2018 and 2017, there were no unrecognized tax benefits. There
were no accruals for the payment of interest and penalties related to unrecognized tax benefits as of December 31,
2019, 2018 and 2017.

Our operating subsidiaries may be subject to audit by various tax authorities and may have different statutes of
limitations expiration dates. Tax authorities may propose adjustments to our income taxes. Listed below are the tax
years that remain subject to examination by a major tax jurisdiction as of December 31, 2019: 

Major Tax Jurisdiction

United States

United Kingdom

Australia

Impact of U.S. Tax Reform

Open Tax Years

2016-2019

2016-2019

2014-2019

On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as
the Tax Cuts and Jobs Act ("Tax Act"). The Tax Act resulted in a reduction of the U.S. Federal Tax rate to 21% from
35% effective for tax years beginning after December 31, 2017. Consequently, we recorded a $63.8 million reduction
of our U.S. deferred tax asset fully offset by a reduction in our valuation allowance in 2017. The Tax Act also repealed
the corporate AMT. Taxpayers with AMT credit carryovers in excess of their tax liability may have the credits refunded
over multiple years between 2018 and 2021. For the year ended December 31, 2017, we had recorded a reduction
to  our  valuation  allowance  of  $7.4  million  and  reclassified  our  AMT  credit  carryforward  to  other  assets  on  our
consolidated balance sheet. The AMT carryforward has been refunded 50% each tax year beginning in 2018 with any
remaining balance expected to be fully refunded in 2021.

246

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

21. RELATED PARTY TRANSACTIONS 

Stone Point Capital LLC

Through several private transactions occurring from May 2012 to July 2012 and an additional private transaction
that closed in May 2018, investment funds managed by Stone Point Capital LLC ("Stone Point") have acquired an
aggregate of 1,635,986 of our Voting Ordinary Shares (which constitutes approximately 9.1% of our outstanding Voting
Ordinary Shares). On November 6, 2013, we appointed James D. Carey to our Board of Directors. Mr. Carey is the
sole member of an entity that is one of four general partners of the entities serving as general partners for Trident, is
a member of the investment committees of such general partners, and is a member and senior principal of Stone Point,
the manager of the Trident funds.

In addition, we have entered into certain agreements with Trident with respect to Trident’s co-investments in the
Atrium, Arden, and StarStone acquisitions. These include investors’ agreements and shareholders’ agreements, which
provide for, among other things: (i) our right to redeem Trident’s equity interest in the Atrium/Arden and StarStone
transactions in cash at fair market value within the 90 days following September 6, 2018 and April 1, 2019, respectively,
and at any time following September 6, 2020 and April 1, 2021, respectively; and (ii) Trident’s right to have its equity
co-investment interests in the Atrium/Arden and StarStone transactions redeemed by us at fair market value (which
we may satisfy in either cash or our ordinary shares) following September 6, 2020 and April 1, 2021, respectively. We
did not exercise our right to redeem Trident's equity interest in Atrium/Arden during the 90 days following September
6, 2018, nor did we exercise our right to redeem Trident's equity interest in StarStone during the 90 days following
April 1, 2019. Pursuant to the terms of the shareholders’ agreements, Mr. Carey serves as a Trident representative on
the boards of the holding companies, including North Bay Holdings Limited ("North Bay"), established in connection
with the Atrium/Arden and StarStone co-investment transactions. Trident also has a second representative on these
boards who is a Stone Point employee.

We, in partnership with StarStone's other shareholders, have recently completed transactions to provide capital

support to StarStone in the form of:

(i) a contribution to its contributed surplus account and a loss portfolio transfer, effective October 1, 2018. To
fund the transaction, the North Bay shareholders contributed an aggregate amount of $135.0 million to North Bay in
proportion to their ownership interests. Trident’s proportionate contribution of $53.1 million was temporarily funded by
North Bay and was reimbursed in the first quarter of 2019; and

(ii) a loss portfolio transfer, effective April 1, 2019, for which shareholders agreed to contribute an aggregate

amount of $48.0 million.

In addition, Enstar has separately entered into a loss portfolio transfer and adverse development cover with
StarStone effective October 1, 2019, whereby StarStone transferred $189.4 million in loss reserves and unearned
premium to a wholly-owned Enstar subsidiary in exchange for premium of $189.4 million. Enstar also provided an
additional $59.0 million adverse development cover in excess of the $189.4 million. 

As of December 31, 2019 and December 31, 2018, the RNCI on our balance sheet relating to these Trident co-

investment transactions was as follows:

Redeemable Noncontrolling Interest

$

420,499 $

439,428

2019

2018

As of December 31, 2019, we had the following additional relationships with Stone Point and its affiliates:

•

•

•

Investments in funds (carried within other investments) managed by Stone Point, with respect to which we
recognized net unrealized gains (losses); 

Investments in registered investment companies affiliated with entities owned by Trident or otherwise affiliated
with Stone Point, with respect to which we recognized net unrealized gains (losses) and interest income; 

Separate accounts managed by Eagle Point Credit Management, PRIMA Capital Advisors and SKY Harbor
Capital  Management,  which  are  affiliates  of  entities  owned  by  Trident,  with  respect  to  which  we  incurred
management fees;

247

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

•

•

Investments in funds (carried within other investments) managed by Sound Point Capital, an entity in which
Mr. Carey  has  an  indirect  minority  ownership  interest  and  serves  as  a  director,  with  respect  to  which  we
recognized net unrealized gains (losses);

Sound Point Capital has acted as collateral manager for certain of our direct investments in CLO debt and
equity securities, with respect to which we recognized net unrealized gains (losses) and interest income; 

• Marble Point Capital, which is an affiliate of an entity owned by Trident, has acted as collateral manager for
certain of our direct investments in CLO debt and equity securities, with respect to which we recognized net
unrealized gains (losses) and interest income;

•

•

A separate account managed by Sound Point Capital, with respect to which we incurred management fees in
prior periods; and

In the fourth quarter of 2018, we invested $25.0 million in Mitchell TopCo Holdings, the parent company of
Mitchell International and Genex Services, as a co-investor alongside certain Trident funds.

The following table presents the amounts included in our consolidated balance sheet related to our related party

transactions with Stone Point and its affiliated entities:

December 31, 2019 December 31, 2018

Short-term investments, available-for-sale, at fair value

$

1,431 $

Fixed maturities, trading, at fair value

Fixed maturities, available-for-sale, at fair value

Equities, at fair value

Other investments, at fair value:

Hedge funds

Fixed income funds

Private equity funds

CLO equities

CLO equity funds

Private Debt

Real estate fund

Cash and cash equivalents

Other assets

Other liabilities

269,131

160,303

121,794

18,993

381,449

34,858

32,560

87,509

16,312

18,106

54,080

10

4,710

—

176,193

—

57,319

19,535

324,561

52,925

15,372

37,260

10,387

8,025

11,739

5,216

4,240

The following table presents the amounts included in net earnings related to our related party transactions with

Stone Point and its affiliated entities: 

Net investment income

Net realized and unrealized gains (losses)

Total net earnings

KaylaRe 

2019

2018

2017

$

$

8,733 $

26,631
35,364 $

7,424 $
207
7,631 $

5,990

24,684

30,674

On  December  15,  2016,  KaylaRe  completed  an  initial  capital  raise  of  $620.0  million.  We  originally  owned
approximately 48.2% of KaylaRe's common shares and recorded our investment in KaylaRe using the equity method
basis of accounting, pursuant to the conclusion that we were not required to consolidate following an analysis based
on the guidance in ASC 810 - Consolidation. 

On May 14, 2018, we completed a transaction to acquire all of the outstanding shares and warrants of KaylaRe,
following the receipt of all required regulatory approvals. In consideration for the acquired shares and warrants of

248

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

KaylaRe, we issued an aggregate of 2,007,017 ordinary shares, comprising 1,501,778 voting ordinary shares and
505,239 Series E non-voting ordinary shares to the shareholders of KaylaRe as follows: (i) 1,204,353 voting ordinary
shares and 505,239 Series E Shares to a fund managed by Hillhouse Capital Management, Ltd.; (ii) 285,986 voting
ordinary  shares  to  Trident;  and  (iii)  11,439  voting  ordinary  shares  to  the  minority  shareholder.  In  addition,  the
Shareholders Agreement between Enstar and the other KaylaRe shareholders was effectively terminated. Effective
May 14, 2018 we consolidated KaylaRe into our consolidated financial statements and any balances between KaylaRe
and Enstar are now eliminated upon consolidation. Refer to Note 3 - "Acquisitions" for additional information. Effective
September  30,  2019,  KaylaRe  and  KaylaRe  Ltd.  merged  with  Cavello  Bay  Reinsurance  Limited,  a  wholly  owned
subsidiary of the Company, with Cavello Bay Reinsurance Limited as the surviving company.

Through a Quota Share Agreement dated December 15, 2016 (the "KaylaRe-StarStone QS"), several of our
StarStone affiliates entered into a Quota Share Treaty with KaylaRe Ltd. pursuant to which KaylaRe Ltd. reinsured
35% of all business written by these StarStone affiliates for risks attaching from January 1, 2016, net of the StarStone
affiliates’ external reinsurance programs. The reinsurance of StarStone's U.S. affiliates was non-renewed as of January
1, 2018, and the reinsurance of its U.K. and European affiliates was non-renewed as of January 1, 2019. In addition,
Fitzwilliam Insurance Limited ("Fitzwilliam"), one of our non-life run-off subsidiaries, ceded $177.2 million of loss reserves
to KaylaRe Ltd. in 2016, on a funds held basis. Under the terms of this reinsurance agreement, Fitzwilliam is entitled
to receive a profit commission calculated with reference to reserve savings made during the term of this agreement.
Our Non-life Run-off subsidiaries did not cede any new business to KaylaRe Ltd. during years ended December 31,
2019 and 2018.

Our consolidated statement of earnings for the years ended December 31, 2018 and 2017 included the following
balances related to transactions between us and KaylaRe and KaylaRe Ltd. up until May 14, 2018, the date of acquisition:

Fee income due to Enstar Limited

Transactions under KaylaRe-StarStone QS:

Ceded premium earned

Net incurred losses

Acquisition costs

2018

2017

$

1,453 $

2,679

(52,651)
31,654

18,774

(234,079)
155,433

99,500

Transactions under Fitzwilliam reinsurance agreement:

Profit Commission

—

18,843

Total net earnings (loss)

$

(770) $

42,376

Hillhouse 

Investment  funds  managed  by  Hillhouse  Capital  Advisors,  Ltd.  ("Hillhouse  Capital")  collectively  own
approximately 9.7% of Enstar’s voting ordinary shares. These funds also own non-voting ordinary shares and warrants
to  purchase  additional  non-voting  ordinary  shares,  which  together  with  their  voting  ordinary  shares,  represent  an
approximate 17.0% economic interest in Enstar. In February 2017, Jie Liu, a Partner of Hillhouse Capital, was appointed
to our Board.

We have direct investments in funds managed by Hillhouse Capital and its affiliate, AnglePoint Asset Management
Ltd. ("AnglePoint"), (together with such parties' affiliates, "Hillhouse"). As of December 31, 2019, the carrying value of
our direct investment in the InRe Fund, L.P. (the "InRe Fund"), which is managed by AnglePoint, was $918.6 million
with the fund's assets being invested in approximately 18% in fixed income securities, 6% in North American equities,
96% in international equities and (20)% in financing, derivatives and other items. 

As of December 31, 2019 and December 31, 2018, our equity method investee, Enhanzed Re, had investments

in a fund managed by AnglePoint, as set forth in the table below.

249

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Our consolidated balance sheet as of December 31, 2019 and 2018 included the following balances related to

transactions with Hillhouse:

Investments in funds managed by AnglePoint, held by Enhanzed Re

Our ownership of equity method investments

Our share of Enhanzed Re's funds managed by AnglePoint

Investment in other funds managed by Hillhouse:

InRe Fund

Other funds

2019

2018

$

$

$

$

327,799

47.4%

155,377

918,633

232,968

1,151,601

$

$

$

$

75,192

47.4%

35,641

678,420

166,646

845,066

On January 1, 2020 Enhanzed Re invested an additional $54.0 million into funds managed by Hillhouse.

The increase in the investment in funds managed by Hillhouse was primarily due to unrealized gains for the year
ended December 31, 2019. We incurred fees of approximately $89.0 million, included within the funds' reported NAV,
for the year ended December 31, 2019 in relation to the direct investment in funds managed by Hillhouse as described
above.

Monument

Monument Insurance Group Limited ("Monument") was established in October 2016 and Enstar has invested a
total of $26.6 million in the common and preferred shares of Monument. We have approximately a 26.6% interest in
Monument. In connection with our investment in Monument, we entered into a Shareholders Agreement with the other
shareholders. We recorded the investment in Monument using the equity method basis of accounting, as we concluded
that we are not required to consolidate based on the guidance in ASC 810 - Consolidation. 

On August 29, 2017, we sold our wholly-owned subsidiary, Laguna, to a subsidiary of Monument for a total
consideration of €25.6 million (approximately $30.8 million). The total loss recorded on the sale of Laguna, for the year
ended December 31, 2017 was $16.3 million, which has been included in earnings from continuing operations before
taxes in our consolidated statement of earnings. This loss includes a cumulative currency translation adjustment balance
of $6.3 million, which has been reclassified from accumulated other comprehensive income and included in earnings
as a component of the loss on sale of Laguna during the year ended December 31, 2017, following the closing of the
sale.

On May 31, 2019, we completed the transfer of our remaining life assurance policies written by our wholly-owned
subsidiary Alpha Insurance SA to a subsidiary of Monument. In this transaction, we transferred policy benefits for life
and annuity contracts with a carrying value of €88.8 million (or approximately $99.1 million) and total assets with a fair
value of €91.1 million (or approximately $101.6 million) to a subsidiary of Monument.

Our investment in the common and preferred shares of Monument, carried in equity method investments on our

consolidated balance sheet, as of December 31, 2019 and 2018 was as follows: 

Investment in Monument

2019

2018

$

60,598 $

42,193

Clear Spring (formerly SeaBright)

Effective January 1, 2017, we sold SeaBright Insurance Company (“SeaBright Insurance”) and its licenses to
Delaware Life Insurance Company ("Delaware Life"), a subsidiary of Guggenheim Partners, LLC. Following the sale,
SeaBright Insurance was renamed Clear Spring Property and Casualty Company (“Clear Spring”). Clear Spring was
subsequently capitalized with $56.0 million of equity, with Enstar retaining a 20% indirect equity interest in Clear Spring.
We have accounted for our equity interest in Clear Spring as an equity method investment as we have significant
influence over its operating and financial policies.

250

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

We have recorded the investment in Clear Spring using the equity method basis of accounting, pursuant to the
conclusion  that  we  are  not  required  to  consolidate  following  an  analysis  based  on  the  guidance  in  ASC  810  -
Consolidation. Our investment in the common shares of Clear Spring, carried in equity method investments on our
consolidated balance sheet, as of December 31, 2019 and 2018 was as follows: 

Investment in Clear Spring

2019

2018

$

10,645 $

10,070

Effective January 1, 2017, StarStone National Insurance Company (“StarStone National”) entered into a ceding
quota share treaty with Clear Spring pursuant to which Clear Spring reinsures 33.3% of core workers' compensation
business written by StarStone National. This agreement was terminated as of December 31, 2018.

Effective January 1, 2017, we also entered into an assuming quota share treaty with Clear Spring pursuant to
which  an  Enstar  subsidiary  reinsures  25%  of  all  workers'  compensation  business  written  by  Clear  Spring. This  is
recorded as other activities.

Our consolidated balance sheet as of December 31, 2019 and 2018 included the following balances between

us and Clear Spring:

Balances under StarStone ceding quota share:

Reinsurance balances recoverable on paid and unpaid losses

$

Prepaid insurance premiums

Ceded payable

Ceded acquisition costs

Balances under assuming quota share:

Losses and LAE

Unearned reinsurance premiums

Funds held

2019

2018

22,812 $
51

3,616

21

6,135

13

8,611

23,718

13,821

14,153

3,233

5,778

3,455

10,242

Our consolidated statement of earnings for the years ended December 31, 2019 and 2018 included the following

amounts between us and Clear Spring:

2019

2018

2017

Amounts under StarStone ceding quota share:

Ceded premium earned

Net incurred losses and LAE

Acquisition costs

$

(14,994) $
6,567

356

Amounts under assuming quota share:

Premium earned

Net incurred losses and LAE

Acquisition costs

3,749
(2,202)
(92)

(29,520)
18,143

7,035

7,380
(4,536)
(1,836)

(14,256)
9,533

6,718

3,564
(1,181)
(1,753)

Total net earnings (loss)

$

(6,616) $

(3,334) $

2,625

251

Table of Contents

AmTrust

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

In  November  2018,  pursuant  to  a  Subscription  Agreement  with  Evergreen  Parent  L.P.  ("Evergreen"),  K-Z
Evergreen, LLC and Trident Pine Acquisition LP ("Trident Pine"), we purchased equity in Evergreen in the aggregate
amount of $200.0 million. Evergreen is an entity formed by private equity funds managed by Stone Point and the
Karfunkel-Zyskind family that acquired the approximately 45% of the issued and outstanding shares of common stock
of AmTrust that the Karfunkel-Zyskind Family and certain of its affiliates and related parties did not already own or
control. The equity interest was in the form of three separate classes of equity securities issued at the same price and
in the same proportion as the equity interest purchased by Trident Pine. In a second transaction in December 2019,
Enstar acquired an additional $25.9 million of Evergreen securities from another investor.

Following  the  closing  of  the  second  transaction,  Enstar  owns  approximately  8.5%  of  the  equity  interest  in
Evergreen and Trident Pine owns approximately 21.8%. Evergreen owns all of the equity interest in AmTrust. In addition,
upon the successful closing of the transaction we received a fee of $3.3 million, half of which was payable upon closing
and the other on the first anniversary of the closing. The fee has been recorded in full in other income within our
consolidated statements of earnings for the year ended December 31, 2018. 

Our indirect investment in the shares of AmTrust, carried in equities on our consolidated balance sheet, as of

December 31, 2019 was as follows: 

Investment in AmTrust

2019

2018

$

240,115 $

200,000

During the years ended December 31, 2019 and 2018 we recorded net investment income of $7.7 million and
$0.3 million, respectively, and net realized and unrealized gains of $10.1 million and $nil, respectively, related to our
indirect equity investment in AmTrust.

Citco

In June 2018, we made a $50.0 million indirect investment in the shares of Citco III Limited ("Citco"), a fund
administrator with global operations. Pursuant to an investment agreement and in consideration for participation therein,
a related party of Hillhouse provided us with investment support. In a private transaction that preceded our co-investment
opportunity, certain Citco shareholders, including Trident, agreed to sell all or a portion of their interests in Citco. As of
December 31, 2019, Trident owned an approximate 3.4% interest in Citco. Mr. Carey currently serves as an observer
to the board of directors of Citco in connection with Trident's investment therein.

Our indirect investment in the shares of Citco, carried in equity method investments on our consolidated balance

sheet, as of December 31, 2019 and 2018 was as follows: 

Investment in Citco

Enhanzed Re

2019

2018

$

51,742 $

50,812

Enhanzed Reinsurance Ltd. ("Enhanzed Re") is a joint venture between Enstar, Allianz SE and Hillhouse that
was capitalized in December 2018. Enhanzed Re is a Bermuda-based Class 4 and Class E reinsurer of life, non-life
run-off, and property and casualty insurance business, initially sourced from Allianz SE and Enstar. Enstar, Allianz and
Hillhouse affiliates have made equity investment commitments in aggregate of $470.0 million to Enhanzed Re. Enstar
owns 47.4% of the entity, Allianz owns 24.9%, and an affiliate of Hillhouse owns 27.7%. As of December 31, 2019,
Enstar contributed $154.1 million of its total capital commitment to Enhanzed Re and had an uncalled amount of $68.7
million.  We  have  accounted  for  our  equity  interest  in  Enhanzed  Re  as  an  equity  method  investment  as  we  have
significant influence over its operating and financial policies.

Enstar acts as the (re)insurance manager for Enhanzed Re, for which it receives fee income recorded within
other  income,  Hillhouse  acts  as  primary  investment  manager,  and  an  affiliate  of  Allianz  SE  provides  investment
management services. Enhanzed Re intends to write business from affiliates of its operating sponsors, Allianz SE and
Enstar. It will seek to underwrite business to maximize diversification by risk and geography.

252

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Our investment in the common shares of Enhanzed Re, carried in equity method investments on our consolidated

balance sheet, as of December 31, 2019 was as follows: 

Investment in Enhanzed Re

2019

2018

$

182,856 $

94,800

We have ceded 10% of the Zurich transaction, as discussed in Note 4 - "Significant New Business", to Enhanzed

Re on the same terms and conditions as those received by Enstar. 

Our consolidated balance sheet as of December 31, 2019 and 2018 included the following balances between

us and Enhanzed Re:

Balances under ceding quota share:

Insurance balances payables

Reinsurance balances recoverable

Funds held

Other assets

$

2019

1,443

59,601

50,089

1,033

Our consolidated statement of earnings for the years ended December 31, 2019 and 2018 included the following

amounts between us and Enhanzed Re:

Amounts under ceding quota share:

Acquisition costs

Other income

Total net earnings (loss)

2019

73

749

822

$

$

253

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

22. DIVIDEND RESTRICTIONS AND STATUTORY FINANCIAL INFORMATION 

Parent Company Dividend Restrictions

There were no significant restrictions on the Parent Company's ability to pay dividends from retained earnings
as of December 31, 2019. Bermuda law permits the payment of dividends if (i) we are not, or would not be after payment,
unable to pay our liabilities as they become due and (ii) the realizable value of our assets is in excess of our liabilities
after taking such payment into account. We have not historically declared a dividend on our ordinary shares. The
issuance of our Series D and E Preferred Shares have resulted in the declaration of dividends. Holders of Series D
and Series E Preferred Shares are entitled to receive, only when, as and if declared, non-cumulative cash dividends,
paid quarterly in arrears on the 1st day of March, June, September and December of each year of 7.0% per annum.
Refer to Note 17 - "Share Capital" for details regarding dividends on preferred shares.

The  Bermuda  Monetary Authority  ("BMA")  acts  as  group  supervisor  to  Enstar.    On  an  annual  basis,  we  are
required to file group statutory financial statements, a group statutory financial return, a group capital and solvency
return, audited group financial statements and a Group Solvency Self-Assessment ("GSSA") with the BMA.  The GSSA
is designed to document our perspective on the capital resources necessary to achieve our business strategies and
remain  solvent,  and  to  provide  the  BMA  with  insights  on  our  risk  management,  governance  procedures  and
documentation related to this process. We are required to maintain available group statutory capital and surplus in an
amount that is at least equal to the group enhanced capital requirement ("Group ECR"). The BMA has also established
a group target capital level equal to 120% of the Group ECR. We are in compliance with these requirements.

Our ability to pay dividends to our shareholders is dependent upon the ability of our insurance and reinsurance
subsidiaries to distribute capital and pay dividends to us. Our insurance and reinsurance subsidiaries are subject to
certain regulatory restrictions on the distribution of capital and payment of dividends in the jurisdictions in which they
operate, as described below. The restrictions are generally based on net income or levels of capital and surplus as
determined in accordance with the relevant statutory accounting practices. Failure of these subsidiaries to meet their
applicable regulatory requirements could result in restrictions on any distributions of capital or retained earnings or
stricter regulatory oversight of the subsidiaries.

Our ability to pay dividends and make other forms of distributions may also be limited by repayment obligations

and financial covenants in our outstanding loan facility agreements.

Subsidiary Statutory Financial Information and Dividend Restrictions

Our  insurance  and  reinsurance  subsidiaries  prepare  their  statutory  financial  statements  in  accordance  with
statutory accounting practices prescribed or permitted by local regulators. Statutory accounting differs from U.S. GAAP,
including in the treatment of investments, acquisition costs and deferred income taxes, amongst other items.  

The statutory capital and surplus amounts for the years ended December 31, 2019 and 2018 and statutory net
income amounts for the years ended December 31, 2019, 2018 and 2017 for our insurance and reinsurance subsidiaries
based in Bermuda, the United Kingdom, Australia, the United States and Continental Europe are summarized in the
table below which includes information relating to acquisitions from the year of acquisition:

Statutory Capital and Surplus

Required

Actual

Statutory Income

Bermuda
U.K.
U.S.
Europe
Australia

2019

2018

2018

2019
$ 2,138,395 $ 1,591,991 $ 4,016,663 $ 3,701,825 $ 643,683 $
1,532,751
861,379
229,344
37,815

715,448
660,470
431,863
26,882

154,644
121,406
11,816
4,847

654,721
392,394
239,582
22,535

837,104
364,507
94,334
18,110

2019

2018

2017

29,486 $ 390,752
77,900
(52,936)
(5,065)
(75,005)
(4,245)
(17,611)
(874)
1,761

As of December 31, 2019, the total amount of net assets of our consolidated subsidiaries that were restricted

was $3.5 billion. 

Certain material aspects of these laws and regulations as they relate to solvency, dividends and capital and

surplus are summarized below.

254

Table of Contents

Bermuda

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Our Bermuda-based insurance and reinsurance subsidiaries are registered under the Insurance Act 1978 of
Bermuda and related regulations, as amended (the "Insurance Act"). The Insurance Act imposes certain solvency and
liquidity  standards  and  auditing  and  reporting  requirements  and  grants  the  BMA  powers  to  supervise,  investigate,
require information and the production of documents and intervene in the affairs of insurance companies.

The Insurance Act requires that our Bermuda-based insurance and reinsurance subsidiaries maintain certain
solvency and liquidity standards. The minimum liquidity ratio requires that the value of relevant assets not be less than
75% of the amount of relevant liabilities. The minimum solvency margin, which varies depending on the class of the
insurer, is determined as a percentage of either net reserves for losses and LAE or premiums or pursuant to a risk-
based  capital  measure.  Our  Bermuda  subsidiaries  with  commercial  insurance  licenses  are  required  to  maintain  a
minimum statutory capital and surplus (Enhanced Capital Requirement or "ECR") at least equal to the greater of a
minimum solvency margin or the Bermuda Solvency Capital Requirement ("BSCR"). The BSCR is calculated based
on a standardized risk-based capital model. 

Each of our regulated Bermuda subsidiaries would be prohibited from declaring or paying any dividends if it were
in breach of its minimum solvency margin or liquidity ratio or if the declaration or payment of such dividends would
cause it to fail to meet such margin or ratio. In addition, each of our regulated Bermuda subsidiaries is prohibited,
without the prior approval of the BMA, from reducing by 15% or more its total statutory capital, or from reducing by
25% of more its total statutory capital and surplus, as set out in its previous year’s statutory financial statements. Our
Bermuda insurance companies that are in run-off are required to seek BMA approval for any dividends or distributions.

As  of  December 31,  2019  and  2018,  each  of  our  Bermuda-based  insurance  and  reinsurance  subsidiaries
exceeded their respective minimum solvency and liquidity requirements. The Bermuda insurance and reinsurance
subsidiaries in aggregate exceeded minimum solvency requirements by $1.9 billion as of December 31, 2019 (2018:
$2.1 billion) and were in compliance with their liquidity requirements.

United Kingdom

U.K. Insurance Companies (non-Lloyd's)

Our U.K. based insurance subsidiaries are regulated by the U.K. Prudential Regulatory Authority (the "PRA")

and the Financial Conduct Authority (the "FCA", together with the PRA, the "U.K. Regulator").

Our U.K.-based insurance subsidiaries are required to maintain adequate financial resources in accordance with
the requirements of the U.K. Regulator. Insurers must comply with a Solvency Capital Requirement ("SCR"), which is
calculated using either the Solvency II standard formula or a bespoke internal model. Our non-Lloyd's U.K. companies
use the standard formula.

The calculation of the minimum capital resources requirements in any particular case depends on, among other
things,  the  type  and  amount  of  insurance  business  written  and  claims  paid  by  the  insurance  company.  As  of
December 31, 2019 and 2018, all of our U.K. insurance subsidiaries maintained capital in excess of the minimum
capital resources requirements and complied with the relevant U.K. Regulator requirements. The U.K.-based insurance
subsidiaries, in aggregate, maintained capital in excess of the minimum capital resources requirements by $695.6
million and $60.7 million as of December 31, 2019 and 2018, respectively.

The U.K. Regulator’s rules require our U.K. insurance subsidiaries to obtain regulatory approval for any proposed
or actual payment of a dividend. The U.K. Regulator uses the SCR, among other tests, when assessing requests to
make distributions.

Lloyd’s

As of December 31, 2019, we participated in the Lloyd’s market through our interests in: (i) Atrium’s Syndicate
609, which is managed by Atrium Underwriters Limited, a Lloyd's managing agent, and the Atrium corporate member;
(ii) StarStone’s Syndicate 1301, which is managed by StarStone Underwriting Limited ("SUL"), a Lloyd’s managing
agent, and the StarStone corporate member; and (iii) Syndicate 2008, a wholly aligned syndicate that has permission
to underwrite RITC business and other run-off or discontinued business type transactions with other Lloyd’s syndicates,
and its corporate member.  During 2015, SUL assumed the role of managing agent for Syndicate 2008 in place of
Shelbourne Syndicate Services Limited as we streamlined our organizational structure and combined Shelbourne and

255

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

StarStone resources into one agency. For the 2019 underwriting year, participation in all three syndicates has been
through a common corporate member.

The underwriting capacity of a member of Lloyd’s is supported by providing Funds at Lloyd’s, as described in
Note  6  -  "Investments".  Business  plans,  including  maximum  underwriting  capacity,  for  Lloyd’s  syndicates  requires
annual approval by the Lloyd’s Franchise Board, which may require changes to any business plan or additional capital
to support underwriting plans.

The  Lloyd’s  market  has  applied  the  Solvency  II  internal  model  under  Lloyd’s  supervision,  and  our  Lloyd’s
operations are required to meet Solvency II standards. Lloyd's has the approval of the PRA to use its internal model
under the Solvency II regime.

United States

Our  U.S.  non-life  run-off  and  active  underwriting  insurance  and  reinsurance  subsidiaries  are  subject  to  the
insurance laws and regulations of the states in which they are domiciled, licensed and/or eligible to conduct business.
These laws restrict the amount of dividends the subsidiaries can pay to us. The restrictions are generally based on
statutory net income and/or certain levels of statutory surplus as determined in accordance with the relevant statutory
accounting requirements of the individual domiciliary states or states in which any of the insurance or reinsurance
subsidiaries are domiciled. Generally, prior regulatory approval must be obtained before an insurer may pay a dividend
or make a distribution above a specified level.

The U.S. insurance and reinsurance subsidiaries are also required to maintain minimum levels of solvency and
liquidity as determined by law, and to comply with Risk-Based Capital ("RBC") requirements and licensing rules as
specified by the National Association of Insurance Commissioners ("NAIC"). RBC is used to evaluate the adequacy
of capital and surplus maintained by our life company in relation to risks associated with: (i) asset risk; (ii) insurance
risk; (iii) interest rate risk and (iv) business risk. For all of our U.S. insurance and reinsurance subsidiaries, with the
exception  of  one  subsidiary  which  has  a  permitted  accounting  practice  to  treat  an  adverse  development  cover
reinsurance agreement as prospective reinsurance, there are no prescribed or permitted statutory accounting practices
that differ significantly from the statutory accounting principles established by NAIC.

As of December 31, 2019, all of our U.S. non-life insurance and reinsurance subsidiaries exceeded their required
levels of risk-based capital. On an aggregate basis, our U.S. non-life insurance and reinsurance subsidiaries exceeded
their minimum levels of risk-based capital as of December 31, 2019 by $488.3 million (December 31, 2018: $359.6
million).

Europe

Our Liechtenstein insurance subsidiary (StarStone Insurance SE) is regulated by the Liechtenstein Financial
Market Authority  ("FMA")  pursuant  to  the  Liechtenstein  Insurance  Supervisory Act. This  subsidiary  is  obligated  to
maintain a minimum solvency margin based on the Solvency II regulations. As of December 31, 2019, this subsidiary
exceeded the Solvency II requirements by $119.0 million (2018: $133.9 million). The amount of dividends that this
subsidiary is permitted to distribute is restricted to freely distributable reserves, which consist of retained earnings, the
current year profit and legal reserves. Any dividend exceeding the current year profit requires the FMA’s approval.
Solvency and capital requirements for this subsidiary are based on the Solvency II framework and must continue to
be met following any distribution.

Our Belgian insurance subsidiary files financial statements and returns with the National Bank of Belgium. This

subsidiary was in compliance with its solvency and capital requirements under Solvency II.

Harper  Insurance  Limited,  which  was  previously  regulated  in  Switzerland,  was  re-domiciled  to  Bermuda  on
January 1, 2019. It is now required to file regulatory returns in both Bermuda and for its branch in the UK. The UK
requirements are more constrictive then those in Bermuda thus these have been included in the "United Kingdom"
section above.

Australia

The  Company’s  Australian  insurance  subsidiary  is  regulated  and  subject  to  prudential  supervision  by  the
Australian Prudential Regulation Authority (“APRA”). APRA is the primary regulatory body responsible for regulating
compliance  with  the  Insurance Act  1973. APRA’s  prudential  standards  require  that  all  insurers  maintain  and  meet

256

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

prescribed  capital  adequacy  requirements  to  enable  their  insurance  obligations  to  be  met  under  a  wide  range  of
circumstances.

A run-off insurer must obtain APRA’s written consent prior to making any capital releases, including any payment
of dividends, not from current year profits. The Company’s insurance subsidiary must provide APRA a valuation prepared
by its Appointed Actuary that demonstrates that the tangible assets of the insurer, after the proposed capital reduction,
are sufficient to cover its insurance liabilities. 

257

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

 23. COMMITMENTS AND CONTINGENCIES  

Concentration of Credit Risk 

We believe that there are no significant concentrations of credit risk associated with our cash and cash equivalents,
fixed maturity investments, or other investments. Cash, cash equivalents and fixed maturity investments are managed
pursuant to guidelines that follow prudent standards of diversification and limit the allowable holdings of a single issue
and  issuers.  Other  investments  are  managed  pursuant  to  guidelines  that  emphasize  diversification  and  liquidity.
Pursuant to these guidelines, we manage and monitor risk across a variety of investment funds and vehicles, markets
and counterparties. We are also subject to custodial credit risk on our investments, which we manage by diversifying
our holdings amongst large financial institutions that are highly regulated.

We have exposure to credit risk on certain of our assets pledged to ceding companies under insurance contracts.
In  addition,  we  are  potentially  exposed  should  any  insurance  intermediaries  be  unable  to  fulfill  their  contractual
obligations with respect to payments of balances owed to and by us.

Credit risk exists in relation to our insurance and reinsurance balances recoverable on paid and unpaid losses.
We remain liable to the extent that counterparties do not meet their contractual obligations and, therefore, we evaluate
and monitor concentration of credit risk among our insurers and reinsurers. Amounts recoverable from reinsurers are
described Note 8 - "Reinsurance Balances Recoverable on Paid and Unpaid Losses".

We are also subject to credit risk in relation to funds held by reinsured companies. Under funds held arrangements,
the reinsured company has retained funds that would otherwise have been remitted to our reinsurance subsidiaries.
The funds may be placed into trust or subject to other security arrangements.  The funds balance is credited with
investment income and losses payable are deducted. We are subject to credit risk if the reinsured company is unable
to honor the value of the funds held balances, such as in the event of insolvency. However, we generally have the
contractual ability to offset any shortfall in the payment of the funds held balances with amounts owed by us to the
reinsured  for  losses  payable  and  other  amounts  contractually  due.  We  routinely  monitor  the  creditworthiness  of
reinsured companies with whom we have funds held arrangements. We have a significant funds held concentration
of $1.0 billion to one reinsured company which has financial strength credit ratings of A+ from A.M. Best and AA from
S&P.

We limit the amount of credit exposure to any one counterparty and none of our counterparty credit exposures,
excluding U.S. Government instruments and the counterparty noted above, exceeded 10% of shareholders’ equity as
of December 31, 2019. Our credit exposure to the U.S. government was $1,082.2 million as of December 31, 2019.

Legal Proceedings

We are, from time to time, involved in various legal proceedings in the ordinary course of business, including
litigation and arbitration regarding claims. Estimated losses relating to claims arising in the ordinary course of business,
including the anticipated outcome of any pending arbitration or litigation are included in the liability for losses and LAE
in our consolidated balance sheets. In addition to claims litigation, we may be subject to other lawsuits and regulatory
actions in the normal course of business, which may involve, among other things, allegations of underwriting errors or
omissions, employment claims or regulatory activity. We do not believe that the resolution of any currently pending
legal proceedings, either individually or taken as a whole, will have a material effect on our business, results of operations
or financial condition. We anticipate that, similar to the rest of the insurance and reinsurance industry, we will continue
to be subject to litigation and arbitration proceedings in the ordinary course of business, including litigation generally
related to the scope of coverage with respect to asbestos and environmental and other claims.

Unfunded Investment Commitments

As of December 31, 2019, we had unfunded commitments of $482.3 million and $93.1 million to private equity

funds and equity method investments, respectively.

Guarantees

As  of  December 31,  2019  and  2018,  parental  guarantees  and  capital  instruments  supporting  subsidiaries'
insurance obligations were $1,031.5 million and $614.5 million, respectively. We also have a FAL facility, which on
February 12, 2019, we increased to issue an aggregate amount of $375.0 million of letters of credit, and we maintained
the provision to further increase the facility up to $400.0 million. The FAL Facility is available to satisfy our Funds at

258

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Lloyd’s requirements and expires in 2023. As of December 31, 2019 there were $252.0 million letters of credit issued
under this facility which have a parental guarantee. 

Significant New Business

We have entered into transaction agreements that are expected to become effective subsequent to December 31,

2019. Refer to Note 4 - "Significant New Business" above.

Redeemable Noncontrolling Interest

We have the right to purchase the RNCI interests from the RNCI holders at certain times in the future (each such
right, a "call right") and the RNCI holders have the right to sell their RNCI interests to us at certain times in the future
(each such right, a "put right"). The RNCI rights held by Trident are described in Note 21 - "Related Party Transactions".
Dowling has a right to participate if Trident exercises its put right.

Leases

2019 Disclosures under ASC 842 - Leases

We adopted the new leasing standard and the related amendments on January 1, 2019 using the modified
retrospective transition method as required by the standard, and based on the detailed analysis of our operating lease
arrangements we have recognized a right-of-use asset and an offsetting lease liability on our consolidated balance
sheet, relating primarily to office space and facilities that we have leased to conduct our business operations. On an
ongoing basis we determine whether an arrangement is a lease or contains a lease at inception and also complete an
assessment to determine the classification of each lease as either a finance lease or an operating lease. Our leases
are all currently classified as operating leases.

Our leases have remaining lease terms of one year to 37 years, some of which include options to extend the
lease term for up to five years and some of which include options to terminate the lease within one year. We consider
these options in determining the lease term used to establish our right-of-use assets and lease liabilities. Only those
renewal options that we believe we are reasonably certain to exercise are taken into account when determining lease
terms. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.

Since a majority of our leases do not provide an implicit discount rate, we use our collateralized incremental
borrowing rate based on the information available at the commencement date of the lease in determining the present
value of lease payments. The starting point for determining a collateralized incremental borrowing rate is our general
unsecured borrowing rate, given the term of the lease and the amount of the related lease payments. This base rate
is then adjusted to reflect the effect of collateral. Since adding collateral improves a lender’s level of security in a lending
arrangement, it has the impact of lowering our implied borrowing rate that we use to determine the present value of
lease payments.

We also adopt a portfolio approach as permitted by ASC 842 whereby we use attributes such as the lease term
to determine the appropriate incremental borrowing rate to be used to determine the present value of lease payments.
In this regard, we use the same incremental borrowing rate for leases with a similar term while ensuring that the use
of this portfolio approach does not result in an outcome that would materially differ from applying the lease accounting
guidance on a lease-by-lease basis.

We  have  lease  agreements  that  contain  both  lease  and  non-lease  components.  For  real  estate  leases,  we
account for lease components together with non-lease components such as common-area maintenance costs as a
single lease component.

As part of our adoption of the new leasing standard, we elected the practical expedient package as well as the
hindsight practical expedient permitted by the FASB in ASC 842. The practical expedient package covers the application
of the new leasing standard to leases that commenced before January 1, 2019, the effective date of the standard and
gives an entity the option of not reassessing, (1) whether any expired or existing contracts are or contain leases, (2)
the lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases. The hindsight
practical expedient permits an entity to consider changes in facts and circumstances from commencement through to
the effective date of the new standard when determining the lease term and assessing any potential impairment of the
recorded right-of-use asset. All these practical expedients were consistently applied to our leases as required by the
leasing standard.

259

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

The table below provides a summary of the components of our lease cost including the gross sublease income
received under sublease arrangements related to certain office spaces that we have leased to conduct our business
operations for the year ended December 31, 2019:

Operating lease cost

Sublease income

Total lease cost

2019

13,627

(542)

13,085

$

$

The table below provides a summary of the cash flow information and non-cash activity related to our operating

leases for the year ended December 31, 2019:

Operating cash flow information:

2019

Cash paid for amounts included in the measurement of lease liabilities

Non-cash activity:

Right-of-use assets obtained in exchange for lease obligations

$

$

11,129

57,536

The table below provides a summary of the leases recorded on our consolidated balance sheets for the year

ended December 31, 2019:

Balance sheet classification

2019

Right-of-use assets

Current lease liabilities

Non-current lease liabilities

Other assets

Other liabilities

Other liabilities

$

46,747

11,403

34,785

Weighted-average remaining lease term and discount rate used for our operating leases are as follows for the

year ended December 31, 2019:

Weighted-average remaining lease term

Weighted-average discount rate

2019

6.3 years
6.3%

The  table  below  provides  a  summary  of  the  maturity  of  the  operating  lease  liabilities  for  the  year  ended

December 31, 2019:

2020

2021

2022

2023

2024

2025 and beyond

Total lease payments

Less: Imputed interest

Present value of lease liabilities

2019

13,663

9,854

8,103

7,044

5,358

13,119

57,141
(10,953)
46,188

$

$

260

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

2018 Comparative Disclosures under ASC 840 - Leases

As discussed in Note 2 - Significant Accounting Policies, on adoption of ASU 2016-02 as codified in ASC 842
on January 1, 2019, we elected the transition option in ASU 2018-11 which amended ASU 2016-02 to allow entities
not to apply the new leases standard in the comparative periods presented in the financial statements in the year of
adoption. Under the transition option, entities can instead opt to continue to apply the legacy guidance in ASC 840 -
Leases, including its disclosure requirements, in the comparative periods presented in the year they adopt the new
leases standard.

Pursuant to the transition option provided in ASU 2018-11 which we elected on adoption of ASU 2016-02 on
January 1, 2019 as discussed above, the following is a schedule of future minimum rental payments that were required
under operating leases that had initial or remaining non-cancelable lease terms in excess of one year as of December
31, 2018:

2019

2020

2021

2022

2023

2024 and beyond

$

$

9,510

10,754

9,772

7,500

6,592

21,276

65,404

Rent expense for the years ended December 31, 2018 and 2017 was $11.3 million and $9.5 million, respectively,

relating to office space and facilities that we leased to conduct our business operations.

261

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

24. SEGMENT INFORMATION 

We have three reportable segments of business that are each managed, operated and separately reported:
(i) Non-life Run-off; (ii) Atrium; and (iii) StarStone. Our other activities, which do not qualify as a reportable segment,
include our corporate expenses, debt servicing costs, holding company income and expenses, foreign exchange and
other miscellaneous items. These segments are described in Note 1 - "Description of Business".

The following tables set forth selected and consolidated statement of earnings results by segment for the years

ended December 31, 2019, 2018, 2017:

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Life and Annuity Policy Benefits

Acquisition costs

Operating expenses

Underwriting income (loss)

Net investment income

Net realized and unrealized gains

Fees and commission income

Other income

Corporate expenses

Interest income (expense)

Net foreign exchange gains (losses)

2019

Non-Life 
Run-Off

Atrium

StarStone

Other

Total

$

$

(25,069)

$ 192,373

$ 917,555

(25,338)

$ 172,356

$ 735,429

$ 168,496

$ 164,059

$ 801,926

$

$

$

18,534

$ 1,103,393

18,512

$ 900,959

20,380

$ 1,154,861

(51,625)

(77,276)

(727,636)

(16,038)

(872,575)

—

(73,642)

(199,756)

(156,527)

275,236

968,350

18,293

34,809

(70,689)

(62,055)

9,918

—

(56,956)

(14,452)

15,375

7,049

6,195

10,160

140

(13,825)

—

(504)

24,590

(4,033)

—

—

(174,711)

(120,629)

(221,050)

47,401

50,957

—

338

(7,790)

(475)

(1,538)

(91)

(642)

—

3,609

(8,410)

(91)

(305,951)

(334,837)

(358,593)

321,276

5,849

1,031,351

—

1,883

28,453

37,170

(45,945)

(138,249)

9,989

3

(52,541)

7,879

(132,157)

(33,022)

876,746

6,931

(218)

(85)

—

(4,437)

55,910

EARNINGS (LOSS) BEFORE INCOME TAXES

1,017,335

Income tax benefit (expense)

Earnings (losses) from equity method investments

(7,250)

56,128

NET EARNINGS (LOSS)

1,066,213

20,557

(125,444)

(33,107)

928,219

Net loss (earnings) attributable to noncontrolling
interest

NET EARNINGS (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED

Dividends on preferred shares

NET EARNINGS (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

(6,409)

(8,432)

24,711

—

9,870

1,059,804

12,125

(100,733)

—

—

—

(33,107)

(35,914)

938,089

(35,914)

$ 1,059,804

$

12,125

$ (100,733)

$

(69,021)

$ 902,175

Underwriting ratios:

Loss ratio 
Acquisition expense ratio
Operating expense ratio 
Combined ratio

47.1%

34.7%

8.8%

90.6%

90.7%

21.8%

15.1%

127.6%

262

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Life and annuity policy benefits

Acquisition costs

Operating expenses

Underwriting income (loss)

Net investment income

Net realized and unrealized losses

Fees and commission income

Other income (losses)

Corporate expenses

Interest income (expense)

Net foreign exchange gains (losses)

$

$

$

$

$

$

Non-Life 
Run-Off

(8,910)

(9,217)

9,427

306,067

—

(4,006)

(158,731)

152,757

226,287

(381,712)

16,466

35,978

(39,093)

(30,616)

2,534

EARNINGS (LOSS) BEFORE INCOME TAXES

(17,399)

Income tax benefit (expense)

Earnings from equity method investments

NET EARNINGS (LOSS)

Net loss (earnings) attributable to
noncontrolling interest

NET EARNINGS (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED

Dividends on preferred shares

NET EARNINGS (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

Underwriting ratios:

Loss ratio

Acquisition expense ratio

Operating expense ratio

Combined ratio

2018

Atrium

StarStone

Other

Total

171,494

$ 1,121,135

$

$

805,562

714,959

(673,383)

—

(135,452)

(156,726)

(250,602)

35,973

(17,672)

—

(541)

—

(624)

(2,856)

$

$

$

32,378

$ 1,316,097

32,067

24,874

(16,899)

(1,003)

(2,686)

—

4,286

2,725

$

$

981,900

895,575

(454,025)

(1,003)

(192,790)

(333,234)

(85,477)

270,671

(10,249)

(412,884)

—

(514)

(28,127)

5,023

1,048

35,088

35,085

(74,141)

(26,217)

(2,668)

153,488

146,315

(69,810)

—

(50,646)

(17,777)

8,082

5,686

(3,251)

18,622

162

(6,921)

—

(3,394)

18,986

(3,732)

—

3,581

42,147

28,329

(236,322)

(25,808)

(260,543)

6,327

—

(52)

—

6,124

42,147

15,254

(229,995)

(25,860)

(212,272)

(3,107)

(6,257)

71,415

—

62,051

25,222

—

8,997

—

(158,580)

—

(25,860)

(12,133)

(150,221)

(12,133)

$

25,222

$

8,997

$ (158,580)

$

(37,993)

$ (162,354)

47.7%

34.6%

12.2%

94.5%

94.2%

18.9%

22.0%

135.1%

263

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Gross premiums written

Net premiums written

Net premiums earned

Net incurred losses and LAE

Life and annuity policy benefits

Acquisition costs

Operating expenses

Underwriting income (loss)

Net investment income

Net realized and unrealized gains (losses)

Fees and commission income (expense)

Other income

Corporate expenses

Interest income (expense)

Net foreign exchange gains

Loss on sale of subsidiary

Income tax benefit (expense)

Earnings from equity method investments

NET EARNINGS (LOSS) FROM CONTINUING
OPERATIONS

Net earnings from discontinued operations, net
of income taxes

NET EARNINGS (LOSS)

Net earnings attributable to noncontrolling
interest

NET EARNINGS (LOSS) ATTRIBUTABLE TO
ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

Underwriting ratios:

Loss ratio

Acquisition expense ratio
Operating expense ratio 
Combined ratio

EARNINGS (LOSS) BEFORE INCOME TAXES

345,593

$

$

$

Non-Life 
Run-Off

14,102

6,482

14,162

190,674

—

(328)

(132,235)

72,273

166,678

179,545

43,849

21,157

(28,970)

(7,347)

—

6,990

5,904

358,487

—

358,487

2017

Atrium

StarStone

Other

Total

$

$

$

$

$

$

153,472

134,214

134,747

(69,419)

—

(47,688)

(17,444)

196

4,218

1,117

22,788

230

(559)

(5,060)

—

10,788

(1,593)

—

9,195

—

9,195

$

$

$

895,160

464,901

459,403

(314,806)

—

(48,012)

(135,558)

(38,973)

27,706

16,613

632

570

—

(1,902)

(926)

—

3,720

988

—

5,719

$ 1,068,453

4,793

4,809

—

(4,015)

(878)

—

(84)

10,187

(6,941)

(1,166)

648

$

$

610,390

613,121

(193,551)

(4,015)

(96,906)

(285,237)

33,412

208,789

190,334

66,103

22,605

(37,014)

(150,748)

3,329

(4,204)

(16,349)

(51,594)

10

—

(28,102)

(17,537)

(16,349)

308,507

6,395

5,904

4,708

(51,584)

320,806

—

4,708

10,993

(40,591)

10,993

331,799

(101,592)

(12,142)

(14,687)

(3,772)

(1,882)

—

(20,341)

$

343,800

$

5,423

$

2,826

$

(40,591)

$

311,458

51.5%

35.4%

13.0%

99.9%

68.5%

10.5%

29.5%

108.5%

264

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

Gross Premiums Written by Geographical Area

The following table summarizes our gross premiums written for the year ended December 31, 2019 by geographic
area.  Geographic  distribution  in  future  years  is  subject  to  variation  based  upon  market  conditions  and  business
strategies. 

Non-life Run-off

Atrium

StarStone

Other

Total

Total

%

Total

%

Total

%

Total

%

Total

%

(In thousands of U.S. dollars, except percentages)

United States

United Kingdom

Europe

Asia

Rest of World

Total

$ (25,012)

99.7 % $102,199

53.1% $ 548,683

59.8% $ 17,239

93.0% $ 643,109

350

(265)

(48)

(94)

(1.4)%

12,972

1.1 %

0.2 %

0.4 %

17,677

5,700

53,825

6.7%

9.2%

3.0%

28.0%

114,822

115,481

75,773

62,796

12.5%

12.6%

8.3%

6.8%

—

1,295

—

—

—%

7.0%

—%

—%

128,144

134,188

81,425

116,527

58.2%

11.6%

12.2%

7.4%

10.6%

$ (25,069)

100.0 % $192,373

100.0% $ 917,555

100.0% $ 18,534

100.0% $1,103,393

100.0%

Assets by Segment

Invested assets are managed on a subsidiary by subsidiary basis, and investment income and realized and
unrealized gains on investments are recognized in each segment as earned. Our total assets as of December 31, 2019
and 2018 by segment were as follows:

Assets by Segment:
Non-life Run-off

Atrium

StarStone

Other

Total assets

2019

2018

$ 15,775,409 $ 13,362,749
591,722

580,405

3,522,353
(514,852)

3,416,132
(814,333)
$ 19,363,315 $ 16,556,270

265

Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

ENSTAR GROUP LIMITED

25. UNAUDITED CONDENSED QUARTERLY FINANCIAL DATA 

INCOME

Net premiums earned

Fees and commission income

Net investment income

December 31,

September 30,

June 30,

March 31,

2019

2018

2019

2018

2019

2018

2019

2018

$ 272,686

$ 231,947

$270,325

$264,597

$276,563

$228,812

$335,287

$ 170,219

9,007

79,376

11,455

68,453

6,587

6,950

6,178

8,352

6,681

8,331

85,472

69,430

77,732

66,469

78,696

66,319

Net realized and unrealized gains (losses)

152,664

(158,213)

148,185

(57,223)

269,711

(54,418)

460,791

(143,030)

Other income (losses)

19,502

34,267

826

8,226

11,030

(9,351)

5,812

1,943

533,235

187,909

511,395

291,980

641,214

239,864

887,267

103,782

EXPENSES

Net incurred losses and loss adjustment
expenses

Life and annuity policy benefits

Acquisition costs

121,416

187,698

222,417

153,974

216,338

92,819

312,404

19,534

(2,199)

95,026

786

—

423

2,194

(160)

96

(46)

55,106

50,282

54,242

66,855

53,334

93,788

30,108

95,260

8,011

5,868

General and administrative expenses

129,569

106,950

113,924

102,553

117,519

102,612

112,074

Interest expense

Net foreign exchange losses (gains)

13,519

12,189

4,644

1,279

14,950

(13,631)

4,640

1,040

13,036

8,922

11,036

(2,587)

(5,519)

(3,850)

369,520

356,463

387,942

316,872

413,355

252,008

525,548

158,735

EARNINGS (LOSS) BEFORE INCOME
TAXES

Income tax benefit (expense)

Earnings from equity method investments

163,715

(168,554)

123,453

(24,892)

227,859

(12,144)

361,719

(54,953)

22,427

11,722

10,688

(14,597)

(746)

(7,518)

(3,646)

(4,749)

(172)

8,488

17,703

3,317

17,713

15,645

8,772

14,697

NET EARNINGS (LOSS)

197,864

(149,378)

126,559

(22,321)

238,054

(145)

365,742

(40,428)

Net loss (earnings) attributable to
noncontrolling interest

NET EARNINGS (LOSS) ATTRIBUTABLE
TO ENSTAR GROUP LIMITED

4,900

42,955

109

11,489

2,713

8,389

2,148

(782)

202,764

(106,423)

126,668

(10,832)

240,767

8,244

367,890

(41,210)

Dividends on preferred shares

(8,925)

(7,000)

(8,925)

(5,133)

(8,925)

—

(9,139)

—

NET EARNINGS (LOSS) ATTRIBUTABLE
TO ENSTAR GROUP LIMITED ORDINARY
SHAREHOLDERS

Earnings Loss) per ordinary share
attributable to Enstar Group Limited:

$ 193,839

$ (113,423) $117,743

$ (15,965) $231,842

$ 8,244

$358,751

$ (41,210)

Basic
Diluted(1):

$

$

9.02

8.89

$

$

(5.29) $

(5.29) $

5.48

5.42

$

$

(0.74) $ 10.79

(0.74) $ 10.70

$

$

0.40

$ 16.71

0.40

$ 16.57

$

$

(2.12)

(2.12)

(1) During a period of loss, the basic weighted average ordinary shares outstanding is used in the denominator of the diluted loss per ordinary share

computation as the effect of including potentially dilutive securities would be anti-dilutive.

266

ENSTAR GROUP LIMITED

SUMMARY OF INVESTMENTS OTHER THAN INVESTMENTS IN RELATED PARTIES
As of December 31, 2019 
(Expressed in thousands of U.S. Dollars)

SCHEDULE I

Type of investment

Fixed maturity securities and short-term investments — Trading and fixed
maturity investments within funds held - directly managed:(2)

Cost (1)

Fair Value

Amount at which
shown in the
balance sheet

U.S. government and agency

$

319,554

$

325,731

$

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Total

Fixed maturity securities and short-term investments — Available-for-sale:(2)

U.S. government and agency

U.K. government

Other government

Corporate

Municipal

Residential mortgage-backed

Commercial mortgage-backed

Asset-backed

Total
Equities(3)
Other investments, at fair value(4)

Total

140,194

600,001

4,398,126

141,905

339,228

783,675

562,020

146,423

617,710

4,615,896

152,010

344,617

801,472

558,217

325,731

146,423

617,710

4,615,896

152,010

344,617

801,472

558,217

7,284,703

7,562,076

7,562,076

410,842

15,067

84,116

410,312

15,349

85,147

410,312

15,349

85,147

1,081,713

1,081,171

1,081,171

15,963

127,704

98,928

202,136

2,036,469

312,407

783,032

15,872

127,219

98,557

202,117

2,035,744

367,812

783,032

15,872

127,219

98,557

202,117

2,035,744

367,812

783,032

$

10,416,611

$

10,748,664

$

10,748,664

(1) Original cost of fixed maturity securities is reduced by repayments and adjusted for amortization of premiums or accretion of discounts. 

(2) The difference in the amount of fixed maturities shown at fair value and the fixed maturities shown in our consolidated balance sheet relates to
the fair value of $15.1 million as of December 31, 2019 for our investment in fixed maturities issued by affiliates of Stone Point. Refer to Note 21
- "Related Party Transactions" of the notes to the consolidated financial statements.

(3) The difference in the amount of equities shown at fair value and the equities shown in our consolidated balance sheet relates to the fair value of
$96.8 million as of December 31, 2019 for our investment in a registered investment company affiliated with entities owned by Trident, $25.0
million as a co-investor alongside Stone Point and a $240.1 million investment in AmTrust. Refer to Note 21 - "Related Party Transactions" of the
notes to the consolidated financial statements.

(4) The difference in the amount of other investments shown at fair value and the other investments shown in our consolidated balance sheet relates
to the fair value of $1,741.4 million as of December 31, 2019 for our other investments in funds or companies owned by or affiliated with certain
related parties. Refer to Note 21 - "Related Party Transactions" of the notes to the consolidated financial statements.

267

 
Table of Contents

ENSTAR GROUP LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT

Balance Sheets - Parent Company Only 
As of December 31, 2019 and 2018 

SCHEDULE II

ASSETS

Cash and cash equivalents

Balances due from subsidiaries

Investments in subsidiaries

Other assets

TOTAL ASSETS

LIABILITIES

Debt obligations

Balances due to subsidiaries

Other liabilities

TOTAL LIABILITIES

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS’ EQUITY

2019

2018

(in thousands of U.S.
dollars, except share data)

$

$

$

4,568

$

134,897

6,050,197

6,391

6,196,053

1,191,207

135,532

27,131

1,353,870

$

$

15,213

25,091

4,843,913

8,596

4,892,813

861,539

120,397

8,944

990,880

Ordinary shares (par value $1 each, issued and outstanding 2019: 21,511,505; 2018: 21,459,997):

Voting Ordinary Shares (issued and outstanding 2019: 18,001,823; 2018: 17,950,315)

18,002

17,950

Non-voting convertible ordinary Series C Shares (issued and outstanding 2019 and 2018:
2,599,672)

Non-voting convertible ordinary Series E Shares (issued and outstanding 2019 and 2018:
910,010)

Preferred Shares:

Series C Preferred Shares (issued and held in treasury 2019 and 2018: 388,571)

Series D Preferred Shares (issued and outstanding 2019 and 2018: 16,000)

Series E Preferred Shares (issued and outstanding 2019 and 2018: 4,400)

Treasury shares, at cost (Series C Preferred Shares 2019 and 2018: 388,571)

Additional paid-in capital

Accumulated other comprehensive income

Retained earnings

Total Enstar Group Limited Shareholders’ Equity

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

2,600

2,600

910

389

400,000

110,000

(421,559)

1,836,778

7,171

2,887,892

4,842,183

910

389

400,000

110,000

(421,559)

1,804,664

10,440

1,976,539

3,901,933

$

6,196,053

$

4,892,813

See accompanying notes to the Condensed Financial Information of Registrant

268

 
Table of Contents

ENSTAR GROUP LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT - CONTINUED

Statements of Earnings - Parent Company Only
For the Years Ended December 31, 2019, 2018 and 2017 

SCHEDULE II

2019

2018
(in thousands of U.S. dollars)

2017

INCOME

Net investment income

Other income

Dividend income from subsidiaries

EXPENSES

General and administrative expenses

Interest expense

Net foreign exchange losses (gains)

$

3,649 $
—

—

3,649

142 $
—

—

142

44,964

51,508
(21,516)
74,956

68,977

27,353

7,655

103,985

116,869

80

1,050

249,055

250,185

87,596

23,138

6,135

EARNINGS (LOSSES) BEFORE EQUITY IN UNDISTRIBUTED
EARNINGS OF SUBSIDIARIES

Equity in undistributed earnings (losses) of subsidiaries - continuing
operations

Equity in undistributed earnings (losses) of subsidiaries -
discontinued operations

NET EARNINGS

Dividends on preferred shares

(71,307)

(103,843)

133,316

1,009,396

(46,378)

167,149

—

938,089
(35,914)

—
(150,221)
(12,133)

10,993

311,458

—

NET EARNINGS (LOSS) ATTRIBUTABLE TO ENSTAR GROUP
LIMITED ORDINARY SHAREHOLDERS

$

902,175 $

(162,354) $

311,458

See accompanying notes to the Condensed Financial Information of Registrant

Statements of Comprehensive Income - Parent Company Only
For the Years Ended December 31, 2019, 2018 and 2017 

2019

2018
(in thousands of U.S. dollars)

2017

NET EARNINGS

OTHER COMPREHENSIVE INCOME (LOSS) RELATING TO
SUBSIDIARIES, NET OF TAX

COMPREHENSIVE INCOME

$

$

938,089 $

(150,221) $

311,458

(3,269)
934,820 $

(27)

34,016

(150,248) $

345,474

See accompanying notes to the Condensed Financial Information of Registrant

269

 
Table of Contents

ENSTAR GROUP LIMITED

CONDENSED FINANCIAL INFORMATION OF REGISTRANT - CONTINUED

Statements of Cash Flows - Parent Company Only
For the Years Ended December 31, 2019, 2018 and 2017 

SCHEDULE II

2019

2018
(in thousands of U.S. dollars)

2017

OPERATING ACTIVITIES:

Net cash flows provided by (used in) operating activities

$

(128,462) $

(128,382) $

97,898

INVESTING ACTIVITIES:

Dividends and return of capital from subsidiaries

Contributions to subsidiaries

Net cash flows used in investing activities

FINANCING ACTIVITIES:

Net proceeds from the issuance of preferred shares

Dividends on preferred shares

Repayment of loans

Receipt of loans

Net cash flows provided by financing activities

NET INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR

65,500
(240,382)
(174,882)

—
(35,914)
(219,000)
547,613

292,699

(10,645)
15,213

101,000
(660,339)
(559,339)

495,357
(12,133)
(898,633)
1,115,885

700,476

12,755

2,458

CASH AND CASH EQUIVALENTS, END OF YEAR

$

4,568 $

15,213 $

See accompanying notes to the Condensed Financial Information of Registrant

Notes to the Condensed Financial Information of Registrant 

217,450
(465,650)
(248,200)

—

—
(696,640)
844,516

147,876

(2,426)
4,884

2,458

The Condensed Financial Information of Registrant should be read in conjunction with our consolidated financial
statements and the accompanying notes thereto included in Part II - Item 8 of this Annual Report on Form 10-K. Our
wholly owned and majority owned subsidiaries are recorded based upon our proportionate share of our subsidiaries'
net assets (similar to presenting them on the equity method). 

Investing activities in the Condensed Statements of Cash Flows primarily represents the flow of funds to and
from subsidiaries to provide cash on hand to fund acquisitions and significant new business. Net investment income
relates to interest on loans to subsidiaries. For the years ended December 31, 2019, 2018, and 2017, interest paid
was $46.5 million, $25.1 million, and $17.6 million, respectively. During the years ended December 31, 2019, 2018,
and 2017, non-cash investing activities included $nil, $nil and $31.6 million, respectively, for dividends and return of
capital from subsidiaries and $nil, $414.8 million and $148.1 million, respectively, for contributions to subsidiaries. In
2018, these transactions represented the contribution of the acquired outstanding shares and warrants of KaylaRe
Holdings,  Ltd  to  another  subsidiary  company.  In  2017,  these  transactions  were  to  settle  intercompany  balances,
resulting in a net reduction in balances due from subsidiaries and an increase in investments in subsidiaries.

As  of  December 31,  2019,  parental  guarantees  and  capital  support  instruments  supporting  subsidiaries'
insurance  obligations  were  $1,031.5  million.  In  addition,  as  of  December 31,  2019  there  were  $252.0  million  of
unsecured letters of credit for Funds at Lloyd's which have a parental guarantee.

As of December 31, 2019 and 2018, retained earnings were $2,887.9 million and $1,976.5 million, respectively,

an increase of $911.4 million. This increase was primarily attributable to the net earnings of $902.2 million.

270

Table of Contents

ENSTAR GROUP LIMITED

SUPPLEMENTARY INSURANCE INFORMATION
(Expressed in thousands of U.S. Dollars)

SCHEDULE III

As of December 31,

Year ended December 31,

Deferred
Acquisition
Costs

Reserves
for Losses
and Loss
Adjustment
Expenses

Policy
Benefits for
Life and
Annuity
Contracts

Unearned
Premiums

Net
Premiums
Earned

Net
Investment
Income

Losses
and Loss
Expenses
and
Policy
Benefits

Amortization
of Deferred
Acquisition
Costs

Other
Operating
Expenses

Net
Premiums
Written

2019

Non-life run-off

$

41,753

$

8,295,361

$

129,715

$

— $

168,496

$

275,236

$

51,625

$

73,642

$

270,445

$

(25,338)

Atrium

StarStone

Other

Total

2018

Non-life run-off

Atrium

StarStone

Other

Total

2017

Non-life run-off

Atrium

StarStone

Other

Total

$

$

$

$

22,184

89,180

388

231,672

1,879,128

23,077

153,505

$ 10,429,238

4,378

$

7,540,662

241,284

1,608,697

18,861

9,409,504

5,949,472

240,873

$

$

20,355

96,004

364

121,101

655

18,385

45,944

—

80,863

518,199

17,998

746,775

136,023

70,429

619,164

17,002

842,618

14,275

64,877

$

$

$

$

$

$

$

$

—

—

—

164,059

801,926

20,380

— $

1,154,861

— $

—

—

105,080

9,427

146,315

714,959

24,874

105,080

$

895,575

— $

—

—

14,162

134,747

459,403

4,809

$

$

$

$

7,049

47,401

(8,410)

321,276

226,287

5,686

35,973

2,725

270,671

166,678

4,218

27,706

10,187

$

$

$

$

77,276

727,636

16,129

56,956

174,711

642

872,666

$

305,951

(306,067) $

69,810

673,383

17,902

4,006

50,646

135,452

2,686

455,028

$

192,790

(190,674) $

69,419

314,806

4,015

328

47,688

48,012

878

$

$

$

$

28,277

128,419

45,945

473,086

197,824

24,698

156,726

28,127

407,375

233,827

29,586

135,558

37,014

$

$

$

$

172,356

735,429

18,512

900,959

(9,217)

153,488

805,562

32,067

981,900

6,482

134,214

464,901

4,793

1,207,743

504,045

—

—

117,207

$

64,984

$

7,398,088

$

583,197

$

117,207

$

613,121

$

208,789

$

197,566

$

96,906

$

435,985

$

610,390

271

 
Table of Contents

2019

Life insurance in force

Premiums earned:

Property and casualty

Life and annuities

ENSTAR GROUP LIMITED

REINSURANCE
For the Years Ended December 31, 2019, 2018 and 2017 
(Expressed in thousands of U.S. Dollars)

SCHEDULE IV

Ceded to
Other
Companies

Gross

Assumed
from
Other

Companies Net Amount

Percentage
of Amount
Assumed
to Net

$

725,293 $

(65,795) $

— $

659,498

—%

Total premiums earned

$ 1,148,251 $

(267,197) $

1,146,956

1,295

(267,174)
(23)

273,807

1,153,589

—

1,272
273,807 $ 1,154,861

23.7%
—%

2018

Life insurance in force

Premiums earned:

Property and casualty

Life and annuities

Total premiums earned

2017

Life insurance in force

Premiums earned:

Property and casualty

Life and annuities

Total premiums earned

$

855,366 $

(84,603) $

— $

770,763

—%

985,637

3,892
989,529 $

(330,110)
(26)

236,182

—

891,709

3,866

(330,136) $

236,182 $

895,575

26.5%
—%

979,291 $

(100,189) $

— $

879,102

—%

899,226

5,900
905,126 $

(433,075)
(1,091)
(434,166) $

142,161

—

608,312

4,809

142,161 $

613,121

23.4%
—%

$

$

$

272

 
Table of Contents

ENSTAR GROUP LIMITED

VALUATION AND QUALIFYING ACCOUNTS
For the Years Ended December 31, 2019, 2018 and 2017 
(Expressed in thousands of U.S. Dollars)

SCHEDULE V

Balance at
Beginning
of Year

Charged to
costs and
expenses

Charged to
other 
accounts 

Deductions (1)

Balance at
End of Year

December 31, 2019

Reinsurance balances recoverable
on paid and unpaid losses:

Provisions for bad debt

156,732

—

Valuation allowance for deferred tax
assets

212,113

2,792

111

—

(9,204)

147,639

(97,515)

117,390

December 31, 2018

Reinsurance balances recoverable
on paid and unpaid losses:

Provisions for bad debt

165,213

—

(1,837)

(6,644)

156,732

Valuation allowance for deferred tax
assets

December 31, 2017

Reinsurance balances recoverable
on paid and unpaid losses:

188,300

(2,492)

18,000

8,305

212,113

Provisions for bad debt

174,516

(1,536)

(4,191)

(3,576)

165,213

Valuation allowance for deferred tax
assets

(1) Credited to the related asset account.

290,861

(16,694)

—

(85,867)

188,300

273

 
Table of Contents

SCHEDULE VI

ENSTAR GROUP LIMITED

SUPPLEMENTARY INFORMATION CONCERNING PROPERTY/CASUALTY INSURANCE OPERATIONS
As of and for the years ended December 31, 2019, 2018 and 2017 
(Expressed in thousands of U.S. Dollars)

As of December 31,

Reserves for
Unpaid
Losses and
Loss
Adjustment
Expenses

Deferred
Acquisition
Costs

Year ended December 31,

Unearned
Premiums

Net
Premiums
Earned

Net
Investment
Income

Current Year

Prior Year

Net Losses and Loss
Expenses Incurred

Net Paid
Losses and
Loss
Expenses

Amortization
of Deferred
Acquisition
Costs

Net
Premiums
Written

$

153,505

$ 10,429,238

$

746,775

$ 1,153,589

$

320,780

$

823,658

$

48,917

$

(1,869,268) $

305,774

$

121,101

64,984

9,409,504

7,398,088

842,618

583,197

891,708

608,312

269,093

198,602

689,782

437,853

(235,757)

(244,302)

(1,384,545)

(945,194)

192,790

96,028

899,687

978,037

605,597

 Affiliation with Registrant

Consolidated Subsidiaries

2019

2018

2017

274

 
Table of Contents

ITEM 9.      CHANGES  IN AND  DISAGREEMENTS  WITH ACCOUNTANTS  ON ACCOUNTING AND  FINANCIAL
DISCLOSURE

Not applicable.

ITEM 9A.   CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of management, including our Chief Executive Officer and our
Chief Financial Officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) of the Exchange Act) as of December 31, 2019. Based on that evaluation, our Chief Executive
Officer and our Chief Financial Officer have concluded that we maintained effective disclosure controls and procedures
to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under
the Exchange Act is recorded, processed, summarized and timely reported as specified in the SEC's rules and forms,
and is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial
Officer, as appropriate, to allow timely decisions regarding required disclosure.

Management’s Annual Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting
(as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act). Our internal control over financial reporting is a
process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with U.S. GAAP. 

Management does not expect that its internal control over financial reporting will prevent all error and fraud. A
control system, no matter how well conceived and operated, has inherent limitations, and accordingly no evaluation
of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.
As a result, even those internal control systems determined to be effective can provide only reasonable assurance
with respect to financial reporting and the preparation of financial statements.

Under the supervision and with the participation of management, including our Chief Executive Officer and our
Chief Financial Officer, we evaluated the effectiveness of our internal control over financial reporting as of December 31,
2019, based on the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in
Internal Control - Integrated Framework (2013). Based on that evaluation, we have concluded that we maintained
effective internal control over financial reporting as of December 31, 2019.

Management excluded Morse TEC, acquired on October 30, 2019, from its evaluation of internal controls over
financial reporting as permitted under Securities and Exchange Commission guidance. The results of Morse TEC since
the acquisition date are included in our consolidated financial statements. Morse TEC constituted approximately 3.5%,
0.0% and 0.0% of total assets, net assets and total income, respectively, as of and for the year ended, December 31,
2019. See Note 3 - "Acquisitions" in the notes to our consolidated financial statements included in Item 8 of this Annual
Report on Form 10-K for a discussion of this acquisition. We are in the process of incorporating our controls and
procedures into this acquisition.

KPMG Audit Limited, the independent registered public accounting firm who audited our consolidated financial
statements included in this Form 10-K, audited our internal control over financial reporting as of December 31, 2019
and their attestation report on our internal control over financial reporting appears below. 

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three months
ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control
over financial reporting. 

275

Table of Contents

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors
Enstar Group Limited:

Opinion on Internal Control Over Financial Reporting 

We  have  audited  Enstar  Group  Limited  and  subsidiaries’  (the  Company)  internal  control  over  financial  reporting  as  of
December 31,  2019,  based  on  the  criteria  established  in  Internal  Control  -  Integrated  Framework  (2013)  issued  by  the
Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material
respects, effective internal control over financial reporting as of December 31, 2019, based on the criteria established in
Internal  Control  -  Integrated  Framework  (2013)  issued  by  the  Committee  of  Sponsoring  Organizations  of  the Treadway
Commission.  

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)
(PCAOB), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated
statements of earnings, comprehensive income, changes in shareholders’ equity, and cash flows for each of the years in the
three-year period ended December 31, 2019,and the related notes and financial statement schedules I to VI (collectively,
the consolidated financial statements), and our report dated February 27, 2020 expressed an unqualified opinion on those
consolidated financial statements.

The Company acquired Morse TEC on October 30, 2019, and management excluded from its assessment of the effectiveness
of the Company’s internal control over financial reporting as of December 31, 2019, Morse TEC’s internal control over financial
reporting associated with total assets, net assets and total income acquired of 3.5%, 0.0% and 0.0% of total assets, net
assets and total income, respectively, as of December 31, 2019. Our audit of internal control over financial reporting of the
Company also excluded an evaluation of the internal control over financial reporting of Morse TEC.

Basis for Opinion 

The  Company’s  management  is  responsible  for  maintaining  effective  internal  control  over  financial  reporting  and  for  its
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Form 10-K as
“Management’s Annual Report on Internal Control Over Financial Reporting” under Item 9A, “Controls and Procedures”. Our
responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are
a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in
all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal
control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design
and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other
procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for
our opinion.

Definition and Limitations of Internal Control Over Financial Reporting 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts
and expenditures of the company are being made only in accordance with authorizations of management and directors of
the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition,
use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also,
projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG Audit Limited

KPMG Audit Limited

Hamilton, Bermuda
February 27, 2020

276

Table of Contents

ITEM 9B.   OTHER INFORMATION

Not applicable. 

PART II (CONTINUED)

PART III

ITEM 10.   DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

All information required by Items 10, 11, 12, 13 and 14 of this Annual Report on Form 10-K is incorporated by
reference from the definitive proxy statement for our 2020 Annual General Meeting of Shareholders that will be filed
with the SEC not later than 120 days after the close of the fiscal year ended December 31, 2019 pursuant to Regulation
14A.

ITEM 11.   EXECUTIVE COMPENSATION

See Item 10 herein.

ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDER MATTERS

See Item 10 herein.

ITEM 13.   CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

See Item 10 herein. 

ITEM 14.   PRINCIPAL ACCOUNTING FEES AND SERVICES

See Item 10 herein.

 ITEM 15.   EXHIBITS, FINANCIAL STATEMENT SCHEDULES

PART IV

(a) Financial Statements and Financial Statement Schedules: see Item 8 in Part II of this report. 

(b) Exhibits: see accompanying exhibit index that precedes the signature page of this report.

 ITEM 16.   FORM 10-K SUMMARY

Omitted at Company's option. 

277

Table of Contents

Exhibit Index

Exhibit

No.

2.1s

2.2

2.3

2.4

2.5s

3.1

3.2

3.3

3.4

3.5

3.6

4.1

4.2

4.3

4.4

4.5

4.6

Description
Stock Purchase Agreement, dated February 17, 2017, by and between Southland National Holdings, Inc.
and Laguna Life Holdings SARL (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K
filed on February 21, 2017).

Amendment No. 1 to Stock Purchase Agreement, dated June 1, 2017, by and between Southland National
Holdings, Inc. and Laguna Life Holdings SARL (incorporated by reference to Exhibit 2.1 to the Company’s
Form 10-Q filed on November 8, 2017).

Amendment No. 2 to Stock Purchase Agreement, dated July 31, 2017, by and between Southland National
Holdings, Inc. and Laguna Life Holdings SARL (incorporated by reference to Exhibit 2.2 to the Company’s
Form 10-Q filed on November 8, 2017).

Amendment No. 3 to Stock Purchase Agreement, dated December 15, 2017, by and between Southland
National Holdings, Inc. and Laguna Life Holdings SARL (incorporated by reference to Exhibit 2.14 to the
Company’s Form 10-K filed on February 28, 2018).

Master Transaction Agreement, dated as of August 31, 2018, by and among Enstar Group Limited, Enstar
Holdings (US) LLC and Maiden Holdings North America, Ltd. (incorporated by reference to Exhibit 2.1 to
the Company’s Form 8-K filed on September 4, 2018).

Memorandum of Association of Enstar Group Limited (incorporated by reference to Exhibit 3.1 to the
Company’s Form 10-K/A filed on May 2, 2011).

Fifth Amended and Restated Bye-Laws of Enstar Group Limited (incorporated by reference to Exhibit 3.1
of the Company’s Form 8-K filed on June 13, 2019).

Certificate of Designations for the Series B Convertible Participating Non-Voting Perpetual Preferred Stock
(incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on July 9, 2013).

Certificate of Designations of Series C Participating Non-Voting Perpetual Preferred Stock of Enstar Group
Limited, dated as of June 13, 2016 (incorporated by reference to Exhibit 3.1 to the Company's Form 8-K
filed on June 17, 2016).

Certificate  of  Designations  of  Series  D  Perpetual  Non-Cumulative  Preferred  Shares  of  Enstar  Group
Limited, dated as of June 27, 2018 (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K
filed on June 27, 2018).

Certificate  of  Designations  of  Series  E  Perpetual  Non-Cumulative  Preferred  Shares  of  Enstar  Group
Limited, dated as of November 21, 2018 (incorporated by reference to Exhibit 4.1 to the Company’s Form
8-K filed on November 21, 2018).

Senior Indenture, dated as of March 10, 2017, between Enstar Group Limited and The Bank of New York
Mellon, as trustee (incorporated by reference to Exhibit 4.1 to the Company's Form 8-K filed on March
10, 2017).

First Supplemental Indenture, dated as of March 10, 2017, between Enstar Group Limited and The Bank
of New York Mellon, as trustee (incorporated by reference to Exhibit 4.2 to the Company's Form 8-K filed
on March 10, 2017).

Second Supplemental Indenture, dated as of March 26, 2019, between Enstar Group Limited and The
Bank of New York Mellon, as trustee (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-
K filed on March 26, 2019).

Third Supplemental Indenture, dated as of May 28, 2019, between Enstar Group Limited and The Bank
of New York Mellon, as trustee (incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K filed
on May 28, 2019).

Deposit Agreement,  dated  as  of  June  27,  2018,  between  Enstar  Group  Limited  and American  Stock
Transfer (incorporated by reference to Exhibit 4.3 to the Company’s Form 8-K filed on June 27, 2018).

Deposit Agreement, dated as of November 21, 2018, between Enstar Group Limited and American Stock
Transfer (incorporated by reference to Exhibit 4.3 to the Company’s Form 8-K filed on November 21,
2018).

4.7*

Description of Securities.

278

Table of Contents

10.1

10.2

10.3

10.4

10.5

10.6

10.7+

10.8+

10.9+

10.10+

10.11+

10.12+

Form of Warrant (incorporated by reference to Exhibit 99.2 to the Company’s Form 8-K filed on April 21,
2011).

Registration Rights Agreement, dated as of January 31, 2007, by and among Castlewood Holdings Limited,
Trident II, L.P., Marsh & McLennan Capital Professionals Fund, L.P., Marsh & McLennan Employees’
Securities Company, L.P., Dominic F. Silvester, J. Christopher Flowers, and other parties thereto set forth
on  the  Schedule  of  Shareholders  attached  thereto  (incorporated  by  reference  to  Exhibit  10.1  of  the
Company’s Form 8-K12B filed on January 31, 2007).

Registration Rights Agreement, dated as of April 20, 2011, by and among Enstar Group Limited, GSCP
VI AIV Navi, Ltd., GSCP VI Offshore Navi, Ltd., GSCP VI Parallel AIV Navi, Ltd., GSCP VI Employee Navi,
Ltd., and GSCP VI GmbH Navi, L.P. (incorporated by reference to Exhibit 99.3 to the Company’s Form 8-
K filed on April 21, 2011).

Registration Rights Agreement, dated April 1, 2014, among Enstar Group Limited, FR XI Offshore AIV,
L.P., First Reserve Fund XII, L.P., FR XII A Parallel Vehicle L.P., FR Torus Co-Investment, L.P. and Corsair
Specialty Investors, L.P. (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on
April 4, 2014).

Form of Waiver Agreement (incorporated herein by reference to Exhibit 4.7 to the Company's Form S-3
filed on October 10, 2017).

Shareholder Rights Agreement, dated June 3, 2015, between Enstar Group Limited and Canada Pension
Plan Investment Board (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on
June 3, 2015.

Form of Director Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company’s
Form S-3 (No. 333-151461) initially filed on June 5, 2008).

Amended and Restated Employment Agreement, dated as of January 21, 2020, by and between Enstar
Group Limited and Dominic F. Silvester (incorporated by reference to Exhibit 10.2 to the Company’s Form
8-K filed on January 27, 2020).

Amended and Restated Employment Agreement, dated as of January 21, 2020, by and between Enstar
Group Limited and Paul J. O’Shea (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-
K filed on January 27, 2020).

Amended and Restated Employment Agreement, dated January 21, 2020, by and between Enstar Group
Limited and Orla M. Gregory (incorporated by reference to Exhibit 10.4 to the Company’s Form 8-K filed
on January 27, 2020).

Employment Agreement, dated December 28, 2017, by and between Enstar Group Limited and Guy T.A.
Bowker (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on January 4, 2018).

Employment Agreement, dated January 8, 2018, by and between Enstar Group Limited and Paul M.J.
Brockman(incorporated by reference to Exhibit 10.1 to the Company’s Form 10-Q filed on May 8, 2019).

10.13*+

Employment Agreement, dated September 9, 2016, by and between Enstar Group Limited and Nazar
Alobaidat.

10.14+

10.15+

10.16+

10.17+

10.18+

10.19+

Enstar  Group  Limited  Deferred  Compensation  and  Ordinary  Share  Plan  for  Non-Employee  Directors,
effective as of June 5, 2007 (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed
on June 11, 2007).

Amended and Restated Enstar Group Limited Deferred Compensation and Ordinary Share Plan for Non-
Employee Directors, effective as of January 1, 2015 (incorporated by reference to Exhibit 10.13 to the
Company’s Form 10-K filed on March 2, 2015).

Form of Non-Employee Director Restricted Stock Award Agreement (incorporated by reference to
Exhibit 10.32 to the Company’s Form 10-K filed on March 2, 2015).

Castlewood Holdings Limited 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.11 to
the proxy statement/prospectus that forms a part of the Company’s Form S-4 declared effective December
15, 2006).

First Amendment to Castlewood Holdings Limited 2006 Equity Incentive Plan (incorporated by reference
to Exhibit 10.2 to the Company’s Form 8-K filed on April 6, 2007).

Form  of  Award  Agreement  under  the  Castlewood  Holdings  Limited  2006  Equity  Incentive  Plan
(incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on April 6, 2007).

279

Table of Contents

10.20+

10.21+

10.22+

10.23+

10.24+

10.25+

10.26+

10.27+

10.28+

Form  of  Stock  Appreciation  Right  Award  Agreement  pursuant  to  the  2006  Equity  Incentive  Plan
(incorporated by reference to Exhibit 10.5 to the Company’s Form 10-Q filed on August 11, 2014).

Form of Restricted Stock Award Agreement pursuant to the 2006 Equity Incentive Plan (incorporated by
reference to Exhibit 10.6 to the Company’s Form 10-Q filed on August 11, 2014).

Enstar Group Limited Amended and Restated 2016 Equity Incentive Plan (incorporated by reference to
Exhibit 10.1 to the Company’s Form 8-K filed on December 2, 2019).

Form of Restricted Stock Award Agreement under the Enstar Group Limited 2016 Equity Incentive Plan
(incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q filed on August 5, 2016).

Form of Stock Appreciation Right Award Agreement under the Enstar Group Limited 2016 Equity Incentive
Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q filed on August 5, 2016).

Form of Restricted Stock Unit Award Agreement under the Enstar Group Limited 2016 Equity Incentive
Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 10-Q filed on November 8, 2016).

Form of Performance Stock Unit Award Agreement under the Enstar Group Limited 2016 Equity Incentive
Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 10-Q filed on November 8, 2016).

Form of Performance Stock Unit Award Agreement (2018) under the Enstar Group Limited 2016 Equity
Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q filed on November
8, 2017).

Form of Performance Stock Unit Award Agreement (3-Year Cycle) (2020) under the Enstar Group Limited
2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the Company’s Form 8-K filed
on January 27, 2020).

10.29*+

Form of Performance Stock Unit Award Agreement (Annual Cycle) (2020) under the Enstar Group Limited
2016 Equity Incentive Plan.

10.30*+

Form  of  Restricted  Stock  Unit Award Agreement  (2020)  under  the  Enstar  Group  Limited  2016  Equity
Incentive Plan.

10.31+

10.32+

10.33+

10.34

10.35

10.36

10.37

10.38

10.39

Joint  Share  Ownership  Agreement,  dated  January  21,  2020,  by  and  among  Enstar  Group  Limited,
Dominic F. Silvester and Zedra Trust Company, as trustee (incorporated by reference to Exhibit 10.1 to
the Company’s Form 8-K filed on January 27, 2020).

Enstar Group Limited Amended and Restated Employee Share Purchase Plan (incorporated by reference
to Exhibit 10.4 to the Company’s Form 10-Q filed on November 8, 2016).

Amended  and  Restated  Enstar  Group  Limited  2019-2021 Annual  Incentive  Program  (incorporated  by
reference to Exhibit 10.30 to the Company’s Form 10-K filed on March 1, 2019).

Amended  and  Restated  Bayshore  Shareholders’  Agreement,  dated  May 8,  2014,  among  Bayshore
Holdings  Limited,  Kenmare  Holdings  Ltd.,  Trident  V,  L.P.,  Trident  V  Parallel  Fund,  L.P.,  Trident  V
Professionals Fund, L.P., and Dowling Capital Partners I, L.P. (incorporated by reference to Exhibit 10.3
of the Company’s Form 10-Q filed on August 11, 2014).

Voting and Shareholders’ Agreement, dated as of December 23, 2015, among North Bay Holdings Limited,
Kenmare Holdings Ltd., Trident V, L.P., Trident V Parallel Fund, L.P., Trident V Professionals Fund, L.P.,
Dowling  Capital  Partners  I,  L.P.,  Atrium  Nominees  Limited,  Bayshore  Holdings  Limited,  Northshore
Holdings Limited and Enstar Group Limited (incorporated by reference to Exhibit 10.1 of the Company’s
Form 8-K filed on December 30, 2015).

Second Amended and Restated Northshore Shareholders’ Agreement, dated as of December 23, 2015,
among  Northshore  Holdings  Limited,  North  Bay  Holdings  Limited  and  Atrium  Nominees  Limited
(incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K filed on December 30, 2015).

Exchange Agreement,  dated  as  of  February  2,  2018,  by  and  among  Enstar  Group  Limited,  KaylaRe
Holdings, Ltd., HH KaylaRe Holdings, Ltd., Hillhouse Fund III, L.P., Trident V, L.P., Trident V Parallel Fund,
L.P,  Trident  V  Professionals  Fund,  L.P.,  Souris  Partners  and  Cavello  Bay  Reinsurance  Limited
(incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on February 8, 2018).

Master Agreement, dated March 1, 2019, by and among Enstar Group Limited, Maiden Holdings, Ltd. and
Maiden Reinsurance Ltd. (incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q filed on
May 8, 2019).

Amendment to Master Agreement, dated June 28, 2019, by and among Enstar Group Limited, Maiden
Holdings, Ltd. and Maiden Reinsurance Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s
Form 10-Q filed on August 6, 2019).

280

Table of Contents

10.40

10.41

10.42

10.43

10.44

10.45

21.1*

23.1*

31.1*

31.2*

32.1**

32.2**

101*

104*

Subscription Agreement,  dated  as  of  December  11,  2018,  by  and  between  Cavello  Bay  Reinsurance
Limited and Enhanzed Reinsurance Limited (incorporated by reference to Exhibit 10.36 to the Company’s
Form 10-K filed on March 1, 2019).

Revolving Credit Agreement, dated as of August 16, 2018, by and among Enstar Group Limited and certain
of its subsidiaries, National Australia Bank Limited, Barclays Bank PLC, Wells Fargo Securities, LLC Wells
Fargo Bank, National Association and each of the lenders party thereto (incorporated by reference to
Exhibit 10.1 of the Company’s Form 8-K filed on August 21, 2018).

First Amendment to Revolving Credit Agreement, dated as of December 19, 2018, by and among Enstar
Group Limited and certain of its subsidiaries, National Australia Bank Limited, Barclays Bank PLC, Wells
Fargo  Securities,  LLC  Wells  Fargo  Bank,  National Association  and  each  of  the  lenders  party  thereto
(incorporated by reference to Exhibit 10.38 to the Company’s Form 10-K filed on March 1, 2019).

Term Loan Credit Agreement, dated as of December 27, 2018, by and among Enstar Group Limited and
certain of its subsidiaries, Wells Fargo Bank, National Association and each of the lenders party thereto
(incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K filed on January 2, 2019).

Letter of Credit Facility Agreement, dated as of August 5, 2019, by and among Enstar Group Limited and
certain of its subsidiaries, National Australia Bank Limited, London Branch, The Bank of Nova Scotia and
each of the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K
filed on August 7, 2019).

First Amendment to Letter of Credit Facility Agreement, dated as of December 9, 2019, by and among
Enstar Group Limited and certain of its subsidiaries, National Australia Bank Limited, London Branch, The
Bank of Nova Scotia and each of the lenders party thereto (incorporated by reference to Exhibit 10.1 to
the Company’s Form 8-K filed on December 11, 2019).

List of Subsidiaries.

Consent of KPMG Audit Limited.

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities
Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002.

Certification  of  Chief  Financial  Officer  pursuant  to  Rule  13a-14(a)  or  Rule  15d-14(a)  of  the  Securities
Exchange Act of 1934 as adopted under Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002.

Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part II,
Item 8 of this Annual Report on Form 10-K.

The cover page from the Company’s Annual Report on Form 10-K for the year ended December 31, 2019,
formatted as Inline XBRL (included in Exhibit 101).

_______________________________

*  filed herewith
** furnished herewith
+ denotes management contract or compensatory arrangement
s certain of the schedules and similar attachments are not filed but Enstar Group Limited undertakes to furnish

a copy of the schedules or similar attachments to the SEC upon request

281

Table of Contents

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on February 27, 2020.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the

following persons on behalf of the registrant and in the capacities indicated on February 27, 2020.

ENSTAR GROUP LIMITED

By:

/S/ DOMINIC F. SILVESTER
Dominic F. Silvester
Chief Executive Officer

Signature

/s/    ROBERT J. CAMPBELL
Robert J. Campbell

/s/    DOMINIC F. SILVESTER
Dominic F. Silvester

/s/    GUY BOWKER
Guy Bowker

/s/    PAUL J. O’SHEA
Paul J. O’Shea

/s/    B. FREDERICK BECKER
B. Frederick Becker

/s/    SANDRA L. BOSS
Sandra L. Boss

/s/    JAMES D. CAREY
James D. Carey

/s/    HANS-PETER GERHARDT
Hans-Peter Gerhardt

/s/    MYRON HENDRY
Myron Hendry

/s/    JIE LIU
Jie Liu

/s/    HITESH PATEL
Hitesh Patel

/s/    POUL A. WINSLOW
Poul A. Winslow

Title

Chairman and Director

Chief Executive Officer and Director

Chief Financial Officer (signing in his capacity as
principal financial officer and principal accounting officer)

President and Director

Director

Director

Director

Director

Director

Director

Director

Director

282

DIRECTORS

Robert Campbell 
Chairman of the Board 
Enstar Group Limited 

Partner 
Beck Mack & Oliver, LLC 

Dominic Silvester
Chief Executive Officer
Enstar Group Limited

B. Frederick (Rick) Becker
Non-Executive Director

James Carey
Senior Principal
Stone Point Capital LLC 

Hans-Peter Gerhardt
Chief Executive Officer (former)
AXA Re, PARIS Re and Asia Capital Reinsurance

W. Myron Hendry
Executive VP, Chief Platform Officer (former)
XL Catlin

Jie Liu
Partner
Hillhouse Capital

Paul O’Shea
President
Enstar Group Limited 

Hitesh Patel
Non-Executive Director 

Poul Winslow
Senior Managing Director & Global Head of  
Capital Markets and Factor Investing
Canada Pension Plan Investment Board

EXECUTIVE OFFICERS

Dominic Silvester 
Chief Executive Officer 

Paul O’Shea 
President 

Orla Gregory 
Chief Operating Officer

Guy Bowker 
Chief Financial Officer

TRANSFER AGENT

American Stock Transfer & Trust Company   
6201, 15th Avenue,  
Brooklyn, NY 11219   
(800) 937-5449

ENSTAR GROUP LIMITED

Head Office
P.O. Box HM 2267,   
Windsor Place,  
3rd Floor , 22 Queen Street,  
Hamilton  HM JX,  
Bermuda

www.enstargroup.com